JAMA 1999

Document Sample
JAMA 1999 Powered By Docstoc
					Volume         Issue       Year8      Month9   Day10       ISOAbbreviation
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
         281           1       1999   Jan              6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan   6   JAMA
281   1   1999   Jan    6   JAMA
281   1   1999   Jan    6   JAMA
281   1   1999   Jan    6   JAMA
281   1   1999   Jan    6   JAMA
281   1   1999   Jan    6   JAMA
281   1   1999   Jan    6   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   2   1999   Jan   13   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   3   1999   Jan   20   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   4   1999   Jan   27   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb   3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   5   1999   Feb    3   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   6   1999   Feb   10   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   7   1999   Feb   17   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   8   1999   Feb   24   JAMA
281   9   1999   Mar    3   JAMA
281   9   1999   Mar    3   JAMA
281   9   1999   Mar    3   JAMA
281   9   1999   Mar    3   JAMA
281   9   1999   Mar    3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281   9   1999   Mar   3   JAMA
281    9   1999   Mar    3   JAMA
281    9   1999   Mar    3   JAMA
281    9   1999   Mar    3   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   10   1999   Mar   10   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11   1999   Mar   17   JAMA
281   11       1999   Mar           17   JAMA
281   11       1999   Mar           17   JAMA
281   11       1999   Mar           17   JAMA
281   11       1999   Mar           17   JAMA
281   11       1999   Mar           17   JAMA
281   11       1999   Mar           17   JAMA
281   11       1999   Mar           17   JAMA
281   11       1999   Mar           17   JAMA
281   11       1999   Mar           17   JAMA
281   11       1999   Mar           17   JAMA
281   11       1999   Mar           17   JAMA
281   11       1999   Mar           17   JAMA
281   11       1999   Mar           17   JAMA
281   11       1999   Mar           17   JAMA
281   11       1999   Mar           17   JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999       Mar   24-31        JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999   Mar   24-31   JAMA
281   12   1999       Mar   24-31       JAMA
281   12   1999       Mar   24-31       JAMA
281   12   1999       Mar   24-31       JAMA
281   12   1999       Mar   24-31       JAMA
281   12   1999       Mar   24-31       JAMA
281   12   1999       Mar   24-31       JAMA
281   12   1999       Mar   24-31       JAMA
281   12   1999       Mar   24-31       JAMA
281   12   1999       Mar   24-31       JAMA
281   12   1999       Mar   24-31       JAMA
281   12   1999       Mar   24-31       JAMA
281   12   1999       Mar   24-31       JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13       1999   Apr           7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr   7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   13   1999   Apr    7   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   14   1999   Apr   14   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   15   1999   Apr   21   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   16   1999   Apr   28   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May   5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   17   1999   May    5   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   18   1999   May   12   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   19   1999   May   19   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   20   1999   May   26   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun    2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   21   1999   Jun   2   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun   9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   22   1999   Jun    9   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23   1999   Jun   16   JAMA
281   23       1999   Jun           16   JAMA
281   23       1999   Jun           16   JAMA
281   23       1999   Jun           16   JAMA
281   23       1999   Jun           16   JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999       Jun   23-30        JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999   Jun   23-30   JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
281   24   1999       Jun   23-30       JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282    1       1999   Jul           7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul   7   JAMA
282   1   1999   Jul    7   JAMA
282   1   1999   Jul    7   JAMA
282   1   1999   Jul    7   JAMA
282   1   1999   Jul    7   JAMA
282   1   1999   Jul    7   JAMA
282   1   1999   Jul    7   JAMA
282   1   1999   Jul    7   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   2   1999   Jul   14   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   3   1999   Jul   21   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   4   1999   Jul   28   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug   4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   5   1999   Aug    4   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   6   1999   Aug   11   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   7   1999   Aug   18   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   8   1999   Aug   25   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep    1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282   9   1999   Sep   1   JAMA
282    9   1999   Sep   1   JAMA
282    9   1999   Sep   1   JAMA
282    9   1999   Sep   1   JAMA
282    9   1999   Sep   1   JAMA
282    9   1999   Sep   1   JAMA
282    9   1999   Sep   1   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep   8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   10   1999   Sep    8   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11   1999   Sep   15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   11       1999   Sep           15   JAMA
282   12   1999       Sep   22-29        JAMA
282   12   1999       Sep   22-29        JAMA
282   12   1999       Sep   22-29        JAMA
282   12   1999       Sep   22-29        JAMA
282   12   1999       Sep   22-29        JAMA
282   12   1999       Sep   22-29        JAMA
282   12   1999       Sep   22-29        JAMA
282   12   1999       Sep   22-29        JAMA
282   12   1999       Sep   22-29        JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999   Sep   22-29   JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   12   1999       Sep   22-29       JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13       1999   Oct           6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct   6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   13   1999   Oct    6   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   14   1999   Oct   13   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   15   1999   Oct   20   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   16   1999   Oct   27   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov   3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   17   1999   Nov    3   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   18   1999   Nov   10   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   19   1999   Nov   17   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   20   1999   Nov   24   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec    1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   21   1999   Dec   1   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec   8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   22   1999   Dec    8   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23   1999   Dec   15   JAMA
282   23       1999   Dec           15   JAMA
282   23       1999   Dec           15   JAMA
282   23       1999   Dec           15   JAMA
282   23       1999   Dec           15   JAMA
282   23       1999   Dec           15   JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999       Dec   22-29        JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
282   24   1999   Dec   22-29   JAMA
ArticleTitle
The emerging epidemic of atherosclerosis. Call for papers.
The emerging epidemic of atherosclerosis. Call for papers.
Bridging the worlds of medicine and science: an interview with Bert I. Shapiro, MD. Interviewed by Yvonne G. Lin.
Bridging the worlds of medicine and science: an interview with Bert I. Shapiro, MD. Interviewed by Yvonne G. Lin.
Addressing the needs of basic and clinical research: analysis of graduates of the University of Pennsylvania MD-PhD program.
Addressing the needs of basic and clinical research: analysis of graduates of the University of Pennsylvania MD-PhD program.
Addressing the needs of basic and clinical research: analysis of graduates of the University of Pennsylvania MD-PhD program.
The evolving relationship between the physician and the scientist in the 20th century.
The evolving relationship between the physician and the scientist in the 20th century.
The evolving relationship between the physician and the scientist in the 20th century.
Reinventing the physician-scientist in the new era of health care.
Reinventing the physician-scientist in the new era of health care.
Treating depression as a recurrent or chronic disease.
Treating depression as a recurrent or chronic disease.
Treating depression as a recurrent or chronic disease.
The rational clinical examination. Does this patient have abdominal aortic aneurysm? .
The rational clinical examination. Does this patient have abdominal aortic aneurysm? .
The rational clinical examination. Does this patient have abdominal aortic aneurysm? .
The rational clinical examination. Does this patient have abdominal aortic aneurysm? .
The rational clinical examination. Does this patient have abdominal aortic aneurysm? .
Recent advances in the pharmacotherapy of smoking.
Recent advances in the pharmacotherapy of smoking.
Recent advances in the pharmacotherapy of smoking.
Recent advances in the pharmacotherapy of smoking.
Recent advances in the pharmacotherapy of smoking.
Recent advances in the pharmacotherapy of smoking.
Recent advances in the pharmacotherapy of smoking.
Recent advances in the pharmacotherapy of smoking.
Recent advances in the pharmacotherapy of smoking.
Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portu
Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portu
Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portu
Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portu
Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portu
Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portu
Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portu
Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portu
Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portu
Trends in infectious disease mortality in the United States during the 20th century.
Trends in infectious disease mortality in the United States during the 20th century.
Trends in infectious disease mortality in the United States during the 20th century.
Trends in infectious disease mortality in the United States during the 20th century.
Trends in infectious disease mortality in the United States during the 20th century.
Trends in infectious disease mortality in the United States during the 20th century.
Trends in infectious disease mortality in the United States during the 20th century.
The protective effect of moderate alcohol consumption on ischemic stroke.
The protective effect of moderate alcohol consumption on ischemic stroke.
The protective effect of moderate alcohol consumption on ischemic stroke.
The protective effect of moderate alcohol consumption on ischemic stroke.
The protective effect of moderate alcohol consumption on ischemic stroke.
The protective effect of moderate alcohol consumption on ischemic stroke.
The protective effect of moderate alcohol consumption on ischemic stroke.
The protective effect of moderate alcohol consumption on ischemic stroke.
The protective effect of moderate alcohol consumption on ischemic stroke.
The protective effect of moderate alcohol consumption on ischemic stroke.
The protective effect of moderate alcohol consumption on ischemic stroke.
Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized contr
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized contr
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized contr
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized contr
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized contr
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized contr
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized contr
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized contr
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized contr
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized contr
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized contr
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized contr
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized contr
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized contr
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized contr
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized contr
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized contr
Proximal myopathy associated with inhaled steroids.
Proximal myopathy associated with inhaled steroids.
Proximal myopathy associated with inhaled steroids.
Abolishing nuclear weapons.
Abolishing nuclear weapons.
Abolishing nuclear weapons.
Clinical crossroads: a 24-year-old woman with anorexia nervosa.
Clinical crossroads: a 24-year-old woman with anorexia nervosa.
Clinical crossroads: a 24-year-old woman with anorexia nervosa.
Clinical crossroads: a 24-year-old woman with anorexia nervosa.
Clinical crossroads: a 24-year-old woman with anorexia nervosa.
Clinical crossroads: a 24-year-old woman with anorexia nervosa.
Evaluating reporting and abstracts of clinical trials.
Evaluating reporting and abstracts of clinical trials.
Evaluating reporting and abstracts of clinical trials.
Evaluating reporting and abstracts of clinical trials.
Sale of goods from physicians' offices.
Sale of goods from physicians' offices.
Sale of goods from physicians' offices.
Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke.
Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke.
Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke.
Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke.
Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke.
Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke.
Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke.
Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke.
Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke.
Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke.
Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke.
Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke.
Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke.
Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke.
Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke.
Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke.
Reducing treatment delay and improving diagnostic accuracy for patients with acute stroke.
From the Centers for Disease Control and Prevention. State-specific prevalence among adults of current cigarette smoking an
From the Centers for Disease Control and Prevention. Trends in ischemic heart disease death rates for blacks and whites--Uni
From the Food and Drug Administration.
From the Food and Drug Administration.
Ebbing epidemic: youth homicide rate at a 14-year low.
Ebbing epidemic: youth homicide rate at a 14-year low.
Pioneers in providing a competency inventory.
Pioneers in providing a competency inventory.
New paradigms sought to explain occupational and environmental disease.
New paradigms sought to explain occupational and environmental disease.
Public health targets teens' private acts.
Public health targets teens' private acts.
Stress and peptic ulcer disease.
Stress and peptic ulcer disease.
Stress and peptic ulcer disease.
Stress and peptic ulcer disease.
Stress and peptic ulcer disease.
A piece of my mind. Vergil.
A piece of my mind. Vergil.
JAMA patient page: alcohol.
Childhood malnutrition and postwar reconstruction in rural El Salvador: a community-based survey.
Childhood malnutrition and postwar reconstruction in rural El Salvador: a community-based survey.
Childhood malnutrition and postwar reconstruction in rural El Salvador: a community-based survey.
Childhood malnutrition and postwar reconstruction in rural El Salvador: a community-based survey.
Childhood malnutrition and postwar reconstruction in rural El Salvador: a community-based survey.
Childhood malnutrition and postwar reconstruction in rural El Salvador: a community-based survey.
Childhood malnutrition and postwar reconstruction in rural El Salvador: a community-based survey.
Childhood malnutrition and postwar reconstruction in rural El Salvador: a community-based survey.
Empowering patients to monitor and manage oral anticoagulation therapy.
Empowering patients to monitor and manage oral anticoagulation therapy.
Empowering patients to monitor and manage oral anticoagulation therapy.
When should patients with heterozygous familial hypercholesterolemia be treated?
When should patients with heterozygous familial hypercholesterolemia be treated?
When should patients with heterozygous familial hypercholesterolemia be treated?
When should patients with heterozygous familial hypercholesterolemia be treated?
When should patients with heterozygous familial hypercholesterolemia be treated?
Management of ventricular arrhythmias: detection, drugs, and devices.
Management of ventricular arrhythmias: detection, drugs, and devices.
Management of ventricular arrhythmias: detection, drugs, and devices.
Management of ventricular arrhythmias: detection, drugs, and devices.
Management of ventricular arrhythmias: detection, drugs, and devices.
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.
Quality end-of-life care: patients' perspectives.
Quality end-of-life care: patients' perspectives.
Quality end-of-life care: patients' perspectives.
Quality end-of-life care: patients' perspectives.
Quality end-of-life care: patients' perspectives.
Quality end-of-life care: patients' perspectives.
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts.
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts.
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts.
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts.
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts.
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts.
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts.
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts.
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts.
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts.
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts.
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts.
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts.
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts.
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts.
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatr
A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled tria
A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled tria
A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled tria
A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled tria
A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled tria
A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled tria
A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled tria
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlle
Academic and legal aspects of authorship disputes.
Academic and legal aspects of authorship disputes.
Academic and legal aspects of authorship disputes.
Public performance reports for cardiac surgery.
Public performance reports for cardiac surgery.
Public performance reports for cardiac surgery.
Reducing sleepiness on the roads and on the wards.
Reducing sleepiness on the roads and on the wards.
Reducing sleepiness on the roads and on the wards.
Reducing sleepiness on the roads and on the wards.
Reducing sleepiness on the roads and on the wards.
Reducing sleepiness on the roads and on the wards.
Talking with patients about screening for prostate cancer.
Talking with patients about screening for prostate cancer.
Talking with patients about screening for prostate cancer.
Talking with patients about screening for prostate cancer.
Beta-blockers as first-line agents for hypertension in the elderly.
Beta-blockers as first-line agents for hypertension in the elderly.
Beta-blockers as first-line agents for hypertension in the elderly.
Beta-blockers as first-line agents for hypertension in the elderly.
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
From the Centers for Disease Control and Prevention. Impact of closure of a sexually transmitted disease clinic on public heal
From the Centers for Disease Control and Prevention. Update: respiratory syncytial virus activity--United States, 1997-98 seas
From the Centers for Disease Control and Prevention. Outbreak of primary and secondary syphilis--Guilford County, North Ca
From the Centers for Disease Control and Prevention. Hypothermia-related deaths--Georgia, January 1996-December 1997, a
From the Centers for Disease Control and Prevention. Hypothermia-related deaths--Georgia, January 1996-December 1997, a
A thought for your pennies.
A thought for your pennies.
Switch to human insulin worries some diabetics.
Switch to human insulin worries some diabetics.
New method to repair faulty genes stirs interest in chimeraplasty technique.
New method to repair faulty genes stirs interest in chimeraplasty technique.
Chlamydial infections and the risk of ectopic pregnancy.
Chlamydial infections and the risk of ectopic pregnancy.
Advances in the treatment of hypertension.
Advances in the treatment of hypertension.
A piece of my mind. Too sad.
A piece of my mind. Too sad.
JAMA patient page: cholesterol.
Soliciting the patient's agenda: have we improved?
Soliciting the patient's agenda: have we improved?
Soliciting the patient's agenda: have we improved?
Soliciting the patient's agenda: have we improved?
Soliciting the patient's agenda: have we improved?
Soliciting the patient's agenda: have we improved?
Soliciting the patient's agenda: have we improved?
Revaccination of high-risk adults with pneumococcal polysaccharide vaccine.
Revaccination of high-risk adults with pneumococcal polysaccharide vaccine.
Revaccination of high-risk adults with pneumococcal polysaccharide vaccine.
Pharmacotherapy for obesity.
Pharmacotherapy for obesity.
Pharmacotherapy for obesity.
Would you say you "had sex" if...?
Would you say you "had sex" if...?
Would you say you "had sex" if...?
Would you say you "had sex" if...?
Would you say you "had sex" if...?
Would you say you "had sex" if...?
Clinical loyalties and the social purposes of medicine.
Clinical loyalties and the social purposes of medicine.
Clinical loyalties and the social purposes of medicine.
Clinical loyalties and the social purposes of medicine.
Clinical loyalties and the social purposes of medicine.
Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-ana
Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-ana
Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-ana
Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-ana
Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-ana
Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-ana
Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-ana
Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-ana
Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-ana
Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-ana
A program to increase the number of family physicians in rural and underserved areas: impact after 22 years.
A program to increase the number of family physicians in rural and underserved areas: impact after 22 years.
A program to increase the number of family physicians in rural and underserved areas: impact after 22 years.
A program to increase the number of family physicians in rural and underserved areas: impact after 22 years.
A program to increase the number of family physicians in rural and underserved areas: impact after 22 years.
A program to increase the number of family physicians in rural and underserved areas: impact after 22 years.
A program to increase the number of family physicians in rural and underserved areas: impact after 22 years.
Prevalence of lysosomal storage disorders.
Prevalence of lysosomal storage disorders.
Prevalence of lysosomal storage disorders.
Prevalence of lysosomal storage disorders.
Prevalence of lysosomal storage disorders.
Prevalence of lysosomal storage disorders.
Prevalence of lysosomal storage disorders.
Safety of revaccination with pneumococcal polysaccharide vaccine.
Safety of revaccination with pneumococcal polysaccharide vaccine.
Safety of revaccination with pneumococcal polysaccharide vaccine.
Safety of revaccination with pneumococcal polysaccharide vaccine.
Safety of revaccination with pneumococcal polysaccharide vaccine.
Safety of revaccination with pneumococcal polysaccharide vaccine.
Safety of revaccination with pneumococcal polysaccharide vaccine.
Safety of revaccination with pneumococcal polysaccharide vaccine.
Safety of revaccination with pneumococcal polysaccharide vaccine.
Safety of revaccination with pneumococcal polysaccharide vaccine.
Safety of revaccination with pneumococcal polysaccharide vaccine.
Safety of revaccination with pneumococcal polysaccharide vaccine.
Safety of revaccination with pneumococcal polysaccharide vaccine.
Safety of revaccination with pneumococcal polysaccharide vaccine.
Safety of revaccination with pneumococcal polysaccharide vaccine.
Safety of revaccination with pneumococcal polysaccharide vaccine.
Safety of revaccination with pneumococcal polysaccharide vaccine.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Treatment of smokeless tobacco addiction with bupropion and behavior modification.
Treatment of smokeless tobacco addiction with bupropion and behavior modification.
Treatment of smokeless tobacco addiction with bupropion and behavior modification.
Treatment of smokeless tobacco addiction with bupropion and behavior modification.
Hospitalizations for dog bite injuries.
Hospitalizations for dog bite injuries.
Hospitalizations for dog bite injuries.
Hospitalizations for dog bite injuries.
Time to clinical stability for patients with community-acquired pneumonia.
Time to clinical stability for patients with community-acquired pneumonia.
Time to clinical stability for patients with community-acquired pneumonia.
Mental health of women in Afghanistan.
Mental health of women in Afghanistan.
Mental health of women in Afghanistan.
Sunlight exposure and cataract.
Sunlight exposure and cataract.
Sunlight exposure and cataract.
Sunlight exposure and cataract.
Sunlight exposure and cataract.
Sunlight exposure and cataract.
Responding to patient requests for physician-assisted suicide.
Responding to patient requests for physician-assisted suicide.
Responding to patient requests for physician-assisted suicide.
Responding to patient requests for physician-assisted suicide.
Responding to patient requests for physician-assisted suicide.
Responding to patient requests for physician-assisted suicide.
Responding to patient requests for physician-assisted suicide.
Responding to patient requests for physician-assisted suicide.
Responding to patient requests for physician-assisted suicide.
Responding to patient requests for physician-assisted suicide.
Responding to patient requests for physician-assisted suicide.
Responding to patient requests for physician-assisted suicide.
Responding to patient requests for physician-assisted suicide.
From the Centers for Disease Control and Prevention. FDA approval of a fourth acellular pertussis vaccine for use among infan
From the Centers for Disease Control and Prevention. Osteoporosis among estrogen-deficient women--United States, 1988-1
From the Centers for Disease Control and Prevention. Impact of the sequential IPV/OPV schedule on vaccination coverage lev
From the Surgeon General. Polio eradication by the year 2000.
From the Surgeon General. Polio eradication by the year 2000.
Learning lessons from true-life school trauma.
Learning lessons from true-life school trauma.
"New Look" reflects changing style of patient safety enhancement.
"New Look" reflects changing style of patient safety enhancement.
A piece of my mind. Underlying cause.
A piece of my mind. Underlying cause.
JAMA patient page: weight management.
Direct-to-consumer marketing of prescription drugs: creating consumer demand.
Direct-to-consumer marketing of prescription drugs: creating consumer demand.
Direct-to-consumer marketing of prescription drugs: creating consumer demand.
Direct-to-consumer marketing of prescription drugs: creating consumer demand.
Direct-to-consumer prescription drug advertising builds bridges between patients and physicians.
Direct-to-consumer prescription drug advertising builds bridges between patients and physicians.
Understanding Parkinson disease.
Understanding Parkinson disease.
Understanding Parkinson disease.
Understanding Parkinson disease.
Understanding Parkinson disease.
Understanding Parkinson disease.
Benefits of lifestyle activity vs structured exercise.
Benefits of lifestyle activity vs structured exercise.
Benefits of lifestyle activity vs structured exercise.
A 40-year-old woman considering contraception, 1 year later.
A 40-year-old woman considering contraception, 1 year later.
A 40-year-old woman considering contraception, 1 year later.
A 40-year-old woman considering contraception, 1 year later.
A 45-year-old woman with premenstrual dysphoric disorder.
A 45-year-old woman with premenstrual dysphoric disorder.
A 45-year-old woman with premenstrual dysphoric disorder.
A 45-year-old woman with premenstrual dysphoric disorder.
A 45-year-old woman with premenstrual dysphoric disorder.
Access to essential drugs in poor countries: a lost battle?
Access to essential drugs in poor countries: a lost battle?
Access to essential drugs in poor countries: a lost battle?
Access to essential drugs in poor countries: a lost battle?
Access to essential drugs in poor countries: a lost battle?
Access to essential drugs in poor countries: a lost battle?
Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients.
Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients.
Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients.
Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients.
Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients.
Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients.
Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients.
Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients.
Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients.
Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients.
Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing.
Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing.
Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing.
Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing.
Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing.
Parkinson disease in twins: an etiologic study.
Parkinson disease in twins: an etiologic study.
Parkinson disease in twins: an etiologic study.
Parkinson disease in twins: an etiologic study.
Parkinson disease in twins: an etiologic study.
Parkinson disease in twins: an etiologic study.
Parkinson disease in twins: an etiologic study.
Parkinson disease in twins: an etiologic study.
Parkinson disease in twins: an etiologic study.
Parkinson disease in twins: an etiologic study.
Parkinson disease in twins: an etiologic study.
Parkinson disease in twins: an etiologic study.
Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial.
Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial.
Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial.
Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial.
Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial.
Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial.
Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial.
Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial.
Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial.
Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial.
Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial.
Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized
Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized
Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized
Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized
Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized
Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized
Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized
Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized
Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized
Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized
Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized
Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized
Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized
Cancer mortality after nonmelanoma skin cancer.
Cancer mortality after nonmelanoma skin cancer.
Cancer mortality after nonmelanoma skin cancer.
Health and human rights in the medical school curriculum.
Health and human rights in the medical school curriculum.
Health and human rights in the medical school curriculum.
Firearm-related homicides among teenagers and young adults.
Firearm-related homicides among teenagers and young adults.
Firearm-related homicides among teenagers and young adults.
Firearm-related homicides among teenagers and young adults.
Firearm-related homicides among teenagers and young adults.
Firearm-related homicides among teenagers and young adults.
Words in "In a word".
Words in "In a word".
Words in "In a word".
Words in "In a word".
Words in "In a word".
Words in "In a word".
The role of alcohol and social stress in Russia's mortality rate.
The role of alcohol and social stress in Russia's mortality rate.
The role of alcohol and social stress in Russia's mortality rate.
Time for action on drug safety.
Time for action on drug safety.
Time for action on drug safety.
Time for action on drug safety.
Time for action on drug safety.
Time for action on drug safety.
Time for action on drug safety.
Time for action on drug safety.
Time for action on drug safety.
Time for action on drug safety.
Time for action on drug safety.
From the Centers for Disease Control and Prevention. Nosocomial Burkholderia cepacia infection and colonization associated
From the Centers for Disease Control and Prevention. Update: multistate outbreak of listeriosis--United States, 1998-1999.
From the Centers for Disease Control and Prevention. Preemptive state tobacco-control laws--United States, 1982-1998.
From the Centers for Disease Control and Prevention. Transmission of measles among a highly vaccinated school population-
Diet supplement data on the Internet.
Diet supplement data on the Internet.
Advisory board aims to develop pragmatic public health policies.
Advisory board aims to develop pragmatic public health policies.
Ultrasound may markedly improve cancer detection in dense breasts.
Ultrasound may markedly improve cancer detection in dense breasts.
HIV drug resistance testing shows promise.
HIV drug resistance testing shows promise.
New perspectives on glaucoma.
New perspectives on glaucoma.
New perspectives on glaucoma.
New perspectives on glaucoma.
New perspectives on glaucoma.
New perspectives on glaucoma.
New perspectives on glaucoma.
JAMA patient page: exercise.
Rejuvenating the symbols of medicine.
Rejuvenating the symbols of medicine.
The white coat: why not follow suit?
The white coat: why not follow suit?
The white coat: why not follow suit?
Aesculapius: a modern tale.
Aesculapius: a modern tale.
Aesculapius: a modern tale.
Aesculapius: a modern tale.
Serpents, staffs, and the emblems of medicine.
Serpents, staffs, and the emblems of medicine.
Treatment of erectile dysfunction in men with diabetes.
Treatment of erectile dysfunction in men with diabetes.
Treatment of erectile dysfunction in men with diabetes.
Treatment of erectile dysfunction in men with diabetes.
The economist's model of physician behavior.
The economist's model of physician behavior.
The economist's model of physician behavior.
Antibiotics for prevention of myocardial infarction? Not yet!
Antibiotics for prevention of myocardial infarction? Not yet!
Antibiotics for prevention of myocardial infarction? Not yet!
JAMA and editorial independence.
Infectious mononucleosis in middle age.
Infectious mononucleosis in middle age.
Infectious mononucleosis in middle age.
Infectious mononucleosis in middle age.
Avoiding the unintended consequences of growth in medical care: how might more be worse?
Avoiding the unintended consequences of growth in medical care: how might more be worse?
Avoiding the unintended consequences of growth in medical care: how might more be worse?
Avoiding the unintended consequences of growth in medical care: how might more be worse?
Avoiding the unintended consequences of growth in medical care: how might more be worse?
Current and remote blood pressure and cognitive decline.
Current and remote blood pressure and cognitive decline.
Current and remote blood pressure and cognitive decline.
Current and remote blood pressure and cognitive decline.
Current and remote blood pressure and cognitive decline.
Current and remote blood pressure and cognitive decline.
Current and remote blood pressure and cognitive decline.
Current and remote blood pressure and cognitive decline.
Current and remote blood pressure and cognitive decline.
Association of managed care market share and health expenditures for fee-for-service Medicare patients.
Association of managed care market share and health expenditures for fee-for-service Medicare patients.
Association of managed care market share and health expenditures for fee-for-service Medicare patients.
Antibiotics and risk of subsequent first-time acute myocardial infarction.
Antibiotics and risk of subsequent first-time acute myocardial infarction.
Antibiotics and risk of subsequent first-time acute myocardial infarction.
Antibiotics and risk of subsequent first-time acute myocardial infarction.
Antibiotics and risk of subsequent first-time acute myocardial infarction.
Antibiotics and risk of subsequent first-time acute myocardial infarction.
Antibiotics and risk of subsequent first-time acute myocardial infarction.
Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study G
Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study G
Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study G
Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study G
Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study G
Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study G
Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study G
Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study G
Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study G
Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study G
Hemodynamic factors and symptomatic carotid artery occlusion.
Hemodynamic factors and symptomatic carotid artery occlusion.
Hemodynamic factors and symptomatic carotid artery occlusion.
Educating physicians to prevent sex-related contact with patients.
Educating physicians to prevent sex-related contact with patients.
Educating physicians to prevent sex-related contact with patients.
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention
From the Centers for Disease Control and Prevention. False-positive laboratory tests for Cryptosporidium involving an enzym
From the Centers for Disease Control and Prevention. Progress toward eliminating Haemophilus influenzae type b disease am
From the Food and Drug Administration.
From the Food and Drug Administration.
New advocates of adequate treatment say have no fear of pain or of prosecution.
New advocates of adequate treatment say have no fear of pain or of prosecution.
Report offers vision for microbicide development.
Report offers vision for microbicide development.
Renewed efforts to improve the quality of health care.
Renewed efforts to improve the quality of health care.
George D. Lundberg ousted as JAMA editor.
George D. Lundberg ousted as JAMA editor.
A piece of my mind. A vision of health care for the next millennium.
A piece of my mind. A vision of health care for the next millennium.
JAMA patient page: blood pressure.
Euthanasia and Law in the Netherlands, by John Griffiths, et al.
Euthanasia and Law in the Netherlands, by John Griffiths, et al.
Euthanasia and Law in the Netherlands, by John Griffiths, et al.
Prognostic indicators for coronary artery disease: ready for the bedside?
Prognostic indicators for coronary artery disease: ready for the bedside?
Prognostic indicators for coronary artery disease: ready for the bedside?
Prognostic indicators for coronary artery disease: ready for the bedside?
Extended-spectrum beta-lactamases: a plague of plasmids.
Extended-spectrum beta-lactamases: a plague of plasmids.
Extended-spectrum beta-lactamases: a plague of plasmids.
Extended-spectrum beta-lactamases: a plague of plasmids.
The eradication of rubella.
The eradication of rubella.
The eradication of rubella.
The eradication of rubella.
Midlife hand grip strength as a predictor of old age disability.
Midlife hand grip strength as a predictor of old age disability.
Midlife hand grip strength as a predictor of old age disability.
Midlife hand grip strength as a predictor of old age disability.
Midlife hand grip strength as a predictor of old age disability.
Midlife hand grip strength as a predictor of old age disability.
Midlife hand grip strength as a predictor of old age disability.
Midlife hand grip strength as a predictor of old age disability.
Midlife hand grip strength as a predictor of old age disability.
Health literacy: report of the Council on Scientific Affairs. Ad Hoc Committee on Health Literacy for the Council on Scientific A
Health literacy: report of the Council on Scientific Affairs. Ad Hoc Committee on Health Literacy for the Council on Scientific A
Health literacy among Medicare enrollees in a managed care organization.
Health literacy among Medicare enrollees in a managed care organization.
Health literacy among Medicare enrollees in a managed care organization.
Health literacy among Medicare enrollees in a managed care organization.
Health literacy among Medicare enrollees in a managed care organization.
Health literacy among Medicare enrollees in a managed care organization.
Health literacy among Medicare enrollees in a managed care organization.
Health literacy among Medicare enrollees in a managed care organization.
Health literacy among Medicare enrollees in a managed care organization.
Health literacy among Medicare enrollees in a managed care organization.
Health literacy among Medicare enrollees in a managed care organization.
Health literacy among Medicare enrollees in a managed care organization.
Sexual dysfunction in the United States: prevalence and predictors.
Sexual dysfunction in the United States: prevalence and predictors.
Sexual dysfunction in the United States: prevalence and predictors.
Sexual dysfunction in the United States: prevalence and predictors.
Sexual dysfunction in the United States: prevalence and predictors.
Sexual dysfunction in the United States: prevalence and predictors.
Sexual dysfunction in the United States: prevalence and predictors.
Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study.
Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study.
Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study.
Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study.
Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study.
Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study.
Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study.
Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study.
Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study.
Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study.
Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study.
Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study.
Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study.
Impaired chronotropic response to exercise stress testing as a predictor of mortality.
Impaired chronotropic response to exercise stress testing as a predictor of mortality.
Impaired chronotropic response to exercise stress testing as a predictor of mortality.
Impaired chronotropic response to exercise stress testing as a predictor of mortality.
Impaired chronotropic response to exercise stress testing as a predictor of mortality.
Impaired chronotropic response to exercise stress testing as a predictor of mortality.
Impaired chronotropic response to exercise stress testing as a predictor of mortality.
Impaired chronotropic response to exercise stress testing as a predictor of mortality.
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
Screening adolescent females for chlamydia infection.
Screening adolescent females for chlamydia infection.
Screening adolescent females for chlamydia infection.
Screening adolescent females for chlamydia infection.
Screening adolescent females for chlamydia infection.
Screening adolescent females for chlamydia infection.
Further evidence linking late-onset Alzheimer disease with chromosome 12.
Further evidence linking late-onset Alzheimer disease with chromosome 12.
Further evidence linking late-onset Alzheimer disease with chromosome 12.
Further evidence linking late-onset Alzheimer disease with chromosome 12.
Further evidence linking late-onset Alzheimer disease with chromosome 12.
Further evidence linking late-onset Alzheimer disease with chromosome 12.
Further evidence linking late-onset Alzheimer disease with chromosome 12.
Further evidence linking late-onset Alzheimer disease with chromosome 12.
Further evidence linking late-onset Alzheimer disease with chromosome 12.
Further evidence linking late-onset Alzheimer disease with chromosome 12.
Further evidence linking late-onset Alzheimer disease with chromosome 12.
Further evidence linking late-onset Alzheimer disease with chromosome 12.
Further evidence linking late-onset Alzheimer disease with chromosome 12.
Further evidence linking late-onset Alzheimer disease with chromosome 12.
Sexual abuse and adolescent pregnancy.
Sexual abuse and adolescent pregnancy.
Sexual abuse and adolescent pregnancy.
Sexual abuse and adolescent pregnancy.
Sexual abuse and adolescent pregnancy.
Sexual abuse and adolescent pregnancy.
Sexual abuse and adolescent pregnancy.
Sexual abuse and adolescent pregnancy.
Sexual abuse and adolescent pregnancy.
Sexual abuse and adolescent pregnancy.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
Nonphysician clinicians in the health care workforce.
From the Centers for Disease Control and Prevention. Forecasted state-specific estimates of self-reported asthma prevalence
From the Centers for Disease Control and Prevention. Decrease in AIDS-related mortality in a state correctional system--New
From the Centers for Disease Control and Prevention. Fatal car trunk entrapment involving children--United States, 1987-199
From the Centers for Disease Control and Prevention. Fatal car trunk entrapment involving children--United States, 1987-199
From the Centers for Disease Control and Prevention. Rapidly growing mycobacterial infection following liposuction and lipos
CDC director invites participation in disease control and prevention.
CDC director invites participation in disease control and prevention.
CDC director invites participation in disease control and prevention.
CDC director invites participation in disease control and prevention.
CDC director invites participation in disease control and prevention.
New studies illuminate brain disorders.
New studies illuminate brain disorders.
Urology.
Urology.
A piece of my mind. Star material.
A piece of my mind. Star material.
JAMA patient page: sexual dysfunction.
Maintenance antiretroviral treatment in HIV infection.
Maintenance antiretroviral treatment in HIV infection.
Service quality in health care.
Service quality in health care.
Service quality in health care.
Service quality in health care.
Service quality in health care.
The challenges of recognizing child abuse: seeing is believing.
The challenges of recognizing child abuse: seeing is believing.
The challenges of recognizing child abuse: seeing is believing.
The value of targeted case management during transitional care.
The value of targeted case management during transitional care.
The value of targeted case management during transitional care.
Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.
Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.
Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.
Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.
Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.
Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.
Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.
Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.
Distribution of variable vs fixed costs of hospital care.
Distribution of variable vs fixed costs of hospital care.
Distribution of variable vs fixed costs of hospital care.
Distribution of variable vs fixed costs of hospital care.
Distribution of variable vs fixed costs of hospital care.
Distribution of variable vs fixed costs of hospital care.
Distribution of variable vs fixed costs of hospital care.
Distribution of variable vs fixed costs of hospital care.
Distribution of variable vs fixed costs of hospital care.
Distribution of variable vs fixed costs of hospital care.
Distribution of variable vs fixed costs of hospital care.
Distribution of variable vs fixed costs of hospital care.
Distribution of variable vs fixed costs of hospital care.
Is physician detection associated with thinner melanomas?
Is physician detection associated with thinner melanomas?
Is physician detection associated with thinner melanomas?
Is physician detection associated with thinner melanomas?
Is physician detection associated with thinner melanomas?
Is physician detection associated with thinner melanomas?
Is physician detection associated with thinner melanomas?
Increased pulse pressure and risk of heart failure in the elderly.
Increased pulse pressure and risk of heart failure in the elderly.
Increased pulse pressure and risk of heart failure in the elderly.
Increased pulse pressure and risk of heart failure in the elderly.
Increased pulse pressure and risk of heart failure in the elderly.
Increased pulse pressure and risk of heart failure in the elderly.
Increased pulse pressure and risk of heart failure in the elderly.
Increased pulse pressure and risk of heart failure in the elderly.
Increased pulse pressure and risk of heart failure in the elderly.
Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project.
Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project.
Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project.
Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project.
Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project.
Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project.
Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project.
Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project.
Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project.
Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project.
Analysis of missed cases of abusive head trauma.
Analysis of missed cases of abusive head trauma.
Analysis of missed cases of abusive head trauma.
Analysis of missed cases of abusive head trauma.
Analysis of missed cases of abusive head trauma.
Analysis of missed cases of abusive head trauma.
Analysis of missed cases of abusive head trauma.
Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial.
Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial.
Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial.
Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial.
Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial.
Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial.
Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial.
Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial.
Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial.
Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial.
Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial.
Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial.
Employment among recent residency program graduates.
Employment among recent residency program graduates.
Employment among recent residency program graduates.
Medical school courses in alternative medicine.
Medical school courses in alternative medicine.
Medical school courses in alternative medicine.
Medical school courses in alternative medicine.
Medical school courses in alternative medicine.
Medical school courses in alternative medicine.
Medical school courses in alternative medicine.
Medical school courses in alternative medicine.
Medical school courses in alternative medicine.
Medical school courses in alternative medicine.
Medical school courses in alternative medicine.
Cardiovascular screening of high school athletes.
Cardiovascular screening of high school athletes.
Cardiovascular screening of high school athletes.
Cardiovascular screening of high school athletes.
Cardiovascular screening of high school athletes.
Cardiovascular screening of high school athletes.
Cardiovascular screening of high school athletes.
Cardiovascular screening of high school athletes.
Cardiovascular screening of high school athletes.
Cardiovascular screening of high school athletes.
Cardiovascular screening of high school athletes.
Licensing boards and the stigma of mental illness.
Licensing boards and the stigma of mental illness.
Licensing boards and the stigma of mental illness.
Licensing boards and the stigma of mental illness.
Licensing boards and the stigma of mental illness.
Licensing boards and the stigma of mental illness.
Managing pain in elderly patients.
Managing pain in elderly patients.
Managing pain in elderly patients.
Managing pain in elderly patients.
Managing pain in elderly patients.
Managing pain in elderly patients.
From the Centers for Disease Control and Prevention. Outbreak of Vibrio parahaemolyticus infection associated with eating r
From the Centers for Disease Control and Prevention. Recommended childhood immunization schedule--United States, 1999
Test for diabetic tendency may aid risk factor studies.
Test for diabetic tendency may aid risk factor studies.
Operation Smile volunteers travel far to transform lives.
Operation Smile volunteers travel far to transform lives.
Enabling students to deal with the disabled.
Enabling students to deal with the disabled.
The cutting edge: surgery sites on the World Wide Web.
The cutting edge: surgery sites on the World Wide Web.
The cutting edge: surgery sites on the World Wide Web.
JAMA patient page: skin cancer.
A concerned optimist: an "exit interview" with Bruce Vladeck, PhD. Interview by Emily Friedman.
A concerned optimist: an "exit interview" with Bruce Vladeck, PhD. Interview by Emily Friedman.
Variations in Medicare health maintenance organizations.
Variations in Medicare health maintenance organizations.
Variations in Medicare health maintenance organizations.
Variations in Medicare health maintenance organizations.
Predictive value of the electrocardiogram in acute coronary syndromes.
Predictive value of the electrocardiogram in acute coronary syndromes.
Predictive value of the electrocardiogram in acute coronary syndromes.
Predictive value of the electrocardiogram in acute coronary syndromes.
Disability discrimination in America: HIV/AIDS and other health conditions.
Disability discrimination in America: HIV/AIDS and other health conditions.
Disability discrimination in America: HIV/AIDS and other health conditions.
Disability discrimination in America: HIV/AIDS and other health conditions.
Disability discrimination in America: HIV/AIDS and other health conditions.
Disability discrimination in America: HIV/AIDS and other health conditions.
A 75-year-old woman with an abdominal aortic aneurysm and emphysema, 1 year later.
A 75-year-old woman with an abdominal aortic aneurysm and emphysema, 1 year later.
A 75-year-old woman with an abdominal aortic aneurysm and emphysema, 1 year later.
A 75-year-old woman with an abdominal aortic aneurysm and emphysema, 1 year later.
An asymptomatic 41-year-old man with HIV infection.
An asymptomatic 41-year-old man with HIV infection.
An asymptomatic 41-year-old man with HIV infection.
An asymptomatic 41-year-old man with HIV infection.
An asymptomatic 41-year-old man with HIV infection.
Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women.
Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women.
Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women.
Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women.
Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women.
Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women.
Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women.
Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiologic
Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiologic
Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiologic
Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiologic
Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiologic
Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiologic
Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiologic
Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiologic
Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiologic
Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiologic
Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiologic
Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.
Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.
Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.
Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.
Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.
Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.
Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.
Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.
Should the electrocardiogram be used to guide therapy for patients with left bundle-branch block and suspected myocardial i
Should the electrocardiogram be used to guide therapy for patients with left bundle-branch block and suspected myocardial i
Should the electrocardiogram be used to guide therapy for patients with left bundle-branch block and suspected myocardial i
Should the electrocardiogram be used to guide therapy for patients with left bundle-branch block and suspected myocardial i
Should the electrocardiogram be used to guide therapy for patients with left bundle-branch block and suspected myocardial i
Should the electrocardiogram be used to guide therapy for patients with left bundle-branch block and suspected myocardial i
Should the electrocardiogram be used to guide therapy for patients with left bundle-branch block and suspected myocardial i
Should the electrocardiogram be used to guide therapy for patients with left bundle-branch block and suspected myocardial i
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Prognostic value of the admission electrocardiogram in acute coronary syndromes.
Diagnosing myocardial infarction: should patients carry a copy of their ECG?
Diagnosing myocardial infarction: should patients carry a copy of their ECG?
Diagnosing myocardial infarction: should patients carry a copy of their ECG?
HELLP syndrome.
HELLP syndrome.
HELLP syndrome.
HELLP syndrome.
HELLP syndrome.
HELLP syndrome.
HELLP syndrome.
HELLP syndrome.
Cardiac rupture after myocardial infarction.
Cardiac rupture after myocardial infarction.
Cardiac rupture after myocardial infarction.
Voucher incentives to increase childhood immunization rates.
Voucher incentives to increase childhood immunization rates.
Voucher incentives to increase childhood immunization rates.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
Use of antiretroviral therapy by intravenous drug users with HIV.
From the Centers for Disease Control and Prevention. HIV testing--United States, 1996.
From the Centers for Disease Control and Prevention. Increases in unsafe sex and rectal gonorrhea among men who have sex
From the Centers for Disease Control and Prevention. Update: influenza activity--United States, 1998-99 season.
New organization promotes patient-oriented research.
New organization promotes patient-oriented research.
Funding stem cell research.
Funding stem cell research.
Chronic pain linked with poor sleep; exploration of causes and treatment.
Chronic pain linked with poor sleep; exploration of causes and treatment.
Patients in pain need round-the-clock care.
Patients in pain need round-the-clock care.
Practice-based research networks answer primary care questions.
Practice-based research networks answer primary care questions.
Practice-based research networks answer primary care questions.
Practice-based research networks answer primary care questions.
JAMA patient page: breast cancer.
Bioethics: The Birth of Bioethics by Albert R. Jonsen.
Bioethics: The Birth of Bioethics by Albert R. Jonsen.
Bioethics: The Birth of Bioethics by Albert R. Jonsen.
Physician-legislators: physicians practicing public service.
Physician-legislators: physicians practicing public service.
Going Hollywood with patient rights in managed care.
Going Hollywood with patient rights in managed care.
American independence and the right to emergency care.
American independence and the right to emergency care.
Patients' rights proposals: the insurers' perspective.
Patients' rights proposals: the insurers' perspective.
A patients' bill of rights: the medical student's role.
A patients' bill of rights: the medical student's role.
Defining a "patients' bill of rights" for the next century.
Defining a "patients' bill of rights" for the next century.
Report card on molecular genetic testing: room for improvement?
Report card on molecular genetic testing: room for improvement?
Report card on molecular genetic testing: room for improvement?
Report card on molecular genetic testing: room for improvement?
Meta-analysis and epidemiologic studies in drug development and postmarketing surveillance.
Meta-analysis and epidemiologic studies in drug development and postmarketing surveillance.
Meta-analysis and epidemiologic studies in drug development and postmarketing surveillance.
Quality assurance in molecular genetic testing laboratories.
Quality assurance in molecular genetic testing laboratories.
Quality assurance in molecular genetic testing laboratories.
Quality assurance in molecular genetic testing laboratories.
Quality assurance in molecular genetic testing laboratories.
Quality assurance in molecular genetic testing laboratories.
Quality assurance in molecular genetic testing laboratories.
Quality assurance in molecular genetic testing laboratories.
Quality assurance in molecular genetic testing laboratories.
The role of meta-analysis in the regulatory process for foods, drugs, and devices.
The role of meta-analysis in the regulatory process for foods, drugs, and devices.
The role of meta-analysis in the regulatory process for foods, drugs, and devices.
The role of meta-analysis in the regulatory process for foods, drugs, and devices.
Postmarketing surveillance and adverse drug reactions: current perspectives and future needs.
Postmarketing surveillance and adverse drug reactions: current perspectives and future needs.
Postmarketing surveillance and adverse drug reactions: current perspectives and future needs.
Postmarketing surveillance and adverse drug reactions: current perspectives and future needs.
Postmarketing surveillance and adverse drug reactions: current perspectives and future needs.
Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study.
Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study.
Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study.
Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study.
Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study.
Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study.
Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study.
Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study.
Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study.
Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study.
Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study.
Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study.
Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study.
Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study.
Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study.
Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica.
Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica.
Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica.
Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica.
Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica.
Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica.
Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica.
Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica.
Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica.
Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica.
Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica.
Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica.
Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica.
Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica.
Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTEN
Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTEN
Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTEN
Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTEN
Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTEN
Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTEN
Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTEN
Maternal psychological distress and parenting stress after the birth of a very low-birth-weight infant.
Maternal psychological distress and parenting stress after the birth of a very low-birth-weight infant.
Maternal psychological distress and parenting stress after the birth of a very low-birth-weight infant.
Maternal psychological distress and parenting stress after the birth of a very low-birth-weight infant.
Maternal psychological distress and parenting stress after the birth of a very low-birth-weight infant.
Maternal psychological distress and parenting stress after the birth of a very low-birth-weight infant.
Maternal psychological distress and parenting stress after the birth of a very low-birth-weight infant.
Maternal psychological distress and parenting stress after the birth of a very low-birth-weight infant.
Maternal psychological distress and parenting stress after the birth of a very low-birth-weight infant.
Sleep disorders and attention-deficit/hyperactivity disorder.
Sleep disorders and attention-deficit/hyperactivity disorder.
Sleep disorders and attention-deficit/hyperactivity disorder.
Sleep disorders and attention-deficit/hyperactivity disorder.
Sleep disorders and attention-deficit/hyperactivity disorder.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Hormone replacement therapy for secondary prevention of coronary heart disease.
Renin profiling to predict response to antihypertensive therapy.
Renin profiling to predict response to antihypertensive therapy.
Renin profiling to predict response to antihypertensive therapy.
Renin profiling to predict response to antihypertensive therapy.
Inhaled corticosteroids and likelihood of cataract extraction.
Inhaled corticosteroids and likelihood of cataract extraction.
Inhaled corticosteroids and likelihood of cataract extraction.
Inhaled corticosteroids and likelihood of cataract extraction.
Inhaled corticosteroids and likelihood of cataract extraction.
Inhaled corticosteroids and likelihood of cataract extraction.
Inhaled corticosteroids and likelihood of cataract extraction.
Inhaled corticosteroids and likelihood of cataract extraction.
Inhaled corticosteroids and likelihood of cataract extraction.
Inhaled corticosteroids and likelihood of cataract extraction.
Inhaled corticosteroids and likelihood of cataract extraction.
Inhaled corticosteroids and likelihood of cataract extraction.
Inhaled corticosteroids and likelihood of cataract extraction.
Inhaled corticosteroids and likelihood of cataract extraction.
Inhaled corticosteroids and likelihood of cataract extraction.
Inhaled corticosteroids and likelihood of cataract extraction.
Inhaled corticosteroids and likelihood of cataract extraction.
From the Centers for Disease Control and Prevention. Update: recommendations to prevent hepatitis B virus transmission--U
From the Centers for Disease Control and Prevention. Surveillance of morbidity during wildfires--Central Florida, 1998.
From the Centers for Disease Control and Prevention. Bioterrorism alleging use of anthrax and interim guidelines for manage
From the Food and Drug Administration.
From the Food and Drug Administration.
HELP network says firearms data gap makes reducing gun injuries more difficult. Handgun Epidemic Lowering Plan.
HELP network says firearms data gap makes reducing gun injuries more difficult. Handgun Epidemic Lowering Plan.
Aging research on the international agenda.
Aging research on the international agenda.
Russian physicians helped to upgrade medical skills.
Russian physicians helped to upgrade medical skills.
25 years of school-based health centers.
25 years of school-based health centers.
JAMA patient page: parenting.
HIV vaccine trial in Africa.
HIV vaccine trial in Africa.
Sam Ho, MD: idealist, innovator, entrepreneur. Interview by Fitzhugh Mullan.
Sam Ho, MD: idealist, innovator, entrepreneur. Interview by Fitzhugh Mullan.
Sam Ho, MD: idealist, innovator, entrepreneur. Interview by Fitzhugh Mullan.
Sam Ho, MD: idealist, innovator, entrepreneur. Interview by Fitzhugh Mullan.
Influenza control--unfinished business.
Influenza control--unfinished business.
Influenza control--unfinished business.
Influenza control--unfinished business.
Global health at the crossroads: Surgeon General's report on the 50th World Health Assembly.
Global health at the crossroads: Surgeon General's report on the 50th World Health Assembly.
Medical futility in end-of-life care: report of the Council on Ethical and Judicial Affairs.
Medical futility in end-of-life care: report of the Council on Ethical and Judicial Affairs.
Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus.
Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus.
Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus.
A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor.
A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor.
A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor.
A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor.
A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor.
A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor.
A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor.
A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor.
A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor.
A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor.
A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor.
A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor.
A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor.
A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor.
A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor.
Plaque rupture and sudden death related to exertion in men with coronary artery disease.
Plaque rupture and sudden death related to exertion in men with coronary artery disease.
Plaque rupture and sudden death related to exertion in men with coronary artery disease.
Plaque rupture and sudden death related to exertion in men with coronary artery disease.
Plaque rupture and sudden death related to exertion in men with coronary artery disease.
Plaque rupture and sudden death related to exertion in men with coronary artery disease.
Plaque rupture and sudden death related to exertion in men with coronary artery disease.
Plaque rupture and sudden death related to exertion in men with coronary artery disease.
Plaque rupture and sudden death related to exertion in men with coronary artery disease.
Association of dietary intake of fat and fatty acids with risk of breast cancer.
Association of dietary intake of fat and fatty acids with risk of breast cancer.
Association of dietary intake of fat and fatty acids with risk of breast cancer.
Association of dietary intake of fat and fatty acids with risk of breast cancer.
Association of dietary intake of fat and fatty acids with risk of breast cancer.
Association of dietary intake of fat and fatty acids with risk of breast cancer.
Association of dietary intake of fat and fatty acids with risk of breast cancer.
Association of dietary intake of fat and fatty acids with risk of breast cancer.
Association of dietary intake of fat and fatty acids with risk of breast cancer.
Association of dietary intake of fat and fatty acids with risk of breast cancer.
Association of dietary intake of fat and fatty acids with risk of breast cancer.
Association of dietary intake of fat and fatty acids with risk of breast cancer.
Effectiveness of influenza vaccine in health care professionals: a randomized trial.
Effectiveness of influenza vaccine in health care professionals: a randomized trial.
Effectiveness of influenza vaccine in health care professionals: a randomized trial.
Effectiveness of influenza vaccine in health care professionals: a randomized trial.
Effectiveness of influenza vaccine in health care professionals: a randomized trial.
Effectiveness of influenza vaccine in health care professionals: a randomized trial.
Effectiveness of influenza vaccine in health care professionals: a randomized trial.
Effectiveness of influenza vaccine in health care professionals: a randomized trial.
Effectiveness of influenza vaccine in health care professionals: a randomized trial.
Effectiveness of influenza vaccine in health care professionals: a randomized trial.
Effectiveness of influenza vaccine in health care professionals: a randomized trial.
Effectiveness of influenza vaccine in health care professionals: a randomized trial.
Effectiveness of influenza vaccine in health care professionals: a randomized trial.
Influenza-associated morbidity and mortality in young and middle-aged women.
Influenza-associated morbidity and mortality in young and middle-aged women.
Influenza-associated morbidity and mortality in young and middle-aged women.
Influenza-associated morbidity and mortality in young and middle-aged women.
Influenza-associated morbidity and mortality in young and middle-aged women.
Influenza-associated morbidity and mortality in young and middle-aged women.
Influenza-associated morbidity and mortality in young and middle-aged women.
Influenza-associated morbidity and mortality in young and middle-aged women.
Curbside consultation and malpractice policies.
Curbside consultation and malpractice policies.
Curbside consultation and malpractice policies.
Oncologists' practice of euthanasia and physician-assisted suicide.
Oncologists' practice of euthanasia and physician-assisted suicide.
Oncologists' practice of euthanasia and physician-assisted suicide.
Oncologists' practice of euthanasia and physician-assisted suicide.
Oncologists' practice of euthanasia and physician-assisted suicide.
Oncologists' practice of euthanasia and physician-assisted suicide.
Oncologists' practice of euthanasia and physician-assisted suicide.
Oncologists' practice of euthanasia and physician-assisted suicide.
Oncologists' practice of euthanasia and physician-assisted suicide.
Effects of methylmercury exposure on neurodevelopment.
Effects of methylmercury exposure on neurodevelopment.
Effects of methylmercury exposure on neurodevelopment.
Effects of methylmercury exposure on neurodevelopment.
Effects of methylmercury exposure on neurodevelopment.
Effects of methylmercury exposure on neurodevelopment.
Effects of methylmercury exposure on neurodevelopment.
Effects of methylmercury exposure on neurodevelopment.
Clinical crossroads: a 45-year-old man with low back pain.
Clinical crossroads: a 45-year-old man with low back pain.
Clinical crossroads: a 45-year-old man with low back pain.
Clinical crossroads: a 45-year-old man with low back pain.
Clinical crossroads: a 45-year-old man with low back pain.
Clinical crossroads: a 45-year-old man with low back pain.
Clinical crossroads: a 45-year-old man with low back pain.
Clinical crossroads: a 45-year-old man with low back pain.
Clinical crossroads: a 45-year-old man with low back pain.
Clinical crossroads: a 45-year-old man with low back pain.
Clinical crossroads: a 45-year-old man with low back pain.
Clinical crossroads: a 45-year-old man with low back pain.
Clinical crossroads: a 45-year-old man with low back pain.
Clinical crossroads: a 45-year-old man with low back pain.
Clinical crossroads: a 45-year-old man with low back pain.
Clinical crossroads: a 45-year-old man with low back pain.
Clinical crossroads: a 45-year-old man with low back pain.
From the Centers for Disease Control and Prevention. Change in recommendation for meningococcal vaccine for travelers.
From the Centers for Disease Control and Prevention. Human rabies--Virginia, 1998.
From the Centers for Disease Control and Prevention. Human rabies--Virginia, 1998.
From the Centers for Disease Control and Prevention. Needs assessment following hurricane Georges--Dominican Republic, 1
FDA may get welcome new funds in its budget.
FDA may get welcome new funds in its budget.
Millennial influenza vaccine.
Millennial influenza vaccine.
Brew it or chew it? Military seeks ways to caffeinate.
Brew it or chew it? Military seeks ways to caffeinate.
HIV researchers air new findings.
HIV researchers air new findings.
New horizons in the treatment of osteoarthritis of the knee.
New horizons in the treatment of osteoarthritis of the knee.
New horizons in the treatment of osteoarthritis of the knee.
New horizons in the treatment of osteoarthritis of the knee.
A piece of my mind. Sherry and Richard.
A piece of my mind. Sherry and Richard.
JAMA patient page: flu.
Preventive therapy for tuberculosis in HIV infection.
Preventive therapy for tuberculosis in HIV infection.
Preventive therapy for tuberculosis in HIV infection.
AIDS vaccine trial.
AIDS vaccine trial.
Perils, pitfalls, and possibilities in talking about medical risk.
Perils, pitfalls, and possibilities in talking about medical risk.
Perils, pitfalls, and possibilities in talking about medical risk.
Perils, pitfalls, and possibilities in talking about medical risk.
Perils, pitfalls, and possibilities in talking about medical risk.
Perils, pitfalls, and possibilities in talking about medical risk.
Treating insomnia in older adults: taking a long-term view.
Treating insomnia in older adults: taking a long-term view.
Treating insomnia in older adults: taking a long-term view.
Treating insomnia in older adults: taking a long-term view.
Treating insomnia in older adults: taking a long-term view.
Treating insomnia in older adults: taking a long-term view.
Treating insomnia in older adults: taking a long-term view.
From disease prevention to health promotion.
From disease prevention to health promotion.
The rational clinical examination. Is this patient hypovolemic?
The rational clinical examination. Is this patient hypovolemic?
The rational clinical examination. Is this patient hypovolemic?
The rational clinical examination. Is this patient hypovolemic?
The rational clinical examination. Is this patient hypovolemic?
The rational clinical examination. Is this patient hypovolemic?
Perceived risks of heart disease and cancer among cigarette smokers.
Perceived risks of heart disease and cancer among cigarette smokers.
Perceived risks of heart disease and cancer among cigarette smokers.
Perceived risks of heart disease and cancer among cigarette smokers.
Perceived risks of heart disease and cancer among cigarette smokers.
Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic.
Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic.
Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic.
Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic.
Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic.
Ethnic variation in cardiovascular disease risk factors among children and young adults: findings from the Third National Healt
Ethnic variation in cardiovascular disease risk factors among children and young adults: findings from the Third National Healt
Ethnic variation in cardiovascular disease risk factors among children and young adults: findings from the Third National Healt
Ethnic variation in cardiovascular disease risk factors among children and young adults: findings from the Third National Healt
Ethnic variation in cardiovascular disease risk factors among children and young adults: findings from the Third National Healt
Ethnic variation in cardiovascular disease risk factors among children and young adults: findings from the Third National Healt
Ethnic variation in cardiovascular disease risk factors among children and young adults: findings from the Third National Healt
Ethnic variation in cardiovascular disease risk factors among children and young adults: findings from the Third National Healt
Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.
Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.
Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.
Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.
Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.
Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.
Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.
Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.
Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.
Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.
Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.
Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.
Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.
Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.
Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.
Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.
Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.
Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.
Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.
Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.
Internet access and use among disadvantaged inner-city patients.
Internet access and use among disadvantaged inner-city patients.
Internet access and use among disadvantaged inner-city patients.
Internet access and use among disadvantaged inner-city patients.
Internet access and use among disadvantaged inner-city patients.
Internet access and use among disadvantaged inner-city patients.
Internet access and use among disadvantaged inner-city patients.
Powder-free protein-poor natural rubber latex gloves and latex sensitization.
Powder-free protein-poor natural rubber latex gloves and latex sensitization.
Powder-free protein-poor natural rubber latex gloves and latex sensitization.
Powder-free protein-poor natural rubber latex gloves and latex sensitization.
Powder-free protein-poor natural rubber latex gloves and latex sensitization.
Powder-free protein-poor natural rubber latex gloves and latex sensitization.
Powder-free protein-poor natural rubber latex gloves and latex sensitization.
Ergotism related to concurrent administration of ergotamine tartrate and indinavir.
Ergotism related to concurrent administration of ergotamine tartrate and indinavir.
Ergotism related to concurrent administration of ergotamine tartrate and indinavir.
Ergotism related to concurrent administration of ergotamine tartrate and indinavir.
Ergotism related to concurrent administration of ergotamine tartrate and indinavir.
Ergotism related to concurrent administration of ergotamine tartrate and indinavir.
Ergotism related to concurrent administration of ergotamine tartrate and indinavir.
Clinical crossroads: a 29-year-old man with multiple sclerosis.
Clinical crossroads: a 29-year-old man with multiple sclerosis.
Clinical crossroads: a 29-year-old man with multiple sclerosis.
Clinical crossroads: a 29-year-old man with multiple sclerosis.
Clinical crossroads: a 29-year-old man with multiple sclerosis.
Clinical crossroads: a 29-year-old man with multiple sclerosis.
Defining and improving health care quality.
Defining and improving health care quality.
Defining and improving health care quality.
Defining and improving health care quality.
Defining and improving health care quality.
Defining and improving health care quality.
Defining and improving health care quality.
Putting babies "back to sleep".
Putting babies "back to sleep".
Putting babies "back to sleep".
From the Centers for Disease Control and Prevention. Recall of Tripedia vaccine.
From the Centers for Disease Control and Prevention. Farm worker illness following exposure to carbofuran and other pestici
From the Centers for Disease Control and Prevention. Adverse events associated with ingestion of gamma-butyrolactone--Mi
From the Centers for Disease Control and Prevention. Adverse events associated with ingestion of gamma-butyrolactone--Mi
Confidential Spanish registry of HIV-infected individuals.
Confidential Spanish registry of HIV-infected individuals.
"Epidemic!" exhibits infectious disease world.
"Epidemic!" exhibits infectious disease world.
Several groups attempting regulation of Internet Rx.
Several groups attempting regulation of Internet Rx.
Ovarian cancer investigators aim at cell signaling pathways.
Ovarian cancer investigators aim at cell signaling pathways.
Internet resources in otolaryngology-head and neck surgery.
Internet resources in otolaryngology-head and neck surgery.
Internet resources in otolaryngology-head and neck surgery.
JAMA patient page: insomnia.
JAMA 100 years ago: euphoria vs. euthanasia.
JAMA 100 years ago: euphoria vs. euthanasia.
JAMA 100 years ago: euphoria vs. euthanasia.
Tobacco and alcohol use in G-rated children's animated films.
Tobacco and alcohol use in G-rated children's animated films.
Tobacco and alcohol use in G-rated children's animated films.
Tobacco and alcohol use in G-rated children's animated films.
Tobacco and alcohol use in G-rated children's animated films.
The need for concrete improvement in abstract quality.
The need for concrete improvement in abstract quality.
The need for concrete improvement in abstract quality.
Who is responsible for the common good in a competitive market?
Who is responsible for the common good in a competitive market?
Who is responsible for the common good in a competitive market?
A 24-year-old woman with anorexia nervosa, 1 year later.
A 24-year-old woman with anorexia nervosa, 1 year later.
A 24-year-old woman with anorexia nervosa, 1 year later.
A 24-year-old woman with anorexia nervosa, 1 year later.
An 87-year-old woman taking a benzodiazepine.
An 87-year-old woman taking a benzodiazepine.
An 87-year-old woman taking a benzodiazepine.
An 87-year-old woman taking a benzodiazepine.
An 87-year-old woman taking a benzodiazepine.
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Asso
Accuracy of data in abstracts of published research articles.
Accuracy of data in abstracts of published research articles.
Accuracy of data in abstracts of published research articles.
Accuracy of data in abstracts of published research articles.
Accuracy of data in abstracts of published research articles.
Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study.
Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study.
Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study.
Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study.
Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study.
Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study.
Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study.
Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study.
Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study.
Risk factors for parvovirus B19 infection in pregnancy.
Risk factors for parvovirus B19 infection in pregnancy.
Risk factors for parvovirus B19 infection in pregnancy.
Risk factors for parvovirus B19 infection in pregnancy.
Risk factors for parvovirus B19 infection in pregnancy.
Risk factors for parvovirus B19 infection in pregnancy.
Risk factors for parvovirus B19 infection in pregnancy.
Risk factors for parvovirus B19 infection in pregnancy.
Risk factors for parvovirus B19 infection in pregnancy.
Risk factors for parvovirus B19 infection in pregnancy.
Risk factors for parvovirus B19 infection in pregnancy.
Market forces and unsponsored research in academic health centers.
Market forces and unsponsored research in academic health centers.
Market forces and unsponsored research in academic health centers.
Market forces and unsponsored research in academic health centers.
Market forces and unsponsored research in academic health centers.
Market forces and unsponsored research in academic health centers.
Market forces and unsponsored research in academic health centers.
Market forces and unsponsored research in academic health centers.
Managed care and physicians' provision of charity care.
Managed care and physicians' provision of charity care.
Managed care and physicians' provision of charity care.
Managed care and physicians' provision of charity care.
Managed care and physicians' provision of charity care.
Managed care and physicians' provision of charity care.
Managed care and physicians' provision of charity care.
Genotypic analysis of HIV-1 isolates to identify antiretroviral resistance mutations from source patients involved in health car
Genotypic analysis of HIV-1 isolates to identify antiretroviral resistance mutations from source patients involved in health car
Genotypic analysis of HIV-1 isolates to identify antiretroviral resistance mutations from source patients involved in health car
Genotypic analysis of HIV-1 isolates to identify antiretroviral resistance mutations from source patients involved in health car
Genotypic analysis of HIV-1 isolates to identify antiretroviral resistance mutations from source patients involved in health car
Genotypic analysis of HIV-1 isolates to identify antiretroviral resistance mutations from source patients involved in health car
Genotypic analysis of HIV-1 isolates to identify antiretroviral resistance mutations from source patients involved in health car
Effect of immediate-release glipizide on hypoglycemic vulnerability in fasted, elderly patients with type 2 diabetes.
Effect of immediate-release glipizide on hypoglycemic vulnerability in fasted, elderly patients with type 2 diabetes.
Effect of immediate-release glipizide on hypoglycemic vulnerability in fasted, elderly patients with type 2 diabetes.
Effect of immediate-release glipizide on hypoglycemic vulnerability in fasted, elderly patients with type 2 diabetes.
Effect of immediate-release glipizide on hypoglycemic vulnerability in fasted, elderly patients with type 2 diabetes.
Effect of immediate-release glipizide on hypoglycemic vulnerability in fasted, elderly patients with type 2 diabetes.
Effect of immediate-release glipizide on hypoglycemic vulnerability in fasted, elderly patients with type 2 diabetes.
Effect of immediate-release glipizide on hypoglycemic vulnerability in fasted, elderly patients with type 2 diabetes.
Doctoring doctors.
Doctoring doctors.
Doctoring doctors.
Respiratory effects of secondhand smoke.
Respiratory effects of secondhand smoke.
Respiratory effects of secondhand smoke.
Respiratory effects of secondhand smoke.
Marginal medicine.
Marginal medicine.
Marginal medicine.
Marginal medicine.
Marginal medicine.
Combating antimicrobial resistance in India.
Combating antimicrobial resistance in India.
Combating antimicrobial resistance in India.
Control of outbreaks due to organisms producing extended-spectrum beta-lactamases.
Control of outbreaks due to organisms producing extended-spectrum beta-lactamases.
Control of outbreaks due to organisms producing extended-spectrum beta-lactamases.
Control of outbreaks due to organisms producing extended-spectrum beta-lactamases.
From the Centers for Disease Control and Prevention. Nosocomial group A streptococcal infections associated with asymptom
From the Centers for Disease Control and Prevention. Hemolysis associated with 25% human albumin diluted with sterile wat
From the Centers for Disease Control and Prevention. Hemolysis associated with 25% human albumin diluted with sterile wat
Applying the evidence in Australia.
Applying the evidence in Australia.
Scary scenarios spark action at bioterrorism symposium.
Scary scenarios spark action at bioterrorism symposium.
Scary scenarios spark action at bioterrorism symposium.
Weaving webs for physicians.
Weaving webs for physicians.
AIDS researchers target poor adherence.
AIDS researchers target poor adherence.
Technical and clinical progress in telemedicine.
Technical and clinical progress in telemedicine.
Technical and clinical progress in telemedicine.
Technical and clinical progress in telemedicine.
A piece of my mind. A mother's voice.
A piece of my mind. A mother's voice.
JAMA patient page: stroke.
Historical perspective of medical residency training: 50 years of changes.
Historical perspective of medical residency training: 50 years of changes.
Historical perspective of medical residency training: 50 years of changes.
An apology for those who leave medicine.
An apology for those who leave medicine.
Medicare's role in financing graduate medical education.
Medicare's role in financing graduate medical education.
Medicare's role in financing graduate medical education.
Medicare antifraud initiatives: effects on resident education.
Medicare antifraud initiatives: effects on resident education.
The new face of medical education.
The new face of medical education.
The new face of medical education.
When is diabetes diabetes?
When is diabetes diabetes?
When is diabetes diabetes?
Advancing cardiac resuscitation: lessons from externally controlled trials.
Advancing cardiac resuscitation: lessons from externally controlled trials.
Advancing cardiac resuscitation: lessons from externally controlled trials.
Advancing cardiac resuscitation: lessons from externally controlled trials.
Users' guides to the medical literature: XV. How to use an article about disease probability for differential diagnosis. Evidence
Users' guides to the medical literature: XV. How to use an article about disease probability for differential diagnosis. Evidence
Users' guides to the medical literature: XV. How to use an article about disease probability for differential diagnosis. Evidence
Users' guides to the medical literature: XV. How to use an article about disease probability for differential diagnosis. Evidence
Users' guides to the medical literature: XV. How to use an article about disease probability for differential diagnosis. Evidence
Users' guides to the medical literature: XV. How to use an article about disease probability for differential diagnosis. Evidence
An international study of patient compliance with hemodialysis.
An international study of patient compliance with hemodialysis.
An international study of patient compliance with hemodialysis.
An international study of patient compliance with hemodialysis.
An international study of patient compliance with hemodialysis.
An international study of patient compliance with hemodialysis.
An international study of patient compliance with hemodialysis.
An international study of patient compliance with hemodialysis.
An international study of patient compliance with hemodialysis.
An international study of patient compliance with hemodialysis.
Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 dia
Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 dia
Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 dia
Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 dia
Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 dia
Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 dia
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascul
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascul
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascul
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascul
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascul
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascul
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascul
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascul
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascul
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascul
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascul
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascul
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascul
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascul
Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation.
Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation.
Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation.
Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation.
Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation.
Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation.
Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation.
Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation.
Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation.
Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation.
Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation.
Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation.
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: O
Tales of the unnatural: correction.
Tales of the unnatural: correction.
Tales of the unnatural: correction.
Promoting patient safety by preventing medical error.
Promoting patient safety by preventing medical error.
Promoting patient safety by preventing medical error.
Method of physician payment and patient trust.
Method of physician payment and patient trust.
Method of physician payment and patient trust.
Method of physician payment and patient trust.
Calcium intake and colon cancer biomarkers.
Calcium intake and colon cancer biomarkers.
Calcium intake and colon cancer biomarkers.
Calcium intake and colon cancer biomarkers.
Calcium intake and colon cancer biomarkers.
Putting computer-based evidence in the hands of clinicians.
Putting computer-based evidence in the hands of clinicians.
Putting computer-based evidence in the hands of clinicians.
Putting computer-based evidence in the hands of clinicians.
Putting computer-based evidence in the hands of clinicians.
Antiviral therapies for long-term suppression of genital herpes.
Antiviral therapies for long-term suppression of genital herpes.
Antiviral therapies for long-term suppression of genital herpes.
Antiviral therapies for long-term suppression of genital herpes.
Antiviral therapies for long-term suppression of genital herpes.
Antiviral therapies for long-term suppression of genital herpes.
Antiviral therapies for long-term suppression of genital herpes.
Pharmaceutical benefits managers and optimizing prescribing.
Pharmaceutical benefits managers and optimizing prescribing.
Pharmaceutical benefits managers and optimizing prescribing.
Pharmaceutical benefits managers and optimizing prescribing.
Pharmaceutical benefits managers and optimizing prescribing.
Pharmaceutical benefits managers and optimizing prescribing.
Pharmaceutical benefits managers and optimizing prescribing.
Pharmaceutical benefits managers and optimizing prescribing.
From the Centers for Disease Control and Prevention. New population standard for age-adjusting death rates.
From the Centers for Disease Control and Prevention. HIV postexposure prophylaxis registry closing.
From the Centers for Disease Control and Prevention. Update: influenza activity--United States, 1998-99 season.
From the Food and Drug Administration.
From the Food and Drug Administration.
Passion for poetry, compassion for others.
Passion for poetry, compassion for others.
Diabetes research plan presented to Congress.
Diabetes research plan presented to Congress.
Will TSEs taint the US blood supply?
Will TSEs taint the US blood supply?
JAMA patient page: CPR.
Outbreak of type A botulism and development of a botulism surveillance and antitoxin release system in Argentina.
Outbreak of type A botulism and development of a botulism surveillance and antitoxin release system in Argentina.
Outbreak of type A botulism and development of a botulism surveillance and antitoxin release system in Argentina.
Outbreak of type A botulism and development of a botulism surveillance and antitoxin release system in Argentina.
Outbreak of type A botulism and development of a botulism surveillance and antitoxin release system in Argentina.
Outbreak of type A botulism and development of a botulism surveillance and antitoxin release system in Argentina.
Outbreak of type A botulism and development of a botulism surveillance and antitoxin release system in Argentina.
Outbreak of type A botulism and development of a botulism surveillance and antitoxin release system in Argentina.
Outbreak of type A botulism and development of a botulism surveillance and antitoxin release system in Argentina.
Outbreak of type A botulism and development of a botulism surveillance and antitoxin release system in Argentina.
Outbreak of type A botulism and development of a botulism surveillance and antitoxin release system in Argentina.
Outbreak of type A botulism and development of a botulism surveillance and antitoxin release system in Argentina.
Outbreak of type A botulism and development of a botulism surveillance and antitoxin release system in Argentina.
Outbreak of type A botulism and development of a botulism surveillance and antitoxin release system in Argentina.
Reorganizing the delivery of intensive care may improve patient outcomes.
Reorganizing the delivery of intensive care may improve patient outcomes.
Reorganizing the delivery of intensive care may improve patient outcomes.
Healing words: emotional expression and disease outcome.
Healing words: emotional expression and disease outcome.
Healing words: emotional expression and disease outcome.
Is there a role for androgenic anabolic steroids in medical practice?
Is there a role for androgenic anabolic steroids in medical practice?
Is there a role for androgenic anabolic steroids in medical practice?
Pharmacological treatment of alcohol dependence: a review of the evidence.
Pharmacological treatment of alcohol dependence: a review of the evidence.
Pharmacological treatment of alcohol dependence: a review of the evidence.
Pharmacological treatment of alcohol dependence: a review of the evidence.
Pharmacological treatment of alcohol dependence: a review of the evidence.
Pharmacological treatment of alcohol dependence: a review of the evidence.
Pharmacological treatment of alcohol dependence: a review of the evidence.
Pharmacological treatment of alcohol dependence: a review of the evidence.
Pharmacological treatment of alcohol dependence: a review of the evidence.
Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery.
Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery.
Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery.
Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery.
Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery.
Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery.
Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery.
Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery.
Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery.
Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery.
Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery.
Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a rando
Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a rando
Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a rando
Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a rando
Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a rando
Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a rando
Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a rando
Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a rando
Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a rando
Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a rando
Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Dep
Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Dep
Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Dep
Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Dep
Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Dep
Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Dep
Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Dep
Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Dep
Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Dep
Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Dep
Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Dep
Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Dep
Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Dep
Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Dep
Diabetes and decline in heart disease mortality in US adults.
Diabetes and decline in heart disease mortality in US adults.
Diabetes and decline in heart disease mortality in US adults.
Diabetes and decline in heart disease mortality in US adults.
Diabetes and decline in heart disease mortality in US adults.
Diabetes and decline in heart disease mortality in US adults.
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized con
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized con
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized con
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized con
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized con
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized con
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized con
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized con
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized con
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized con
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized con
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized con
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized con
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized con
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized con
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized con
Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
Low-fat dairy foods and colonic epithelial cell proliferation.
Low-fat dairy foods and colonic epithelial cell proliferation.
Low-fat dairy foods and colonic epithelial cell proliferation.
Low-fat dairy foods and colonic epithelial cell proliferation.
Medicaid and children's access to care.
Medicaid and children's access to care.
Medicaid and children's access to care.
Electronic information retrieval by physicians and medical librarians.
Electronic information retrieval by physicians and medical librarians.
Electronic information retrieval by physicians and medical librarians.
Acupuncture and amitriptyline for HIV-related peripheral neuropathic pain.
Acupuncture and amitriptyline for HIV-related peripheral neuropathic pain.
Acupuncture and amitriptyline for HIV-related peripheral neuropathic pain.
Acupuncture and amitriptyline for HIV-related peripheral neuropathic pain.
Acupuncture and amitriptyline for HIV-related peripheral neuropathic pain.
Acupuncture and amitriptyline for HIV-related peripheral neuropathic pain.
Acupuncture and amitriptyline for HIV-related peripheral neuropathic pain.
Acupuncture and amitriptyline for HIV-related peripheral neuropathic pain.
Acupuncture and amitriptyline for HIV-related peripheral neuropathic pain.
Postexposure prophylaxis following HIV exposure.
Postexposure prophylaxis following HIV exposure.
Postexposure prophylaxis following HIV exposure.
Postexposure prophylaxis following HIV exposure.
Postexposure prophylaxis following HIV exposure.
Postexposure prophylaxis following HIV exposure.
Postexposure prophylaxis following HIV exposure.
Postexposure prophylaxis following HIV exposure.
Computer-based support systems for women with breast cancer.
Computer-based support systems for women with breast cancer.
Computer-based support systems for women with breast cancer.
From the Centers for Disease Control and Prevention. Norwalk-like viral gastroenteritis in US Army trainees--Texas, 1998.
From the Centers for Disease Control and Prevention. Total tooth loss among persons aged > or =65 years--selected states, 19
From the Centers for Disease Control and Prevention. Outbreaks of gastrointestinal illness of unknown etiology associated wi
Breathing life into an NIH exhibit on asthma.
Breathing life into an NIH exhibit on asthma.
High-tech angina relief explored in treatment trials.
High-tech angina relief explored in treatment trials.
Putting a new face on women's health.
Putting a new face on women's health.
Advances in the use of computed tomography.
Advances in the use of computed tomography.
Advances in the use of computed tomography.
JAMA patient page: alcohol.
Risk of stroke in users of oral contraceptives.
Risk of stroke in users of oral contraceptives.
Challenging the cholinergic hypothesis in Alzheimer disease.
Challenging the cholinergic hypothesis in Alzheimer disease.
Challenging the cholinergic hypothesis in Alzheimer disease.
Challenging the cholinergic hypothesis in Alzheimer disease.
Challenging the cholinergic hypothesis in Alzheimer disease.
Understanding resource use in liver transplantation.
Understanding resource use in liver transplantation.
Understanding resource use in liver transplantation.
Disclosing physician financial incentives.
Disclosing physician financial incentives.
Disclosing physician financial incentives.
Disclosing physician financial incentives.
Criteria and recommendations for vitamin C intake.
Criteria and recommendations for vitamin C intake.
Criteria and recommendations for vitamin C intake.
Criteria and recommendations for vitamin C intake.
Criteria and recommendations for vitamin C intake.
Criteria and recommendations for vitamin C intake.
Criteria and recommendations for vitamin C intake.
Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease.
Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease.
Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease.
Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease.
Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease.
Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease.
Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease.
Cholinergic markers in elderly patients with early signs of Alzheimer disease.
Cholinergic markers in elderly patients with early signs of Alzheimer disease.
Cholinergic markers in elderly patients with early signs of Alzheimer disease.
Cholinergic markers in elderly patients with early signs of Alzheimer disease.
Cholinergic markers in elderly patients with early signs of Alzheimer disease.
Cholinergic markers in elderly patients with early signs of Alzheimer disease.
Cholinergic markers in elderly patients with early signs of Alzheimer disease.
Cholinergic markers in elderly patients with early signs of Alzheimer disease.
Cholinergic markers in elderly patients with early signs of Alzheimer disease.
Cholinergic markers in elderly patients with early signs of Alzheimer disease.
Cholinergic markers in elderly patients with early signs of Alzheimer disease.
Biological determinants of cancer progression in men with prostate cancer.
Biological determinants of cancer progression in men with prostate cancer.
Biological determinants of cancer progression in men with prostate cancer.
Biological determinants of cancer progression in men with prostate cancer.
Biological determinants of cancer progression in men with prostate cancer.
Biological determinants of cancer progression in men with prostate cancer.
Biological determinants of cancer progression in men with prostate cancer.
Biological determinants of cancer progression in men with prostate cancer.
A prospective study of egg consumption and risk of cardiovascular disease in men and women.
A prospective study of egg consumption and risk of cardiovascular disease in men and women.
A prospective study of egg consumption and risk of cardiovascular disease in men and women.
A prospective study of egg consumption and risk of cardiovascular disease in men and women.
A prospective study of egg consumption and risk of cardiovascular disease in men and women.
A prospective study of egg consumption and risk of cardiovascular disease in men and women.
A prospective study of egg consumption and risk of cardiovascular disease in men and women.
A prospective study of egg consumption and risk of cardiovascular disease in men and women.
A prospective study of egg consumption and risk of cardiovascular disease in men and women.
A prospective study of egg consumption and risk of cardiovascular disease in men and women.
A prospective study of egg consumption and risk of cardiovascular disease in men and women.
A prospective study of egg consumption and risk of cardiovascular disease in men and women.
A prospective study of egg consumption and risk of cardiovascular disease in men and women.
A prospective study of egg consumption and risk of cardiovascular disease in men and women.
A prospective study of egg consumption and risk of cardiovascular disease in men and women.
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantatio
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantatio
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantatio
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantatio
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantatio
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantatio
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantatio
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantatio
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantatio
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantatio
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantatio
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantatio
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
HIV testing after implementation of name-based reporting.
Long-term effects of home visits on children's behavior.
Long-term effects of home visits on children's behavior.
Long-term effects of home visits on children's behavior.
Long-term effects of home visits on children's behavior.
Long-term effects of home visits on children's behavior.
Long-term effects of home visits on children's behavior.
Long-term effects of home visits on children's behavior.
Influence of hospital volume on mortality following major cancer surgery.
Influence of hospital volume on mortality following major cancer surgery.
Influence of hospital volume on mortality following major cancer surgery.
Influence of hospital volume on mortality following major cancer surgery.
Influence of hospital volume on mortality following major cancer surgery.
Influence of hospital volume on mortality following major cancer surgery.
Influence of hospital volume on mortality following major cancer surgery.
Influence of hospital volume on mortality following major cancer surgery.
Influence of hospital volume on mortality following major cancer surgery.
Influence of hospital volume on mortality following major cancer surgery.
Influence of hospital volume on mortality following major cancer surgery.
Influence of hospital volume on mortality following major cancer surgery.
From the Centers for Disease Control and Prevention. Neighborhood safety and the prevalence of physical inactivity--selected
From the Centers for Disease Control and Prevention. Mass treatment of humans who drank unpasteurized milk from rabid c
From the Centers for Disease Control and Prevention. Preterm singleton births--United States, 1989-1996.
From the Centers for Disease Control and Prevention. Decrease in infant mortality and sudden infant death syndrome among
IOM committee gazes into new vaccine future. Institute of Medicine.
IOM committee gazes into new vaccine future. Institute of Medicine.
Hyperprescribers feel pain of legal prosecution in Spain.
Hyperprescribers feel pain of legal prosecution in Spain.
Sunscreen, in-office dispensing, surgery debated at annual dermatology meeting.
Sunscreen, in-office dispensing, surgery debated at annual dermatology meeting.
JAMA patient page: vitamin C.
Educating patients: one-year anniversary of the JAMA Patient Page.
Educating patients: one-year anniversary of the JAMA Patient Page.
Educating patients: one-year anniversary of the JAMA Patient Page.
Educating patients: one-year anniversary of the JAMA Patient Page.
Letters: a forum for scientific discourse.
Letters: a forum for scientific discourse.
Letters: a forum for scientific discourse.
Serogroup B meningococcal disease: new outbreaks, new strategies.
Serogroup B meningococcal disease: new outbreaks, new strategies.
Serogroup B meningococcal disease: new outbreaks, new strategies.
A 45-year-old man with low back pain and a numb left foot, 1 year later.
A 45-year-old man with low back pain and a numb left foot, 1 year later.
A 45-year-old man with low back pain and a numb left foot, 1 year later.
A 45-year-old man with low back pain and a numb left foot, 1 year later.
A 73-year-old woman with osteoporosis.
A 73-year-old woman with osteoporosis.
A 73-year-old woman with osteoporosis.
A 73-year-old woman with osteoporosis.
A 73-year-old woman with osteoporosis.
Hormone replacement therapy and high S phase in breast cancer.
Hormone replacement therapy and high S phase in breast cancer.
Hormone replacement therapy and high S phase in breast cancer.
Hormone replacement therapy and high S phase in breast cancer.
Hormone replacement therapy and high S phase in breast cancer.
Hormone replacement therapy and high S phase in breast cancer.
Hormone replacement therapy and high S phase in breast cancer.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicat
Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicat
Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicat
Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicat
Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicat
Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicat
Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicat
Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicat
Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicat
Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicat
Occult vitamin D deficiency in postmenopausal US women with acute hip fracture.
Occult vitamin D deficiency in postmenopausal US women with acute hip fracture.
Occult vitamin D deficiency in postmenopausal US women with acute hip fracture.
Occult vitamin D deficiency in postmenopausal US women with acute hip fracture.
Occult vitamin D deficiency in postmenopausal US women with acute hip fracture.
Occult vitamin D deficiency in postmenopausal US women with acute hip fracture.
Occult vitamin D deficiency in postmenopausal US women with acute hip fracture.
Occult vitamin D deficiency in postmenopausal US women with acute hip fracture.
Occult vitamin D deficiency in postmenopausal US women with acute hip fracture.
Occult vitamin D deficiency in postmenopausal US women with acute hip fracture.
Effect of age on excess mortality in obesity.
Effect of age on excess mortality in obesity.
Effect of age on excess mortality in obesity.
Effect of age on excess mortality in obesity.
Effect of age on excess mortality in obesity.
Effect of age on excess mortality in obesity.
Effect of age on excess mortality in obesity.
Effect of age on excess mortality in obesity.
Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain.
Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain.
Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain.
Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain.
Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain.
Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain.
Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain.
Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain.
Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain.
Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain.
Treatment of attention-deficit/hyperactivity disorder.
Treatment of attention-deficit/hyperactivity disorder.
Treatment of attention-deficit/hyperactivity disorder.
Treatment of attention-deficit/hyperactivity disorder.
Treatment of attention-deficit/hyperactivity disorder.
Treatment of attention-deficit/hyperactivity disorder.
Treatment of attention-deficit/hyperactivity disorder.
Treatment of attention-deficit/hyperactivity disorder.
Treatment of attention-deficit/hyperactivity disorder.
Self-prescribing by physicians.
Self-prescribing by physicians.
Self-prescribing by physicians.
Self-prescribing by physicians.
Self-prescribing by physicians.
Self-prescribing by physicians.
Self-prescribing by physicians.
Self-prescribing by physicians.
Self-prescribing by physicians.
Euthanasia and end-of-life care.
Euthanasia and end-of-life care.
Euthanasia and end-of-life care.
Euthanasia and end-of-life care.
Abstinence and safer sex among adolescents.
Abstinence and safer sex among adolescents.
Abstinence and safer sex among adolescents.
Abstinence and safer sex among adolescents.
Abstinence and safer sex among adolescents.
Abstinence and safer sex among adolescents.
Abstinence and safer sex among adolescents.
Abstinence and safer sex among adolescents.
Abstinence and safer sex among adolescents.
Abstinence and safer sex among adolescents.
Abstinence and safer sex among adolescents.
Abstinence and safer sex among adolescents.
Abstinence and safer sex among adolescents.
Abstinence and safer sex among adolescents.
Abstinence and safer sex among adolescents.
Abstinence and safer sex among adolescents.
Abstinence and safer sex among adolescents.
From the Centers for Disease Control and Prevention. Decline in cigarette consumption following implementation of a compr
From the Centers for Disease Control and Prevention. Impact of vaccines universally recommended for children--United State
From the Centers for Disease Control and Prevention. Ten great public health achievements--United States, 1900-1999.
The global HIV/AIDS epidemic.
The global HIV/AIDS epidemic.
Creation of a "European CDC" debated.
Creation of a "European CDC" debated.
Cyberinformation for seniors.
Cyberinformation for seniors.
Therapeutic marijuana use supported while thorough proposed study done.
Therapeutic marijuana use supported while thorough proposed study done.
Screening mammography under age 50.
Screening mammography under age 50.
Screening mammography under age 50.
Screening mammography under age 50.
Screening mammography under age 50.
JAMA Patient Page: meningitis.
Needlestick injuries among French medical students.
Needlestick injuries among French medical students.
Needlestick injuries among French medical students.
Needlestick injuries among French medical students.
Needlestick injuries among French medical students.
Needlestick injuries among French medical students.
Needlestick injuries among French medical students.
X-ray analysis of hair reveals breast cancer.
X-ray analysis of hair reveals breast cancer.
Human health and the environment: are physician educators lagging behind?
Human health and the environment: are physician educators lagging behind?
Effects of noise on hearing.
Effects of noise on hearing.
Effects of noise on hearing.
Violations of informed consent during war.
Violations of informed consent during war.
Environmental medicine: from the concert hall to the barracks.
Environmental medicine: from the concert hall to the barracks.
Evaluating the role of HPV testing for women with equivocal Papanicolaou test findings.
Evaluating the role of HPV testing for women with equivocal Papanicolaou test findings.
Evaluating the role of HPV testing for women with equivocal Papanicolaou test findings.
Management of prostate cancer after prostatectomy: treating the patient, not the PSA.
Management of prostate cancer after prostatectomy: treating the patient, not the PSA.
Management of prostate cancer after prostatectomy: treating the patient, not the PSA.
Large-core needle biopsy of nonpalpable breast lesions.
Large-core needle biopsy of nonpalpable breast lesions.
Large-core needle biopsy of nonpalpable breast lesions.
Large-core needle biopsy of nonpalpable breast lesions.
Large-core needle biopsy of nonpalpable breast lesions.
Large-core needle biopsy of nonpalpable breast lesions.
Large-core needle biopsy of nonpalpable breast lesions.
Large-core needle biopsy of nonpalpable breast lesions.
Large-core needle biopsy of nonpalpable breast lesions.
Large-core needle biopsy of nonpalpable breast lesions.
Large-core needle biopsy of nonpalpable breast lesions.
Large-core needle biopsy of nonpalpable breast lesions.
A prospective study of folate intake and the risk of breast cancer.
A prospective study of folate intake and the risk of breast cancer.
A prospective study of folate intake and the risk of breast cancer.
A prospective study of folate intake and the risk of breast cancer.
A prospective study of folate intake and the risk of breast cancer.
A prospective study of folate intake and the risk of breast cancer.
A prospective study of folate intake and the risk of breast cancer.
A prospective study of folate intake and the risk of breast cancer.
A prospective study of folate intake and the risk of breast cancer.
A prospective study of folate intake and the risk of breast cancer.
A prospective study of folate intake and the risk of breast cancer.
Rising incidence of renal cell cancer in the United States.
Rising incidence of renal cell cancer in the United States.
Rising incidence of renal cell cancer in the United States.
Rising incidence of renal cell cancer in the United States.
Rising incidence of renal cell cancer in the United States.
Rising incidence of renal cell cancer in the United States.
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-
Genetic testing in families with hereditary nonpolyposis colon cancer.
Genetic testing in families with hereditary nonpolyposis colon cancer.
Genetic testing in families with hereditary nonpolyposis colon cancer.
Genetic testing in families with hereditary nonpolyposis colon cancer.
Genetic testing in families with hereditary nonpolyposis colon cancer.
Genetic testing in families with hereditary nonpolyposis colon cancer.
Genetic testing in families with hereditary nonpolyposis colon cancer.
Genetic testing in families with hereditary nonpolyposis colon cancer.
Genetic testing in families with hereditary nonpolyposis colon cancer.
Genetic testing in families with hereditary nonpolyposis colon cancer.
Genetic testing in families with hereditary nonpolyposis colon cancer.
Genetic testing in families with hereditary nonpolyposis colon cancer.
Genetic testing in families with hereditary nonpolyposis colon cancer.
Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy.
Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy.
Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy.
Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy.
Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy.
Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy.
Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy.
Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy.
Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy.
Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy.
Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy.
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.
Natural history of progression after PSA elevation following radical prostatectomy.
Natural history of progression after PSA elevation following radical prostatectomy.
Natural history of progression after PSA elevation following radical prostatectomy.
Natural history of progression after PSA elevation following radical prostatectomy.
Natural history of progression after PSA elevation following radical prostatectomy.
Natural history of progression after PSA elevation following radical prostatectomy.
Natural history of progression after PSA elevation following radical prostatectomy.
Natural history of progression after PSA elevation following radical prostatectomy.
Natural history of progression after PSA elevation following radical prostatectomy.
Natural history of progression after PSA elevation following radical prostatectomy.
Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma.
Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma.
Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma.
Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma.
Thyroid cancer in patients with hepatitis C infection.
Thyroid cancer in patients with hepatitis C infection.
Thyroid cancer in patients with hepatitis C infection.
Thyroid cancer in patients with hepatitis C infection.
Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.
Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.
Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.
Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.
Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.
Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.
Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.
Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.
Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Resear
Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Resear
Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Resear
Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Resear
Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Resear
Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Resear
Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Resear
Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Resear
Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Resear
Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.
Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.
Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.
Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.
Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.
Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.
Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.
Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.
Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.
Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.
Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.
Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.
Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.
Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.
Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.
From the Centers for Disease Control and Prevention. Screening for colorectal cancer--United States, 1997.
From the Food and Drug Administration.
From the Food and Drug Administration.
25 years of community cancer center care.
25 years of community cancer center care.
Bone marrow/stem cells: no edge in breast cancer.
Bone marrow/stem cells: no edge in breast cancer.
Better cancer patient care requires systemic changes.
Better cancer patient care requires systemic changes.
Issues in prostate cancer screening.
Issues in prostate cancer screening.
A piece of my mind. Messages.
A piece of my mind. Messages.
JAMA Patient Page: Pap test.
The safety of new medicines: the importance of asking the right questions.
The safety of new medicines: the importance of asking the right questions.
The safety of new medicines: the importance of asking the right questions.
The safety of new medicines: the importance of asking the right questions.
The safety of new medicines: the importance of asking the right questions.
Advances in molecular genetics and management of hypertrophic cardiomyopathy.
Advances in molecular genetics and management of hypertrophic cardiomyopathy.
Advances in molecular genetics and management of hypertrophic cardiomyopathy.
Advances in molecular genetics and management of hypertrophic cardiomyopathy.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
The safety of newly approved medicines: do recent market removals mean there is a problem?
The safety of newly approved medicines: do recent market removals mean there is a problem?
The safety of newly approved medicines: do recent market removals mean there is a problem?
The safety of newly approved medicines: do recent market removals mean there is a problem?
The safety of newly approved medicines: do recent market removals mean there is a problem?
The safety of newly approved medicines: do recent market removals mean there is a problem?
The safety of newly approved medicines: do recent market removals mean there is a problem?
The safety of newly approved medicines: do recent market removals mean there is a problem?
Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart diseas
Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart diseas
Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart diseas
Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart diseas
Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart diseas
Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart diseas
Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart diseas
Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart diseas
Malondialdehyde-modified LDL as a marker of acute coronary syndromes.
Malondialdehyde-modified LDL as a marker of acute coronary syndromes.
Malondialdehyde-modified LDL as a marker of acute coronary syndromes.
Malondialdehyde-modified LDL as a marker of acute coronary syndromes.
Malondialdehyde-modified LDL as a marker of acute coronary syndromes.
Malondialdehyde-modified LDL as a marker of acute coronary syndromes.
Malondialdehyde-modified LDL as a marker of acute coronary syndromes.
The definition of anemia in older persons.
The definition of anemia in older persons.
The definition of anemia in older persons.
The definition of anemia in older persons.
The definition of anemia in older persons.
The definition of anemia in older persons.
The definition of anemia in older persons.
Depressed adolescents grown up.
Depressed adolescents grown up.
Depressed adolescents grown up.
Depressed adolescents grown up.
Depressed adolescents grown up.
Depressed adolescents grown up.
Depressed adolescents grown up.
Depressed adolescents grown up.
Depressed adolescents grown up.
Depressed adolescents grown up.
Depressed adolescents grown up.
Depressed adolescents grown up.
Depressed adolescents grown up.
Depressed adolescents grown up.
First unaffected pregnancy using preimplantation genetic diagnosis for sickle cell anemia.
First unaffected pregnancy using preimplantation genetic diagnosis for sickle cell anemia.
First unaffected pregnancy using preimplantation genetic diagnosis for sickle cell anemia.
First unaffected pregnancy using preimplantation genetic diagnosis for sickle cell anemia.
First unaffected pregnancy using preimplantation genetic diagnosis for sickle cell anemia.
First unaffected pregnancy using preimplantation genetic diagnosis for sickle cell anemia.
First unaffected pregnancy using preimplantation genetic diagnosis for sickle cell anemia.
First unaffected pregnancy using preimplantation genetic diagnosis for sickle cell anemia.
Saw palmetto for benign prostatic hyperplasia.
Saw palmetto for benign prostatic hyperplasia.
Saw palmetto for benign prostatic hyperplasia.
Legal implications of practicing alternative medicine.
Legal implications of practicing alternative medicine.
Legal implications of practicing alternative medicine.
Primary care research and protection for human subjects.
Primary care research and protection for human subjects.
Primary care research and protection for human subjects.
Does use of potent antiretroviral therapy differ by health care setting?
Does use of potent antiretroviral therapy differ by health care setting?
Does use of potent antiretroviral therapy differ by health care setting?
Does use of potent antiretroviral therapy differ by health care setting?
Does use of potent antiretroviral therapy differ by health care setting?
Does use of potent antiretroviral therapy differ by health care setting?
Postoperative radiotherapy for single brain metastases.
Postoperative radiotherapy for single brain metastases.
Postoperative radiotherapy for single brain metastases.
Postoperative radiotherapy for single brain metastases.
Postoperative radiotherapy for single brain metastases.
Postoperative radiotherapy for single brain metastases.
Postoperative radiotherapy for single brain metastases.
Evidence supporting antileukotriene agents for asthma.
Evidence supporting antileukotriene agents for asthma.
Evidence supporting antileukotriene agents for asthma.
Endovaginal ultrasound to evaluate endometrial abnormalities.
Endovaginal ultrasound to evaluate endometrial abnormalities.
Endovaginal ultrasound to evaluate endometrial abnormalities.
Endovaginal ultrasound to evaluate endometrial abnormalities.
Endovaginal ultrasound to evaluate endometrial abnormalities.
From the Centers for Disease Control and Prevention. Progress toward poliomyelitis eradication--Pakistan, 1994-1998.
From the Centers for Disease Control and Prevention. Final stages of poliomyelitis eradication--Western Pacific Region, 1997-
Growing Hispanic association serves increasing population.
Growing Hispanic association serves increasing population.
Futurists see longer, better life in the third millennium.
Futurists see longer, better life in the third millennium.
Hospice care in the United States: a conversation with Florence S. Wald. Interview by M. J. Friedrich.
Hospice care in the United States: a conversation with Florence S. Wald. Interview by M. J. Friedrich.
Diabetes care and patient-oriented outcomes.
Diabetes care and patient-oriented outcomes.
Diabetes care and patient-oriented outcomes.
JAMA Patient Page: sickle cell anemia.
Induction/maintenance treatment regimens for HIV.
Induction/maintenance treatment regimens for HIV.
Induction/maintenance treatment regimens for HIV.
International aspects of US government tobacco bills.
International aspects of US government tobacco bills.
International aspects of US government tobacco bills.
Lessons from investigations of foodborne disease outbreaks.
Lessons from investigations of foodborne disease outbreaks.
Closer to a cure for the common cold?
Closer to a cure for the common cold?
Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Gro
Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Gro
Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Gro
Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Gro
Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Gro
Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Gro
Preventing stroke in patients with atrial fibrillation.
Preventing stroke in patients with atrial fibrillation.
Preventing stroke in patients with atrial fibrillation.
Preventing stroke in patients with atrial fibrillation.
Preventing stroke in patients with atrial fibrillation.
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bise
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bise
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bise
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bise
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bise
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bise
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bise
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bise
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bise
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bise
Homocysteine and risk of cardiovascular disease among postmenopausal women.
Homocysteine and risk of cardiovascular disease among postmenopausal women.
Homocysteine and risk of cardiovascular disease among postmenopausal women.
Homocysteine and risk of cardiovascular disease among postmenopausal women.
Homocysteine and risk of cardiovascular disease among postmenopausal women.
Homocysteine and risk of cardiovascular disease among postmenopausal women.
Homocysteine and risk of cardiovascular disease among postmenopausal women.
Homocysteine and risk of cardiovascular disease among postmenopausal women.
Homocysteine and risk of cardiovascular disease among postmenopausal women.
Homocysteine and risk of cardiovascular disease among postmenopausal women.
Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washing
Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washing
Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washing
Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washing
Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washing
Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washing
Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washing
Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washing
Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washing
Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washing
Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washing
Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washing
Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Northe
Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Northe
Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Northe
Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Northe
Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Northe
Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Northe
Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Northe
Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Northe
Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Northe
Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Northe
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinic
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinic
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinic
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinic
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinic
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinic
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinic
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinic
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinic
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinic
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinic
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinic
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinic
Informing patients about urinary incontinence.
Informing patients about urinary incontinence.
Informing patients about urinary incontinence.
High-altitude cerebral edema.
High-altitude cerebral edema.
High-altitude cerebral edema.
High-altitude cerebral edema.
High-altitude cerebral edema.
High-altitude cerebral edema.
High-altitude cerebral edema.
Editorial independence and THE JOURNAL.
Editorial independence and THE JOURNAL.
Editorial independence and THE JOURNAL.
Editorial independence and THE JOURNAL.
Editorial independence and THE JOURNAL.
Editorial independence and THE JOURNAL.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
The firing of Dr Lundberg.
From the Centers for Disease Control and Prevention. Outbreak of Hendra-like virus--Malaysia and Singapore, 1998-1999.
From the Centers for Disease Control and Prevention. Outbreak of Hendra-like virus--Malaysia and Singapore, 1998-1999.
From the Centers for Disease Control and Prevention. Outbreaks of Shigella sonnei infection associated with eating fresh pars
Drug doings Down Under.
Drug doings Down Under.
AAMC analyzes 1997 Balanced Budget Act. Association of American Medical Colleges.
AAMC analyzes 1997 Balanced Budget Act. Association of American Medical Colleges.
The arts of healing.
The arts of healing.
A piece of my mind. Saying good-bye.
A piece of my mind. Saying good-bye.
JAMA Patient Page: food-borne illnesses.
The trials and tribulations of clinical practice guidelines.
The trials and tribulations of clinical practice guidelines.
The trials and tribulations of clinical practice guidelines.
The trials and tribulations of clinical practice guidelines.
The trials and tribulations of clinical practice guidelines.
Prophylactic cesarean delivery for the prevention of perinatal human immunodeficiency virus transmission: the case for restr
Prophylactic cesarean delivery for the prevention of perinatal human immunodeficiency virus transmission: the case for restr
Prophylactic cesarean delivery for the prevention of perinatal human immunodeficiency virus transmission: the case for restr
Prophylactic cesarean delivery for the prevention of perinatal human immunodeficiency virus transmission: the case for restr
A 55-year-old man with attention-deficit/hyperactivity disorder, 1 year later.
A 55-year-old man with attention-deficit/hyperactivity disorder, 1 year later.
A 55-year-old man with attention-deficit/hyperactivity disorder, 1 year later.
A 55-year-old man with attention-deficit/hyperactivity disorder, 1 year later.
A 44-year-old woman with severe pain at the end of life.
A 44-year-old woman with severe pain at the end of life.
A 44-year-old woman with severe pain at the end of life.
A 44-year-old woman with severe pain at the end of life.
A 44-year-old woman with severe pain at the end of life.
Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
Clinical epidemiological quality in molecular genetic research: the need for methodological standards.
Clinical epidemiological quality in molecular genetic research: the need for methodological standards.
Clinical epidemiological quality in molecular genetic research: the need for methodological standards.
Clinical epidemiological quality in molecular genetic research: the need for methodological standards.
Clinical epidemiological quality in molecular genetic research: the need for methodological standards.
Clinical epidemiological quality in molecular genetic research: the need for methodological standards.
Clinical epidemiological quality in molecular genetic research: the need for methodological standards.
Tourism and hotel revenues before and after passage of smoke-free restaurant ordinances.
Tourism and hotel revenues before and after passage of smoke-free restaurant ordinances.
Tourism and hotel revenues before and after passage of smoke-free restaurant ordinances.
Tourism and hotel revenues before and after passage of smoke-free restaurant ordinances.
Tourism and hotel revenues before and after passage of smoke-free restaurant ordinances.
Tourism and hotel revenues before and after passage of smoke-free restaurant ordinances.
Tourism and hotel revenues before and after passage of smoke-free restaurant ordinances.
Risk of meningococcal infection in college students.
Risk of meningococcal infection in college students.
Risk of meningococcal infection in college students.
Risk of meningococcal infection in college students.
Risk of meningococcal infection in college students.
Risk of meningococcal infection in college students.
Risk of meningococcal infection in college students.
Risk of meningococcal infection in college students.
Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical lit
Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical lit
Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical lit
Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical lit
Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical lit
Fall-induced injuries and deaths among older adults.
Fall-induced injuries and deaths among older adults.
Fall-induced injuries and deaths among older adults.
Fall-induced injuries and deaths among older adults.
Fall-induced injuries and deaths among older adults.
Fall-induced injuries and deaths among older adults.
Fall-induced injuries and deaths among older adults.
Fall-induced injuries and deaths among older adults.
Fall-induced injuries and deaths among older adults.
Fall-induced injuries and deaths among older adults.
Are enteric infections associated with unpasteurized orange juice?
Are enteric infections associated with unpasteurized orange juice?
Are enteric infections associated with unpasteurized orange juice?
Dose of tricyclic antidepressants in elderly patients.
Dose of tricyclic antidepressants in elderly patients.
Dose of tricyclic antidepressants in elderly patients.
Care of prison inmates by impaired disciplined physicians.
Care of prison inmates by impaired disciplined physicians.
Care of prison inmates by impaired disciplined physicians.
Care of prison inmates by impaired disciplined physicians.
Care of prison inmates by impaired disciplined physicians.
Care of prison inmates by impaired disciplined physicians.
Care of prison inmates by impaired disciplined physicians.
Care of prison inmates by impaired disciplined physicians.
Care of prison inmates by impaired disciplined physicians.
Care of prison inmates by impaired disciplined physicians.
Low-dose hydrocortisone for chronic fatigue syndrome.
Low-dose hydrocortisone for chronic fatigue syndrome.
Low-dose hydrocortisone for chronic fatigue syndrome.
Low-dose hydrocortisone for chronic fatigue syndrome.
Low-dose hydrocortisone for chronic fatigue syndrome.
Low-dose hydrocortisone for chronic fatigue syndrome.
Low-dose hydrocortisone for chronic fatigue syndrome.
Low-dose hydrocortisone for chronic fatigue syndrome.
Low-dose hydrocortisone for chronic fatigue syndrome.
Low-dose hydrocortisone for chronic fatigue syndrome.
Low-dose hydrocortisone for chronic fatigue syndrome.
Low-dose hydrocortisone for chronic fatigue syndrome.
Low-dose hydrocortisone for chronic fatigue syndrome.
Low-dose hydrocortisone for chronic fatigue syndrome.
From the Centers for Disease Control and Prevention. Back pain among persons working on small or family farms--eight Color
From the Centers for Disease Control and Prevention. Assessment of public health computer readiness for 2000--United State
From the Centers for Disease Control and Prevention. Knowledge and use of folic acid by women of childbearing age--United
Eradication efforts need needle-free delivery.
Eradication efforts need needle-free delivery.
Schizophrenia researchers striving for early detection and intervention.
Schizophrenia researchers striving for early detection and intervention.
New findings in the genetics of alcoholism.
New findings in the genetics of alcoholism.
New findings in the genetics of alcoholism.
New findings in the genetics of alcoholism.
New findings in the genetics of alcoholism.
JAMA Patient Page: fall-induced injuries.
Primary care physicians should be coordinators, not gatekeepers.
Primary care physicians should be coordinators, not gatekeepers.
Primary care physicians should be coordinators, not gatekeepers.
Primary care physicians should be coordinators, not gatekeepers.
Primary care physicians should be coordinators, not gatekeepers.
Primary care physicians should be coordinators, not gatekeepers.
Primary care physicians should be coordinators, not gatekeepers.
Medical, legal, and societal implications of androstenedione use.
Medical, legal, and societal implications of androstenedione use.
Medical, legal, and societal implications of androstenedione use.
Decisions regarding treatment of seriously ill newborns.
Decisions regarding treatment of seriously ill newborns.
Decisions regarding treatment of seriously ill newborns.
Geographic variation in physician visits for uninsured children: the role of the safety net.
Geographic variation in physician visits for uninsured children: the role of the safety net.
Geographic variation in physician visits for uninsured children: the role of the safety net.
Geographic variation in physician visits for uninsured children: the role of the safety net.
Geographic variation in physician visits for uninsured children: the role of the safety net.
Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based M
Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based M
Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based M
Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based M
Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based M
Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based M
Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based M
Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based M
Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based M
Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized con
Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized con
Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized con
Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized con
Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized con
Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized con
Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized con
Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized con
Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized con
Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized con
Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized con
Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized con
Protein-energy undernutrition among elderly hospitalized patients: a prospective study.
Protein-energy undernutrition among elderly hospitalized patients: a prospective study.
Protein-energy undernutrition among elderly hospitalized patients: a prospective study.
Protein-energy undernutrition among elderly hospitalized patients: a prospective study.
Protein-energy undernutrition among elderly hospitalized patients: a prospective study.
Protein-energy undernutrition among elderly hospitalized patients: a prospective study.
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirem
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirem
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirem
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirem
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirem
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirem
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirem
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirem
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirem
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirem
Long-term intake of dietary fiber and decreased risk of coronary heart disease among women.
Long-term intake of dietary fiber and decreased risk of coronary heart disease among women.
Long-term intake of dietary fiber and decreased risk of coronary heart disease among women.
Long-term intake of dietary fiber and decreased risk of coronary heart disease among women.
Long-term intake of dietary fiber and decreased risk of coronary heart disease among women.
Long-term intake of dietary fiber and decreased risk of coronary heart disease among women.
Long-term intake of dietary fiber and decreased risk of coronary heart disease among women.
Long-term intake of dietary fiber and decreased risk of coronary heart disease among women.
Long-term intake of dietary fiber and decreased risk of coronary heart disease among women.
Long-term intake of dietary fiber and decreased risk of coronary heart disease among women.
Long-term intake of dietary fiber and decreased risk of coronary heart disease among women.
Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents.
Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents.
Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents.
Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents.
Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents.
Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents.
Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents.
Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents.
Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents.
Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents.
Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents.
Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents.
Diagnosing abdominal aortic aneurysm.
Diagnosing abdominal aortic aneurysm.
Diagnosing abdominal aortic aneurysm.
Diagnosing abdominal aortic aneurysm.
Should beta-blockers be used to treat hypertension in elderly patients?
Should beta-blockers be used to treat hypertension in elderly patients?
Should beta-blockers be used to treat hypertension in elderly patients?
Should beta-blockers be used to treat hypertension in elderly patients?
Screening for type 2 diabetes.
Screening for type 2 diabetes.
Screening for type 2 diabetes.
Screening for type 2 diabetes.
Screening for type 2 diabetes.
Screening for type 2 diabetes.
Screening for type 2 diabetes.
Glycemic control and quality of life in patients with type 2 diabetes.
Glycemic control and quality of life in patients with type 2 diabetes.
Glycemic control and quality of life in patients with type 2 diabetes.
Glycemic control and quality of life in patients with type 2 diabetes.
Glycemic control and quality of life in patients with type 2 diabetes.
Glycemic control and quality of life in patients with type 2 diabetes.
Glycemic control and quality of life in patients with type 2 diabetes.
Adding behavioral therapy to medication for smoking cessation.
Adding behavioral therapy to medication for smoking cessation.
Adding behavioral therapy to medication for smoking cessation.
Adding behavioral therapy to medication for smoking cessation.
Adding behavioral therapy to medication for smoking cessation.
Adding behavioral therapy to medication for smoking cessation.
Adding behavioral therapy to medication for smoking cessation.
Adding behavioral therapy to medication for smoking cessation.
Adding behavioral therapy to medication for smoking cessation.
Adding behavioral therapy to medication for smoking cessation.
Adding behavioral therapy to medication for smoking cessation.
Adding behavioral therapy to medication for smoking cessation.
Adding behavioral therapy to medication for smoking cessation.
Adding behavioral therapy to medication for smoking cessation.
Adding behavioral therapy to medication for smoking cessation.
Adding behavioral therapy to medication for smoking cessation.
Adding behavioral therapy to medication for smoking cessation.
From the Centers for Disease Control and Prevention. Frequency of vaccine-related and therapeutic injections--Romania, 199
From the Centers for Disease Control and Prevention. Impact of multiple births on low birthweight--Massachusetts, 1989-199
From the Centers for Disease Control and Prevention. Aldicarb as a cause of food poisoning--Louisiana, 1998.
From the Food and Drug Administration.
From the Food and Drug Administration.
Association for patient-oriented research.
Association for patient-oriented research.
New report rejects accrediting of those who provide ethics consultation services.
New report rejects accrediting of those who provide ethics consultation services.
Billions in compensation for toxic oil poisoning victims.
Billions in compensation for toxic oil poisoning victims.
Pediatricians alerted to five new vaccines.
Pediatricians alerted to five new vaccines.
JAMA Patient Page: fiber.
Can physician profiles be trusted?
Can physician profiles be trusted?
Can physician profiles be trusted?
Hormone replacement therapy and risk of breast cancer.
Hormone replacement therapy and risk of breast cancer.
Hormone replacement therapy and risk of breast cancer.
Hormone replacement therapy and risk of breast cancer.
Hormone replacement therapy and risk of breast cancer.
The need for global action against multidrug-resistant tuberculosis.
The need for global action against multidrug-resistant tuberculosis.
The need for global action against multidrug-resistant tuberculosis.
The need for global action against multidrug-resistant tuberculosis.
The need for global action against multidrug-resistant tuberculosis.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency dep
Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency dep
Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency dep
Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency dep
Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency dep
Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency dep
Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency dep
Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency dep
Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency dep
Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency dep
Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency dep
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.
A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men.
A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men.
A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men.
A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men.
A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men.
A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men.
A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men.
A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men.
A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men.
A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men.
The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease.
The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease.
The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease.
The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease.
The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease.
The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease.
The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease.
The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease.
The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease.
The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease.
Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Stud
Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Stud
Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Stud
Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Stud
Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Stud
Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Stud
The realities of resident research requirements.
The realities of resident research requirements.
The realities of resident research requirements.
Yoga for carpal tunnel syndrome.
Yoga for carpal tunnel syndrome.
Yoga for carpal tunnel syndrome.
Yoga for carpal tunnel syndrome.
Yoga for carpal tunnel syndrome.
Yoga for carpal tunnel syndrome.
Yoga for carpal tunnel syndrome.
Yoga for carpal tunnel syndrome.
Yoga for carpal tunnel syndrome.
Yoga for carpal tunnel syndrome.
Yoga for carpal tunnel syndrome.
Epidural analgesia and cesarean delivery.
Epidural analgesia and cesarean delivery.
Epidural analgesia and cesarean delivery.
Epidural analgesia and cesarean delivery.
Epidural analgesia and cesarean delivery.
Epidural analgesia and cesarean delivery.
Epidural analgesia and cesarean delivery.
Epidural analgesia and cesarean delivery.
Epidural analgesia and cesarean delivery.
Epidural analgesia and cesarean delivery.
Epidural analgesia and cesarean delivery.
Epidural analgesia and cesarean delivery.
Epidural analgesia and cesarean delivery.
Cost-effectiveness of interferon treatment for hepatitis C.
Cost-effectiveness of interferon treatment for hepatitis C.
Cost-effectiveness of interferon treatment for hepatitis C.
Cost-effectiveness of interferon treatment for hepatitis C.
Cost-effectiveness of interferon treatment for hepatitis C.
Cost-effectiveness of interferon treatment for hepatitis C.
From the Centers for Disease Control and Prevention. Motor-vehicle safety: a 20th century public health achievement.
Care gap "unconscionable"; universal coverage AAP aim. American Academy of Pediatrics.
Care gap "unconscionable"; universal coverage AAP aim. American Academy of Pediatrics.
New pharmaceutical approaches to stroke prevention, treatment.
New pharmaceutical approaches to stroke prevention, treatment.
Improved stroke imaging techniques.
Improved stroke imaging techniques.
Buckle up! Is not enough: enhancing protection of the restrained child.
Buckle up! Is not enough: enhancing protection of the restrained child.
Buckle up! Is not enough: enhancing protection of the restrained child.
Buckle up! Is not enough: enhancing protection of the restrained child.
JAMA Patient Page: asthma.
Choosing the best strategy to prevent childhood iron deficiency.
Choosing the best strategy to prevent childhood iron deficiency.
Choosing the best strategy to prevent childhood iron deficiency.
Declines in drowning: exploring the epidemiology of favorable trends.
Declines in drowning: exploring the epidemiology of favorable trends.
Declines in drowning: exploring the epidemiology of favorable trends.
Declines in drowning: exploring the epidemiology of favorable trends.
Declines in drowning: exploring the epidemiology of favorable trends.
Declines in drowning: exploring the epidemiology of favorable trends.
Declines in drowning: exploring the epidemiology of favorable trends.
Encouraging news from the SERM frontier. Selective estrogen receptor modulator.
Encouraging news from the SERM frontier. Selective estrogen receptor modulator.
Encouraging news from the SERM frontier. Selective estrogen receptor modulator.
Encouraging news from the SERM frontier. Selective estrogen receptor modulator.
Editorial governance of the Journal of the American Medical Association: a report.
Editorial governance of the Journal of the American Medical Association: a report.
Editorial governance of the Journal of the American Medical Association: a report.
The rational clinical examination. Does this patient have aortic regurgitation?
The rational clinical examination. Does this patient have aortic regurgitation?
The rational clinical examination. Does this patient have aortic regurgitation?
The rational clinical examination. Does this patient have aortic regurgitation?
The rational clinical examination. Does this patient have aortic regurgitation?
Reticulocyte hemoglobin content to diagnose iron deficiency in children.
Reticulocyte hemoglobin content to diagnose iron deficiency in children.
Reticulocyte hemoglobin content to diagnose iron deficiency in children.
Reticulocyte hemoglobin content to diagnose iron deficiency in children.
Reticulocyte hemoglobin content to diagnose iron deficiency in children.
Reticulocyte hemoglobin content to diagnose iron deficiency in children.
Reticulocyte hemoglobin content to diagnose iron deficiency in children.
Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia.
Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia.
Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia.
Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia.
Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia.
Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia.
Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia.
Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia.
Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia.
Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia.
Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia.
Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia.
Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness.
Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness.
Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness.
Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness.
Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness.
Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness.
Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness.
Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness.
Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness.
Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients. Multicenter Study of Periopera
Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients. Multicenter Study of Periopera
Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients. Multicenter Study of Periopera
Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients. Multicenter Study of Periopera
Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients. Multicenter Study of Periopera
Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients. Multicenter Study of Periopera
Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients. Multicenter Study of Periopera
Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients. Multicenter Study of Periopera
Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients. Multicenter Study of Periopera
Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients. Multicenter Study of Periopera
Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients. Multicenter Study of Periopera
Trends in unintentional drowning: the role of alcohol and medical care.
Trends in unintentional drowning: the role of alcohol and medical care.
Trends in unintentional drowning: the role of alcohol and medical care.
Trends in unintentional drowning: the role of alcohol and medical care.
Trends in unintentional drowning: the role of alcohol and medical care.
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple
New perspectives in glaucoma.
New perspectives in glaucoma.
New perspectives in glaucoma.
New perspectives in glaucoma.
New perspectives in glaucoma.
Interpretation of research on sexual abuse of boys.
Interpretation of research on sexual abuse of boys.
Interpretation of research on sexual abuse of boys.
Interpretation of research on sexual abuse of boys.
Interpretation of research on sexual abuse of boys.
Interpretation of research on sexual abuse of boys.
Interpretation of research on sexual abuse of boys.
Interpretation of research on sexual abuse of boys.
Interpretation of research on sexual abuse of boys.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
Autopsy rates and diagnosis.
From the Centers for Disease Control and Prevention. Outbreak of poliomyelitis--Angola, 1999.
From the Centers for Disease Control and Prevention. Update: influenza activity--United States and worldwide, 1998-99 seaso
From the Centers for Disease Control and Prevention. Impact of arthritis and other rheumatic conditions on the health-care s
From the Health Care Financing Administration.
From the Health Care Financing Administration.
Treat arthritis earlier, better.
Treat arthritis earlier, better.
Survey says patients expect little physician help on sex.
Survey says patients expect little physician help on sex.
Respiratory research's reach.
Respiratory research's reach.
Why the rise in asthma? New insight, few answers.
Why the rise in asthma? New insight, few answers.
A piece of my mind. Cold blue.
A piece of my mind. Cold blue.
JAMA Patient Page: water safety.
A new source of resistance to HIV drugs.
A new source of resistance to HIV drugs.
A new source of resistance to HIV drugs.
Independence, governance, and trust: redefining the relationship between JAMA and the AMA.
Independence, governance, and trust: redefining the relationship between JAMA and the AMA.
Independence, governance, and trust: redefining the relationship between JAMA and the AMA.
Independence, governance, and trust: redefining the relationship between JAMA and the AMA.
Hypoxia is the cause of brain damage in hyponatremia.
Hypoxia is the cause of brain damage in hyponatremia.
Reducing blood lead levels: benefits and strategies.
Reducing blood lead levels: benefits and strategies.
Reducing blood lead levels: benefits and strategies.
Risk of transmission of bovine spongiform encephalopathy to humans in the United States: report of the Council on Scientific
Risk of transmission of bovine spongiform encephalopathy to humans in the United States: report of the Council on Scientific
Risk of transmission of bovine spongiform encephalopathy to humans in the United States: report of the Council on Scientific
Risk of transmission of bovine spongiform encephalopathy to humans in the United States: report of the Council on Scientific
Risk of transmission of bovine spongiform encephalopathy to humans in the United States: report of the Council on Scientific
Risk of transmission of bovine spongiform encephalopathy to humans in the United States: report of the Council on Scientific
Risk of transmission of bovine spongiform encephalopathy to humans in the United States: report of the Council on Scientific
A 29-year-old man with multiple sclerosis, 1 year later.
A 29-year-old man with multiple sclerosis, 1 year later.
A 29-year-old man with multiple sclerosis, 1 year later.
A 29-year-old man with multiple sclerosis, 1 year later.
A 75-year-old man with congestive heart failure.
A 75-year-old man with congestive heart failure.
A 75-year-old man with congestive heart failure.
A 75-year-old man with congestive heart failure.
A 75-year-old man with congestive heart failure.
Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.
Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.
Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.
Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.
Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.
Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.
Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.
Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.
Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.
Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.
Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.
Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.
Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.
Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study.
Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality.
Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality.
Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality.
Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality.
Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality.
Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality.
Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality.
Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality.
Association of dental caries and blood lead levels.
Association of dental caries and blood lead levels.
Association of dental caries and blood lead levels.
Association of dental caries and blood lead levels.
Association of dental caries and blood lead levels.
Association of dental caries and blood lead levels.
Relationship of ascorbic acid to blood lead levels.
Relationship of ascorbic acid to blood lead levels.
Relationship of ascorbic acid to blood lead levels.
Relationship of ascorbic acid to blood lead levels.
Relationship of ascorbic acid to blood lead levels.
Relationship of ascorbic acid to blood lead levels.
Meta-analysis of tacrine for Alzheimer disease: the influence of industry sponsors.
Meta-analysis of tacrine for Alzheimer disease: the influence of industry sponsors.
Meta-analysis of tacrine for Alzheimer disease: the influence of industry sponsors.
Meta-analysis of tacrine for Alzheimer disease: the influence of industry sponsors.
Meta-analysis of tacrine for Alzheimer disease: the influence of industry sponsors.
Poetry and medicine.
Poetry and medicine.
Damages and the expert witness.
Damages and the expert witness.
Abdominal adiposity and risk of heart disease.
Abdominal adiposity and risk of heart disease.
Abdominal adiposity and risk of heart disease.
Abdominal adiposity and risk of heart disease.
Patient self-management of oral anticoagulation.
Patient self-management of oral anticoagulation.
Patient self-management of oral anticoagulation.
Patient self-management of oral anticoagulation.
Clinical crossroads: a 45-year-old woman with premenstrual dysphoric disorder.
Clinical crossroads: a 45-year-old woman with premenstrual dysphoric disorder.
Clinical crossroads: a 45-year-old woman with premenstrual dysphoric disorder.
Anonymous HIV testing and medical care.
Anonymous HIV testing and medical care.
Anonymous HIV testing and medical care.
From the Centers for Disease Control and Prevention. Determination of nicotine, pH, and moisture content of six US commer
From the Centers for Disease Control and Prevention. Prenatal discussion of HIV testing and maternal HIV testing--14 states, 1
Governance plan paves way for search for JAMA editor.
Governance plan paves way for search for JAMA editor.
Prostate detection possibility.
Prostate detection possibility.
Probing informed consent in schizophrenia research.
Probing informed consent in schizophrenia research.
Lithium: proving its mettle for 50 years.
Lithium: proving its mettle for 50 years.
Lithium: proving its mettle for 50 years.
Stress-induced immunomodulation: implications for infectious diseases?
Stress-induced immunomodulation: implications for infectious diseases?
Stress-induced immunomodulation: implications for infectious diseases?
Stress-induced immunomodulation: implications for infectious diseases?
Stress-induced immunomodulation: implications for infectious diseases?
Stress-induced immunomodulation: implications for infectious diseases?
Stress-induced immunomodulation: implications for infectious diseases?
Stress-induced immunomodulation: implications for infectious diseases?
JAMA Patient Page: lead poisoning.
Lyme disease serology: problems and opportunities.
Lyme disease serology: problems and opportunities.
Lyme disease serology: problems and opportunities.
Lyme disease serology: problems and opportunities.
Lyme disease serology: problems and opportunities.
Progress in understanding ventilator-induced lung injury.
Progress in understanding ventilator-induced lung injury.
Progress in understanding ventilator-induced lung injury.
New options for prevention and control of influenza.
New options for prevention and control of influenza.
New options for prevention and control of influenza.
Users' Guides to the Medical Literature: XVIII. How to use an article evaluating the clinical impact of a computer-based clinica
Users' Guides to the Medical Literature: XVIII. How to use an article evaluating the clinical impact of a computer-based clinica
Users' Guides to the Medical Literature: XVIII. How to use an article evaluating the clinical impact of a computer-based clinica
Users' Guides to the Medical Literature: XVIII. How to use an article evaluating the clinical impact of a computer-based clinica
Users' Guides to the Medical Literature: XVIII. How to use an article evaluating the clinical impact of a computer-based clinica
Users' Guides to the Medical Literature: XVIII. How to use an article evaluating the clinical impact of a computer-based clinica
Role of serology in the diagnosis of Lyme disease.
Role of serology in the diagnosis of Lyme disease.
Role of serology in the diagnosis of Lyme disease.
Role of serology in the diagnosis of Lyme disease.
Role of serology in the diagnosis of Lyme disease.
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomiz
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomiz
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomiz
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomiz
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomiz
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomiz
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomiz
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomiz
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomiz
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomiz
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomiz
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomiz
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomiz
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomiz
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measl
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measl
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measl
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measl
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measl
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measl
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measl
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measl
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measl
The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.
The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.
The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.
The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.
The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.
The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.
The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.
Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers.
Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers.
Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers.
Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers.
Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers.
Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
Liver enzyme elevations in patients treated with traditional Chinese medicine.
Liver enzyme elevations in patients treated with traditional Chinese medicine.
Liver enzyme elevations in patients treated with traditional Chinese medicine.
Liver enzyme elevations in patients treated with traditional Chinese medicine.
Liver enzyme elevations in patients treated with traditional Chinese medicine.
Liver enzyme elevations in patients treated with traditional Chinese medicine.
Liver enzyme elevations in patients treated with traditional Chinese medicine.
Inappropriate secretion of natriuretic peptides in a patient with a cerebral tumor.
Inappropriate secretion of natriuretic peptides in a patient with a cerebral tumor.
Inappropriate secretion of natriuretic peptides in a patient with a cerebral tumor.
Inappropriate secretion of natriuretic peptides in a patient with a cerebral tumor.
Inappropriate secretion of natriuretic peptides in a patient with a cerebral tumor.
Inappropriate secretion of natriuretic peptides in a patient with a cerebral tumor.
Inappropriate secretion of natriuretic peptides in a patient with a cerebral tumor.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
The law, the AMA, and partial-birth abortion. American Medical Association.
From the Centers for Disease Control and Prevention. Blastomycosis acquired occupationally during prairie dog relocation--Co
From the Centers for Disease Control and Prevention. Blastomycosis acquired occupationally during prairie dog relocation--Co
From the Centers for Disease Control and Prevention. Cluster of HIV-positive young women--New York, 1997-1998.
From the Food and Drug Administration.
From the Food and Drug Administration.
Spain leads world in organ donation and transplantation.
Spain leads world in organ donation and transplantation.
Debate revived on hepatitis B vaccine value.
Debate revived on hepatitis B vaccine value.
Debate revived on hepatitis B vaccine value.
Mentally healthy men at midlife.
Mentally healthy men at midlife.
"If I work hard(er), I will be loved." Roots of physician stress explored.
"If I work hard(er), I will be loved." Roots of physician stress explored.
A piece of my mind. Master class.
A piece of my mind. Master class.
JAMA Patient Page: immunizations.
Voters and health care in the 1998 election.
Voters and health care in the 1998 election.
Voters and health care in the 1998 election.
Voters and health care in the 1998 election.
Voters and health care in the 1998 election.
Voters and health care in the 1998 election.
Voters and health care in the 1998 election.
What is carpal tunnel syndrome?
What is carpal tunnel syndrome?
What is carpal tunnel syndrome?
What is carpal tunnel syndrome?
Coronary angiography: a long look at a short queue.
Coronary angiography: a long look at a short queue.
Coronary angiography: a long look at a short queue.
Coronary angiography: a long look at a short queue.
Intranasal influenza vaccine: adding to the armamentarium for influenza control.
Intranasal influenza vaccine: adding to the armamentarium for influenza control.
Intranasal influenza vaccine: adding to the armamentarium for influenza control.
Intranasal influenza vaccine: adding to the armamentarium for influenza control.
The rational clinical examination. Does this adult patient have acute meningitis?
The rational clinical examination. Does this adult patient have acute meningitis?
The rational clinical examination. Does this adult patient have acute meningitis?
The rational clinical examination. Does this adult patient have acute meningitis?
The rational clinical examination. Does this adult patient have acute meningitis?
The rational clinical examination. Does this adult patient have acute meningitis?
The rational clinical examination. Does this adult patient have acute meningitis?
A new doctor in the house: ethical issues in hospitalist systems.
A new doctor in the house: ethical issues in hospitalist systems.
A new doctor in the house: ethical issues in hospitalist systems.
A new doctor in the house: ethical issues in hospitalist systems.
A new doctor in the house: ethical issues in hospitalist systems.
A new doctor in the house: ethical issues in hospitalist systems.
A new doctor in the house: ethical issues in hospitalist systems.
Mandatory reporting of diseases and conditions by health care professionals and laboratories.
Mandatory reporting of diseases and conditions by health care professionals and laboratories.
Mandatory reporting of diseases and conditions by health care professionals and laboratories.
Mandatory reporting of diseases and conditions by health care professionals and laboratories.
Mandatory reporting of diseases and conditions by health care professionals and laboratories.
Mandatory reporting of diseases and conditions by health care professionals and laboratories.
Mandatory reporting of diseases and conditions by health care professionals and laboratories.
Quality of care in investor-owned vs not-for-profit HMOs.
Quality of care in investor-owned vs not-for-profit HMOs.
Quality of care in investor-owned vs not-for-profit HMOs.
Quality of care in investor-owned vs not-for-profit HMOs.
Quality of care in investor-owned vs not-for-profit HMOs.
Quality of care in investor-owned vs not-for-profit HMOs.
Quality of care in investor-owned vs not-for-profit HMOs.
Prevalence of carpal tunnel syndrome in a general population.
Prevalence of carpal tunnel syndrome in a general population.
Prevalence of carpal tunnel syndrome in a general population.
Prevalence of carpal tunnel syndrome in a general population.
Prevalence of carpal tunnel syndrome in a general population.
Prevalence of carpal tunnel syndrome in a general population.
Prevalence of carpal tunnel syndrome in a general population.
Prevalence of carpal tunnel syndrome in a general population.
Prevalence of carpal tunnel syndrome in a general population.
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list re
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list re
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list re
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list re
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list re
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list re
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list re
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list re
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list re
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list re
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list re
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list re
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list re
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list re
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
Risks and benefits of gun ownership.
Risks and benefits of gun ownership.
Risks and benefits of gun ownership.
A close look at standards for therapeutic touch.
A close look at standards for therapeutic touch.
A close look at standards for therapeutic touch.
Gabapentin for postherpetic neuralgia.
Gabapentin for postherpetic neuralgia.
Gabapentin for postherpetic neuralgia.
Gabapentin for postherpetic neuralgia.
Gabapentin for painful diabetic neuropathy.
Gabapentin for painful diabetic neuropathy.
Gabapentin for painful diabetic neuropathy.
Gabapentin for painful diabetic neuropathy.
Gabapentin for painful diabetic neuropathy.
Exploring the ethics of clinical role conflicts.
Exploring the ethics of clinical role conflicts.
Exploring the ethics of clinical role conflicts.
Exploring the ethics of clinical role conflicts.
Exploring the ethics of clinical role conflicts.
Exploring the ethics of clinical role conflicts.
Effect of lifestyle changes on coronary heart disease.
Effect of lifestyle changes on coronary heart disease.
Effect of lifestyle changes on coronary heart disease.
Effect of lifestyle changes on coronary heart disease.
Effect of lifestyle changes on coronary heart disease.
Effect of lifestyle changes on coronary heart disease.
Effect of lifestyle changes on coronary heart disease.
From the Centers for Disease Control and Prevention. Illnesses associated with occupational use of flea-control products--Cal
From the Centers for Disease Control and Prevention. Illnesses associated with occupational use of flea-control products--Cal
From the Centers for Disease Control and Prevention. Patients' reports of counseling on mammography screening by health-c
Animal feed antibiotic use raises drug resistance fear.
Animal feed antibiotic use raises drug resistance fear.
Report on Australian research ups funding.
Report on Australian research ups funding.
Opinions divided on high-dose chemotherapy for breast cancer.
Opinions divided on high-dose chemotherapy for breast cancer.
Experts debate drugs for healthy women with breast cancer risk.
Experts debate drugs for healthy women with breast cancer risk.
Prescribing for seniors: neither too much nor too little.
Prescribing for seniors: neither too much nor too little.
Prescribing for seniors: neither too much nor too little.
A piece of my mind. To whom shall I tell my grief?
A piece of my mind. To whom shall I tell my grief?
JAMA Patient Page: carpal tunnel syndrome.
HIV/AIDS guidelines.
False memories, lasting scars.
False memories, lasting scars.
Molecular diagnosis of hereditary nonpolyposis colorectal cancer.
Molecular diagnosis of hereditary nonpolyposis colorectal cancer.
Molecular diagnosis of hereditary nonpolyposis colorectal cancer.
Should patients with diabetes drink to their health?
Should patients with diabetes drink to their health?
Should patients with diabetes drink to their health?
Should patients with diabetes drink to their health?
Acquired aplastic anemia.
Acquired aplastic anemia.
Acquired aplastic anemia.
Acquired aplastic anemia.
Acquired aplastic anemia.
Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
Resolving the gatekeeper conundrum: what patients value in primary care and referrals to specialists.
Resolving the gatekeeper conundrum: what patients value in primary care and referrals to specialists.
Resolving the gatekeeper conundrum: what patients value in primary care and referrals to specialists.
Resolving the gatekeeper conundrum: what patients value in primary care and referrals to specialists.
Resolving the gatekeeper conundrum: what patients value in primary care and referrals to specialists.
Resolving the gatekeeper conundrum: what patients value in primary care and referrals to specialists.
Resolving the gatekeeper conundrum: what patients value in primary care and referrals to specialists.
Resolving the gatekeeper conundrum: what patients value in primary care and referrals to specialists.
Resolving the gatekeeper conundrum: what patients value in primary care and referrals to specialists.
Resolving the gatekeeper conundrum: what patients value in primary care and referrals to specialists.
Low-density lipoprotein cholesterol and the risk of dementia with stroke.
Low-density lipoprotein cholesterol and the risk of dementia with stroke.
Low-density lipoprotein cholesterol and the risk of dementia with stroke.
Low-density lipoprotein cholesterol and the risk of dementia with stroke.
Low-density lipoprotein cholesterol and the risk of dementia with stroke.
Low-density lipoprotein cholesterol and the risk of dementia with stroke.
Low-density lipoprotein cholesterol and the risk of dementia with stroke.
Low-density lipoprotein cholesterol and the risk of dementia with stroke.
Low-density lipoprotein cholesterol and the risk of dementia with stroke.
Low-density lipoprotein cholesterol and the risk of dementia with stroke.
Low-density lipoprotein cholesterol and the risk of dementia with stroke.
Low-density lipoprotein cholesterol and the risk of dementia with stroke.
Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition tes
Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition tes
Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition tes
Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition tes
Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition tes
Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition tes
Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition tes
Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition tes
Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition tes
Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition tes
Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus.
Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus.
Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus.
Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus.
Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus.
Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus.
Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus.
Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus.
Stressful events and peptic ulcer disease.
Stressful events and peptic ulcer disease.
Stressful events and peptic ulcer disease.
NIH consensus definition and classification of prostatitis.
NIH consensus definition and classification of prostatitis.
NIH consensus definition and classification of prostatitis.
NIH consensus definition and classification of prostatitis.
Managed care market share, fee-for-service Medicare, and information theory.
Managed care market share, fee-for-service Medicare, and information theory.
Managed care market share, fee-for-service Medicare, and information theory.
Managed care market share, fee-for-service Medicare, and information theory.
Managed care market share, fee-for-service Medicare, and information theory.
Garcinia cambogia for weight loss.
Garcinia cambogia for weight loss.
Garcinia cambogia for weight loss.
Garcinia cambogia for weight loss.
Garcinia cambogia for weight loss.
Garcinia cambogia for weight loss.
Garcinia cambogia for weight loss.
Garcinia cambogia for weight loss.
Garcinia cambogia for weight loss.
Garcinia cambogia for weight loss.
Spinal manipulation for tension-type headache.
Spinal manipulation for tension-type headache.
Spinal manipulation for tension-type headache.
Spinal manipulation for tension-type headache.
Spinal manipulation for tension-type headache.
Spinal manipulation for tension-type headache.
Spinal manipulation for tension-type headache.
Spinal manipulation for tension-type headache.
Spinal manipulation for tension-type headache.
Spinal manipulation for tension-type headache.
Alendronate and fracture prevention.
Alendronate and fracture prevention.
Alendronate and fracture prevention.
Alendronate and fracture prevention.
From the Centers for Disease Control and Prevention. Availability of updated HIV treatment guidelines.
From the Centers for Disease Control and Prevention. Trends in HIV-related sexual risk behaviors among high school students
From the Centers for Disease Control and Prevention. Heat-related illnesses and deaths--Missouri, 1998, and United States, 1
From the Centers for Disease Control and Prevention. Heat-related illnesses and deaths--Missouri, 1998, and United States, 1
Environmental health center aims at children.
Environmental health center aims at children.
Safety of antidepressant use in pregnant and nursing women.
Safety of antidepressant use in pregnant and nursing women.
Third millennium challenge: hepatitis C.
Third millennium challenge: hepatitis C.
A piece of my mind. The blue drape.
A piece of my mind. The blue drape.
JAMA Patient Page: drug adherence.
Function of the thymus in HIV-infected adults.
Function of the thymus in HIV-infected adults.
Function of the thymus in HIV-infected adults.
Function of the thymus in HIV-infected adults.
HIV test warning.
Hospital peer review and clinical privileges actions: to report or not report.
Hospital peer review and clinical privileges actions: to report or not report.
Hospital peer review and clinical privileges actions: to report or not report.
Herpes simplex virus vaccines--why don't antibodies protect?
Herpes simplex virus vaccines--why don't antibodies protect?
Herpes simplex virus vaccines--why don't antibodies protect?
A 69-year-old man with chronic dizziness, 1 year later.
A 69-year-old man with chronic dizziness, 1 year later.
A 69-year-old man with chronic dizziness, 1 year later.
A 69-year-old man with chronic dizziness, 1 year later.
A 43-year-old woman coping with cancer.
A 43-year-old woman coping with cancer.
A 43-year-old woman coping with cancer.
A 43-year-old woman coping with cancer.
A 43-year-old woman coping with cancer.
Strategies to sustain success in childhood immunizations. The National Vaccine Advisory Committee.
Strategies to sustain success in childhood immunizations. The National Vaccine Advisory Committee.
Strategies to sustain success in childhood immunizations. The National Vaccine Advisory Committee.
Strategies to sustain success in childhood immunizations. The National Vaccine Advisory Committee.
Strategies to sustain success in childhood immunizations. The National Vaccine Advisory Committee.
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.
Hospital peer review and the National Practitioner Data Bank: clinical privileges action reports.
Hospital peer review and the National Practitioner Data Bank: clinical privileges action reports.
Hospital peer review and the National Practitioner Data Bank: clinical privileges action reports.
Hospital peer review and the National Practitioner Data Bank: clinical privileges action reports.
Hospital peer review and the National Practitioner Data Bank: clinical privileges action reports.
Hospital peer review and the National Practitioner Data Bank: clinical privileges action reports.
Hospital peer review and the National Practitioner Data Bank: clinical privileges action reports.
Hospital peer review and the National Practitioner Data Bank: clinical privileges action reports.
Hospital peer review and the National Practitioner Data Bank: clinical privileges action reports.
Hospital peer review and the National Practitioner Data Bank: clinical privileges action reports.
Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients.
Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients.
Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients.
Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients.
Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients.
Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients.
Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients.
Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients.
Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients.
Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients.
Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients.
Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients.
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV
Update of cost-effectiveness analysis for solvent-detergent-treated plasma.
Update of cost-effectiveness analysis for solvent-detergent-treated plasma.
Update of cost-effectiveness analysis for solvent-detergent-treated plasma.
Update of cost-effectiveness analysis for solvent-detergent-treated plasma.
Update of cost-effectiveness analysis for solvent-detergent-treated plasma.
Chronic multisystem illness among Gulf War veterans.
Chronic multisystem illness among Gulf War veterans.
Chronic multisystem illness among Gulf War veterans.
Chronic multisystem illness among Gulf War veterans.
Chronic multisystem illness among Gulf War veterans.
Chronic multisystem illness among Gulf War veterans.
Chronic multisystem illness among Gulf War veterans.
Chronic multisystem illness among Gulf War veterans.
Chronic multisystem illness among Gulf War veterans.
Chronic multisystem illness among Gulf War veterans.
Chronic multisystem illness among Gulf War veterans.
Increase in the use of breast-conserving surgery.
Increase in the use of breast-conserving surgery.
Increase in the use of breast-conserving surgery.
Increasing prevalence of antimicrobial resistance among uropathogens.
Increasing prevalence of antimicrobial resistance among uropathogens.
Increasing prevalence of antimicrobial resistance among uropathogens.
Increasing prevalence of antimicrobial resistance among uropathogens.
Alendronate and fracture prevention.
Alendronate and fracture prevention.
Alendronate and fracture prevention.
Alendronate and fracture prevention.
Alendronate and fracture prevention.
Alendronate and fracture prevention.
Alendronate and fracture prevention.
Relapse of depressive symptoms after discontinuing sertraline.
Relapse of depressive symptoms after discontinuing sertraline.
Relapse of depressive symptoms after discontinuing sertraline.
Relapse of depressive symptoms after discontinuing sertraline.
From the Centers for Disease Control and Prevention. Anonymous or confidential HIV counseling and voluntary testing in fed
From the Centers for Disease Control and Prevention. Improvements in workplace safety--United States, 1900-1999.
From the Centers for Disease Control and Prevention. Improvements in workplace safety--United States, 1900-1999.
From the Centers for Disease Control and Prevention. Outbreak of influenza A infection among travelers--Alaska and the Yuko
Drug safety takes cooperation.
Drug safety takes cooperation.
Are they real? IOM report on breast implant problems. Institute of Medicine.
Are they real? IOM report on breast implant problems. Institute of Medicine.
Noncompliance may cause half of antihypertensive drug "failures".
Noncompliance may cause half of antihypertensive drug "failures".
Anticoagulant-induced thrombosis.
Anticoagulant-induced thrombosis.
Can an amulet cure leukemia?
Can an amulet cure leukemia?
JAMA Patient Page: heart attack.
Physician service opportunities abroad.
Virginity examinations in Turkey: role of forensic physicians in controlling female sexuality.
Virginity examinations in Turkey: role of forensic physicians in controlling female sexuality.
Virginity examinations in Turkey: role of forensic physicians in controlling female sexuality.
Virginity examinations in Turkey: role of forensic physicians in controlling female sexuality.
Virginity examinations in Turkey: role of forensic physicians in controlling female sexuality.
Virginity examinations in Turkey: role of forensic physicians in controlling female sexuality.
Virginity examinations in Turkey: role of forensic physicians in controlling female sexuality.
Virginity examinations in Turkey: role of forensic physicians in controlling female sexuality.
What can we do about violence?
What can we do about violence?
What can we do about violence?
War and health: from Solferino to Kosovo--the evolving role of physicians.
War and health: from Solferino to Kosovo--the evolving role of physicians.
War and health: from Solferino to Kosovo--the evolving role of physicians.
War and health: from Solferino to Kosovo--the evolving role of physicians.
The future of firearm violence prevention: building on success.
The future of firearm violence prevention: building on success.
Screening and intervention for intimate partner abuse: practices and attitudes of primary care physicians.
Screening and intervention for intimate partner abuse: practices and attitudes of primary care physicians.
Screening and intervention for intimate partner abuse: practices and attitudes of primary care physicians.
Screening and intervention for intimate partner abuse: practices and attitudes of primary care physicians.
Screening and intervention for intimate partner abuse: practices and attitudes of primary care physicians.
Screening and intervention for intimate partner abuse: practices and attitudes of primary care physicians.
Screening and intervention for intimate partner abuse: practices and attitudes of primary care physicians.
Underascertainment of child abuse mortality in the United States.
Underascertainment of child abuse mortality in the United States.
Underascertainment of child abuse mortality in the United States.
Underascertainment of child abuse mortality in the United States.
Underascertainment of child abuse mortality in the United States.
Underascertainment of child abuse mortality in the United States.
Underascertainment of child abuse mortality in the United States.
Underascertainment of child abuse mortality in the United States.
Underascertainment of child abuse mortality in the United States.
Underascertainment of child abuse mortality in the United States.
Underascertainment of child abuse mortality in the United States.
Prenatal exposure to wartime famine and development of antisocial personality disorder in early adulthood.
Prenatal exposure to wartime famine and development of antisocial personality disorder in early adulthood.
Prenatal exposure to wartime famine and development of antisocial personality disorder in early adulthood.
Prenatal exposure to wartime famine and development of antisocial personality disorder in early adulthood.
Prenatal exposure to wartime famine and development of antisocial personality disorder in early adulthood.
Prenatal exposure to wartime famine and development of antisocial personality disorder in early adulthood.
The medical costs of gunshot injuries in the United States.
The medical costs of gunshot injuries in the United States.
The medical costs of gunshot injuries in the United States.
The medical costs of gunshot injuries in the United States.
The medical costs of gunshot injuries in the United States.
The medical costs of gunshot injuries in the United States.
The medical costs of gunshot injuries in the United States.
Recent trends in violence-related behaviors among high school students in the United States.
Recent trends in violence-related behaviors among high school students in the United States.
Recent trends in violence-related behaviors among high school students in the United States.
Recent trends in violence-related behaviors among high school students in the United States.
Recent trends in violence-related behaviors among high school students in the United States.
Recent trends in violence-related behaviors among high school students in the United States.
Disability associated with psychiatric comorbidity and health status in Bosnian refugees living in Croatia.
Disability associated with psychiatric comorbidity and health status in Bosnian refugees living in Croatia.
Disability associated with psychiatric comorbidity and health status in Bosnian refugees living in Croatia.
Disability associated with psychiatric comorbidity and health status in Bosnian refugees living in Croatia.
Disability associated with psychiatric comorbidity and health status in Bosnian refugees living in Croatia.
Disability associated with psychiatric comorbidity and health status in Bosnian refugees living in Croatia.
Disability associated with psychiatric comorbidity and health status in Bosnian refugees living in Croatia.
Disability associated with psychiatric comorbidity and health status in Bosnian refugees living in Croatia.
Disability associated with psychiatric comorbidity and health status in Bosnian refugees living in Croatia.
Disability associated with psychiatric comorbidity and health status in Bosnian refugees living in Croatia.
Thromboembolic events following arthroscopic knee surgery.
Thromboembolic events following arthroscopic knee surgery.
Thromboembolic events following arthroscopic knee surgery.
Thromboembolic events following arthroscopic knee surgery.
Thromboembolic events following arthroscopic knee surgery.
Thromboembolic events following arthroscopic knee surgery.
Thromboembolic events following arthroscopic knee surgery.
Injury monitoring in US prison systems.
Injury monitoring in US prison systems.
Public health surveillance for firearm injuries.
Public health surveillance for firearm injuries.
Public health surveillance for firearm injuries.
Public health surveillance for firearm injuries.
Perceived effectiveness of international medical personnel working in Bosnia.
Perceived effectiveness of international medical personnel working in Bosnia.
Perceived effectiveness of international medical personnel working in Bosnia.
Perceived effectiveness of international medical personnel working in Bosnia.
Perceived effectiveness of international medical personnel working in Bosnia.
Perceived effectiveness of international medical personnel working in Bosnia.
Firearm use in G- and PG-rated movies.
Firearm use in G- and PG-rated movies.
Firearm use in G- and PG-rated movies.
Firearm use in G- and PG-rated movies.
Firearm use in G- and PG-rated movies.
Firearm use in G- and PG-rated movies.
Firearm use in G- and PG-rated movies.
Eschewing accidents.
Eschewing accidents.
Violent criminal activity among handgun purchasers with prior misdemeanor convictions.
Violent criminal activity among handgun purchasers with prior misdemeanor convictions.
Violent criminal activity among handgun purchasers with prior misdemeanor convictions.
Violent criminal activity among handgun purchasers with prior misdemeanor convictions.
Violent criminal activity among handgun purchasers with prior misdemeanor convictions.
Violent criminal activity among handgun purchasers with prior misdemeanor convictions.
Violent criminal activity among handgun purchasers with prior misdemeanor convictions.
Violent criminal activity among handgun purchasers with prior misdemeanor convictions.
Violent criminal activity among handgun purchasers with prior misdemeanor convictions.
From the Surgeon General. The framework convention on tobacco control. A report from the 52nd World Health Assembly.
From the Surgeon General. The framework convention on tobacco control. A report from the 52nd World Health Assembly.
Addressing mental health needs of Balkan refugees.
Addressing mental health needs of Balkan refugees.
Volunteers help Kosovar refugees in camps.
Volunteers help Kosovar refugees in camps.
Fixing femurs in a rain forest: an orthopedic surgeon visits Peru.
Fixing femurs in a rain forest: an orthopedic surgeon visits Peru.
Advice for aspiring volunteer physicians.
Advice for aspiring volunteer physicians.
A case of mutual distrust.
A case of mutual distrust.
JAMA Patient Page: child abuse.
Race, gender, and partnership in the patient-physician relationship.
Race, gender, and partnership in the patient-physician relationship.
Race, gender, and partnership in the patient-physician relationship.
Race, gender, and partnership in the patient-physician relationship.
Race, gender, and partnership in the patient-physician relationship.
Race, gender, and partnership in the patient-physician relationship.
Race, gender, and partnership in the patient-physician relationship.
Race, gender, and partnership in the patient-physician relationship.
Race, gender, and partnership in the patient-physician relationship.
Race, gender, and partnership in the patient-physician relationship.
Race, gender, and partnership in the patient-physician relationship.
Genetic factors in septic shock.
Genetic factors in septic shock.
Genetic factors in septic shock.
Genetic factors in septic shock.
Genetic factors in septic shock.
Can perinatal HIV infection be eliminated in the United States?
Can perinatal HIV infection be eliminated in the United States?
Can perinatal HIV infection be eliminated in the United States?
Pemphigus--diseases of antidesmosomal autoimmunity.
Pemphigus--diseases of antidesmosomal autoimmunity.
Pemphigus--diseases of antidesmosomal autoimmunity.
Pemphigus--diseases of antidesmosomal autoimmunity.
Pemphigus--diseases of antidesmosomal autoimmunity.
Andrew Jackson's exposure to mercury and lead: poisoned president?
Andrew Jackson's exposure to mercury and lead: poisoned president?
Andrew Jackson's exposure to mercury and lead: poisoned president?
Andrew Jackson's exposure to mercury and lead: poisoned president?
Andrew Jackson's exposure to mercury and lead: poisoned president?
Andrew Jackson's exposure to mercury and lead: poisoned president?
Andrew Jackson's exposure to mercury and lead: poisoned president?
Andrew Jackson's exposure to mercury and lead: poisoned president?
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study
Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream inf
Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream inf
Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream inf
Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream inf
Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream inf
Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream inf
Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream inf
Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization sta
Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization sta
Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization sta
Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization sta
Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization sta
Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization sta
Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization sta
Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization sta
Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization sta
Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization sta
Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization sta
Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization sta
Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization sta
Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization sta
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. S
Trends in perinatal transmission of HIV/AIDS in the United States.
Trends in perinatal transmission of HIV/AIDS in the United States.
Trends in perinatal transmission of HIV/AIDS in the United States.
Trends in perinatal transmission of HIV/AIDS in the United States.
Trends in perinatal transmission of HIV/AIDS in the United States.
Trends in perinatal transmission of HIV/AIDS in the United States.
Trends in perinatal transmission of HIV/AIDS in the United States.
Trends in perinatal transmission of HIV/AIDS in the United States.
Trends in perinatal transmission of HIV/AIDS in the United States.
Trends in perinatal transmission of HIV/AIDS in the United States.
Trends in perinatal transmission of HIV/AIDS in the United States.
Correcting the odds ratio in cohort studies of common outcomes.
Correcting the odds ratio in cohort studies of common outcomes.
Correcting the odds ratio in cohort studies of common outcomes.
Correcting the odds ratio in cohort studies of common outcomes.
Correcting the odds ratio in cohort studies of common outcomes.
Infant growth after in utero exposure to zidovudine.
Infant growth after in utero exposure to zidovudine.
Infant growth after in utero exposure to zidovudine.
Infant growth after in utero exposure to zidovudine.
Infant growth after in utero exposure to zidovudine.
Infant growth after in utero exposure to zidovudine.
Infant growth after in utero exposure to zidovudine.
Health literacy and numeracy.
Health literacy and numeracy.
Health literacy and numeracy.
Health literacy and numeracy.
Health literacy and numeracy.
Health literacy and numeracy.
Health literacy and the JAMA Patient Page.
Health literacy and the JAMA Patient Page.
Health literacy and the JAMA Patient Page.
Health literacy and the JAMA Patient Page.
Health literacy and the JAMA Patient Page.
Health literacy and the JAMA Patient Page.
Health literacy and the JAMA Patient Page.
Health literacy and the JAMA Patient Page.
Health literacy and the JAMA Patient Page.
Diuretics for hypertension.
Diuretics for hypertension.
Diuretics for hypertension.
Diuretics for hypertension.
Diuretics for hypertension.
Diuretics for hypertension.
Diuretics for hypertension.
Diuretics for hypertension.
Diuretics for hypertension.
Diuretics for hypertension.
Diuretics for hypertension.
Diuretics for hypertension.
Diuretics for hypertension.
Diuretics for hypertension.
Diuretics for hypertension.
Diuretics for hypertension.
Diuretics for hypertension.
From the Centers for Disease Control and Prevention. Resources to address interpersonal violence among youth.
From the Centers for Disease Control and Prevention. Revised recommendations for routine poliomyelitis vaccination.
From the Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine--United States, 1
Heading for better health care in Peru.
Heading for better health care in Peru.
Protecting subjects of clinical research.
Protecting subjects of clinical research.
FDA weighs communicating drug-related risk to patients.
FDA weighs communicating drug-related risk to patients.
Case management for domestic violence.
Case management for domestic violence.
Advances in the treatment of chronic viral hepatitis.
Advances in the treatment of chronic viral hepatitis.
Advances in the treatment of chronic viral hepatitis.
JAMA Patient Page. HIV/AIDS.
Perinatal HIV prevention.
Perinatal HIV prevention.
Planning for a kidney transplant: is my doctor listening?
Planning for a kidney transplant: is my doctor listening?
Planning for a kidney transplant: is my doctor listening?
Nocturnal eating syndromes: to sleep, perchance to eat.
Nocturnal eating syndromes: to sleep, perchance to eat.
Nocturnal eating syndromes: to sleep, perchance to eat.
Therapy for fracture prevention.
Therapy for fracture prevention.
Therapy for fracture prevention.
Therapy for fracture prevention.
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Globa
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Globa
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Globa
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Globa
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Globa
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Globa
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Globa
Glucocorticoid-induced adrenal insufficiency.
Glucocorticoid-induced adrenal insufficiency.
Glucocorticoid-induced adrenal insufficiency.
Glucocorticoid-induced adrenal insufficiency.
Resolving discrepancies between a meta-analysis and a subsequent large controlled trial.
Resolving discrepancies between a meta-analysis and a subsequent large controlled trial.
Resolving discrepancies between a meta-analysis and a subsequent large controlled trial.
Resolving discrepancies between a meta-analysis and a subsequent large controlled trial.
Resolving discrepancies between a meta-analysis and a subsequent large controlled trial.
Behavioral and neuroendocrine characteristics of the night-eating syndrome.
Behavioral and neuroendocrine characteristics of the night-eating syndrome.
Behavioral and neuroendocrine characteristics of the night-eating syndrome.
Behavioral and neuroendocrine characteristics of the night-eating syndrome.
Behavioral and neuroendocrine characteristics of the night-eating syndrome.
Behavioral and neuroendocrine characteristics of the night-eating syndrome.
Behavioral and neuroendocrine characteristics of the night-eating syndrome.
Behavioral and neuroendocrine characteristics of the night-eating syndrome.
Behavioral and neuroendocrine characteristics of the night-eating syndrome.
Behavioral and neuroendocrine characteristics of the night-eating syndrome.
Association between use of unconventional therapies and conventional medical services.
Association between use of unconventional therapies and conventional medical services.
Association between use of unconventional therapies and conventional medical services.
Association between use of unconventional therapies and conventional medical services.
Association between use of unconventional therapies and conventional medical services.
Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates. A randomized controlled trial.
Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates. A randomized controlled trial.
Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates. A randomized controlled trial.
Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates. A randomized controlled trial.
Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates. A randomized controlled trial.
Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates. A randomized controlled trial.
Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates. A randomized controlled trial.
Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates. A randomized controlled trial.
Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates. A randomized controlled trial.
Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates. A randomized controlled trial.
Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates. A randomized controlled trial.
Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates. A randomized controlled trial.
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-ye
Estimating time to conduct a meta-analysis from number of citations retrieved.
Estimating time to conduct a meta-analysis from number of citations retrieved.
Estimating time to conduct a meta-analysis from number of citations retrieved.
Physicians assessing the Internet: the PAI project.
Physicians assessing the Internet: the PAI project.
Physicians assessing the Internet: the PAI project.
Physicians assessing the Internet: the PAI project.
Myocardial infarction associated with ovarian hyperstimulation syndrome.
Myocardial infarction associated with ovarian hyperstimulation syndrome.
Myocardial infarction associated with ovarian hyperstimulation syndrome.
Myocardial infarction associated with ovarian hyperstimulation syndrome.
Myocardial infarction associated with ovarian hyperstimulation syndrome.
Myocardial infarction associated with ovarian hyperstimulation syndrome.
Myocardial infarction associated with ovarian hyperstimulation syndrome.
Access to essential drugs in poor countries.
Access to essential drugs in poor countries.
Access to essential drugs in poor countries.
Access to essential drugs in poor countries.
Fixed vs variable costs of hospital care.
Fixed vs variable costs of hospital care.
Fixed vs variable costs of hospital care.
Fixed vs variable costs of hospital care.
Bartenders' pulmonary function after establishment of a smoke-free workplace.
Bartenders' pulmonary function after establishment of a smoke-free workplace.
Bartenders' pulmonary function after establishment of a smoke-free workplace.
Bartenders' pulmonary function after establishment of a smoke-free workplace.
From the Centers for Disease Control and Prevention. Firearm-associated deaths and hospitalizations--California, 1995-1996.
From the Centers for Disease Control and Prevention. Deaths among children aged < or = 5 years from farm machinery runov
From the Centers for Disease Control and Prevention. Deaths among children aged < or = 5 years from farm machinery runov
NEJM editor Jerome P. Kassirer, MD, loses post over "administrative issues".
NEJM editor Jerome P. Kassirer, MD, loses post over "administrative issues".
Mild cognitive impairment raises Alzheimer disease risk.
Mild cognitive impairment raises Alzheimer disease risk.
Researchers urged to tell public how animal studies benefit human health.
Researchers urged to tell public how animal studies benefit human health.
A piece of my mind. Partnership for good dying.
A piece of my mind. Partnership for good dying.
JAMA Patient Page: tuberculosis.
Are surrogate markers adequate to assess cardiovascular disease drugs?
Are surrogate markers adequate to assess cardiovascular disease drugs?
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular dis
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular dis
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular dis
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular dis
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular dis
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular dis
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular dis
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular dis
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular dis
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular dis
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular dis
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular dis
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular dis
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular dis
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular dis
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular dis
Editors and owners--stretching reputation too far.
Editors and owners--stretching reputation too far.
When is breastfeeding not best? The dilemma facing HIV-infected women in resource-poor settings.
When is breastfeeding not best? The dilemma facing HIV-infected women in resource-poor settings.
When is breastfeeding not best? The dilemma facing HIV-infected women in resource-poor settings.
When is breastfeeding not best? The dilemma facing HIV-infected women in resource-poor settings.
When is breastfeeding not best? The dilemma facing HIV-infected women in resource-poor settings.
The potential benefits of decision aids in clinical medicine.
The potential benefits of decision aids in clinical medicine.
The potential benefits of decision aids in clinical medicine.
The potential benefits of decision aids in clinical medicine.
Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an in
Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an in
Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an in
Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an in
Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an in
Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an in
A 45-year-old woman with premenstrual dysphoric disorder, 1 year later.
A 45-year-old woman with premenstrual dysphoric disorder, 1 year later.
A 45-year-old woman with premenstrual dysphoric disorder, 1 year later.
A 45-year-old woman with premenstrual dysphoric disorder, 1 year later.
A 69-year-old man with anger and angina.
A 69-year-old man with anger and angina.
A 69-year-old man with anger and angina.
A 69-year-old man with anger and angina.
A 69-year-old man with anger and angina.
A 69-year-old man with anger and angina.
A 69-year-old man with anger and angina.
Psychiatric disorders among survivors of the Oklahoma City bombing.
Psychiatric disorders among survivors of the Oklahoma City bombing.
Psychiatric disorders among survivors of the Oklahoma City bombing.
Psychiatric disorders among survivors of the Oklahoma City bombing.
Psychiatric disorders among survivors of the Oklahoma City bombing.
Psychiatric disorders among survivors of the Oklahoma City bombing.
Psychiatric disorders among survivors of the Oklahoma City bombing.
Psychiatric disorders among survivors of the Oklahoma City bombing.
Psychiatric disorders among survivors of the Oklahoma City bombing.
Psychiatric disorders among survivors of the Oklahoma City bombing.
Hypoglycemia and the decision to drive a motor vehicle by persons with diabetes.
Hypoglycemia and the decision to drive a motor vehicle by persons with diabetes.
Hypoglycemia and the decision to drive a motor vehicle by persons with diabetes.
Hypoglycemia and the decision to drive a motor vehicle by persons with diabetes.
Hypoglycemia and the decision to drive a motor vehicle by persons with diabetes.
Hypoglycemia and the decision to drive a motor vehicle by persons with diabetes.
Hypoglycemia and the decision to drive a motor vehicle by persons with diabetes.
HIV transmission through breastfeeding: a study in Malawi.
HIV transmission through breastfeeding: a study in Malawi.
HIV transmission through breastfeeding: a study in Malawi.
HIV transmission through breastfeeding: a study in Malawi.
HIV transmission through breastfeeding: a study in Malawi.
HIV transmission through breastfeeding: a study in Malawi.
HIV transmission through breastfeeding: a study in Malawi.
HIV transmission through breastfeeding: a study in Malawi.
HIV transmission through breastfeeding: a study in Malawi.
HIV transmission through breastfeeding: a study in Malawi.
HIV transmission through breastfeeding: a study in Malawi.
HIV transmission through breastfeeding: a study in Malawi.
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled tri
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled tri
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled tri
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled tri
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled tri
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled tri
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled tri
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled tri
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled tri
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled tri
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled tri
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled tri
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled tri
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled tri
Utility of telemedicine on Johnston Atoll.
Utility of telemedicine on Johnston Atoll.
Association of the CCR5delta32 mutation with improved response to antiretroviral therapy.
Association of the CCR5delta32 mutation with improved response to antiretroviral therapy.
Association of the CCR5delta32 mutation with improved response to antiretroviral therapy.
Association of the CCR5delta32 mutation with improved response to antiretroviral therapy.
Association of the CCR5delta32 mutation with improved response to antiretroviral therapy.
Association of the CCR5delta32 mutation with improved response to antiretroviral therapy.
Women's beliefs about breastfeeding and transmission of AIDS in rural Côte d'Ivoire.
Women's beliefs about breastfeeding and transmission of AIDS in rural Côte d'Ivoire.
Women's beliefs about breastfeeding and transmission of AIDS in rural Côte d'Ivoire.
Aspirin and risk of hemorrhagic stroke.
Aspirin and risk of hemorrhagic stroke.
Aspirin and risk of hemorrhagic stroke.
Aspirin and risk of hemorrhagic stroke.
Aspirin and risk of hemorrhagic stroke.
Aspirin and risk of hemorrhagic stroke.
Aspirin and risk of hemorrhagic stroke.
Aspirin and risk of hemorrhagic stroke.
Aspirin and risk of hemorrhagic stroke.
Aspirin and risk of hemorrhagic stroke.
Aspirin and risk of hemorrhagic stroke.
Aspirin and risk of hemorrhagic stroke.
Doctor, you've got E-mail.
Doctor, you've got E-mail.
Doctor, you've got E-mail.
Doctor, you've got E-mail.
Doctor, you've got E-mail.
Doctor, you've got E-mail.
Doctor, you've got E-mail.
Doctor, you've got E-mail.
Doctor, you've got E-mail.
From the Centers for Disease Control and Prevention. Outbreak of Salmonella serotype Muenchen infections associated with
From the Centers for Disease Control and Prevention. Decline in deaths from heart disease and stroke--United States, 1900-1
Hormonally active agents throughout the environment.
Hormonally active agents throughout the environment.
Emergency departments open new doors to technology, patient service.
Emergency departments open new doors to technology, patient service.
A piece of my mind. Stroke.
A piece of my mind. Stroke.
JAMA Patient Page: diabetes.
Graduate medical education.
Medical schools in Canada.
Medical schools in the United States.
Instilling professionalism in medical education.
Instilling professionalism in medical education.
Instilling professionalism in medical education.
Instilling professionalism in medical education.
Educating medical students for work in culturally diverse societies.
Educating medical students for work in culturally diverse societies.
Educating medical students for work in culturally diverse societies.
Educating medical students for work in culturally diverse societies.
Educating medical students for work in culturally diverse societies.
Educating medical students for work in culturally diverse societies.
Educating medical students for work in culturally diverse societies.
Educating medical students for work in culturally diverse societies.
Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing educati
Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing educati
Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing educati
Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing educati
Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing educati
Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing educati
Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing educati
Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing educati
Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing educati
Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing educati
Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing educati
Simulation technology for health care professional skills training and assessment.
Simulation technology for health care professional skills training and assessment.
Simulation technology for health care professional skills training and assessment.
Simulation technology for health care professional skills training and assessment.
Simulation technology for health care professional skills training and assessment.
Simulation technology for health care professional skills training and assessment.
Simulation technology for health care professional skills training and assessment.
Simulation technology for health care professional skills training and assessment.
Simulation technology for health care professional skills training and assessment.
Simulation technology for health care professional skills training and assessment.
Simulation technology for health care professional skills training and assessment.
Simulation technology for health care professional skills training and assessment.
Simulation technology for health care professional skills training and assessment.
Simulation technology for health care professional skills training and assessment.
Simulation technology for health care professional skills training and assessment.
Graduate medical education, 1998-1999: a closer look.
Graduate medical education, 1998-1999: a closer look.
Graduate medical education, 1998-1999: a closer look.
Graduate medical education, 1998-1999: a closer look.
Graduate medical education, 1998-1999: a closer look.
Review of US medical school finances, 1997-1998.
Review of US medical school finances, 1997-1998.
Review of US medical school finances, 1997-1998.
Review of US medical school finances, 1997-1998.
Review of US medical school finances, 1997-1998.
Educational programs in US medical schools, 1998-1999.
Educational programs in US medical schools, 1998-1999.
Educational programs in US medical schools, 1998-1999.
Educational programs in US medical schools, 1998-1999.
Educational programs in US medical schools, 1998-1999.
Mindful practice.
Mindful practice.
Mindful practice.
Mindful practice.
Teaching professionalism in undergraduate medical education.
Teaching professionalism in undergraduate medical education.
Teaching professionalism in undergraduate medical education.
Teaching professionalism in undergraduate medical education.
Teaching professionalism in undergraduate medical education.
Teaching professionalism in undergraduate medical education.
Tobacco dependence curricula in US undergraduate medical education.
Tobacco dependence curricula in US undergraduate medical education.
Tobacco dependence curricula in US undergraduate medical education.
Tobacco dependence curricula in US undergraduate medical education.
Tobacco dependence curricula in US undergraduate medical education.
Tobacco dependence curricula in US undergraduate medical education.
Unlicensed vaccines and bioweapon defense in World War II.
Unlicensed vaccines and bioweapon defense in World War II.
Unlicensed vaccines and bioweapon defense in World War II.
Unlicensed vaccines and bioweapon defense in World War II.
Lessons outside the lecture hall.
Lessons outside the lecture hall.
What should I do if my patient does not speak English?
What should I do if my patient does not speak English?
The patient-physician relationship: is three a crowd?
The patient-physician relationship: is three a crowd?
JAMA Patient Page. Tobacco.
JAMA Patient Page: head injury.
Traumatic brain injury and concussion in sports.
Traumatic brain injury and concussion in sports.
Traumatic brain injury and concussion in sports.
Otitis media--the pharyngeal connection.
Otitis media--the pharyngeal connection.
Otitis media--the pharyngeal connection.
Professional medical associations: ethical and practical guidelines.
Professional medical associations: ethical and practical guidelines.
Professional medical associations: ethical and practical guidelines.
Consensus conference. Rehabilitation of persons with traumatic brain injury. NIH Consensus Development Panel on Rehabilit
Consensus conference. Rehabilitation of persons with traumatic brain injury. NIH Consensus Development Panel on Rehabilit
Consensus conference. Rehabilitation of persons with traumatic brain injury. NIH Consensus Development Panel on Rehabilit
Consensus conference. Rehabilitation of persons with traumatic brain injury. NIH Consensus Development Panel on Rehabilit
Consensus conference. Rehabilitation of persons with traumatic brain injury. NIH Consensus Development Panel on Rehabilit
Neuropsychological impairment in amateur soccer players.
Neuropsychological impairment in amateur soccer players.
Neuropsychological impairment in amateur soccer players.
Neuropsychological impairment in amateur soccer players.
Neuropsychological impairment in amateur soccer players.
Neuropsychological impairment in amateur soccer players.
Neuropsychological impairment in amateur soccer players.
Relationship between concussion and neuropsychological performance in college football players.
Relationship between concussion and neuropsychological performance in college football players.
Relationship between concussion and neuropsychological performance in college football players.
Relationship between concussion and neuropsychological performance in college football players.
Relationship between concussion and neuropsychological performance in college football players.
Relationship between concussion and neuropsychological performance in college football players.
Relationship between concussion and neuropsychological performance in college football players.
Relationship between concussion and neuropsychological performance in college football players.
Relationship between concussion and neuropsychological performance in college football players.
Relationship between concussion and neuropsychological performance in college football players.
Relationship between concussion and neuropsychological performance in college football players.
Relationship between concussion and neuropsychological performance in college football players.
Relationship between concussion and neuropsychological performance in college football players.
Relationship between concussion and neuropsychological performance in college football players.
Relationship between concussion and neuropsychological performance in college football players.
Relationship between concussion and neuropsychological performance in college football players.
Relationship between concussion and neuropsychological performance in college football players.
Traumatic brain injury in high school athletes.
Traumatic brain injury in high school athletes.
Traumatic brain injury in high school athletes.
Traumatic brain injury in high school athletes.
Traumatic brain injury in high school athletes.
Trends in hospitalization associated with traumatic brain injury.
Trends in hospitalization associated with traumatic brain injury.
Trends in hospitalization associated with traumatic brain injury.
Trends in hospitalization associated with traumatic brain injury.
Adenoidectomy and adenotonsillectomy for recurrent acute otitis media: parallel randomized clinical trials in children not pre
Adenoidectomy and adenotonsillectomy for recurrent acute otitis media: parallel randomized clinical trials in children not pre
Adenoidectomy and adenotonsillectomy for recurrent acute otitis media: parallel randomized clinical trials in children not pre
Adenoidectomy and adenotonsillectomy for recurrent acute otitis media: parallel randomized clinical trials in children not pre
Adenoidectomy and adenotonsillectomy for recurrent acute otitis media: parallel randomized clinical trials in children not pre
Adenoidectomy and adenotonsillectomy for recurrent acute otitis media: parallel randomized clinical trials in children not pre
Adenoidectomy and adenotonsillectomy for recurrent acute otitis media: parallel randomized clinical trials in children not pre
Adenoidectomy and adenotonsillectomy for recurrent acute otitis media: parallel randomized clinical trials in children not pre
Adenoidectomy and adenotonsillectomy for recurrent acute otitis media: parallel randomized clinical trials in children not pre
Adenoidectomy and adenotonsillectomy for recurrent acute otitis media: parallel randomized clinical trials in children not pre
Adenoidectomy and adenotonsillectomy for recurrent acute otitis media: parallel randomized clinical trials in children not pre
Adenoidectomy and adenotonsillectomy for recurrent acute otitis media: parallel randomized clinical trials in children not pre
Adenoidectomy and adenotonsillectomy for recurrent acute otitis media: parallel randomized clinical trials in children not pre
Osler maneuver to detect pseudohypertension.
Osler maneuver to detect pseudohypertension.
Osler maneuver to detect pseudohypertension.
Agenda setting in the patient-physician relationship.
Agenda setting in the patient-physician relationship.
Agenda setting in the patient-physician relationship.
Agenda setting in the patient-physician relationship.
Percutaneous electrical nerve stimulation for treatment of low back pain.
Percutaneous electrical nerve stimulation for treatment of low back pain.
Percutaneous electrical nerve stimulation for treatment of low back pain.
Percutaneous electrical nerve stimulation for treatment of low back pain.
Percutaneous electrical nerve stimulation for treatment of low back pain.
Sildenafil for diabetic men with erectile dysfunction.
Sildenafil for diabetic men with erectile dysfunction.
Sildenafil for diabetic men with erectile dysfunction.
Sildenafil for diabetic men with erectile dysfunction.
Sildenafil for diabetic men with erectile dysfunction.
Sildenafil for diabetic men with erectile dysfunction.
Sildenafil for diabetic men with erectile dysfunction.
Sildenafil for diabetic men with erectile dysfunction.
Sildenafil for diabetic men with erectile dysfunction.
Advances in medical care: promise, problems, and proper application.
Advances in medical care: promise, problems, and proper application.
Advances in medical care: promise, problems, and proper application.
Advances in medical care: promise, problems, and proper application.
Advances in medical care: promise, problems, and proper application.
Advances in medical care: promise, problems, and proper application.
Advances in medical care: promise, problems, and proper application.
Advances in medical care: promise, problems, and proper application.
Advances in medical care: promise, problems, and proper application.
Higher standards for epidemiologic studies--replication prior to publication?
Higher standards for epidemiologic studies--replication prior to publication?
Higher standards for epidemiologic studies--replication prior to publication?
From the Centers for Disease Control and Prevention. Cigarette smoking among high school students--11 states, 1991-1997.
From the Centers for Disease Control and Prevention. Use of pulsed-field gel electrophoresis for investigation of a cluster of i
From the Food and Drug Administration.
From the Food and Drug Administration.
Several classes of new drugs emerging for Parkinson disease.
Several classes of new drugs emerging for Parkinson disease.
Human genome studies expected to revolutionize cancer classification.
Human genome studies expected to revolutionize cancer classification.
Physical medicine and rehabilitation.
Physical medicine and rehabilitation.
Physical medicine and rehabilitation.
Physical medicine and rehabilitation.
Facing our morality: the virtue of a common life.
Facing our morality: the virtue of a common life.
Admission trends in a rural South African hospital during the early years of the HIV epidemic.
Admission trends in a rural South African hospital during the early years of the HIV epidemic.
Admission trends in a rural South African hospital during the early years of the HIV epidemic.
Admission trends in a rural South African hospital during the early years of the HIV epidemic.
Admission trends in a rural South African hospital during the early years of the HIV epidemic.
Admission trends in a rural South African hospital during the early years of the HIV epidemic.
Admission trends in a rural South African hospital during the early years of the HIV epidemic.
Measuring the quality of trials: the quality of quality scales.
Measuring the quality of trials: the quality of quality scales.
Measuring the quality of trials: the quality of quality scales.
Measuring the quality of trials: the quality of quality scales.
The future of organ and tissue transplantation: can T-cell costimulatory pathway modifiers revolutionize the prevention of gr
The future of organ and tissue transplantation: can T-cell costimulatory pathway modifiers revolutionize the prevention of gr
The future of organ and tissue transplantation: can T-cell costimulatory pathway modifiers revolutionize the prevention of gr
The future of organ and tissue transplantation: can T-cell costimulatory pathway modifiers revolutionize the prevention of gr
The future of organ and tissue transplantation: can T-cell costimulatory pathway modifiers revolutionize the prevention of gr
The future of organ and tissue transplantation: can T-cell costimulatory pathway modifiers revolutionize the prevention of gr
Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial.
Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial.
Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial.
Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial.
Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial.
Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial.
Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial.
Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial.
Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial.
Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial.
Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial.
Academic managed care organizations and adverse selection under Medicaid managed care in Tennessee.
Academic managed care organizations and adverse selection under Medicaid managed care in Tennessee.
Academic managed care organizations and adverse selection under Medicaid managed care in Tennessee.
Academic managed care organizations and adverse selection under Medicaid managed care in Tennessee.
Academic managed care organizations and adverse selection under Medicaid managed care in Tennessee.
Academic managed care organizations and adverse selection under Medicaid managed care in Tennessee.
Academic managed care organizations and adverse selection under Medicaid managed care in Tennessee.
Academic managed care organizations and adverse selection under Medicaid managed care in Tennessee.
Academic managed care organizations and adverse selection under Medicaid managed care in Tennessee.
Empirical evidence of design-related bias in studies of diagnostic tests.
Empirical evidence of design-related bias in studies of diagnostic tests.
Empirical evidence of design-related bias in studies of diagnostic tests.
Empirical evidence of design-related bias in studies of diagnostic tests.
Empirical evidence of design-related bias in studies of diagnostic tests.
Empirical evidence of design-related bias in studies of diagnostic tests.
Empirical evidence of design-related bias in studies of diagnostic tests.
Empirical evidence of design-related bias in studies of diagnostic tests.
Empirical evidence of design-related bias in studies of diagnostic tests.
The hazards of scoring the quality of clinical trials for meta-analysis.
The hazards of scoring the quality of clinical trials for meta-analysis.
The hazards of scoring the quality of clinical trials for meta-analysis.
The hazards of scoring the quality of clinical trials for meta-analysis.
The hazards of scoring the quality of clinical trials for meta-analysis.
The hazards of scoring the quality of clinical trials for meta-analysis.
Prognostic value of a treadmill exercise score in symptomatic patients with nonspecific ST-T abnormalities on resting ECG.
Prognostic value of a treadmill exercise score in symptomatic patients with nonspecific ST-T abnormalities on resting ECG.
Prognostic value of a treadmill exercise score in symptomatic patients with nonspecific ST-T abnormalities on resting ECG.
Prognostic value of a treadmill exercise score in symptomatic patients with nonspecific ST-T abnormalities on resting ECG.
Prognostic value of a treadmill exercise score in symptomatic patients with nonspecific ST-T abnormalities on resting ECG.
Prognostic value of a treadmill exercise score in symptomatic patients with nonspecific ST-T abnormalities on resting ECG.
Prognostic value of a treadmill exercise score in symptomatic patients with nonspecific ST-T abnormalities on resting ECG.
Ultrasonography and limited computed tomography in the diagnosis and management of appendicitis in children.
Ultrasonography and limited computed tomography in the diagnosis and management of appendicitis in children.
Ultrasonography and limited computed tomography in the diagnosis and management of appendicitis in children.
Ultrasonography and limited computed tomography in the diagnosis and management of appendicitis in children.
Ultrasonography and limited computed tomography in the diagnosis and management of appendicitis in children.
Ultrasonography and limited computed tomography in the diagnosis and management of appendicitis in children.
Ultrasonography and limited computed tomography in the diagnosis and management of appendicitis in children.
Ultrasonography and limited computed tomography in the diagnosis and management of appendicitis in children.
Ultrasonography and limited computed tomography in the diagnosis and management of appendicitis in children.
Ultrasonography and limited computed tomography in the diagnosis and management of appendicitis in children.
Community-acquired methicillin-resistant Staphylococcus aureus and familial transmission.
Community-acquired methicillin-resistant Staphylococcus aureus and familial transmission.
Community-acquired methicillin-resistant Staphylococcus aureus and familial transmission.
Community-acquired methicillin-resistant Staphylococcus aureus and familial transmission.
Community-acquired methicillin-resistant Staphylococcus aureus and familial transmission.
Community-acquired methicillin-resistant Staphylococcus aureus and familial transmission.
Increasing risk of melanoma with increasing age.
Increasing risk of melanoma with increasing age.
Increasing risk of melanoma with increasing age.
Medicare fee for service: a model of managed care?
Medicare fee for service: a model of managed care?
Chinese herbal medicine for irritable bowel syndrome.
Chinese herbal medicine for irritable bowel syndrome.
Chinese herbal medicine for irritable bowel syndrome.
Chinese herbal medicine for irritable bowel syndrome.
Chinese herbal medicine for irritable bowel syndrome.
Chinese herbal medicine for irritable bowel syndrome.
Chinese herbal medicine for irritable bowel syndrome.
Chinese herbal medicine for irritable bowel syndrome.
Chinese herbal medicine for irritable bowel syndrome.
Teaching human rights in the medical curriculum.
Teaching human rights in the medical curriculum.
Teaching human rights in the medical curriculum.
Improving survival following out-of-hospital cardiac arrest.
Improving survival following out-of-hospital cardiac arrest.
Improving survival following out-of-hospital cardiac arrest.
Improving survival following out-of-hospital cardiac arrest.
Improving survival following out-of-hospital cardiac arrest.
Organic solvent exposure during pregnancy and congenital malformations.
Organic solvent exposure during pregnancy and congenital malformations.
Organic solvent exposure during pregnancy and congenital malformations.
Organic solvent exposure during pregnancy and congenital malformations.
From the Centers for Disease Control and Prevention. Control of infectious diseases, 1900-1999.
From the Centers for Disease Control and Prevention. Control of infectious diseases, 1900-1999.
Too many physicians trained in Spain.
Too many physicians trained in Spain.
Steps toward understanding, alleviating osteoarthritis will help aging population.
Steps toward understanding, alleviating osteoarthritis will help aging population.
A piece of my mind. Mikey.
A piece of my mind. Mikey.
JAMA Patient Page: appendicitis.
Potential use of a caspase against HIV.
Potential use of a caspase against HIV.
JAMA 100 years ago: the right to die.
JAMA 100 years ago: the right to die.
JAMA 100 years ago: the right to die.
Enhancing performance measurement: NCQA's road map for a health information framework. National Committee for Qualit
Enhancing performance measurement: NCQA's road map for a health information framework. National Committee for Qualit
Enhancing performance measurement: NCQA's road map for a health information framework. National Committee for Qualit
Enhancing performance measurement: NCQA's road map for a health information framework. National Committee for Qualit
Enhancing performance measurement: NCQA's road map for a health information framework. National Committee for Qualit
Enhancing performance measurement: NCQA's road map for a health information framework. National Committee for Qualit
Enhancing performance measurement: NCQA's road map for a health information framework. National Committee for Qualit
Enhancing performance measurement: NCQA's road map for a health information framework. National Committee for Qualit
Quality measures and electronic medical systems.
Quality measures and electronic medical systems.
Quality measures and electronic medical systems.
Fraud and abuse law.
Fraud and abuse law.
Fraud and abuse law.
Primary HIV-1 resistance: a new phase in the epidemic?
Primary HIV-1 resistance: a new phase in the epidemic?
Primary HIV-1 resistance: a new phase in the epidemic?
An asymptomatic 41-year-old man with HIV infection, 1 year later.
An asymptomatic 41-year-old man with HIV infection, 1 year later.
An asymptomatic 41-year-old man with HIV infection, 1 year later.
An asymptomatic 41-year-old man with HIV infection, 1 year later.
An asymptomatic 41-year-old man with HIV infection, 1 year later.
A 26-year-old woman seeking an abortion.
A 26-year-old woman seeking an abortion.
A 26-year-old woman seeking an abortion.
A 26-year-old woman seeking an abortion.
A 26-year-old woman seeking an abortion.
Health care fraud and abuse.
Health care fraud and abuse.
Health care fraud and abuse.
Capturing the patient's view of change as a clinical outcome measure.
Capturing the patient's view of change as a clinical outcome measure.
Capturing the patient's view of change as a clinical outcome measure.
Capturing the patient's view of change as a clinical outcome measure.
Capturing the patient's view of change as a clinical outcome measure.
Capturing the patient's view of change as a clinical outcome measure.
Capturing the patient's view of change as a clinical outcome measure.
Capturing the patient's view of change as a clinical outcome measure.
Capturing the patient's view of change as a clinical outcome measure.
Capturing the patient's view of change as a clinical outcome measure.
Safety of early discharge for Medicaid newborns.
Safety of early discharge for Medicaid newborns.
Safety of early discharge for Medicaid newborns.
Safety of early discharge for Medicaid newborns.
Safety of early discharge for Medicaid newborns.
Safety of early discharge for Medicaid newborns.
Safety of early discharge for Medicaid newborns.
Safety of early discharge for Medicaid newborns.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.
HIV-1 drug resistance in newly infected individuals.
HIV-1 drug resistance in newly infected individuals.
HIV-1 drug resistance in newly infected individuals.
HIV-1 drug resistance in newly infected individuals.
HIV-1 drug resistance in newly infected individuals.
HIV-1 drug resistance in newly infected individuals.
HIV-1 drug resistance in newly infected individuals.
HIV-1 drug resistance in newly infected individuals.
HIV-1 drug resistance in newly infected individuals.
HIV-1 drug resistance in newly infected individuals.
HIV-1 drug resistance in newly infected individuals.
HIV-1 drug resistance in newly infected individuals.
HIV-1 drug resistance in newly infected individuals.
HIV-1 drug resistance in newly infected individuals.
HIV-1 drug resistance in newly infected individuals.
Implications of "market baskets," a pharmaceutical marketing practice.
Implications of "market baskets," a pharmaceutical marketing practice.
Vitamin K-supplemented snacks containing olestra: implication for patients taking warfarin.
Vitamin K-supplemented snacks containing olestra: implication for patients taking warfarin.
Vitamin K-supplemented snacks containing olestra: implication for patients taking warfarin.
Recommendations for lightning safety.
Recommendations for lightning safety.
Recommendations for lightning safety.
Recommendations for lightning safety.
Diabetes and decline in heart disease mortality.
Diabetes and decline in heart disease mortality.
Diabetes and decline in heart disease mortality.
Protection under the Americans with Disabilities Act.
Protection under the Americans with Disabilities Act.
Protection under the Americans with Disabilities Act.
Protection under the Americans with Disabilities Act.
Behavioral and pharmacological treatment for insomnia.
Behavioral and pharmacological treatment for insomnia.
Behavioral and pharmacological treatment for insomnia.
Behavioral and pharmacological treatment for insomnia.
Comprehensive home care after hospitalization of elderly patients.
Comprehensive home care after hospitalization of elderly patients.
Comprehensive home care after hospitalization of elderly patients.
Should benzodiazepines in an 87-year-old woman be tapered and discontinued?
Should benzodiazepines in an 87-year-old woman be tapered and discontinued?
Should benzodiazepines in an 87-year-old woman be tapered and discontinued?
From the Centers for Disease Control and Prevention. Progress toward the elimination of tuberculosis--United States, 1998.
From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant St
From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant St
From the Centers for Disease Control and Prevention. Health status of and intervention for US-bound Kosovar refugees--Fort
Sentinel node biopsy successful in patients with oral cancer.
Sentinel node biopsy successful in patients with oral cancer.
Keeping depression at bay helps patients with Parkinson disease.
Keeping depression at bay helps patients with Parkinson disease.
New surgical approaches to Parkinson disease.
New surgical approaches to Parkinson disease.
Evolving trends and treatment advances in pediatric poisoning.
Evolving trends and treatment advances in pediatric poisoning.
Evolving trends and treatment advances in pediatric poisoning.
A piece of my mind. What we are made of.
A piece of my mind. What we are made of.
JAMA Patient Page: newborn care.
Harassment of lesbians as medical students and physicians.
Harassment of lesbians as medical students and physicians.
Harassment of lesbians as medical students and physicians.
Harassment of lesbians as medical students and physicians.
Harassment of lesbians as medical students and physicians.
Harassment of lesbians as medical students and physicians.
Sexual orientation and youth suicide.
Sexual orientation and youth suicide.
Sexual orientation and youth suicide.
Sexual orientation and youth suicide.
Domestic partnership benefits at medical universities.
Domestic partnership benefits at medical universities.
Uneasy partners: the lesbian and gay health care community and the AMA.
Uneasy partners: the lesbian and gay health care community and the AMA.
Uneasy partners: the lesbian and gay health care community and the AMA.
Gay men and lesbians in medicine: has discrimination left the room?
Gay men and lesbians in medicine: has discrimination left the room?
A future without tobacco: a call for papers.
A future without tobacco: a call for papers.
A future without tobacco: a call for papers.
Service excellence in health care.
Service excellence in health care.
Service excellence in health care.
The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be
The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be
The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be
The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be
The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be
The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be
The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be
The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be
Pharmacologic treatment of depression during pregnancy.
Pharmacologic treatment of depression during pregnancy.
Pharmacologic treatment of depression during pregnancy.
Pharmacologic treatment of depression during pregnancy.
Pharmacologic treatment of depression during pregnancy.
Pharmacologic treatment of depression during pregnancy.
Pharmacologic treatment of depression during pregnancy.
Pharmacologic treatment of depression during pregnancy.
Pharmacologic treatment of depression during pregnancy.
Blended payment methods in physician organizations under managed care.
Blended payment methods in physician organizations under managed care.
Blended payment methods in physician organizations under managed care.
Blended payment methods in physician organizations under managed care.
The relationship between cyclooxygenase-2 expression and colorectal cancer.
The relationship between cyclooxygenase-2 expression and colorectal cancer.
The relationship between cyclooxygenase-2 expression and colorectal cancer.
The relationship between cyclooxygenase-2 expression and colorectal cancer.
The relationship between cyclooxygenase-2 expression and colorectal cancer.
The relationship between cyclooxygenase-2 expression and colorectal cancer.
The relationship between cyclooxygenase-2 expression and colorectal cancer.
The relationship between cyclooxygenase-2 expression and colorectal cancer.
The relationship between cyclooxygenase-2 expression and colorectal cancer.
The relationship between cyclooxygenase-2 expression and colorectal cancer.
Smoking in China: findings of the 1996 National Prevalence Survey.
Smoking in China: findings of the 1996 National Prevalence Survey.
Smoking in China: findings of the 1996 National Prevalence Survey.
Smoking in China: findings of the 1996 National Prevalence Survey.
Smoking in China: findings of the 1996 National Prevalence Survey.
Smoking in China: findings of the 1996 National Prevalence Survey.
Smoking in China: findings of the 1996 National Prevalence Survey.
Smoking in China: findings of the 1996 National Prevalence Survey.
Smoking in China: findings of the 1996 National Prevalence Survey.
Smoking in China: findings of the 1996 National Prevalence Survey.
Smoking in China: findings of the 1996 National Prevalence Survey.
Smoking in China: findings of the 1996 National Prevalence Survey.
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for preven
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for preven
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for preven
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for preven
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for preven
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for preven
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for preven
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for preven
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for preven
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for preven
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for preven
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for preven
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for preven
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for preven
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for preven
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for preven
Fruit and vegetable intake in relation to risk of ischemic stroke.
Fruit and vegetable intake in relation to risk of ischemic stroke.
Fruit and vegetable intake in relation to risk of ischemic stroke.
Fruit and vegetable intake in relation to risk of ischemic stroke.
Fruit and vegetable intake in relation to risk of ischemic stroke.
Fruit and vegetable intake in relation to risk of ischemic stroke.
Fruit and vegetable intake in relation to risk of ischemic stroke.
Fruit and vegetable intake in relation to risk of ischemic stroke.
Fruit and vegetable intake in relation to risk of ischemic stroke.
Fruit and vegetable intake in relation to risk of ischemic stroke.
Fruit and vegetable intake in relation to risk of ischemic stroke.
Fruit and vegetable intake in relation to risk of ischemic stroke.
Fruit and vegetable intake in relation to risk of ischemic stroke.
Sexual dysfunction in the United States.
Sexual dysfunction in the United States.
Sexual dysfunction in the United States.
Sexual dysfunction in the United States.
Tobacco and alcohol use in children's animated films: Pecos Bill kicks the habit.
Tobacco and alcohol use in children's animated films: Pecos Bill kicks the habit.
Tobacco and alcohol use in children's animated films: Pecos Bill kicks the habit.
Tobacco and alcohol use in children's animated films: Pecos Bill kicks the habit.
Tobacco and alcohol use in children's animated films: Pecos Bill kicks the habit.
Direct-to-consumer advertising: education or anathema?
Direct-to-consumer advertising: education or anathema?
Direct-to-consumer advertising: education or anathema?
Direct-to-consumer advertising: education or anathema?
Direct-to-consumer advertising: education or anathema?
Direct-to-consumer advertising: education or anathema?
Direct-to-consumer advertising: education or anathema?
Direct-to-consumer advertising: education or anathema?
Direct-to-consumer advertising: education or anathema?
Direct-to-consumer advertising: education or anathema?
Screening mammography for women younger than 50 years.
Screening mammography for women younger than 50 years.
Screening mammography for women younger than 50 years.
Left bundle-branch block and the ECG in diagnosis of acute myocardial infarction.
Left bundle-branch block and the ECG in diagnosis of acute myocardial infarction.
Left bundle-branch block and the ECG in diagnosis of acute myocardial infarction.
Left bundle-branch block and the ECG in diagnosis of acute myocardial infarction.
Left bundle-branch block and the ECG in diagnosis of acute myocardial infarction.
Dietary fat and risk of breast cancer.
Dietary fat and risk of breast cancer.
Dietary fat and risk of breast cancer.
Dietary fat and risk of breast cancer.
Dietary fat and risk of breast cancer.
Dietary fat and risk of breast cancer.
Dietary fat and risk of breast cancer.
Dietary fat and risk of breast cancer.
From the Centers for Disease Control and Prevention. Multiple human exposures to a rabid bear cub at a petting zoo and bar
From the Centers for Disease Control and Prevention. Satellite broadcast on diagnostic and therapeutic dilemmas for gonoco
From the Centers for Disease Control and Prevention. State-specific maternal mortality among black and white women--Unite
From the Centers for Disease Control and Prevention. Availability of hepatitis B vaccine that does not contain thimerosal as a
From the Food and Drug Administration.
From the Food and Drug Administration.
Recommendations on stem cell research.
Recommendations on stem cell research.
Slowing decline in AIDS deaths prompts concern.
Slowing decline in AIDS deaths prompts concern.
Slowing decline in AIDS deaths prompts concern.
Recognizing and treating depression in the elderly.
Recognizing and treating depression in the elderly.
Experts describe optimal symptom management for hospice patients.
Experts describe optimal symptom management for hospice patients.
Women's health on the Web.
Women's health on the Web.
Islands I hardly knew.
Islands I hardly knew.
JAMA Patient Page: diet.
Lack of evidence about tube feeding--food for thought.
Lack of evidence about tube feeding--food for thought.
Lack of evidence about tube feeding--food for thought.
High-dose chemotherapy and breast cancer.
High-dose chemotherapy and breast cancer.
High-dose chemotherapy and breast cancer.
Users' Guides to the Medical Literature: XIX. Applying clinical trial results B. Guidelines for determining whether a drug is exer
Users' Guides to the Medical Literature: XIX. Applying clinical trial results B. Guidelines for determining whether a drug is exer
Users' Guides to the Medical Literature: XIX. Applying clinical trial results B. Guidelines for determining whether a drug is exer
Users' Guides to the Medical Literature: XIX. Applying clinical trial results B. Guidelines for determining whether a drug is exer
Users' Guides to the Medical Literature: XIX. Applying clinical trial results B. Guidelines for determining whether a drug is exer
Users' Guides to the Medical Literature: XIX. Applying clinical trial results B. Guidelines for determining whether a drug is exer
Tube feeding in patients with advanced dementia: a review of the evidence.
Tube feeding in patients with advanced dementia: a review of the evidence.
Tube feeding in patients with advanced dementia: a review of the evidence.
Tube feeding in patients with advanced dementia: a review of the evidence.
Tube feeding in patients with advanced dementia: a review of the evidence.
Tube feeding in patients with advanced dementia: a review of the evidence.
Unintended pregnancy among adult women exposed to abuse or household dysfunction during their childhood.
Unintended pregnancy among adult women exposed to abuse or household dysfunction during their childhood.
Unintended pregnancy among adult women exposed to abuse or household dysfunction during their childhood.
Unintended pregnancy among adult women exposed to abuse or household dysfunction during their childhood.
Unintended pregnancy among adult women exposed to abuse or household dysfunction during their childhood.
Unintended pregnancy among adult women exposed to abuse or household dysfunction during their childhood.
Unintended pregnancy among adult women exposed to abuse or household dysfunction during their childhood.
Unintended pregnancy among adult women exposed to abuse or household dysfunction during their childhood.
Unintended pregnancy among adult women exposed to abuse or household dysfunction during their childhood.
Unintended pregnancy among adult women exposed to abuse or household dysfunction during their childhood.
Unintended pregnancy among adult women exposed to abuse or household dysfunction during their childhood.
Unintended pregnancy among adult women exposed to abuse or household dysfunction during their childhood.
Unintended pregnancy among adult women exposed to abuse or household dysfunction during their childhood.
Prevalence of attempting weight loss and strategies for controlling weight.
Prevalence of attempting weight loss and strategies for controlling weight.
Prevalence of attempting weight loss and strategies for controlling weight.
Prevalence of attempting weight loss and strategies for controlling weight.
Prevalence of attempting weight loss and strategies for controlling weight.
Prevalence of attempting weight loss and strategies for controlling weight.
Prevalence of attempting weight loss and strategies for controlling weight.
Prevalence of attempting weight loss and strategies for controlling weight.
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a ran
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation
Modified directly observed therapy for treatment of human immunodeficiency virus.
Modified directly observed therapy for treatment of human immunodeficiency virus.
Modified directly observed therapy for treatment of human immunodeficiency virus.
Modified directly observed therapy for treatment of human immunodeficiency virus.
Modified directly observed therapy for treatment of human immunodeficiency virus.
Modified directly observed therapy for treatment of human immunodeficiency virus.
Modified directly observed therapy for treatment of human immunodeficiency virus.
Modified directly observed therapy for treatment of human immunodeficiency virus.
Prenatal and postnatal methylmercury exposure and neurodevelopmental outcomes.
Prenatal and postnatal methylmercury exposure and neurodevelopmental outcomes.
Prenatal and postnatal methylmercury exposure and neurodevelopmental outcomes.
Prenatal and postnatal methylmercury exposure and neurodevelopmental outcomes.
Prenatal and postnatal methylmercury exposure and neurodevelopmental outcomes.
Prenatal and postnatal methylmercury exposure and neurodevelopmental outcomes.
Prenatal and postnatal methylmercury exposure and neurodevelopmental outcomes.
Some implications of the prion paradigm: caveat denaturor.
Some implications of the prion paradigm: caveat denaturor.
A new potential hazard of ear piercing?
A new potential hazard of ear piercing?
A new potential hazard of ear piercing?
Medical futility in end-of-life care.
Medical futility in end-of-life care.
Medical futility in end-of-life care.
Medical futility in end-of-life care.
Health care service quality.
Health care service quality.
Health care service quality.
Health care service quality.
Health care service quality.
Health care service quality.
Moxibustion for breech presentation.
Moxibustion for breech presentation.
Moxibustion for breech presentation.
Moxibustion for breech presentation.
Parkinson disease in twins.
Parkinson disease in twins.
Parkinson disease in twins.
Parkinson disease in twins.
Parkinson disease in twins.
Parkinson disease in twins.
Parkinson disease in twins.
Parkinson disease in twins.
Parkinson disease in twins.
Parkinson disease in twins.
From the Centers for Disease Control and Prevention. Carbon monoxide poisoning deaths associated with camping--Georgia,
From the Centers for Disease Control and Prevention. Carbon monoxide poisoning deaths associated with camping--Georgia,
From the Centers for Disease Control and Prevention. Menigococcal disease--New England, 1993-1998.
From the Centers for Disease Control and Prevention. Epidemiology of measles--United States, 1998.
Illicit drug users not idle; report says 70% go to work.
Illicit drug users not idle; report says 70% go to work.
Like trying to get blood from a . . . federal agency.
Like trying to get blood from a . . . federal agency.
Hopes for HIV eradication dim as stopping HAART allows resurgence.
Hopes for HIV eradication dim as stopping HAART allows resurgence.
Science-based views of drug addiction and its treatment.
Science-based views of drug addiction and its treatment.
Science-based views of drug addiction and its treatment.
JAMA Patient Page: osteoporosis.
Resolving disagreements in the patient-physician relationship: tools for improving communication in managed care.
Resolving disagreements in the patient-physician relationship: tools for improving communication in managed care.
Resolving disagreements in the patient-physician relationship: tools for improving communication in managed care.
Resolving disagreements in the patient-physician relationship: tools for improving communication in managed care.
Resolving disagreements in the patient-physician relationship: tools for improving communication in managed care.
Resolving disagreements in the patient-physician relationship: tools for improving communication in managed care.
Resolving disagreements in the patient-physician relationship: tools for improving communication in managed care.
Resolving disagreements in the patient-physician relationship: tools for improving communication in managed care.
Resolving disagreements in the patient-physician relationship: tools for improving communication in managed care.
Resolving disagreements in the patient-physician relationship: tools for improving communication in managed care.
Resolving disagreements in the patient-physician relationship: tools for improving communication in managed care.
Resolving disagreements in the patient-physician relationship: tools for improving communication in managed care.
Resolving disagreements in the patient-physician relationship: tools for improving communication in managed care.
Resolving disagreements in the patient-physician relationship: tools for improving communication in managed care.
Resolving disagreements in the patient-physician relationship: tools for improving communication in managed care.
Resolving disagreements in the patient-physician relationship: tools for improving communication in managed care.
Conflict of interest and cost-effectiveness analysis.
Conflict of interest and cost-effectiveness analysis.
Conflict of interest and cost-effectiveness analysis.
Political considerations for changing medical screening programs.
Political considerations for changing medical screening programs.
Political considerations for changing medical screening programs.
Legal issues concerning electronic health information: privacy, quality, and liability.
Legal issues concerning electronic health information: privacy, quality, and liability.
Legal issues concerning electronic health information: privacy, quality, and liability.
Legal issues concerning electronic health information: privacy, quality, and liability.
Legal issues concerning electronic health information: privacy, quality, and liability.
Legal issues concerning electronic health information: privacy, quality, and liability.
Why don't physicians follow clinical practice guidelines? A framework for improvement.
Why don't physicians follow clinical practice guidelines? A framework for improvement.
Why don't physicians follow clinical practice guidelines? A framework for improvement.
Why don't physicians follow clinical practice guidelines? A framework for improvement.
Why don't physicians follow clinical practice guidelines? A framework for improvement.
Why don't physicians follow clinical practice guidelines? A framework for improvement.
Why don't physicians follow clinical practice guidelines? A framework for improvement.
Why don't physicians follow clinical practice guidelines? A framework for improvement.
Why don't physicians follow clinical practice guidelines? A framework for improvement.
Why don't physicians follow clinical practice guidelines? A framework for improvement.
Why don't physicians follow clinical practice guidelines? A framework for improvement.
Evaluation of conflict of interest in economic analyses of new drugs used in oncology.
Evaluation of conflict of interest in economic analyses of new drugs used in oncology.
Evaluation of conflict of interest in economic analyses of new drugs used in oncology.
Evaluation of conflict of interest in economic analyses of new drugs used in oncology.
Evaluation of conflict of interest in economic analyses of new drugs used in oncology.
Evaluation of conflict of interest in economic analyses of new drugs used in oncology.
Evaluation of conflict of interest in economic analyses of new drugs used in oncology.
Evaluation of conflict of interest in economic analyses of new drugs used in oncology.
Prognostic value of 24-hour blood pressure in pregnancy.
Prognostic value of 24-hour blood pressure in pregnancy.
Prognostic value of 24-hour blood pressure in pregnancy.
Prognostic value of 24-hour blood pressure in pregnancy.
Prognostic value of 24-hour blood pressure in pregnancy.
Prognostic value of 24-hour blood pressure in pregnancy.
Prognostic value of 24-hour blood pressure in pregnancy.
Prognostic value of 24-hour blood pressure in pregnancy.
Prognostic value of 24-hour blood pressure in pregnancy.
Prognostic value of 24-hour blood pressure in pregnancy.
Prognostic value of 24-hour blood pressure in pregnancy.
Bronchiolitis-associated hospitalizations among US children, 1980-1996.
Bronchiolitis-associated hospitalizations among US children, 1980-1996.
Bronchiolitis-associated hospitalizations among US children, 1980-1996.
Bronchiolitis-associated hospitalizations among US children, 1980-1996.
Bronchiolitis-associated hospitalizations among US children, 1980-1996.
Bronchiolitis-associated hospitalizations among US children, 1980-1996.
Bronchiolitis-associated hospitalizations among US children, 1980-1996.
Bronchiolitis-associated hospitalizations among US children, 1980-1996.
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study.
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study.
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study.
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study.
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study.
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study.
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study.
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study.
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study.
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study.
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study.
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study.
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study.
A population-based study of school scoliosis screening.
A population-based study of school scoliosis screening.
A population-based study of school scoliosis screening.
A population-based study of school scoliosis screening.
A population-based study of school scoliosis screening.
A population-based study of school scoliosis screening.
A population-based study of school scoliosis screening.
A population-based study of school scoliosis screening.
A population-based study of school scoliosis screening.
A population-based study of school scoliosis screening.
Total parenteral nutrition for critically ill patients.
Total parenteral nutrition for critically ill patients.
Total parenteral nutrition for critically ill patients.
Total parenteral nutrition for critically ill patients.
Total parenteral nutrition for critically ill patients.
Total parenteral nutrition for critically ill patients.
Total parenteral nutrition for critically ill patients.
Total parenteral nutrition for critically ill patients.
Total parenteral nutrition for critically ill patients.
Total parenteral nutrition for critically ill patients.
Total parenteral nutrition for critically ill patients.
Total parenteral nutrition for critically ill patients.
Total parenteral nutrition for critically ill patients.
Total parenteral nutrition for critically ill patients.
Total parenteral nutrition for critically ill patients.
Electron beam computed tomography to detect coronary artery disease.
Electron beam computed tomography to detect coronary artery disease.
Electron beam computed tomography to detect coronary artery disease.
Recognizing abusive head trauma in children.
Recognizing abusive head trauma in children.
Recognizing abusive head trauma in children.
Recognizing abusive head trauma in children.
Recognizing abusive head trauma in children.
Recognizing abusive head trauma in children.
Recognizing abusive head trauma in children.
Recognizing abusive head trauma in children.
Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.
Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.
Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.
Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.
Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.
Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.
Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.
Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.
Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.
From the Centers for Disease Control and Prevention. High prevalence of chlamydial and gonococcal infection in women ente
From the Centers for Disease Control and Prevention. Bidi use among urban youth--Massachusetts, March-April 1999.
New technique treats male infertility.
New technique treats male infertility.
1999 Albert Lasker Medical Research Awards presented.
1999 Albert Lasker Medical Research Awards presented.
R U E 4 Y2K?
R U E 4 Y2K?
What's in a (drug) name? Plenty!
What's in a (drug) name? Plenty!
JAMA Patient Page: respiratory problems.
Contraceptive effectiveness: what should the counseling message be?
Contraceptive effectiveness: what should the counseling message be?
Genetically enhanced rice to help fight malnutrition.
Genetically enhanced rice to help fight malnutrition.
Physician counseling about exercise.
Physician counseling about exercise.
Physician counseling about exercise.
Physician counseling about exercise.
Physician counseling about exercise.
Physician counseling about exercise.
Physician counseling about exercise.
Physician counseling about exercise.
Patients, physicians, and weight control.
Patients, physicians, and weight control.
Patients, physicians, and weight control.
Caloric imbalance and public health policy.
Caloric imbalance and public health policy.
Caloric imbalance and public health policy.
Are health care professionals advising obese patients to lose weight?
Are health care professionals advising obese patients to lose weight?
Are health care professionals advising obese patients to lose weight?
Are health care professionals advising obese patients to lose weight?
Are health care professionals advising obese patients to lose weight?
Are health care professionals advising obese patients to lose weight?
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Reducing children's television viewing to prevent obesity: a randomized controlled trial.
Reducing children's television viewing to prevent obesity: a randomized controlled trial.
Reducing children's television viewing to prevent obesity: a randomized controlled trial.
Reducing children's television viewing to prevent obesity: a randomized controlled trial.
Reducing children's television viewing to prevent obesity: a randomized controlled trial.
Reducing children's television viewing to prevent obesity: a randomized controlled trial.
Reducing children's television viewing to prevent obesity: a randomized controlled trial.
Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight wo
Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight wo
Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight wo
Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight wo
Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight wo
Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight wo
Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight wo
Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight wo
Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight wo
Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men.
Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men.
Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men.
Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men.
Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men.
Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men.
Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men.
Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men.
Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men.
Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men.
Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men.
Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults.
Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults.
Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults.
Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults.
Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults.
Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults.
Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults.
Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults.
Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults.
Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults.
Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults.
Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults.
Annual deaths attributable to obesity in the United States.
Annual deaths attributable to obesity in the United States.
Annual deaths attributable to obesity in the United States.
Annual deaths attributable to obesity in the United States.
Annual deaths attributable to obesity in the United States.
Annual deaths attributable to obesity in the United States.
Annual deaths attributable to obesity in the United States.
Annual deaths attributable to obesity in the United States.
The disease burden associated with overweight and obesity.
The disease burden associated with overweight and obesity.
The disease burden associated with overweight and obesity.
The disease burden associated with overweight and obesity.
The disease burden associated with overweight and obesity.
The disease burden associated with overweight and obesity.
The disease burden associated with overweight and obesity.
The disease burden associated with overweight and obesity.
The disease burden associated with overweight and obesity.
The spread of the obesity epidemic in the United States, 1991-1998.
The spread of the obesity epidemic in the United States, 1991-1998.
The spread of the obesity epidemic in the United States, 1991-1998.
The spread of the obesity epidemic in the United States, 1991-1998.
The spread of the obesity epidemic in the United States, 1991-1998.
The spread of the obesity epidemic in the United States, 1991-1998.
The spread of the obesity epidemic in the United States, 1991-1998.
The spread of the obesity epidemic in the United States, 1991-1998.
CSF leptin levels after exogenous administration of recombinant methionyl human leptin.
CSF leptin levels after exogenous administration of recombinant methionyl human leptin.
CSF leptin levels after exogenous administration of recombinant methionyl human leptin.
CSF leptin levels after exogenous administration of recombinant methionyl human leptin.
CSF leptin levels after exogenous administration of recombinant methionyl human leptin.
CSF leptin levels after exogenous administration of recombinant methionyl human leptin.
Lifestyle and structured interventions to increase physical activity.
Lifestyle and structured interventions to increase physical activity.
Lifestyle and structured interventions to increase physical activity.
Lifestyle and structured interventions to increase physical activity.
Lifestyle and structured interventions to increase physical activity.
Lifestyle and structured interventions to increase physical activity.
Lifestyle and structured interventions to increase physical activity.
Lifestyle and structured interventions to increase physical activity.
Lifestyle and structured interventions to increase physical activity.
Lifestyle and structured interventions to increase physical activity.
Lifestyle and structured interventions to increase physical activity.
From the Centers for Disease Control and Prevention. Inadvertent use of Bicillin C-R for treatment of syphilis--Maryland, 1998
From the Centers for Disease Control and Prevention. Mortality patterns--United States, 1997.
Better control coming for clotting and bleeding.
Better control coming for clotting and bleeding.
Knockout science: chubby mice provide new insights into obesity.
Knockout science: chubby mice provide new insights into obesity.
Recent advances in basic obesity research.
Recent advances in basic obesity research.
JAMA Patient Page. Weight management.
From the Centers for Disease Control and Prevention. Publication of survey results of assessment of state health agencies' rea
Serving two masters: medical practice vs administrative ethics.
Serving two masters: medical practice vs administrative ethics.
Community considerations: the many effects of miscoding.
Community considerations: the many effects of miscoding.
Physicians' duties in an era of cost containment: advocacy or betrayal?
Physicians' duties in an era of cost containment: advocacy or betrayal?
Physicians' duties in an era of cost containment: advocacy or betrayal?
Physicians' duties in an era of cost containment: advocacy or betrayal?
Should doctors ever lie on behalf of patients?
Should doctors ever lie on behalf of patients?
How gravely ill becomes dying: a key to end-of-life care.
How gravely ill becomes dying: a key to end-of-life care.
How gravely ill becomes dying: a key to end-of-life care.
Exploring the benefits and limits of highly active antiretroviral therapy.
Exploring the benefits and limits of highly active antiretroviral therapy.
Exploring the benefits and limits of highly active antiretroviral therapy.
Exploring the benefits and limits of highly active antiretroviral therapy.
Exploring the benefits and limits of highly active antiretroviral therapy.
Ten encounters with the US health sector, 1930-1999.
Ten encounters with the US health sector, 1930-1999.
Ten encounters with the US health sector, 1930-1999.
Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study.
Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study.
Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study.
Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study.
Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study.
Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study.
Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study.
Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study.
Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study.
Adverse childhood experiences and smoking during adolescence and adulthood.
Adverse childhood experiences and smoking during adolescence and adulthood.
Adverse childhood experiences and smoking during adolescence and adulthood.
Adverse childhood experiences and smoking during adolescence and adulthood.
Adverse childhood experiences and smoking during adolescence and adulthood.
Adverse childhood experiences and smoking during adolescence and adulthood.
Adverse childhood experiences and smoking during adolescence and adulthood.
Adverse childhood experiences and smoking during adolescence and adulthood.
Adverse childhood experiences and smoking during adolescence and adulthood.
Adverse childhood experiences and smoking during adolescence and adulthood.
Adverse childhood experiences and smoking during adolescence and adulthood.
Placental abruption and adverse perinatal outcomes.
Placental abruption and adverse perinatal outcomes.
Placental abruption and adverse perinatal outcomes.
Placental abruption and adverse perinatal outcomes.
Placental abruption and adverse perinatal outcomes.
Placental abruption and adverse perinatal outcomes.
Placental abruption and adverse perinatal outcomes.
Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUP
Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUP
Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUP
Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUP
Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUP
Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUP
Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUP
Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUP
Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUP
Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUP
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.
Informed consent for tissue research.
Informed consent for tissue research.
Informed consent for tissue research.
Informed consent for tissue research.
Informed consent for tissue research.
Informed consent for tissue research.
Informed consent for tissue research.
Recognition and treatment of anthrax.
Recognition and treatment of anthrax.
Recognition and treatment of anthrax.
Postexposure prophylaxis for occupational exposure to HIV.
Postexposure prophylaxis for occupational exposure to HIV.
Postexposure prophylaxis for occupational exposure to HIV.
Postexposure prophylaxis for occupational exposure to HIV.
Exercise echocardiography vs exercise SPECT testing.
Exercise echocardiography vs exercise SPECT testing.
Exercise echocardiography vs exercise SPECT testing.
Exercise echocardiography vs exercise SPECT testing.
Exercise echocardiography vs exercise SPECT testing.
Exercise echocardiography vs exercise SPECT testing.
Exercise echocardiography vs exercise SPECT testing.
Exercise echocardiography vs exercise SPECT testing.
Exercise echocardiography vs exercise SPECT testing.
Exercise echocardiography vs exercise SPECT testing.
Exercise echocardiography vs exercise SPECT testing.
Exercise echocardiography vs exercise SPECT testing.
Exercise echocardiography vs exercise SPECT testing.
Exercise echocardiography vs exercise SPECT testing.
Managed care, charity care, and the common good.
Managed care, charity care, and the common good.
Managed care, charity care, and the common good.
Managed care, charity care, and the common good.
Managed care, charity care, and the common good.
Managed care, charity care, and the common good.
Managed care, charity care, and the common good.
Managed care, charity care, and the common good.
Managed care, charity care, and the common good.
Managed care, charity care, and the common good.
Managed care, charity care, and the common good.
From the Centers for Disease Control and Prevention. Progress toward poliomyelitis eradication--Afghanistan, 1994-1999.
From the Centers for Disease Control and Prevention. Folic acid campaign and evaluation--southwestern Virginia, 1997-1999.
From the Centers for Disease Control and Prevention. Rubella outbreak--Westchester County, New York, 1997-1998.
From the Food and Drug Administration.
From the Food and Drug Administration.
Wit: a play raises issues of emotional needs of patients.
Wit: a play raises issues of emotional needs of patients.
Crash risk among older drivers studied.
Crash risk among older drivers studied.
Catherine D. DeAngelis, MD, is named new JAMA editor.
Catherine D. DeAngelis, MD, is named new JAMA editor.
A piece of my mind. Lisa's stories.
A piece of my mind. Lisa's stories.
JAMA Patient Page: tobacco.
Quality management practices in Medicaid managed care: a national survey of Medicaid and commercial health plans particip
Quality management practices in Medicaid managed care: a national survey of Medicaid and commercial health plans particip
Quality management practices in Medicaid managed care: a national survey of Medicaid and commercial health plans particip
Quality management practices in Medicaid managed care: a national survey of Medicaid and commercial health plans particip
Quality management practices in Medicaid managed care: a national survey of Medicaid and commercial health plans particip
Fair conduct and fair reporting of clinical trials.
Fair conduct and fair reporting of clinical trials.
Fair conduct and fair reporting of clinical trials.
Limiting infant exposure to thimerosal in vaccines and other sources of mercury.
Limiting infant exposure to thimerosal in vaccines and other sources of mercury.
Limiting infant exposure to thimerosal in vaccines and other sources of mercury.
Limiting infant exposure to thimerosal in vaccines and other sources of mercury.
Limiting infant exposure to thimerosal in vaccines and other sources of mercury.
Potential effects of the "premium-support" proposal on the security of Medicare.
Potential effects of the "premium-support" proposal on the security of Medicare.
Potential effects of the "premium-support" proposal on the security of Medicare.
Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis.
Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis.
Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis.
Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis.
Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis.
Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit.
Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit.
Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit.
Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit.
Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit.
Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit.
Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit.
Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental D
Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental D
Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental D
Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental D
Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental D
Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental D
Clinical and angiographic characteristics of exertion-related acute myocardial infarction.
Clinical and angiographic characteristics of exertion-related acute myocardial infarction.
Clinical and angiographic characteristics of exertion-related acute myocardial infarction.
Clinical and angiographic characteristics of exertion-related acute myocardial infarction.
Clinical and angiographic characteristics of exertion-related acute myocardial infarction.
Clinical and angiographic characteristics of exertion-related acute myocardial infarction.
Clinical and angiographic characteristics of exertion-related acute myocardial infarction.
Clinical and angiographic characteristics of exertion-related acute myocardial infarction.
Clinical and angiographic characteristics of exertion-related acute myocardial infarction.
Clinical and angiographic characteristics of exertion-related acute myocardial infarction.
Clinical and angiographic characteristics of exertion-related acute myocardial infarction.
Clinical and angiographic characteristics of exertion-related acute myocardial infarction.
Clinical and angiographic characteristics of exertion-related acute myocardial infarction.
Clinical and angiographic characteristics of exertion-related acute myocardial infarction.
Hepatitis B vaccination among children in inner-city public housing, 1991-1997.
Hepatitis B vaccination among children in inner-city public housing, 1991-1997.
Hepatitis B vaccination among children in inner-city public housing, 1991-1997.
Hepatitis B vaccination among children in inner-city public housing, 1991-1997.
Hepatitis B vaccination among children in inner-city public housing, 1991-1997.
Hepatitis B vaccination among children in inner-city public housing, 1991-1997.
Hepatitis B vaccination among children in inner-city public housing, 1991-1997.
Clinical crossroads: a 73-year old woman with osteoporosis.
Clinical crossroads: a 73-year old woman with osteoporosis.
Clinical crossroads: a 73-year old woman with osteoporosis.
Perceptions of health risks by cigarette smokers.
Perceptions of health risks by cigarette smokers.
Perceptions of health risks by cigarette smokers.
Perceptions of health risks by cigarette smokers.
Perceptions of health risks by cigarette smokers.
Perceptions of health risks by cigarette smokers.
Perceptions of health risks by cigarette smokers.
Appropriate use of child car seats.
Appropriate use of child car seats.
Appropriate use of child car seats.
Hypovolemia in patients with hyperglycemia.
Hypovolemia in patients with hyperglycemia.
Hypovolemia in patients with hyperglycemia.
Computer-based genetic counseling.
Computer-based genetic counseling.
Ticlopidine and TTP after coronary stenting.
Ticlopidine and TTP after coronary stenting.
Ticlopidine and TTP after coronary stenting.
Ticlopidine and TTP after coronary stenting.
Ticlopidine and TTP after coronary stenting.
Ticlopidine and TTP after coronary stenting.
Ticlopidine and TTP after coronary stenting.
Ticlopidine and TTP after coronary stenting.
Ticlopidine and TTP after coronary stenting.
Ticlopidine and TTP after coronary stenting.
Ticlopidine and TTP after coronary stenting.
From the Centers for Disease Control and Prevention. Primary and secondary syphilis--United States, 1998.
From the Centers for Disease Control and Prevention. Update: West Nile-like viral encephalitis--New York, 1999.
Vision researchers seek to be armed against damaging ARMD. Age-related macular degeneration.
Vision researchers seek to be armed against damaging ARMD. Age-related macular degeneration.
Primary care physicians and posttraumatic stress disorder.
Primary care physicians and posttraumatic stress disorder.
Military medicine in the Balkans now.
Military medicine in the Balkans now.
High-dose chemotherapy for breast cancer.
High-dose chemotherapy for breast cancer.
High-dose chemotherapy for breast cancer.
High-dose chemotherapy for breast cancer.
JAMA Patient Page: hepatitis B.
Impact of new technologies in medicine: a global theme issue.
Impact of new technologies in medicine: a global theme issue.
Impact of new technologies in medicine: a global theme issue.
Fetal surgery for myelomeningocele: promise, progress, and problems.
Fetal surgery for myelomeningocele: promise, progress, and problems.
Fetal surgery for myelomeningocele: promise, progress, and problems.
Medical innovation and the critical role of health technology assessment.
Medical innovation and the critical role of health technology assessment.
Medical innovation and the critical role of health technology assessment.
Ten lessons for evidence-based technology assessment.
Ten lessons for evidence-based technology assessment.
Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled
Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled
Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled
Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled
Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled
Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled
Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled
Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled
Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled
Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled
Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled
Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled
Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled
Enhancement of clinicians' diagnostic reasoning by computer-based consultation: a multisite study of 2 systems.
Enhancement of clinicians' diagnostic reasoning by computer-based consultation: a multisite study of 2 systems.
Enhancement of clinicians' diagnostic reasoning by computer-based consultation: a multisite study of 2 systems.
Enhancement of clinicians' diagnostic reasoning by computer-based consultation: a multisite study of 2 systems.
Enhancement of clinicians' diagnostic reasoning by computer-based consultation: a multisite study of 2 systems.
Enhancement of clinicians' diagnostic reasoning by computer-based consultation: a multisite study of 2 systems.
Enhancement of clinicians' diagnostic reasoning by computer-based consultation: a multisite study of 2 systems.
Enhancement of clinicians' diagnostic reasoning by computer-based consultation: a multisite study of 2 systems.
Enhancement of clinicians' diagnostic reasoning by computer-based consultation: a multisite study of 2 systems.
Enhancement of clinicians' diagnostic reasoning by computer-based consultation: a multisite study of 2 systems.
Enhancement of clinicians' diagnostic reasoning by computer-based consultation: a multisite study of 2 systems.
Enhancement of clinicians' diagnostic reasoning by computer-based consultation: a multisite study of 2 systems.
Enhancement of clinicians' diagnostic reasoning by computer-based consultation: a multisite study of 2 systems.
Enhancement of clinicians' diagnostic reasoning by computer-based consultation: a multisite study of 2 systems.
Enhancement of clinicians' diagnostic reasoning by computer-based consultation: a multisite study of 2 systems.
Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with co
Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with co
Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with co
Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with co
Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with co
Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with co
Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with co
Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with co
Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with co
Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with co
Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team.
Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team.
Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team.
Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team.
Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team.
Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team.
Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team.
Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team.
Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team.
Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team.
Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team.
Live-birth rates and multiple-birth risk using in vitro fertilization.
Live-birth rates and multiple-birth risk using in vitro fertilization.
Live-birth rates and multiple-birth risk using in vitro fertilization.
Live-birth rates and multiple-birth risk using in vitro fertilization.
Live-birth rates and multiple-birth risk using in vitro fertilization.
Live-birth rates and multiple-birth risk using in vitro fertilization.
Live-birth rates and multiple-birth risk using in vitro fertilization.
Live-birth rates and multiple-birth risk using in vitro fertilization.
Live-birth rates and multiple-birth risk using in vitro fertilization.
Live-birth rates and multiple-birth risk using in vitro fertilization.
Live-birth rates and multiple-birth risk using in vitro fertilization.
Improvement in hindbrain herniation demonstrated by serial fetal magnetic resonance imaging following fetal surgery for my
Improvement in hindbrain herniation demonstrated by serial fetal magnetic resonance imaging following fetal surgery for my
Improvement in hindbrain herniation demonstrated by serial fetal magnetic resonance imaging following fetal surgery for my
Improvement in hindbrain herniation demonstrated by serial fetal magnetic resonance imaging following fetal surgery for my
Improvement in hindbrain herniation demonstrated by serial fetal magnetic resonance imaging following fetal surgery for my
Improvement in hindbrain herniation demonstrated by serial fetal magnetic resonance imaging following fetal surgery for my
Improvement in hindbrain herniation demonstrated by serial fetal magnetic resonance imaging following fetal surgery for my
Improvement in hindbrain herniation demonstrated by serial fetal magnetic resonance imaging following fetal surgery for my
Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus.
Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus.
Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus.
Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus.
Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus.
Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus.
Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus.
Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus.
Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus.
Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus.
Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus.
Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus.
Serum sickness-like reaction with bupropion.
Serum sickness-like reaction with bupropion.
Serum sickness-like reaction with bupropion.
Serum sickness-like reaction with bupropion.
Regular exercise and subclinical myocardial injury during prolonged aerobic exercise.
Regular exercise and subclinical myocardial injury during prolonged aerobic exercise.
Regular exercise and subclinical myocardial injury during prolonged aerobic exercise.
Regular exercise and subclinical myocardial injury during prolonged aerobic exercise.
Cause-specific mortality in cellular telephone users.
Cause-specific mortality in cellular telephone users.
Cause-specific mortality in cellular telephone users.
Cause-specific mortality in cellular telephone users.
Cause-specific mortality in cellular telephone users.
Disclosure of physicians' financial incentives.
Disclosure of physicians' financial incentives.
Disclosure of physicians' financial incentives.
Multiple-birth risk associated with in vitro fertilization: revised guidelines.
Multiple-birth risk associated with in vitro fertilization: revised guidelines.
Multiple-birth risk associated with in vitro fertilization: revised guidelines.
Progressing from disease prevention to health promotion.
Progressing from disease prevention to health promotion.
Progressing from disease prevention to health promotion.
Progressing from disease prevention to health promotion.
Progressing from disease prevention to health promotion.
Progressing from disease prevention to health promotion.
Symptom reduction after writing about stressful experiences.
Symptom reduction after writing about stressful experiences.
Symptom reduction after writing about stressful experiences.
Symptom reduction after writing about stressful experiences.
Symptom reduction after writing about stressful experiences.
From the Centers for Disease Control and Prevention. Healthier mothers and babies--1900-1999.
From the Centers for Disease Control and Prevention. Healthier mothers and babies--1900-1999.
From the Centers for Disease Control and Prevention. Update: West Nile virus encephalitis--New York, 1999.
Consortium concurs on care for children with asthma.
Consortium concurs on care for children with asthma.
New laser target: otitis media.
New laser target: otitis media.
Lab-on-a-chip shows promise in defining and diagnosing cancers.
Lab-on-a-chip shows promise in defining and diagnosing cancers.
Millennial child: intern's admission note, November 17, 2150.
Millennial child: intern's admission note, November 17, 2150.
JAMA Patient Page: infertility.
Caring for patients at the end of life: call for papers.
Caring for patients at the end of life: call for papers.
Caring for patients at the end of life: call for papers.
Caring for patients at the end of life: call for papers.
Sexual behaviors and reproductive health outcomes: associations with wife abuse in India.
Sexual behaviors and reproductive health outcomes: associations with wife abuse in India.
Sexual behaviors and reproductive health outcomes: associations with wife abuse in India.
Sexual behaviors and reproductive health outcomes: associations with wife abuse in India.
Sexual behaviors and reproductive health outcomes: associations with wife abuse in India.
Sexual behaviors and reproductive health outcomes: associations with wife abuse in India.
Sexual behaviors and reproductive health outcomes: associations with wife abuse in India.
Sexual behaviors and reproductive health outcomes: associations with wife abuse in India.
Sexual behaviors and reproductive health outcomes: associations with wife abuse in India.
Keeping research subjects out of harm's way.
Keeping research subjects out of harm's way.
Keeping research subjects out of harm's way.
COX-1-sparing NSAIDs--is the enthusiasm justified?
COX-1-sparing NSAIDs--is the enthusiasm justified?
COX-1-sparing NSAIDs--is the enthusiasm justified?
COX-1-sparing NSAIDs--is the enthusiasm justified?
COX-1-sparing NSAIDs--is the enthusiasm justified?
An 87-year-old woman taking a benzodiazepine, 1 year later.
An 87-year-old woman taking a benzodiazepine, 1 year later.
An 87-year-old woman taking a benzodiazepine, 1 year later.
An 87-year-old woman taking a benzodiazepine, 1 year later.
A 40-year-old woman with a strong family history of breast cancer.
A 40-year-old woman with a strong family history of breast cancer.
A 40-year-old woman with a strong family history of breast cancer.
A 40-year-old woman with a strong family history of breast cancer.
A 40-year-old woman with a strong family history of breast cancer.
Challenges to human subject protections in US medical research.
Challenges to human subject protections in US medical research.
Challenges to human subject protections in US medical research.
Challenges to human subject protections in US medical research.
Borrelia burgdorferi-specific immune complexes in acute Lyme disease.
Borrelia burgdorferi-specific immune complexes in acute Lyme disease.
Borrelia burgdorferi-specific immune complexes in acute Lyme disease.
Borrelia burgdorferi-specific immune complexes in acute Lyme disease.
Borrelia burgdorferi-specific immune complexes in acute Lyme disease.
Borrelia burgdorferi-specific immune complexes in acute Lyme disease.
Borrelia burgdorferi-specific immune complexes in acute Lyme disease.
Borrelia burgdorferi-specific immune complexes in acute Lyme disease.
Hysterectomy and sexual functioning.
Hysterectomy and sexual functioning.
Hysterectomy and sexual functioning.
Hysterectomy and sexual functioning.
Hysterectomy and sexual functioning.
Hysterectomy and sexual functioning.
Hysterectomy and sexual functioning.
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Misadministration of topical bovine thrombin.
Misadministration of topical bovine thrombin.
Misadministration of topical bovine thrombin.
Misadministration of topical bovine thrombin.
Misadministration of topical bovine thrombin.
Misadministration of topical bovine thrombin.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
Attitudes toward and definitions of having sex.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
The crisis in clinical research.
From the Centers for Disease Control and Prevention. Safer and healthier foods--1900-1999.
From the Centers for Disease Control and Prevention. Safer and healthier foods--1900-1999.
Child psychiatrists address problem of youth violence.
Child psychiatrists address problem of youth violence.
New vaccine targets childhood pneumonia.
New vaccine targets childhood pneumonia.
Report documents causes of child death.
Report documents causes of child death.
Gauging the impact of statins using number needed to treat.
Gauging the impact of statins using number needed to treat.
Gauging the impact of statins using number needed to treat.
Gauging the impact of statins using number needed to treat.
A piece of my mind. Ward 55.
A piece of my mind. Ward 55.
JAMA Patient Page: arthritis.
Medical students' attitudes toward physician-assisted suicide.
Medical students' attitudes toward physician-assisted suicide.
Medical students' attitudes toward physician-assisted suicide.
Medical students' attitudes toward physician-assisted suicide.
Medical students' attitudes toward physician-assisted suicide.
Legal rights to health care at the end of life.
Legal rights to health care at the end of life.
Private and public choices in end-of-life care.
Private and public choices in end-of-life care.
Private and public choices in end-of-life care.
Aging, death, and population health.
Aging, death, and population health.
Economics, ethics, and end-of-life care.
Economics, ethics, and end-of-life care.
Chlamydia pneumoniae and atherosclerosis.
Chlamydia pneumoniae and atherosclerosis.
Chlamydia pneumoniae and atherosclerosis.
Chlamydia pneumoniae and atherosclerosis.
Conquering cardiovascular disease: progress and promise.
Conquering cardiovascular disease: progress and promise.
Conquering cardiovascular disease: progress and promise.
Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.
Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.
Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.
Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.
Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.
Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.
An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.
An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.
An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.
An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.
An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.
An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.
An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.
Preventing coronary artery disease by lowering cholesterol levels: fifty years from bench to bedside.
Preventing coronary artery disease by lowering cholesterol levels: fifty years from bench to bedside.
Preventing coronary artery disease by lowering cholesterol levels: fifty years from bench to bedside.
Preventing coronary artery disease by lowering cholesterol levels: fifty years from bench to bedside.
Preventing coronary artery disease by lowering cholesterol levels: fifty years from bench to bedside.
Hemodynamic shear stress and its role in atherosclerosis.
Hemodynamic shear stress and its role in atherosclerosis.
Hemodynamic shear stress and its role in atherosclerosis.
Hemodynamic shear stress and its role in atherosclerosis.
Hemodynamic shear stress and its role in atherosclerosis.
Hemodynamic shear stress and its role in atherosclerosis.
Hemodynamic shear stress and its role in atherosclerosis.
Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults.
Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults.
Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults.
Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults.
Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults.
Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults.
Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults.
Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults.
Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults.
Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults.
Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults.
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLAN
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLAN
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLAN
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLAN
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLAN
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLAN
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLAN
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLAN
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLAN
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLAN
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLAN
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLAN
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLAN
Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large
Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large
Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large
Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large
Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large
Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large
Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large
Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large
Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large
Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large
Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large
Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cer
Anemia in older patients.
Anemia in older patients.
Anemia in older patients.
National Stroke Association guidelines to prevent stroke.
National Stroke Association guidelines to prevent stroke.
National Stroke Association guidelines to prevent stroke.
National Stroke Association guidelines to prevent stroke.
National Stroke Association guidelines to prevent stroke.
National Stroke Association guidelines to prevent stroke.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
Antibiotic use and risk of myocardial infarction.
From The Surgeon General. Tuberculosis--battling an ancient scourge.
From The Surgeon General. Tuberculosis--battling an ancient scourge.
From the Food and Drug Administration.
From the Food and Drug Administration.
New class of anti-HIV drugs.
New class of anti-HIV drugs.
Poor nations ravaged by AIDS need the right resources now.
Poor nations ravaged by AIDS need the right resources now.
AHA addresses atherosclerosis testing. American Heart Association.
AHA addresses atherosclerosis testing. American Heart Association.
JAMA Patient Page: general health.
Oral contraceptives and women's health in Japan.
Oral contraceptives and women's health in Japan.
Oral contraceptives and women's health in Japan.
Oral contraceptives and women's health in Japan.
Oral contraceptives and women's health in Japan.
Oral contraceptives and women's health in Japan.
Smoldering arteries? Low-grade inflammation and coronary heart disease.
Smoldering arteries? Low-grade inflammation and coronary heart disease.
Smoldering arteries? Low-grade inflammation and coronary heart disease.
Smoldering arteries? Low-grade inflammation and coronary heart disease.
Susceptibility to otitis media: strong evidence that genetics plays a role.
Susceptibility to otitis media: strong evidence that genetics plays a role.
Susceptibility to otitis media: strong evidence that genetics plays a role.
Susceptibility to otitis media: strong evidence that genetics plays a role.
Thrombolytic therapy for deep venous thrombosis?
Thrombolytic therapy for deep venous thrombosis?
Thrombolytic therapy for deep venous thrombosis?
Thrombolytic therapy for deep venous thrombosis?
Thrombolytic therapy for deep venous thrombosis?
Thrombolytic therapy for deep venous thrombosis?
Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance
Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance
Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance
Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance
Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance
Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance
Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance
Gender-dependent differences in outcome after the treatment of infection in hospitalized patients.
Gender-dependent differences in outcome after the treatment of infection in hospitalized patients.
Gender-dependent differences in outcome after the treatment of infection in hospitalized patients.
Gender-dependent differences in outcome after the treatment of infection in hospitalized patients.
Gender-dependent differences in outcome after the treatment of infection in hospitalized patients.
Gender-dependent differences in outcome after the treatment of infection in hospitalized patients.
Gender-dependent differences in outcome after the treatment of infection in hospitalized patients.
A prospective study of weight change and health-related quality of life in women.
A prospective study of weight change and health-related quality of life in women.
A prospective study of weight change and health-related quality of life in women.
A prospective study of weight change and health-related quality of life in women.
A prospective study of weight change and health-related quality of life in women.
A prospective study of weight change and health-related quality of life in women.
A prospective study of weight change and health-related quality of life in women.
A prospective study of weight change and health-related quality of life in women.
A prospective study of weight change and health-related quality of life in women.
A prospective study of weight change and health-related quality of life in women.
Elevated C-reactive protein levels in overweight and obese adults.
Elevated C-reactive protein levels in overweight and obese adults.
Elevated C-reactive protein levels in overweight and obese adults.
Elevated C-reactive protein levels in overweight and obese adults.
Elevated C-reactive protein levels in overweight and obese adults.
Elevated C-reactive protein levels in overweight and obese adults.
Elevated C-reactive protein levels in overweight and obese adults.
The heritability of otitis media: a twin and triplet study.
The heritability of otitis media: a twin and triplet study.
The heritability of otitis media: a twin and triplet study.
The heritability of otitis media: a twin and triplet study.
The heritability of otitis media: a twin and triplet study.
The heritability of otitis media: a twin and triplet study.
The heritability of otitis media: a twin and triplet study.
The heritability of otitis media: a twin and triplet study.
The heritability of otitis media: a twin and triplet study.
The heritability of otitis media: a twin and triplet study.
The heritability of otitis media: a twin and triplet study.
Resource use in liver transplantation.
Resource use in liver transplantation.
Resource use in liver transplantation.
Moderate- vs high-dose methadone for opioid dependence.
Moderate- vs high-dose methadone for opioid dependence.
Moderate- vs high-dose methadone for opioid dependence.
Moderate- vs high-dose methadone for opioid dependence.
Moderate- vs high-dose methadone for opioid dependence.
Moderate- vs high-dose methadone for opioid dependence.
Moderate- vs high-dose methadone for opioid dependence.
Moderate- vs high-dose methadone for opioid dependence.
Moderate- vs high-dose methadone for opioid dependence.
Moderate- vs high-dose methadone for opioid dependence.
Increasing incidence of renal cell cancer.
Increasing incidence of renal cell cancer.
Increasing incidence of renal cell cancer.
Increasing incidence of renal cell cancer.
Increasing incidence of renal cell cancer.
Increasing incidence of renal cell cancer.
Increasing incidence of renal cell cancer.
Increasing incidence of renal cell cancer.
Increasing incidence of renal cell cancer.
Increasing incidence of renal cell cancer.
Recommendations for vitamin C intake.
Recommendations for vitamin C intake.
Recommendations for vitamin C intake.
Recommendations for vitamin C intake.
Recommendations for vitamin C intake.
Recommendations for vitamin C intake.
From the Centers for Disease Control and Prevention. Cigarette smoking among adults--United States, 1997.
From the Centers for Disease Control and Prevention. Recommendations regarding the use of vaccines that contain thimeros
From the Centers for Disease Control and Prevention. Shortage of intravenous penicillin G--United States.
From the Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation.
From the Centers for Disease Control and Prevention. Assessment of laboratory tests for plasma homocysteine--selected labo
Spinal cord injury research shows promise.
Spinal cord injury research shows promise.
Chest physicians explore worldwide use of home mechanical ventilation.
Chest physicians explore worldwide use of home mechanical ventilation.
Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax.
Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax.
Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax.
Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax.
A piece of my mind. A rainbow from Joanne.
A piece of my mind. A rainbow from Joanne.
JAMA Patient Page: ear infection.
Where does Helicobacter pylori come from and why is it going away?
Where does Helicobacter pylori come from and why is it going away?
Where does Helicobacter pylori come from and why is it going away?
Chronic stress and mortality among older adults.
Chronic stress and mortality among older adults.
Chronic stress and mortality among older adults.
Chronic stress and mortality among older adults.
Chronic stress and mortality among older adults.
Chronic stress and mortality among older adults.
William Osler at 150: an overview of a life.
William Osler at 150: an overview of a life.
William Osler at 150: an overview of a life.
William Osler at 150: an overview of a life.
William Osler at 150: an overview of a life.
William Osler at 150: an overview of a life.
Expert panel vs decision-analysis recommendations for postdischarge coronary angiography after myocardial infarction.
Expert panel vs decision-analysis recommendations for postdischarge coronary angiography after myocardial infarction.
Expert panel vs decision-analysis recommendations for postdischarge coronary angiography after myocardial infarction.
Expert panel vs decision-analysis recommendations for postdischarge coronary angiography after myocardial infarction.
Expert panel vs decision-analysis recommendations for postdischarge coronary angiography after myocardial infarction.
Expert panel vs decision-analysis recommendations for postdischarge coronary angiography after myocardial infarction.
Expert panel vs decision-analysis recommendations for postdischarge coronary angiography after myocardial infarction.
Fecal and oral shedding of Helicobacter pylori from healthy infected adults.
Fecal and oral shedding of Helicobacter pylori from healthy infected adults.
Fecal and oral shedding of Helicobacter pylori from healthy infected adults.
Fecal and oral shedding of Helicobacter pylori from healthy infected adults.
Fecal and oral shedding of Helicobacter pylori from healthy infected adults.
Fecal and oral shedding of Helicobacter pylori from healthy infected adults.
Relationship between modifiable health risks and short-term health care charges.
Relationship between modifiable health risks and short-term health care charges.
Relationship between modifiable health risks and short-term health care charges.
Relationship between modifiable health risks and short-term health care charges.
Relationship between modifiable health risks and short-term health care charges.
Relationship between modifiable health risks and short-term health care charges.
Relationship between modifiable health risks and short-term health care charges.
Foregone health care among adolescents.
Foregone health care among adolescents.
Foregone health care among adolescents.
Foregone health care among adolescents.
Foregone health care among adolescents.
Foregone health care among adolescents.
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
Caregiving as a risk factor for mortality: the Caregiver Health Effects Study.
Caregiving as a risk factor for mortality: the Caregiver Health Effects Study.
Caregiving as a risk factor for mortality: the Caregiver Health Effects Study.
Caregiving as a risk factor for mortality: the Caregiver Health Effects Study.
Caregiving as a risk factor for mortality: the Caregiver Health Effects Study.
Caregiving as a risk factor for mortality: the Caregiver Health Effects Study.
Coffee consumption and risk of gallstone disease.
Coffee consumption and risk of gallstone disease.
Coffee consumption and risk of gallstone disease.
Into thin air: deaths on Everest
Into thin air: deaths on Everest
Preventing prion transmission in corneal transplants.
Preventing prion transmission in corneal transplants.
Preventing prion transmission in corneal transplants.
Preventing prion transmission in corneal transplants.
Reductions in motor vehicle-related injuries and deaths.
Reductions in motor vehicle-related injuries and deaths.
Reductions in motor vehicle-related injuries and deaths.
Stress-induced immunomodulation.
Stress-induced immunomodulation.
Stress-induced immunomodulation.
Stress-induced immunomodulation.
Cholinergic markers in Alzheimer disease.
Cholinergic markers in Alzheimer disease.
Cholinergic markers in Alzheimer disease.
Cholinergic markers in Alzheimer disease.
Toxicity associated with isoniazid preventive therapy.
Toxicity associated with isoniazid preventive therapy.
Toxicity associated with isoniazid preventive therapy.
From the Centers for Disease Control and Prevention. Surveillance for acute pesticide-related illness during the Medfly Eradic
From the Centers for Disease Control and Prevention. Surveillance for acute pesticide-related illness during the Medfly Eradic
From the Centers for Disease Control and Prevention. Tobacco use--United States, 1900-1999.
From the Centers for Disease Control and Prevention. Tobacco use--United States, 1900-1999.
From the Centers for Disease Control and Prevention. Tobacco use--United States, 1900-1999.
Pesticide study aids Parkinson research.
Pesticide study aids Parkinson research.
New recommendation for adult immunization.
New recommendation for adult immunization.
Fetal pig neural cells for Parkinson disease.
Fetal pig neural cells for Parkinson disease.
Genetic test information fears unfounded.
Genetic test information fears unfounded.
AIDS in paradise.
AIDS in paradise.
JAMA Patient Page: caregiving.
The need for perspective in evidence-based medicine.
The need for perspective in evidence-based medicine.
The need for perspective in evidence-based medicine.
Involving patients in medical decisions: how can physicians do better?
Involving patients in medical decisions: how can physicians do better?
Involving patients in medical decisions: how can physicians do better?
Adefovir for the treatment of HIV infection: if not now, when?
Adefovir for the treatment of HIV infection: if not now, when?
Adefovir for the treatment of HIV infection: if not now, when?
Adefovir for the treatment of HIV infection: if not now, when?
A 44-year-old woman with severe pain at the end of life, 1 year later.
A 44-year-old woman with severe pain at the end of life, 1 year later.
A 44-year-old woman with severe pain at the end of life, 1 year later.
A 44-year-old woman with severe pain at the end of life, 1 year later.
A 36-year-old woman with endometriosis, pelvic pain, and infertility.
A 36-year-old woman with endometriosis, pelvic pain, and infertility.
A 36-year-old woman with endometriosis, pelvic pain, and infertility.
A 36-year-old woman with endometriosis, pelvic pain, and infertility.
A 36-year-old woman with endometriosis, pelvic pain, and infertility.
Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.
Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.
Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.
Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.
Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.
Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.
Factors associated with use of cardiopulmonary resuscitation in seriously ill hospitalized adults.
Factors associated with use of cardiopulmonary resuscitation in seriously ill hospitalized adults.
Factors associated with use of cardiopulmonary resuscitation in seriously ill hospitalized adults.
Factors associated with use of cardiopulmonary resuscitation in seriously ill hospitalized adults.
Factors associated with use of cardiopulmonary resuscitation in seriously ill hospitalized adults.
Factors associated with use of cardiopulmonary resuscitation in seriously ill hospitalized adults.
Factors associated with use of cardiopulmonary resuscitation in seriously ill hospitalized adults.
Factors associated with use of cardiopulmonary resuscitation in seriously ill hospitalized adults.
Factors associated with use of cardiopulmonary resuscitation in seriously ill hospitalized adults.
Factors associated with use of cardiopulmonary resuscitation in seriously ill hospitalized adults.
Factors associated with use of cardiopulmonary resuscitation in seriously ill hospitalized adults.
Factors associated with use of cardiopulmonary resuscitation in seriously ill hospitalized adults.
Head and neck injuries among ice hockey players wearing full face shields vs half face shields.
Head and neck injuries among ice hockey players wearing full face shields vs half face shields.
Head and neck injuries among ice hockey players wearing full face shields vs half face shields.
Head and neck injuries among ice hockey players wearing full face shields vs half face shields.
Head and neck injuries among ice hockey players wearing full face shields vs half face shields.
Head and neck injuries among ice hockey players wearing full face shields vs half face shields.
Head and neck injuries among ice hockey players wearing full face shields vs half face shields.
Head and neck injuries among ice hockey players wearing full face shields vs half face shields.
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology.
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology.
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology.
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology.
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology.
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology.
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology.
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology.
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology.
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology.
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology.
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology.
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology.
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology.
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology.
Informed decision making in outpatient practice: time to get back to basics.
Informed decision making in outpatient practice: time to get back to basics.
Informed decision making in outpatient practice: time to get back to basics.
Informed decision making in outpatient practice: time to get back to basics.
Informed decision making in outpatient practice: time to get back to basics.
Informed decision making in outpatient practice: time to get back to basics.
Informed decision making in outpatient practice: time to get back to basics.
Informed decision making in outpatient practice: time to get back to basics.
Informed decision making in outpatient practice: time to get back to basics.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
Hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy.
Transmissible spongiform encephalopathies and the US blood supply.
Transmissible spongiform encephalopathies and the US blood supply.
Transmissible spongiform encephalopathies and the US blood supply.
Bleeding risk with trastuzumab (Herceptin) treatment.
Bleeding risk with trastuzumab (Herceptin) treatment.
Bleeding risk with trastuzumab (Herceptin) treatment.
Bleeding risk with trastuzumab (Herceptin) treatment.
Treatment of hyponatremic encephalopathy.
Treatment of hyponatremic encephalopathy.
Treatment of hyponatremic encephalopathy.
Treatment of hyponatremic encephalopathy.
Treatment of hyponatremic encephalopathy.
Treatment of hyponatremic encephalopathy.
Safety of FDA-approved drugs.
Safety of FDA-approved drugs.
Safety of FDA-approved drugs.
Safety of FDA-approved drugs.
From the Centers for Disease Control and Prevention. Influenza activity--United States, 1999-2000 season.
From the Centers for Disease Control and Prevention. Reptile-associated salmonellosis--selected states, 1996-1998.
From the Centers for Disease Control and Prevention. Reptile-associated salmonellosis--selected states, 1996-1998.
2020 Vision: NIH heads foresee the future.
2020 Vision: NIH heads foresee the future.
Current issues in managing sports-related concussion.
Current issues in managing sports-related concussion.
Current issues in managing sports-related concussion.
Current issues in managing sports-related concussion.
JAMA Patient Page: patient-physician communication.
MedlinePgn   LastName           PublicationType
84-5         Winker
84-5                            Editorial
98-9         Shapiro
98-9                            Interview
96-7, 99     Schwartz
96-7, 99     Gaulton
96-7, 99                        Journal Article
95, 99       Bromley
95, 99                          Historical Article
95, 99                          Journal Article
94           Huang
94                              Editorial
83-4         Glass
83-4                            Comment
83-4                            Editorial
77-82
77-82        Lederle
77-82        Simel
77-82                           Journal Article
77-82                           Meta-Analysis
72-6
72-6         Hughes
72-6         Goldstein
72-6         Hurt
72-6         Shiffman
72-6                            Journal Article
72-6                            Research Support, Non-U.S. Gov't
72-6                            Research Support, U.S. Gov't, P.H.S.
72-6                            Review
67-71
67-71        Hanberger
67-71        Garcia-Rodriguez
67-71        Gobernado
67-71        Goossens
67-71        Nilsson
67-71        Struelens
67-71                           Journal Article
67-71                           Research Support, Non-U.S. Gov't
61-6
61-6         Armstrong
61-6         Conn
61-6         Pinner
61-6                            Journal Article
61-6                            Research Support, Non-U.S. Gov't
61-6                            Research Support, U.S. Gov't, P.H.S.
53-60
53-60   Sacco
53-60   Elkind
53-60   Boden-Albala
53-60   Lin
53-60   Kargman
53-60   Hauser
53-60   Shea
53-60   Paik
53-60                  Journal Article
53-60                  Research Support, U.S. Gov't, P.H.S.
46-52
46-52   Leviton
46-52   Goldenberg
46-52   Baker
46-52   Schwartz
46-52   Freda
46-52   Fish
46-52   Cliver
46-52   Rouse
46-52   Chazotte
46-52   Merkatz
46-52   Raczynski
46-52                  Clinical Trial
46-52                  Journal Article
46-52                  Multicenter Study
46-52                  Randomized Controlled Trial
46-52                  Research Support, U.S. Gov't, P.H.S.
39-45
39-45   Reynolds
39-45   Frank
39-45   Perel
39-45   Imber
39-45   Cornes
39-45   Miller
39-45   Mazumdar
39-45   Houck
39-45   Dew
39-45   Stack
39-45   Pollock
39-45   Kupfer
39-45                  Clinical Trial
39-45                  Journal Article
39-45                  Randomized Controlled Trial
39-45                  Research Support, U.S. Gov't, P.H.S.
37      Herzog
37                     Case Reports
37                     Letter
36-7                      Fouts
36-7                                        Comment
36-7                                        Letter
36                        Metcalf
36                                          Comment
36                                          Letter
35-6                      Harper
35-6                                        Comment
35-6                                        Letter
34-5                      Mago
34-5                      Crits-Christoph
34-5                                        Comment
34-5                                        Letter
34                        Lyman
34                                          Comment
34                                          Letter
32-3; author reply 33-4   Villa
32-3; author reply 33-4   Bonacina
32-3; author reply 33-4   Paese
32-3; author reply 33-4   Omboni
32-3; author reply 33-4                     Comment
32-3; author reply 33-4                     Letter
32; author reply 33-4     Palma
32; author reply 33-4                       Comment
32; author reply 33-4                       Letter
32; author reply 33-4     Stolz
31-2; author reply 33-4   Campa
31-2; author reply 33-4                     Comment
31-2; author reply 33-4                     Letter
31; author reply 33-4     Mines
31; author reply 33-4     Rosenzweig
31; author reply 33-4                       Comment
31; author reply 33-4                       Letter
29-30                                       Journal Article
28-9                                        Journal Article
27                        Nightingale
27                                          Journal Article
25-6                      Cole
25-6                                        News
24                        Phillips
24                                          News
22-4                      Phillips
22-4                                        News
21-2                      Mitka
21-2                                        News
10-1                      Levenstein
10-1                      Ackerman
10-1     Kiecolt-Glaser
10-1     Dubois
10-1                      Journal Article
9        Kerr
9                         Journal Article
104                       Journal Article
184-90
184-90   Brentlinger
184-90   Hernán
184-90   Hernández-Díaz
184-90   Azaroff
184-90   McCall
184-90                    Journal Article
184-90                    Research Support, Non-U.S. Gov't
182-3    Ansell
182-3                     Comment
182-3                     Editorial
180-1    Rifkind
180-1    Schucker
180-1    Gordon
180-1                     Comment
180-1                     Editorial
172-9
172-9    Cannom
172-9    Prystowsky
172-9                     Journal Article
172-9                     Meta-Analysis
169-71
169-71   Villarino
169-71   Burman
169-71   Wang
169-71   Lundergan
169-71   Catanzaro
169-71   Bock
169-71   Jones
169-71   Nolan
169-71                    Clinical Trial
169-71                    Comparative Study
169-71                    Journal Article
169-71                    Multicenter Study
169-71                    Randomized Controlled Trial
169-71                    Research Support, U.S. Gov't, P.H.S.
163-8
163-8    Singer
163-8    Martin
163-8    Kelner
163-8                     Journal Article
163-8                  Research Support, Non-U.S. Gov't
158-62
158-62   Van Beneden
158-62   Keene
158-62   Strang
158-62   Werker
158-62   King
158-62   Mahon
158-62   Hedberg
158-62   Bell
158-62   Kelly
158-62   Balan
158-62   Mac Kenzie
158-62   Fleming
158-62                 Journal Article
158-62                 Research Support, U.S. Gov't, P.H.S.
151-7
151-7    Culnane
151-7    Fowler
151-7    Lee
151-7    McSherry
151-7    Brady
151-7    O'Donnell
151-7    Mofenson
151-7    Gortmaker
151-7    Shapiro
151-7    Scott
151-7    Jimenez
151-7    Moore
151-7    Diaz
151-7    Flynn
151-7    Cunningham
151-7    Oleske
151-7                  Clinical Trial
151-7                  Journal Article
151-7                  Multicenter Study
151-7                  Randomized Controlled Trial
145-50
145-50   Sawicki
145-50                 Clinical Trial
145-50                 Journal Article
145-50                 Multicenter Study
145-50                 Randomized Controlled Trial
145-50                 Research Support, Non-U.S. Gov't
137-44
137-44   Stein
137-44   Illingworth
137-44                    Kwiterovich
137-44                    Liacouras
137-44                    Siimes
137-44                    Jacobson
137-44                    Brewster
137-44                    Hopkins
137-44                    Davidson
137-44                    Graham
137-44                    Arensman
137-44                    Knopp
137-44                    DuJovne
137-44                    Williams
137-44                    Isaacsohn
137-44                    Jacobsen
137-44                    Laskarzewski
137-44                    Ames
137-44                    Gormley
137-44                                   Clinical Trial
137-44                                   Journal Article
137-44                                   Multicenter Study
137-44                                   Randomized Controlled Trial
137-44                                   Research Support, Non-U.S. Gov't
135-6                     Silverstein
135-6                                    Comment
135-6                                    Letter
135                       Volavka
135                                      Comment
135                                      Letter
134-5                     Sloan
134-5                                    Comment
134-5                                    Letter
134; author reply 134-5   Smith
134; author reply 134-5                  Comment
134; author reply 134-5                  Letter
133                       Rosenthal
133                       Feldman
133                                      Comment
133                                      Letter
131-3                     Kendall
131-3                     Cohen
131-3                                    Comment
131-3                                    Letter
131                       Weinstein
131                                      Comment
131                                      Letter
130-1                     Haubrich
130-1                     Richman
130-1                                Comment
130-1                                Letter
130; author reply 131   Clay
130; author reply 131   Rathbun
130; author reply 131   Slater
130; author reply 131                Comment
130; author reply 131                Letter
127-8                                Journal Article
127                                  Journal Article
125-6                                Journal Article
124-5                                Case Reports
124-5                                Journal Article
122                     Jefferson
122                                  News
121-2                   Mitka
121-2                                News
119-21                  Stephenson
119-21                               News
117-8                   Cates
117-8                                Journal Article
114-6                   Pickering
114-6                                Journal Article
112-3                   Frey
112-3                                Journal Article
206                                  Journal Article
283-7
283-7                   Marvel
283-7                   Epstein
283-7                   Flowers
283-7                   Beckman
283-7                                Journal Article
283-7                                Research Support, Non-U.S. Gov't
280-1                   Nichol
280-1                                Comment
280-1                                Editorial
278-80                  Williamson
278-80                               Comment
278-80                               Editorial
275-7
275-7                   Sanders
275-7                   Reinisch
275-7                                Journal Article
275-7                                Research Support, Non-U.S. Gov't
275-7                                Research Support, U.S. Gov't, P.H.S.
268-74
268-74                  Bloche
268-74                               Journal Article
268-74                Research Support, Non-U.S. Gov't
268-74                Research Support, U.S. Gov't, P.H.S.
261-7
261-7    Veenstra
261-7    Saint
261-7    Saha
261-7    Lumley
261-7    Sullivan
261-7                 Journal Article
261-7                 Meta-Analysis
261-7                 Research Support, Non-U.S. Gov't
261-7                 Research Support, U.S. Gov't, P.H.S.
255-60
255-60   Rabinowitz
255-60   Diamond
255-60   Markham
255-60   Hazelwood
255-60                Journal Article
255-60                Research Support, U.S. Gov't, P.H.S.
249-54
249-54   Meikle
249-54   Hopwood
249-54   Clague
249-54   Carey
249-54                Journal Article
249-54                Research Support, Non-U.S. Gov't
243-8
243-8    Jackson
243-8    Benson
243-8    Sneller
243-8    Butler
243-8    Thompson
243-8    Chen
243-8    Lewis
243-8    Carlone
243-8    DeStefano
243-8    Holder
243-8    Lezhava
243-8    Williams
243-8                 Clinical Trial
243-8                 Comparative Study
243-8                 Journal Article
243-8                 Research Support, U.S. Gov't, P.H.S.
235-42
235-42   Davidson
235-42   Hauptman
235-42   DiGirolamo
235-42                      Foreyt
235-42                      Halsted
235-42                      Heber
235-42                      Heimburger
235-42                      Lucas
235-42                      Robbins
235-42                      Chung
235-42                      Heymsfield
235-42                                    Clinical Trial
235-42                                    Journal Article
235-42                                    Multicenter Study
235-42                                    Randomized Controlled Trial
235-42                                    Research Support, Non-U.S. Gov't
233                         Berigan
233                         Deagle
233                                       Case Reports
233                                       Letter
232-3                       Quinlan
232-3                       Sacks
232-3                                     Comment
232-3                                     Letter
231-2                       Siegel
231-2                                     Comment
231-2                                     Letter
230-1                       Westermeyer
230-1                                     Comment
230-1                                     Letter
229-30                      Milton
229-30                                    Comment
229-30                                    Letter
229; author reply 230       Dillon
229; author reply 230                     Comment
229; author reply 230                     Letter
228-9                       Rieger
228-9                                     Comment
228-9                                     Letter
228; author reply 228-9     Menzel
228; author reply 228-9                   Comment
228; author reply 228-9                   Letter
227-8; author reply 228-9   Ganzini
227-8; author reply 228-9   Sullivan
227-8; author reply 228-9                 Comment
227-8; author reply 228-9                 Letter
227; author reply 228-9     Back
227; author reply 228-9                   Comment
227; author reply 228-9                   Letter
226                                       Journal Article
224-6                Journal Article
223-4                Journal Article
221      Satcher
221                  News
220      Mitka
220                  News
217-9    Phillips
217-9                News
215-6    Pust
215-6                Journal Article
296                  Journal Article
382-4    Hollon
382-4                Journal Article
382-4                Research Support, U.S. Gov't, P.H.S.
382-4
380-2    Holmer
380-2                Journal Article
376-8    Cummings
376-8                Comment
376-8                Editorial
376-8                Research Support, Non-U.S. Gov't
376-8                Research Support, U.S. Gov't, P.H.S.
376-8
375-6    Pratt
375-6                Comment
375-6                Editorial
374      Delbanco
374      Hartman
374                  Comment
374                  Journal Article
368-73   Parry
368-73               Case Reports
368-73               Clinical Conference
368-73               Journal Article
368-73               Research Support, Non-U.S. Gov't
361-7
361-7    Pécoul
361-7    Chirac
361-7    Trouiller
361-7    Pinel
361-7                Journal Article
354-60
354-60   Davidson
354-60   Caldwell
354-60   Curtis
354-60   Hudson
354-60   Steinberg
354-60                 Comparative Study
354-60                 Journal Article
354-60                 Research Support, Non-U.S. Gov't
354-60                 Research Support, U.S. Gov't, P.H.S.
347-53
347-53   Brown
347-53   Garber
347-53                 Journal Article
347-53                 Research Support, Non-U.S. Gov't
341-6
341-6    Tanner
341-6    Ottman
341-6    Goldman
341-6    Ellenberg
341-6    Chan
341-6    Mayeux
341-6    Langston
341-6                  Journal Article
341-6                  Research Support, Non-U.S. Gov't
341-6                  Research Support, U.S. Gov't, P.H.S.
341-6                  Twin Study
335-40
335-40   Andersen
335-40   Wadden
335-40   Bartlett
335-40   Zemel
335-40   Verde
335-40   Franckowiak
335-40                 Clinical Trial
335-40                 Journal Article
335-40                 Randomized Controlled Trial
335-40                 Research Support, U.S. Gov't, P.H.S.
327-34
327-34   Dunn
327-34   Marcus
327-34   Kampert
327-34   Garcia
327-34   Kohl
327-34   Blair
327-34                 Clinical Trial
327-34                 Comparative Study
327-34                 Journal Article
327-34                 Randomized Controlled Trial
327-34                 Research Support, Non-U.S. Gov't
327-34                 Research Support, U.S. Gov't, P.H.S.
325      Spratt
325                    Comment
325                                        Letter
324-5                        Cobey
324-5                                      Comment
324-5                                      Letter
324                          Bosch
324                                        Comment
324                                        Letter
323-4                        Christoffel
323-4                                      Comment
323-4                                      Letter
322-3                        Myhre
322-3                                      Comment
322-3                                      Letter
322; author reply 323        Henderson
322; author reply 323                      Comment
322; author reply 323                      Letter
321-2                        Vlassov
321-2                                      Comment
321-2                                      Letter
320-1                        Rybacki
320-1                                      Comment
320-1                                      Letter
319-20; author reply 320-1   Shatin
319-20; author reply 320-1   Gardner
319-20; author reply 320-1   Stergachis
319-20; author reply 320-1                 Comment
319-20; author reply 320-1                 Letter
319; author reply 320-1      Burkhart
319; author reply 320-1                    Comment
319; author reply 320-1                    Letter
318                                        Journal Article
317-8                                      Journal Article
316-7                                      Journal Article
315-6                                      Journal Article
313                          Marwick
313                                        News
312-3                        Marwick
312-3                                      News
311-2                        Jefferson
311-2                                      News
309-10                       Stephenson
309-10                                     News
306-8                        Dreyer
306-8                        Lipton
306-8                                      Journal Article
306-8                                      Research Support, Non-U.S. Gov't
306-8                                      Research Support, U.S. Gov't, P.H.S.
306-8                Review
306-8
394                  Journal Article
479      Lahey
479                  Journal Article
478      Jones
478                  Historical Article
478                  Journal Article
476-7    Stanton
476-7                Biography
476-7                Historical Article
476-7                Journal Article
475      Williams
475                  Journal Article
465-6    Lipshultz
465-6    Kim
465-6                Comment
465-6                Journal Article
462-5    Reinhardt
462-5                Comment
462-5                Editorial
461-2    Folsom
461-2                Comment
461-2                Editorial
460                  Editorial
454-9    Auwaerter
454-9                Case Reports
454-9                Clinical Conference
454-9                Journal Article
446-53
446-53   Fisher
446-53   Welch
446-53               Journal Article
446-53               Research Support, Non-U.S. Gov't
438-45
438-45   Glynn
438-45   Beckett
438-45   Hebert
438-45   Morris
438-45   Scherr
438-45   Evans
438-45               Journal Article
438-45               Research Support, U.S. Gov't, P.H.S.
432-7
432-7    Baker
432-7                Journal Article
427-31
427-31                      Meier
427-31                      Derby
427-31                      Jick
427-31                      Vasilakis
427-31                                             Journal Article
427-31                                             Research Support, Non-U.S. Gov't
421-6
421-6                       Rendell
421-6                       Rajfer
421-6                       Wicker
421-6                       Smith
421-6                                              Clinical Trial
421-6                                              Journal Article
421-6                                              Multicenter Study
421-6                                              Randomized Controlled Trial
421-6                                              Research Support, Non-U.S. Gov't
420                         Kario
420                         Pickering
420                                                Letter
419-20                      Thomasson
419-20                                             Comment
419-20                                             Letter
417-9                       Siegel
417-9                       Swislocki
417-9                                              Comment
417-9                                              Letter
416-7; author reply 417-9   Walsh
416-7; author reply 417-9                          Comment
416-7; author reply 417-9                          Letter
416; author reply 417-9     Papadakis
416; author reply 417-9     Mikhailidis
416; author reply 417-9                            Comment
416; author reply 417-9                            Letter
416; author reply 417-9     McDiarmid
416; author reply 417-9     Hensel
415-6; author reply 417-9   Mason
415-6; author reply 417-9   Freemantle
415-6; author reply 417-9                          Comment
415-6; author reply 417-9                          Letter
415; author reply 417-9     Kandzari
415; author reply 417-9     Goldschmidt-Clermont
415; author reply 417-9                            Comment
415; author reply 417-9                            Letter
414; author reply 417-9     Krut
414; author reply 417-9                            Comment
414; author reply 417-9                            Letter
414; author reply 417-9     Haq
414; author reply 417-9   Wallis
414; author reply 417-9   Yeo
414; author reply 417-9   Jackson
414; author reply 417-9   Ramsay
411-2                                    Journal Article
409-10                                   Journal Article
408                       Nightingale
408                                      Journal Article
406-7                     Marwick
406-7                                    News
405                       Stephenson
405                                      News
404                       Mitka
404                                      News
403                       Goldsmith
403                                      News
402                       Hasselbacher
402                                      Journal Article
484                                      Journal Article
568-9                     Vander Veer
568-9                                    Historical Article
568-9                                    Journal Article
565-6                     Goldstein
565-6                     Holmboe
565-6                                    Comment
565-6                                    Editorial
563-4                     Fierer
563-4                     Guiney
563-4                                    Comment
563-4                                    Editorial
561-2                     Plotkin
561-2                     Katz
561-2                     Cordero
561-2                                    Journal Article
558-60
558-60                    Rantanen
558-60                    Guralnik
558-60                    Foley
558-60                    Masaki
558-60                    Leveille
558-60                    Curb
558-60                    White
558-60                                   Journal Article
552-7
552-7                                    Journal Article
545-51
545-51                    Gazmararian
545-51   Baker
545-51   Williams
545-51   Parker
545-51   Scott
545-51   Green
545-51   Fehrenbach
545-51   Ren
545-51   Koplan
545-51                Journal Article
545-51                Research Support, Non-U.S. Gov't
537-44
537-44   Laumann
537-44   Paik
537-44   Rosen
537-44                Journal Article
537-44                Research Support, Non-U.S. Gov't
537-44                Research Support, U.S. Gov't, P.H.S.
530-6
530-6    Daviglus
530-6    Liao
530-6    Greenland
530-6    Dyer
530-6    Liu
530-6    Xie
530-6    Huang
530-6    Prineas
530-6    Stamler
530-6                 Journal Article
530-6                 Research Support, Non-U.S. Gov't
530-6                 Research Support, U.S. Gov't, P.H.S.
524-9
524-9    Lauer
524-9    Francis
524-9    Okin
524-9    Pashkow
524-9    Snader
524-9    Marwick
524-9                 Journal Article
517-23
517-23   Wiener
517-23   Quinn
517-23   Bradford
517-23   Goering
517-23   Nathan
517-23   Bush
517-23   Weinstein
517-23                Journal Article
517-23                                     Research Support, Non-U.S. Gov't
514-5                      Klausner
514-5                                      Comment
514-5                                      Letter
514; author reply 515      Goldenfeld
514; author reply 515                      Comment
514; author reply 515                      Letter
513-4                      Scott
513-4                      Grubber
513-4                      Abou-Donia
513-4                      Church
513-4                      Saunders
513-4                      Roses
513-4                      Pericak-Vance
513-4                      Conneally
513-4                      Small
513-4                      Haines
513-4                                      Comment
513-4                                      Letter
513-4                                      Research Support, Non-U.S. Gov't
513-4                                      Research Support, U.S. Gov't, P.H.S.
512-3                      Wenk
512-3                      Houtz
512-3                                      Comment
512-3                                      Letter
512; author reply 513      Kempen
512; author reply 513                      Comment
512; author reply 513                      Letter
511-2; author reply 513    Zanga
511-2; author reply 513                    Comment
511-2; author reply 513                    Letter
511                        Monahan
511                                        Comment
511                                        Letter
510-1; author reply 511    Pournadeali
510-1; author reply 511    Yarnall
510-1; author reply 511                    Comment
510-1; author reply 511                    Letter
510; author reply 511      Boodley
510; author reply 511      Pulcini
510; author reply 511      Harper
510; author reply 511                      Comment
510; author reply 511                      Letter
509-10; author reply 511   Cawley
509-10; author reply 511   Jones
509-10; author reply 511                   Comment
509-10; author reply 511                   Letter
509; author reply 511   Owens
509; author reply 511                Comment
509; author reply 511                Letter
507-8                                Journal Article
506-7                                Journal Article
505-6                                Case Reports
505-6                                Journal Article
504-5                                Journal Article
501-2                   Marwick
501-2                                Biography
501-2                                Historical Article
501-2                                News
501-2                                Portraits
499-501                 Stephenson
499-501                              News
495-6                   Litwin
495-6                                Journal Article
493                     Shin
493                                  Journal Article
584                                  Journal Article
497-8                   Mayers
497-8                                Journal Article
661-5
661-5                   Kenagy
661-5                   Berwick
661-5                   Shore
661-5                                Journal Article
657-9                   Leventhal
657-9                                Comment
657-9                                Editorial
656-7                   Boling
656-7                                Comment
656-7                                Editorial
650-5
650-5                   Maron
650-5                   Casey
650-5                   Poliac
650-5                   Gohman
650-5                   Almquist
650-5                   Aeppli
650-5                                Journal Article
644-9
644-9                   Roberts
644-9                   Frutos
644-9                   Ciavarella
644-9                   Gussow
644-9                   Mensah
644-9    Kampe
644-9    Straus
644-9    Joseph
644-9    Rydman
644-9                Journal Article
644-9                Research Support, Non-U.S. Gov't
644-9                Research Support, U.S. Gov't, P.H.S.
640-3
640-3    Epstein
640-3    Lange
640-3    Gruber
640-3    Mofid
640-3    Koch
640-3                Journal Article
634-9
634-9    Chae
634-9    Pfeffer
634-9    Glynn
634-9    Mitchell
634-9    Taylor
634-9    Hennekens
634-9                Journal Article
634-9                Research Support, U.S. Gov't, P.H.S.
627-33
627-33   O'Connor
627-33   Quinton
627-33   Traven
627-33   Ramunno
627-33   Dodds
627-33   Marciniak
627-33   Wennberg
627-33               Journal Article
627-33               Research Support, U.S. Gov't, P.H.S.
621-6
621-6    Jenny
621-6    Hymel
621-6    Ritzen
621-6    Reinert
621-6    Hay
621-6                Journal Article
613-20
613-20   Naylor
613-20   Brooten
613-20   Campbell
613-20   Jacobsen
613-20   Mezey
613-20   Pauly
613-20                       Schwartz
613-20                                  Clinical Trial
613-20                                  Journal Article
613-20                                  Randomized Controlled Trial
613-20                                  Research Support, U.S. Gov't, P.H.S.
611                          Sunshine
611                                     Comment
611                                     Letter
610-1                        Tsuruoka
610-1                        Kajii
610-1                                   Comment
610-1                                   Letter
609-10; author reply 610-1   Sergeant
609-10; author reply 610-1              Comment
609-10; author reply 610-1              Letter
609; author reply 610-1      Pedigo
609; author reply 610-1                 Comment
609; author reply 610-1                 Letter
609; author reply 610-1      Carlston
608-9                        Koller
608-9                                   Comment
608-9                                   Letter
607-8; author reply 609      Gunn
607-8; author reply 609      Friedman
607-8; author reply 609                 Comment
607-8; author reply 609                 Letter
607; author reply 608-9      Carek
607; author reply 608-9      Futrell
607; author reply 608-9                 Comment
607; author reply 608-9                 Letter
606-7                        Chander
606-7                                   Comment
606-7                                   Letter
606; author reply 607        Fost
606; author reply 607                   Comment
606; author reply 607                   Letter
605-6                        Kempen
605-6                                   Comment
605-6                                   Letter
605; author reply 606        Levitt
605; author reply 606                   Comment
605; author reply 606                   Letter
603-4                                   Journal Article
601-3                                   Journal Article
599                          Marwick
599                                     News
597-8                        Phillips
597-8                News
595-6    Mitka
595-6                News
593-4    Peters
593-4    Sikorski
593-4                Directory
676                  Journal Article
757-61   Vladeck
757-61               Interview
755-6    Retchin
755-6                Comment
755-6                Comparative Study
755-6                Editorial
753-4    Estes
753-4    Salem
753-4                Comment
753-4                Editorial
745-52
745-52   Gostin
745-52   Feldblum
745-52   Webber
745-52               Legal Cases
745-52               Research Support, Non-U.S. Gov't
744      Parker
744      Hartman
744                  Comment
744                  Journal Article
739-44   Makadon
739-44               Case Reports
739-44               Clinical Conference
739-44               Journal Article
739-44               Research Support, Non-U.S. Gov't
736-8
736-8    Gupta
736-8    Scholes
736-8    Stamm
736-8                Journal Article
736-8                Research Support, Non-U.S. Gov't
736-8                Research Support, U.S. Gov't, P.H.S.
727-35
727-35   Strong
727-35   Malcom
727-35   McMahan
727-35   Tracy
727-35   Newman
727-35   Herderick
727-35   Cornhill
727-35                                        Journal Article
727-35                                        Multicenter Study
727-35                                        Research Support, U.S. Gov't, P.H.S.
720-6
720-6                       Riley
720-6                       Potosky
720-6                       Klabunde
720-6                       Warren
720-6                       Ballard-Barbash
720-6                                         Comparative Study
720-6                                         Journal Article
714-9
714-9                       Shlipak
714-9                       Lyons
714-9                       Go
714-9                       Chou
714-9                       Evans
714-9                       Browner
714-9                                         Journal Article
707-13
707-13                      Savonitto
707-13                      Ardissino
707-13                      Granger
707-13                      Morando
707-13                      Prando
707-13                      Mafrici
707-13                      Cavallini
707-13                      Melandri
707-13                      Thompson
707-13                      Vahanian
707-13                      Ohman
707-13                      Califf
707-13                      Van de Werf
707-13                      Topol
707-13                                        Journal Article
707-13                                        Multicenter Study
707-13                                        Research Support, Non-U.S. Gov't
705                         Kao
705                                           Comment
705                                           Letter
704-5                       Buist
704-5                       Winter
704-5                                         Comment
704-5                                         Letter
703-4; author reply 704-5   Minakami
703-4; author reply 704-5   Sato
703-4; author reply 704-5                     Comment
703-4; author reply 704-5                  Letter
703                           Cheng
703                                        Comment
703                                        Letter
702-3                         Golden
702-3                                      Comment
702-3                                      Letter
700-1                         Murri
700-1                         Ammassari
700-1                         De Luca
700-1                         Cingolani
700-1                         Antinori
700-1                         Ortona
700-1                                      Comment
700-1                                      Letter
699-700; author reply 700-1   Michaels
699-700; author reply 700-1   Clark
699-700; author reply 700-1   Kissinger
699-700; author reply 700-1                Comment
699-700; author reply 700-1                Letter
699; author reply 700-1       Mannheimer
699; author reply 700-1       Curtis
699; author reply 700-1       El-Sadr
699; author reply 700-1                    Comment
699; author reply 700-1                    Letter
699; author reply 700-1       Anderson
697-8                                      Journal Article
696-7                                      Journal Article
695-6                                      Journal Article
693                           Friedrich
693                                        News
692-3                         Marwick
692-3                                      News
691-2                         Lamberg
691-2                                      News
689-90                        Lamberg
689-90                                     News
686-8                         Nutting
686-8                         Beasley
686-8                         Werner
686-8                                      Journal Article
772                                        Journal Article
849-50                        Caplan
849-50                                     Historical Article
849-50                                     Journal Article
862                           Oberstar
862                                        Journal Article
861      Mariner
861                    Journal Article
859-60   Baker
859-60                 Journal Article
858      Kahn
858                    Journal Article
857      Shalala
857                    Journal Article
856      Weiss
856                    Editorial
845-7    Grody
845-7    Pyeritz
845-7                  Comment
845-7                  Editorial
841-4    Temple
841-4                  Comment
841-4                  Journal Article
835-40
835-40   McGovern
835-40   Benach
835-40   Wallenstein
835-40   Desnick
835-40   Keenlyside
835-40                 Journal Article
835-40                 Research Support, Non-U.S. Gov't
835-40                 Research Support, U.S. Gov't, P.H.S.
830-4
830-4    Berlin
830-4    Colditz
830-4                  Journal Article
824-9
824-9    Brewer
824-9    Colditz
824-9                  Journal Article
824-9                  Research Support, U.S. Gov't, P.H.S.
818-23
818-23   Ghoname
818-23   Craig
818-23   White
818-23   Ahmed
818-23   Hamza
818-23   Henderson
818-23   Gajraj
818-23   Huber
818-23   Gatchel
818-23                 Clinical Trial
818-23                 Comparative Study
818-23                                           Journal Article
818-23                                           Randomized Controlled Trial
818-23                                           Research Support, Non-U.S. Gov't
811-7
811-7                       Steffen
811-7                       Collard
811-7                       Tornieporth
811-7                       Campbell-Forrester
811-7                       Ashley
811-7                       Thompson
811-7                       Mathewson
811-7                       Maes
811-7                       Stephenson
811-7                       DuPont
811-7                       von Sonnenburg
811-7                                            Journal Article
811-7                                            Research Support, Non-U.S. Gov't
806-10
806-10                      Steinhubl
806-10                      Tan
806-10                      Foody
806-10                      Topol
806-10                                           Journal Article
806-10                                           Multicenter Study
799-805
799-805                     Singer
799-805                     Salvator
799-805                     Guo
799-805                     Collin
799-805                     Lilien
799-805                     Baley
799-805                                          Journal Article
799-805                                          Research Support, U.S. Gov't, P.H.S.
797                         Yuen
797                         Pelayo
797                                              Case Reports
797                                              Comment
797                                              Letter
796; author reply 797       Vandenbroucke
796; author reply 797                            Comment
796; author reply 797                            Letter
795-6; author reply 796-7   Heckbert
795-6; author reply 796-7   Weiss
795-6; author reply 796-7   Psaty
795-6; author reply 796-7                        Comment
795-6; author reply 796-7                        Letter
795; author reply 796-7     Sullivan
795; author reply 796-7                           Comment
795; author reply 796-7                           Letter
794-5; author reply 796-7   Ong
794-5; author reply 796-7   Sorensen
794-5; author reply 796-7   Hayward
794-5; author reply 796-7   Webb
794-5; author reply 796-7   Collins
794-5; author reply 796-7                         Comment
794-5; author reply 796-7                         Letter
794; author reply 796-7     Banks
794; author reply 796-7     Beral
794; author reply 796-7                           Comment
794; author reply 796-7                           Letter
794; author reply 796-7     Pan
794; author reply 796-7     Boal
793-4                       Blaufox
793-4                       Wassertheil-Smoller
793-4                                             Comment
793-4                                             Letter
792-3                       Hassaballa
792-3                                             Comment
792-3                                             Letter
791-2; author reply 792-3   Wasserman
791-2; author reply 792-3   Kemp
791-2; author reply 792-3   Rachelefsky
791-2; author reply 792-3   Fireman
791-2; author reply 792-3   Shapiro
791-2; author reply 792-3   Busse
791-2; author reply 792-3                         Comment
791-2; author reply 792-3                         Letter
791; author reply 792-3     Whitmore
791; author reply 792-3                           Comment
791; author reply 792-3                           Letter
791; author reply 792-3     Kao
791; author reply 792-3     Frantz
791; author reply 792-3     Shenenberger
790                                               Journal Article
789-90                                            Journal Article
787-9                                             Journal Article
786                         Nightingale
786                                               Journal Article
784-5                       Marwick
784-5                                             News
784                         Swan
784                                               News
783                         Mitka
783                                               News
781-2    Friedrich
781-2                  News
866                    Journal Article
889      Voelker
889                    News
947-51   Ho
947-51                 Interview
947-51                 Portraits
947-51                 Research Support, Non-U.S. Gov't
944-5    Glezen
944-5                  Comment
944-5                  Editorial
944-5                  Research Support, Non-U.S. Gov't
942-3    Satcher
942-3                  Journal Article
937-41
937-41                 Journal Article
931-6    Henderson
931-6                  Journal Article
931-6                  Review
927-30
927-30   Dobroszycki
927-30   Herwaldt
927-30   Boctor
927-30   Miller
927-30   Linden
927-30   Eberhard
927-30   Yoon
927-30   Ali
927-30   Tanowitz
927-30   Graham
927-30   Weiss
927-30   Wittner
927-30                 Case Reports
927-30                 Journal Article
921-6
921-6    Burke
921-6    Farb
921-6    Malcom
921-6    Liang
921-6    Smialek
921-6    Virmani
921-6                  Comparative Study
921-6                  Journal Article
914-20
914-20   Holmes
914-20   Hunter
914-20                      Colditz
914-20                      Stampfer
914-20                      Hankinson
914-20                      Speizer
914-20                      Rosner
914-20                      Willett
914-20                                  Journal Article
914-20                                  Research Support, Non-U.S. Gov't
914-20                                  Research Support, U.S. Gov't, P.H.S.
908-13
908-13                      Wilde
908-13                      McMillan
908-13                      Serwint
908-13                      Butta
908-13                      O'Riordan
908-13                      Steinhoff
908-13                                  Clinical Trial
908-13                                  Journal Article
908-13                                  Multicenter Study
908-13                                  Randomized Controlled Trial
908-13                                  Research Support, Non-U.S. Gov't
908-13                                  Research Support, U.S. Gov't, P.H.S.
901-7
901-7                       Neuzil
901-7                       Reed
901-7                       Mitchel
901-7                       Griffin
901-7                                   Journal Article
901-7                                   Research Support, Non-U.S. Gov't
901-7                                   Research Support, U.S. Gov't, P.H.S.
899                         Block
899                                     Comment
899                                     Letter
898-9                       MacDonald
898-9                                   Comment
898-9                                   Letter
898; author reply 898-9     Lynn
898; author reply 898-9                 Comment
898; author reply 898-9                 Letter
897-8; author reply 898-9   Spudis
897-8; author reply 898-9               Comment
897-8; author reply 898-9               Letter
896-7                       Stern
896-7                       Gochfeld
896-7                                   Comment
896-7                                   Letter
896; author reply 897       Grandjean
896; author reply 897     White
896; author reply 897                    Comment
896; author reply 897                    Letter
895                       Johnson
895                                      Comment
895                                      Letter
894-5; author reply 895   Winstanley
894-5; author reply 895                  Comment
894-5; author reply 895                  Letter
894; author reply 895     Pretorius
894; author reply 895                    Comment
894; author reply 895                    Letter
894; author reply 895     Meade
894; author reply 895     Gray
893-4; author reply 895   Davis
893-4; author reply 895                  Comment
893-4; author reply 895                  Letter
893; author reply 895     Brien
893; author reply 895                    Comment
893; author reply 895                    Letter
892                                      Journal Article
891-2                                    Case Reports
891-2                                    Journal Article
890-1                                    Journal Article
888                       Marwick
888                                      News
887-8                     Marwick
887-8                                    News
885-6                     Lamberg
885-6                                    News
883-5                     Stephenson
883-5                                    News
876-8                     LaPrade
876-8                     Swiontkowski
876-8                                    Journal Article
876-8                                    Research Support, Non-U.S. Gov't
874                       Robertson
874                                      Journal Article
962                                      Journal Article
881-2                     Brewer
881-2                                    Journal Article
881-2                                    Research Support, Non-U.S. Gov't
978                       Stephenson
978                                      News
1037-41
1037-41                   Bogardus
1037-41                   Holmboe
1037-41   Jekel
1037-41               Journal Article
1037-41               Research Support, Non-U.S. Gov't
1034-5    Reynolds
1034-5    Buysse
1034-5    Kupfer
1034-5                Comment
1034-5                Editorial
1034-5                Research Support, U.S. Gov't, P.H.S.
1034-5
1030-3    Breslow
1030-3                Journal Article
1022-9
1022-9    McGee
1022-9    Abernethy
1022-9    Simel
1022-9                Journal Article
1022-9                Meta-Analysis
1019-21
1019-21   Ayanian
1019-21   Cleary
1019-21               Journal Article
1019-21               Research Support, Non-U.S. Gov't
1014-8
1014-8    Nolan
1014-8    Goldberg
1014-8    Buskin
1014-8                Journal Article
1006-13
1006-13   Winkleby
1006-13   Robinson
1006-13   Sundquist
1006-13   Kraemer
1006-13               Journal Article
1006-13               Research Support, Non-U.S. Gov't
1006-13               Research Support, U.S. Gov't, P.H.S.
1000-5
1000-5    Strain
1000-5    Bigelow
1000-5    Liebson
1000-5    Stitzer
1000-5                Clinical Trial
1000-5                Comparative Study
1000-5                Journal Article
1000-5                Randomized Controlled Trial
1000-5                Research Support, U.S. Gov't, P.H.S.
991-9
991-9                       Morin
991-9                       Colecchi
991-9                       Stone
991-9                       Sood
991-9                       Brink
991-9                                     Clinical Trial
991-9                                     Journal Article
991-9                                     Randomized Controlled Trial
991-9                                     Research Support, U.S. Gov't, P.H.S.
988-9                       Robinson
988-9                       Flowers
988-9                       Alperson
988-9                       Norris
988-9                                     Letter
988-9                                     Research Support, U.S. Gov't, P.H.S.
988-9
988                         Levy
988                         Allouache
988                         Chabane
988                         Leynadier
988                         Burney
988                                       Letter
988                                       Research Support, Non-U.S. Gov't
987                         Rosenthal
987                         Sala
987                         Chichmanian
987                         Batt
987                         Cassuto
987                                       Case Reports
987                                       Letter
986-7                       Roback
986-7                                     Comment
986-7                                     Letter
985-6; author reply 986-7   Levy
985-6; author reply 986-7                 Comment
985-6; author reply 986-7                 Letter
984-5                       Golden
984-5                                     Comment
984-5                                     Letter
984; author reply 985       Early
984; author reply 985       Roberts
984; author reply 985                     Comment
984; author reply 985                     Letter
983-4                       Moy
983-4                                     Comment
983-4                                     Letter
982                                       Journal Article
981-2                         Journal Article
979-80                        Case Reports
979-80                        Journal Article
977       Bosch
977                           News
976       Goldsmith
976                           News
975-6     Marwick
975-6                         News
973-5     Friedrich
973-5                         News
971-2     Rothschild
971-2     Kuppersmith
971-2                         Directory
1056                          Journal Article
1068f     Reiling
1068f                         Historical Article
1068f                         Journal Article
1131-6
1131-6    Goldstein
1131-6    Sobel
1131-6    Newman
1131-6                        Journal Article
1129-30   Winker
1129-30                       Comment
1129-30                       Editorial
1127-8    Fletcher
1127-8                        Comment
1127-8                        Editorial
1126      Daley
1126      Hartman
1126                          Comment
1126                          Journal Article
1121-5    Salzman
1121-5                        Case Reports
1121-5                        Clinical Conference
1121-5                        Journal Article
1121-5                        Research Support, Non-U.S. Gov't
1112-20
1112-20   Gorelick
1112-20   Sacco
1112-20   Smith
1112-20   Alberts
1112-20   Mustone-Alexander
1112-20   Rader
1112-20   Ross
1112-20   Raps
1112-20    Ozer
1112-20    Brass
1112-20    Malone
1112-20    Goldberg
1112-20    Booss
1112-20    Hanley
1112-20    Toole
1112-20    Greengold
1112-20    Rhew
1112-20                    Consensus Development Conference
1112-20                    Journal Article
1112-20                    Research Support, Non-U.S. Gov't
1112-20                    Review
1110-1
1110-1     Pitkin
1110-1     Branagan
1110-1     Burmeister
1110-1                     Journal Article
1106-9
1106-9     Khattak
1106-9     K-Moghtader
1106-9     McMartin
1106-9     Barrera
1106-9     Kennedy
1106-9     Koren
1106-9                     Journal Article
1106-9                     Research Support, Non-U.S. Gov't
1099-105
1099-105   Valeur-Jensen
1099-105   Pedersen
1099-105   Westergaard
1099-105   Jensen
1099-105   Lebech
1099-105   Andersen
1099-105   Aaby
1099-105   Melbye
1099-105                   Journal Article
1099-105                   Research Support, Non-U.S. Gov't
1093-8
1093-8     Weissman
1093-8     Saglam
1093-8     Campbell
1093-8     Causino
1093-8     Blumenthal
1093-8                     Journal Article
1093-8                     Research Support, Non-U.S. Gov't
1087-92
1087-92                   Cunningham
1087-92                   Grossman
1087-92                   St Peter
1087-92                   Lesser
1087-92                                        Journal Article
1087-92                                        Research Support, Non-U.S. Gov't
1085-6                    Tack
1085-6                    Bremer
1085-6                    Harris
1085-6                    Landay
1085-6                    Kessler
1085-6                    Kuritzkes
1085-6                                         Letter
1084-5                    Burge
1084-5                    Schmitz-Fiorentino
1084-5                    Sood
1084-5                    Schade
1084-5                                         Letter
1084-5                                         Research Support, Non-U.S. Gov't
1084-5                                         Research Support, U.S. Gov't, P.H.S.
1084-5
1084                      Lipsitt
1084                                           Comment
1084                                           Letter
1083                      Smith
1083                      Sears
1083                                           Comment
1083                                           Letter
1082; author reply 1083   Spitzer
1082; author reply 1083                        Letter
1082; author reply 1083   David
1082; author reply 1083                        Comment
1082; author reply 1083   Houghton
1081-2                    Sehgal
1081-2                                         Comment
1081-2                                         Letter
1080-1                    Lautenbach
1080-1                    Fishman
1080-1                                         Comment
1080-1                                         Letter
1077-8                                         Journal Article
1076-7                                         Case Reports
1076-7                                         Journal Article
1073-4                    Swan
1073-4                                         News
1071-3                    Marwick
1071-3                                         Congresses
1071-3                 News
1070-1   Mitka
1070-1                 News
1069     Stephenson
1069                   News
1066-8   Strode
1066-8   Gustke
1066-8   Allen
1066-8                 Journal Article
1065     Nenner
1065                   Journal Article
1146                   Journal Article
1231     Cassell
1231                   Historical Article
1231                   Journal Article
1230     Oransky
1230                   Journal Article
1228-9   Jindal
1228-9   Dowdal
1228-9                 Journal Article
1227     Krieger
1227                   Journal Article
1226     Robinson
1226     Gottlieb
1226                   Editorial
1222-4   Vinicor
1222-4                 Comment
1222-4                 Editorial
1220-2   Olson
1220-2   Fontanarosa
1220-2                 Comment
1220-2                 Editorial
1214-9   Richardson
1214-9   Wilson
1214-9   Guyatt
1214-9   Cook
1214-9   Nishikawa
1214-9                 Journal Article
1211-3
1211-3   Bleyer
1211-3   Hylander
1211-3   Sudo
1211-3   Nomoto
1211-3   de la Torre
1211-3   Chen
1211-3   Burkart
1211-3                 Comparative Study
1211-3                   Journal Article
1203-10
1203-10    Davidson
1203-10    Schriger
1203-10    Peters
1203-10    Lorber
1203-10                  Journal Article
1197-202
1197-202   Shaywitz
1197-202   Pugh
1197-202   Fulbright
1197-202   Skudlarski
1197-202   Mencl
1197-202   Constable
1197-202   Naftolin
1197-202   Palter
1197-202   Marchione
1197-202   Katz
1197-202   Shankweiler
1197-202   Fletcher
1197-202   Lacadie
1197-202   Keltz
1197-202   Gore
1197-202                 Clinical Trial
1197-202                 Journal Article
1197-202                 Randomized Controlled Trial
1197-202                 Research Support, U.S. Gov't, P.H.S.
1189-96
1189-96    Osganian
1189-96    Stampfer
1189-96    Spiegelman
1189-96    Rimm
1189-96    Cutler
1189-96    Feldman
1189-96    Montgomery
1189-96    Webber
1189-96    Lytle
1189-96    Bausserman
1189-96    Nader
1189-96                  Journal Article
1189-96                  Research Support, U.S. Gov't, P.H.S.
1182-8
1182-8     Cobb
1182-8     Fahrenbruch
1182-8     Walsh
1182-8     Copass
1182-8     Olsufka
1182-8    Breskin
1182-8    Hallstrom
1182-8                Clinical Trial
1182-8                Comparative Study
1182-8                Journal Article
1182-8                Research Support, Non-U.S. Gov't
1175-81
1175-81   Stiell
1175-81   Wells
1175-81   Field
1175-81   Spaite
1175-81   De Maio
1175-81   Ward
1175-81   Munkley
1175-81   Lyver
1175-81   Luinstra
1175-81   Campeau
1175-81   Maloney
1175-81   Dagnone
1175-81               Clinical Trial
1175-81               Controlled Clinical Trial
1175-81               Journal Article
1175-81               Multicenter Study
1175-81               Research Support, Non-U.S. Gov't
1174      Thalberg
1174                  Comment
1174                  Letter
1174      Pierce
1174                  Comment
1174                  Letter
1173-4    McCarthy
1173-4    Finch
1173-4                Comment
1173-4                Letter
1172-3    Holt
1172-3    Lipkin
1172-3    Newmark
1172-3                Comment
1172-3                Letter
1171-2    Ebell
1171-2    Messimer
1171-2    Barry
1171-2                Comment
1171-2                Letter
1170-1    Jefferson
1170-1                Comment
1170-1                Letter
1169-70; author reply 1170-1   Wald
1169-70; author reply 1170-1   Corey
1169-70; author reply 1170-1                 Comment
1169-70; author reply 1170-1                 Letter
1168-9                         Soumerai
1168-9                         Lipton
1168-9                                       Comment
1168-9                                       Letter
1168; author reply 1169        Anderson
1168; author reply 1169        Spivack
1168; author reply 1169                      Comment
1168; author reply 1169                      Letter
1167                                         Journal Article
1167                                         Journal Article
1165-7                                       Journal Article
1164                           Nightingale
1164                                         Journal Article
1159-61                        Friedrich
1159-61                                      News
1158-9                         Marwick
1158-9                                       News
1157-8                         Mitka
1157-8                                       News
1244                                         Journal Article
1334-8, 1340
1334-8, 1340                   Villar
1334-8, 1340                   Shapiro
1334-8, 1340                   Busto
1334-8, 1340                   Riva-Posse
1334-8, 1340                   Verdejo
1334-8, 1340                   Farace
1334-8, 1340                   Rosetti
1334-8, 1340                   San Juan
1334-8, 1340                   Julia
1334-8, 1340                   Becher
1334-8, 1340                   Maslanka
1334-8, 1340                   Swerdlow
1334-8, 1340                                 Journal Article
1330-1                         Randolph
1330-1                                       Comment
1330-1                                       Editorial
1328-9                         Spiegel
1328-9                                       Comment
1328-9                                       Editorial
1326-7                         Dobs
1326-7                                       Comment
1326-7                                       Editorial
1318-25
1318-25    Garbutt
1318-25    West
1318-25    Carey
1318-25    Lohr
1318-25    Crews
1318-25                    Journal Article
1318-25                    Meta-Analysis
1318-25                    Research Support, U.S. Gov't, P.H.S.
1310-7
1310-7     Pronovost
1310-7     Jenckes
1310-7     Dorman
1310-7     Garrett
1310-7     Breslow
1310-7     Rosenfeld
1310-7     Lipsett
1310-7     Bass
1310-7                     Journal Article
1310-7                     Research Support, Non-U.S. Gov't
1304-9
1304-9     Smyth
1304-9     Stone
1304-9     Hurewitz
1304-9     Kaell
1304-9                     Clinical Trial
1304-9                     Journal Article
1304-9                     Multicenter Study
1304-9                     Randomized Controlled Trial
1304-9                     Research Support, Non-U.S. Gov't
1298-303
1298-303   Rumsfeld
1298-303   MaWhinney
1298-303   McCarthy
1298-303   Shroyer
1298-303   VillaNueva
1298-303   O'Brien
1298-303   Moritz
1298-303   Henderson
1298-303   Grover
1298-303   Sethi
1298-303   Hammermeister
1298-303                   Journal Article
1298-303                   Research Support, U.S. Gov't, Non-P.H.S.
1291-7
1291-7     Gu
1291-7     Cowie
1291-7                        Harris
1291-7                                       Comparative Study
1291-7                                       Journal Article
1282-90
1282-90                       Strawford
1282-90                       Barbieri
1282-90                       Van Loan
1282-90                       Parks
1282-90                       Catlin
1282-90                       Barton
1282-90                       Neese
1282-90                       Christiansen
1282-90                       King
1282-90                       Hellerstein
1282-90                                      Clinical Trial
1282-90                                      Journal Article
1282-90                                      Randomized Controlled Trial
1282-90                                      Research Support, Non-U.S. Gov't
1282-90                                      Research Support, U.S. Gov't, P.H.S.
1275-81
1275-81                       Johansen
1275-81                       Mulligan
1275-81                       Schambelan
1275-81                                      Clinical Trial
1275-81                                      Journal Article
1275-81                                      Randomized Controlled Trial
1275-81                                      Research Support, Non-U.S. Gov't
1275-81                                      Research Support, U.S. Gov't, P.H.S.
1274                          Walker
1274                          Segal
1274                                         Comment
1274                                         Letter
1273-4                        Kaestner
1273-4                                       Comment
1273-4                                       Letter
1272-3                        Killoran
1272-3                                       Comment
1272-3                                       Letter
1271-2                        King
1271-2                                       Comment
1271-2                                       Letter
1270-1; author reply 1271-2   Ulett
1270-1; author reply 1271-2                  Comment
1270-1; author reply 1271-2                  Letter
1270; author reply 1271-2     Kaptchuk
1270; author reply 1271-2                    Comment
1270; author reply 1271-2                    Letter
1269-70                   Kahn
1269-70                   Pinkerton
1269-70                   Paltiel
1269-70                                 Comment
1269-70                                 Letter
1269; author reply 1270   Barry
1269; author reply 1270                 Comment
1269; author reply 1270                 Letter
1268-9                    Sheikh
1268-9                                  Comment
1268-9                                  Letter
1266                                    Journal Article
1264-6                                  Journal Article
1263-4                                  Journal Article
1260-1                    Marwick
1260-1                                  News
1258-60                   Mitka
1258-60                                 News
1257-8                    Lamberg
1257-8                                  News
1252-4                    Siegel
1252-4                    Evens
1252-4                                  Journal Article
1352                                    Journal Article
1255-6                    Thorogood
1255-6                                  Journal Article
1433-4                    Davies
1433-4                                  Comment
1433-4                                  Editorial
1433-4                                  Research Support, Non-U.S. Gov't
1433-4                                  Research Support, U.S. Gov't, P.H.S.
1431-2                    Russell
1431-2                                  Comment
1431-2                                  Editorial
1424-30
1424-30                   Miller
1424-30                   Sage
1424-30                                 Journal Article
1415-23
1415-23                   Levine
1415-23                   Rumsey
1415-23                   Daruwala
1415-23                   Park
1415-23                   Wang
1415-23                                 Journal Article
1407-14
1407-14                   Vorchheimer
1407-14    Badimon
1407-14    Fuster
1407-14                  Journal Article
1407-14                  Research Support, Non-U.S. Gov't
1407-14                  Review
1401-6
1401-6     Davis
1401-6     Mohs
1401-6     Marin
1401-6     Purohit
1401-6     Perl
1401-6     Lantz
1401-6     Austin
1401-6     Haroutunian
1401-6                   Journal Article
1401-6                   Research Support, U.S. Gov't, P.H.S.
1395-400
1395-400   Stamey
1395-400   McNeal
1395-400   Yemoto
1395-400   Sigal
1395-400   Johnstone
1395-400                 Journal Article
1395-400                 Research Support, Non-U.S. Gov't
1387-94
1387-94    Hu
1387-94    Stampfer
1387-94    Rimm
1387-94    Manson
1387-94    Ascherio
1387-94    Colditz
1387-94    Rosner
1387-94    Spiegelman
1387-94    Speizer
1387-94    Sacks
1387-94    Hennekens
1387-94    Willett
1387-94                  Journal Article
1387-94                  Research Support, U.S. Gov't, P.H.S.
1381-6
1381-6     Showstack
1381-6     Katz
1381-6     Lake
1381-6     Brown
1381-6     Dudley
1381-6     Belle
1381-6     Wiesner
1381-6                         Zetterman
1381-6                         Everhart
1381-6                                      Journal Article
1381-6                                      Research Support, U.S. Gov't, P.H.S.
1379-80                        Paul
1379-80                        Cross
1379-80                        Costa
1379-80                                     Letter
1378-9; author reply 1379-80   Solomon
1378-9; author reply 1379-80   Benjamin
1378-9; author reply 1379-80   Wasserman
1378-9; author reply 1379-80                Comment
1378-9; author reply 1379-80                Letter
1378; author reply 1379-80     Woods
1378; author reply 1379-80     Binson
1378; author reply 1379-80     Morin
1378; author reply 1379-80     Dilley
1378; author reply 1379-80                  Comment
1378; author reply 1379-80                  Letter
1377-8; author reply 1379-80   Aragón
1377-8; author reply 1379-80   Myers
1377-8; author reply 1379-80                Comment
1377-8; author reply 1379-80                Letter
1376; author reply 1377        Temple
1376; author reply 1377                     Comment
1376; author reply 1377                     Letter
1376; author reply 1377        Levenstein
1375-6; author reply 1377      Dunn
1375-6; author reply 1377                   Comment
1375-6; author reply 1377                   Letter
1375                           Hughes
1375                                        Comment
1375                                        Letter
1374-5; author reply 1375      Simunovic
1374-5; author reply 1375      To
1374-5; author reply 1375      Langer
1374-5; author reply 1375                   Comment
1374-5; author reply 1375                   Letter
1374; author reply 1375        Schwarz
1374; author reply 1375        Ellenhorn
1374; author reply 1375                     Comment
1374; author reply 1375                     Letter
1373                                        Journal Article
1371-2                                      Journal Article
1370-1                                      Journal Article
1369-70                                     Journal Article
1366-7                         Marwick
1366-7                     News
1364, 1366   Bosch
1364, 1366                 News
1363-4       Lamberg
1363-4                     News
1460                       Journal Article
1544         Glass
1544         Molter
1544         Hwang
1544                       Editorial
1543         Winker
1543         Fontanarosa
1543                       Editorial
1541-3       Wenger
1541-3                     Comment
1541-3                     Editorial
1540         Daley
1540         Hartman
1540                       Comment
1540                       Journal Article
1531-40      Greenspan
1531-40                    Case Reports
1531-40                    Clinical Conference
1531-40                    Journal Article
1531-40                    Research Support, Non-U.S. Gov't
1528-30
1528-30      Cobleigh
1528-30      Norlock
1528-30      Oleske
1528-30      Starr
1528-30                    Journal Article
1528-30                    Research Support, Non-U.S. Gov't
1520-7
1520-7       Tappero
1520-7       Lagos
1520-7       Ballesteros
1520-7       Plikaytis
1520-7       Williams
1520-7       Dykes
1520-7       Gheesling
1520-7       Carlone
1520-7       Høiby
1520-7       Holst
1520-7       Nøkleby
1520-7       Rosenqvist
1520-7       Sierra
1520-7       Campa
1520-7     Sotolongo
1520-7     Vega
1520-7     Garcia
1520-7     Herrera
1520-7     Poolman
1520-7     Perkins
1520-7                 Clinical Trial
1520-7                 Journal Article
1520-7                 Randomized Controlled Trial
1520-7                 Research Support, Non-U.S. Gov't
1512-9
1512-9     Gonzales
1512-9     Steiner
1512-9     Lum
1512-9     Barrett
1512-9                 Clinical Trial
1512-9                 Controlled Clinical Trial
1512-9                 Journal Article
1512-9                 Multicenter Study
1512-9                 Research Support, Non-U.S. Gov't
1505-11
1505-11    LeBoff
1505-11    Kohlmeier
1505-11    Hurwitz
1505-11    Franklin
1505-11    Wright
1505-11    Glowacki
1505-11                Journal Article
1505-11                Research Support, Non-U.S. Gov't
1505-11                Research Support, U.S. Gov't, P.H.S.
1498-504
1498-504   Bender
1498-504   Jöckel
1498-504   Trautner
1498-504   Spraul
1498-504   Berger
1498-504               Journal Article
1498-504               Research Support, Non-U.S. Gov't
1493-7
1493-7     Diermayer
1493-7     Hedberg
1493-7     Hoesly
1493-7     Fischer
1493-7     Perkins
1493-7     Reeves
1493-7     Fleming
1493-7                 Journal Article
1493-7                                       Research Support, U.S. Gov't, P.H.S.
1491                           Halpern
1491                                         Comment
1491                                         Letter
1490-1; author reply 1491      Breggin
1490-1; author reply 1491                    Comment
1490-1; author reply 1491                    Letter
1490; author reply 1491        Baughman
1490; author reply 1491                      Comment
1490; author reply 1491                      Letter
1489-90                        Tenery
1489-90                                      Comment
1489-90                                      Letter
1489; author reply 1489-90     Voth
1489; author reply 1489-90                   Comment
1489; author reply 1489-90                   Letter
1488-9; author reply 1489-90   Vatcher
1488-9; author reply 1489-90                 Comment
1488-9; author reply 1489-90                 Letter
1488                           Colebunders
1488                           Schrooten
1488                                         Comment
1488                                         Letter
1486-8                         Masdeu
1486-8                                       Comment
1486-8                                       Letter
1486; author reply 1487        Moore
1486; author reply 1487                      Comment
1486; author reply 1487                      Letter
1486; author reply 1487-8      Panzer
1486; author reply 1487-8                    Comment
1486; author reply 1487-8                    Letter
1485-6; author reply 1487      Cameron
1485-6; author reply 1487                    Comment
1485-6; author reply 1487                    Letter
1485; author reply 1487-8      Berman
1485; author reply 1487-8      Gunn
1485; author reply 1487-8      Aral
1485; author reply 1487-8                    Comment
1485; author reply 1487-8                    Letter
1483-4                                       Journal Article
1482-3                                       Journal Article
1481                                         Journal Article
1479                           Satcher
1479                                         News
1477-8                         Stephenson
1477-8                                       News
1474, 1477   Marwick
1474, 1477                 News
1473-4       Mitka
1473-4                     News
1470-2       Antman
1470-2       Shea
1470-2                     Journal Article
1470-2                     Research Support, U.S. Gov't, P.H.S.
1470-2
1560                       Journal Article
1660         Rosenthal
1660         Pradier
1660         Keita-Perse
1660         Altare
1660         Dellamonica
1660         Cassuto
1660                       Journal Article
1578-9       Stephenson
1578-9                     News
1661         Merritt
1661                       Journal Article
1658-9       Clark
1658-9       Bohne
1658-9                     Journal Article
1657         Schofer
1657                       Journal Article
1656         Brenner
1656                       Editorial
1645-7       Cox
1645-7                     Comment
1645-7                     Editorial
1642-5       Scher
1642-5                     Comment
1642-5                     Editorial
1638-41
1638-41      Meyer
1638-41      Smith
1638-41      Lester
1638-41      Kaelin
1638-41      DiPiro
1638-41      Denison
1638-41      Christian
1638-41      Harvey
1638-41      Selland
1638-41      Durfee
1638-41                    Journal Article
1632-7
1632-7    Zhang
1632-7    Hunter
1632-7    Hankinson
1632-7    Giovannucci
1632-7    Rosner
1632-7    Colditz
1632-7    Speizer
1632-7    Willett
1632-7                   Journal Article
1632-7                   Research Support, U.S. Gov't, P.H.S.
1628-31
1628-31   Chow
1628-31   Devesa
1628-31   Warren
1628-31   Fraumeni
1628-31                  Journal Article
1623-7
1623-7    Cooper
1623-7    Guo
1623-7    Herskovic
1623-7    Macdonald
1623-7    Martenson
1623-7    Al-Sarraf
1623-7    Byhardt
1623-7    Russell
1623-7    Beitler
1623-7    Spencer
1623-7    Asbell
1623-7    Graham
1623-7    Leichman
1623-7                   Clinical Trial
1623-7                   Journal Article
1623-7                   Multicenter Study
1623-7                   Randomized Controlled Trial
1623-7                   Research Support, U.S. Gov't, P.H.S.
1618-22
1618-22   Lerman
1618-22   Hughes
1618-22   Trock
1618-22   Myers
1618-22   Main
1618-22   Bonney
1618-22   Abbaszadegan
1618-22   Harty
1618-22   Franklin
1618-22   Lynch
1618-22                  Journal Article
1618-22                  Research Support, U.S. Gov't, P.H.S.
1611-7
1611-7     Levin
1611-7     Palitz
1611-7     Grossman
1611-7     Conell
1611-7     Finkler
1611-7     Ackerson
1611-7     Rumore
1611-7     Selby
1611-7                   Journal Article
1611-7                   Research Support, Non-U.S. Gov't
1605-10
1605-10    Manos
1605-10    Kinney
1605-10    Hurley
1605-10    Sherman
1605-10    Shieh-Ngai
1605-10    Kurman
1605-10    Ransley
1605-10    Fetterman
1605-10    Hartinger
1605-10    McIntosh
1605-10    Pawlick
1605-10    Hiatt
1605-10                  Journal Article
1605-10                  Research Support, Non-U.S. Gov't
1598-604
1598-604   Shipley
1598-604   Thames
1598-604   Sandler
1598-604   Hanks
1598-604   Zietman
1598-604   Perez
1598-604   Kuban
1598-604   Hancock
1598-604   Smith
1598-604                 Journal Article
1598-604                 Meta-Analysis
1598-604                 Research Support, Non-U.S. Gov't
1591-7
1591-7     Pound
1591-7     Partin
1591-7     Eisenberger
1591-7     Chan
1591-7     Pearson
1591-7     Walsh
1591-7                                             Journal Article
1591-7                                             Research Support, Non-U.S. Gov't
1591-7                                             Research Support, U.S. Gov't, P.H.S.
1588-9                        Csatary
1588-9                        Bakács
1588-9                                             Case Reports
1588-9                                             Letter
1588                          Antonelli
1588                          Ferri
1588                          Fallahi
1588                                               Letter
1587-8                        Nilsson
1587-8                        Tisell
1587-8                        Jansson
1587-8                        Ahlman
1587-8                        Gimm
1587-8                        Eng
1587-8                                             Letter
1587-8                                             Research Support, Non-U.S. Gov't
1586                          Palli
1586                          Russo
1586                          Saieva
1586                          Ciatto
1586                          Rosselli Del Turco
1586                          Distante
1586                          Pacini
1586                                               Comment
1586                                               Letter
1584-6                        Sharkey
1584-6                                             Comment
1584-6                                             Letter
1584; author reply 1585-6     Potters
1584; author reply 1585-6     Freeman
1584; author reply 1585-6                          Comment
1584; author reply 1585-6                          Letter
1583-4; author reply 1585-6   Vicini
1583-4; author reply 1585-6   Kestin
1583-4; author reply 1585-6   Martinez
1583-4; author reply 1585-6                        Comment
1583-4; author reply 1585-6                        Letter
1583; author reply 1585-6     Fuller
1583; author reply 1585-6                          Comment
1583; author reply 1585-6                          Letter
1581-2                                             Journal Article
1580                          Nightingale
1580                                               Journal Article
1579                          Marwick
1579                    News
1576-8    Stephenson
1576-8                  News
1575-6    Marwick
1575-6                  News
1573-5    Friedrich
1573-5                  News
1571      Southgate
1571                    Journal Article
1666                    Journal Article
1753-4    Wood
1753-4                  Comment
1753-4                  Editorial
1753-4                  Research Support, U.S. Gov't, P.H.S.
1753-4
1746-52   Fananapazir
1746-52                 Case Reports
1746-52                 Clinical Conference
1746-52                 Journal Article
1735-45
1735-45   Inglesby
1735-45   Henderson
1735-45   Bartlett
1735-45   Ascher
1735-45   Eitzen
1735-45   Friedlander
1735-45   Hauer
1735-45   McDade
1735-45   Osterholm
1735-45   O'Toole
1735-45   Parker
1735-45   Perl
1735-45   Russell
1735-45   Tonat
1735-45                 Consensus Development Conference
1735-45                 Guideline
1735-45                 Journal Article
1735-45                 Practice Guideline
1735-45                 Research Support, Non-U.S. Gov't
1735-45                 Research Support, U.S. Gov't, P.H.S.
1735-45                 Review
1728-34
1728-34   Friedman
1728-34   Woodcock
1728-34   Lumpkin
1728-34   Shuren
1728-34   Hass
1728-34   Thompson
1728-34                   Journal Article
1722-7
1722-7    Smith
1722-7    Dykes
1722-7    Douglas
1722-7    Krishnaswamy
1722-7    Berk
1722-7                    Journal Article
1722-7                    Research Support, Non-U.S. Gov't
1718-21
1718-21   Holvoet
1718-21   Collen
1718-21   Van de Werf
1718-21                   Comparative Study
1718-21                   Journal Article
1718-21                   Research Support, Non-U.S. Gov't
1714-7
1714-7    Izaks
1714-7    Westendorp
1714-7    Knook
1714-7                    Journal Article
1714-7                    Research Support, Non-U.S. Gov't
1714-7                    Research Support, U.S. Gov't, P.H.S.
1707-13
1707-13   Weissman
1707-13   Wolk
1707-13   Goldstein
1707-13   Moreau
1707-13   Adams
1707-13   Greenwald
1707-13   Klier
1707-13   Ryan
1707-13   Dahl
1707-13   Wickramaratne
1707-13                   Journal Article
1707-13                   Research Support, Non-U.S. Gov't
1707-13                   Research Support, U.S. Gov't, P.H.S.
1701-6
1701-6    Xu
1701-6    Shi
1701-6    Veeck
1701-6    Hughes
1701-6    Rosenwaks
1701-6                    Case Reports
1701-6                    Journal Article
1699      McKinney
1699                                   Comment
1699                                   Letter
1698-9                    Weintraub
1698-9                                 Comment
1698-9                                 Letter
1697-8                    Beasley
1697-8                                 Comment
1697-8                                 Letter
1696-7                    Fessel
1696-7                    Follansbee
1696-7                    Hurley
1696-7                    Klein
1696-7                                 Comment
1696-7                                 Letter
1695-6                    Yaes
1695-6                                 Comment
1695-6                                 Letter
1695; author reply 1696   Carroll
1695; author reply 1696                Comment
1695; author reply 1696                Letter
1695; author reply 1696   Morris
1694                      Go
1694                                   Comment
1694                                   Letter
1693-4                    Bree
1693-4                    Benson
1693-4                    Bohm-Velez
1693-4                                 Comment
1693-4                                 Letter
1691-2                                 Journal Article
1690-1                                 Journal Article
1687-8                    Marwick
1687-8                                 News
1685-6                    Mitka
1685-6                                 News
1683-5                    Wald
1683-5                                 Interview
1676-8                    Berger
1676-8                    Mühlhauser
1676-8                                 Journal Article
1768                                   Journal Article
1680-2                    Montaner
1680-2                                 Journal Article
1680-2                                 Research Support, Non-U.S. Gov't
1849-50                   Mackay
1849-50                                Comment
1849-50                                Journal Article
1845-7    Keene
1845-7                Editorial
1844-5    McIntosh
1844-5                Editorial
1836-43
1836-43   Guyatt
1836-43   Sinclair
1836-43   Cook
1836-43   Glasziou
1836-43               Journal Article
1830-5
1830-5    Ezekowitz
1830-5    Levine
1830-5                Journal Article
1830-5                Meta-Analysis
1822-9
1822-9    Goldie
1822-9    Kuntz
1822-9    Weinstein
1822-9    Freedberg
1822-9    Welton
1822-9    Palefsky
1822-9                Journal Article
1822-9                Research Support, Non-U.S. Gov't
1822-9                Research Support, U.S. Gov't, P.H.S.
1817-21
1817-21   Ridker
1817-21   Manson
1817-21   Buring
1817-21   Shih
1817-21   Matias
1817-21   Hennekens
1817-21               Journal Article
1817-21               Research Support, Non-U.S. Gov't
1817-21               Research Support, U.S. Gov't, P.H.S.
1811-6
1811-6    Villar
1811-6    Macek
1811-6    Simons
1811-6    Hayes
1811-6    Goldoft
1811-6    Lewis
1811-6    Rowan
1811-6    Hursh
1811-6    Patnode
1811-6    Mead
1811-6                Journal Article
1805-10
1805-10                   Cody
1805-10                   Abbott
1805-10                   Marfin
1805-10                   Schulz
1805-10                   Wagner
1805-10                   Robbins
1805-10                   Mohle-Boetani
1805-10                   Vugia
1805-10                                   Journal Article
1797-804
1797-804                  Turner
1797-804                  Wecker
1797-804                  Pohl
1797-804                  Witek
1797-804                  McNally
1797-804                  St George
1797-804                  Winther
1797-804                  Hayden
1797-804                                  Clinical Trial
1797-804                                  Journal Article
1797-804                                  Randomized Controlled Trial
1797-804                                  Research Support, Non-U.S. Gov't
1795                      Correa
1795                                      Comment
1795                                      Letter
1794-5                    Baumgartner
1794-5                                    Comment
1794-5                                    Letter
1794; author reply 1795   Surks
1794; author reply 1795                   Comment
1794; author reply 1795                   Letter
1794; author reply 1795   Basnyat
1793-4                    Hoffman
1793-4                    Wilkes
1793-4                    Schriger
1793-4                    Morgan
1793-4                                    Comment
1793-4                                    Letter
1793                      Manganiello
1793                                      Comment
1793                                      Letter
1792-3                    Balon
1792-3                                    Comment
1792-3                                    Letter
1792                      Zinner
1792                                      Comment
1792                         Letter
1792      Scalettar
1791-2    Van Gerpen
1791-2                       Comment
1791-2                       Letter
1791      Lincoln
1791                         Comment
1791                         Letter
1791      Legere
1791      Basnyat
1791      Pokhrel
1790-1    Fihn
1790-1    Landefeld
1790-1                       Comment
1790-1                       Letter
1790      Fulginiti
1790                         Comment
1790                         Letter
1789-90   Foege
1789-90                      Comment
1789-90                      Letter
1789      Bologna
1789      Gherardi
1789      Goto
1789      Kantemir
1789      Khan
1789      Kim
1789      Kumana
1789      Livaditou
1789      Vilardell-Tarres
1789      Vidmar
1789      Yurenev
1789                         Comment
1789                         Letter
1787-8                       Case Reports
1787-8                       Journal Article
1785-7                       Journal Article
1782-3    Swan
1782-3                       News
1781-2    Marwick
1781-2                       News
1779-81   Friedrich
1779-81                      News
1778      Korones
1778                         Journal Article
1866                         Journal Article
1950-1    Cook
1950-1    Giacomini
1950-1                   Comment
1950-1                   Editorial
1950-1                   Research Support, Non-U.S. Gov't
1946-9    Stringer
1946-9    Rouse
1946-9    Goldenberg
1946-9                   Journal Article
1945      Parker
1945      Hartman
1945                     Comment
1945                     Journal Article
1937-45   Foley
1937-45                  Case Reports
1937-45                  Clinical Conference
1937-45                  Journal Article
1937-45                  Research Support, Non-U.S. Gov't
1927-36
1927-36   Heidenreich
1927-36   McDonald
1927-36   Hastie
1927-36   Fadel
1927-36   Hagan
1927-36   Lee
1927-36   Hlatky
1927-36                  Comparative Study
1927-36                  Journal Article
1927-36                  Meta-Analysis
1927-36                  Research Support, U.S. Gov't, Non-P.H.S.
1927-36                  Research Support, U.S. Gov't, P.H.S.
1919-26
1919-26   Bogardus
1919-26   Concato
1919-26   Feinstein
1919-26                  Journal Article
1919-26                  Research Support, Non-U.S. Gov't
1919-26                  Research Support, U.S. Gov't, Non-P.H.S.
1911-8
1911-8    Glantz
1911-8    Charlesworth
1911-8                   Comparative Study
1911-8                   Journal Article
1911-8                   Research Support, Non-U.S. Gov't
1911-8                   Research Support, U.S. Gov't, P.H.S.
1906-10
1906-10   Harrison
1906-10   Dwyer
1906-10                        Maples
1906-10                        Billmann
1906-10                                      Journal Article
1906-10                                      Research Support, Non-U.S. Gov't
1906-10                                      Research Support, U.S. Gov't, P.H.S.
1900-5
1900-5                         Shaneyfelt
1900-5                         Mayo-Smith
1900-5                         Rothwangl
1900-5                                       Journal Article
1895-9
1895-9                         Kannus
1895-9                         Parkkari
1895-9                         Koskinen
1895-9                         Niemi
1895-9                         Palvanen
1895-9                         Järvinen
1895-9                         Vuori
1895-9                                       Journal Article
1895-9                                       Research Support, Non-U.S. Gov't
1892-3                         Martinelli
1892-3                                       Comment
1892-3                                       Letter
1891-2                         Tan
1891-2                                       Comment
1891-2                                       Letter
1890-1                         Tripoli
1890-1                                       Comment
1890-1                                       Letter
1890; author reply 1890-1      Pittard
1890; author reply 1890-1                    Comment
1890; author reply 1890-1                    Letter
1889-90; author reply 1890-1   Cherry
1889-90; author reply 1890-1   Aufderheide
1889-90; author reply 1890-1                 Comment
1889-90; author reply 1890-1                 Letter
1888-9                         Friedman
1888-9                         Adesanya
1888-9                         Poland
1888-9                                       Comment
1888-9                                       Letter
1887-8; author reply 1888-9    Teitelbaum
1887-8; author reply 1888-9    Bird
1887-8; author reply 1888-9    Weiss
1887-8; author reply 1888-9    Gould
1887-8; author reply 1888-9                  Comment
1887-8; author reply 1888-9                  Letter
1887; author reply 1888-9   Baschetti
1887; author reply 1888-9                 Comment
1887; author reply 1888-9                 Letter
1885-6                                    Journal Article
1884-5                                    Journal Article
1883-4                                    Journal Article
1879-81                     Voelker
1879-81                                   News
1877-8                      Stephenson
1877-8                                    News
1875-6                      Schuckit
1875-6                                    Journal Article
1875-6                                    Research Support, U.S. Gov't, Non-P.H.S.
1875-6                                    Research Support, U.S. Gov't, P.H.S.
1875-6
1962                                      Journal Article
2045-9
2045-9                      Bodenheimer
2045-9                      Lo
2045-9                      Casalino
2045-9                                    Journal Article
2045-9                                    Research Support, Non-U.S. Gov't
2045-9                                    Research Support, U.S. Gov't, P.H.S.
2043-4                      Yesalis
2043-4                                    Comment
2043-4                                    Editorial
2041-3                      Fost
2041-3                                    Comment
2041-3                                    Editorial
2035-40
2035-40                     Long
2035-40                     Marquis
2035-40                                   Journal Article
2035-40                                   Research Support, Non-U.S. Gov't
2029-34                     Barratt
2029-34                     Irwig
2029-34                     Glasziou
2029-34                     Cumming
2029-34                     Raffle
2029-34                     Hicks
2029-34                     Gray
2029-34                     Guyatt
2029-34                                   Journal Article
2020-8
2020-8                      King
2020-8                      Sharp
2020-8                      Vukovich
2020-8      Brown
2020-8      Reifenrath
2020-8      Uhl
2020-8      Parsons
2020-8                   Clinical Trial
2020-8                   Journal Article
2020-8                   Randomized Controlled Trial
2020-8                   Research Support, Non-U.S. Gov't
2013-9
2013-9      Sullivan
2013-9      Sun
2013-9      Walls
2013-9                   Journal Article
2013-9                   Research Support, U.S. Gov't, Non-P.H.S.
2005-12
2005-12     Turner
2005-12     Cull
2005-12     Frighi
2005-12     Holman
2005-12                  Clinical Trial
2005-12                  Journal Article
2005-12                  Randomized Controlled Trial
2005-12                  Research Support, Non-U.S. Gov't
2005-12                  Research Support, U.S. Gov't, P.H.S.
1998-2004
1998-2004   Wolk
1998-2004   Manson
1998-2004   Stampfer
1998-2004   Colditz
1998-2004   Hu
1998-2004   Speizer
1998-2004   Hennekens
1998-2004   Willett
1998-2004                Journal Article
1998-2004                Research Support, U.S. Gov't, P.H.S.
1991-7
1991-7      Saigal
1991-7      Stoskopf
1991-7      Feeny
1991-7      Furlong
1991-7      Burrows
1991-7      Rosenbaum
1991-7      Hoult
1991-7                   Comparative Study
1991-7                   Journal Article
1991-7                   Research Support, Non-U.S. Gov't
1991-7                   Research Support, U.S. Gov't, P.H.S.
1989                          Friend
1989                                         Letter
1989                          Callis
1989                                         Comment
1988-9                        Shaughnessy
1988-9                        Bucci
1988-9                                       Comment
1988-9                                       Letter
1987-8                        Kessel
1987-8                                       Comment
1987-8                                       Letter
1986-7; author reply 1987-8   Goyder
1986-7; author reply 1987-8   Irwig
1986-7; author reply 1987-8                  Comment
1986-7; author reply 1987-8                  Letter
1985-6                        Harari
1985-6                        Iudica-Souza
1985-6                                       Comment
1985-6                                       Letter
1985; author reply 1986       Adelman
1985; author reply 1986                      Comment
1985; author reply 1986                      Letter
1984-5                        Goldman
1984-5                        Shytle
1984-5                        Sanberg
1984-5                                       Comment
1984-5                                       Letter
1984; author reply 1984-5     Domino
1984; author reply 1984-5                    Comment
1984; author reply 1984-5                    Letter
1984; author reply 1984-5                    Research Support, U.S. Gov't, P.H.S.
1983-4; author reply 1984-5   Antonuccio
1983-4; author reply 1984-5   Danton
1983-4; author reply 1984-5                  Comment
1983-4; author reply 1984-5                  Letter
1983; author reply 1984-5     Deagle
1983; author reply 1984-5     Berigan
1983; author reply 1984-5                    Comment
1983; author reply 1984-5                    Letter
1981-2                                       Journal Article
1980-1                                       Journal Article
1979-80                                      Journal Article
1978                          Nightingale
1978                                         Journal Article
1977                          Friedrich
1977                                         News
1976                          Phillips
1976                  News
1975-6    Bosch
1975-6                News
1973-5    Jefferson
1973-5                News
2060                  Journal Article
2142-3    Bindman
2142-3                Comment
2142-3                Editorial
2140-1    Bush
2140-1    Whiteman
2140-1                Comment
2140-1                Editorial
2140-1                Research Support, Non-U.S. Gov't
2138-40   Heymann
2138-40   Brewer
2138-40   Wilson
2138-40   Fineberg
2138-40               Journal Article
2127-37
2127-37   Henderson
2127-37   Inglesby
2127-37   Bartlett
2127-37   Ascher
2127-37   Eitzen
2127-37   Jahrling
2127-37   Hauer
2127-37   Layton
2127-37   McDade
2127-37   Osterholm
2127-37   O'Toole
2127-37   Parker
2127-37   Perl
2127-37   Russell
2127-37   Tonat
2127-37               Consensus Development Conference
2127-37               Historical Article
2127-37               Journal Article
2127-37               Research Support, Non-U.S. Gov't
2127-37               Research Support, U.S. Gov't, Non-P.H.S.
2127-37               Research Support, U.S. Gov't, P.H.S.
2127-37               Review
2119-26
2119-26   Rowe
2119-26   Bota
2119-26   Fabris
2119-26   Therrien
2119-26    Milner
2119-26    Jacono
2119-26                  Clinical Trial
2119-26                  Journal Article
2119-26                  Randomized Controlled Trial
2119-26                  Research Support, Non-U.S. Gov't
2113-8
2113-8     Nappo
2113-8     De Rosa
2113-8     Marfella
2113-8     De Lucia
2113-8     Ingrosso
2113-8     Perna
2113-8     Farzati
2113-8     Giugliano
2113-8                   Clinical Trial
2113-8                   Journal Article
2113-8                   Randomized Controlled Trial
2106-12
2106-12    Leitzmann
2106-12    Willett
2106-12    Rimm
2106-12    Stampfer
2106-12    Spiegelman
2106-12    Colditz
2106-12    Giovannucci
2106-12                  Journal Article
2106-12                  Research Support, U.S. Gov't, P.H.S.
2098-105
2098-105   Hofer
2098-105   Hayward
2098-105   Greenfield
2098-105   Wagner
2098-105   Kaplan
2098-105   Manning
2098-105                 Journal Article
2098-105                 Research Support, U.S. Gov't, Non-P.H.S.
2098-105                 Research Support, U.S. Gov't, P.H.S.
2091-7
2091-7     Gapstur
2091-7     Morrow
2091-7     Sellers
2091-7                   Journal Article
2091-7                   Research Support, U.S. Gov't, P.H.S.
2089       Mylonakis
2089       Koutkia
2089                     Letter
2088                          Harrast
2088                          Kraft
2088                                        Letter
2087-8; author reply 2088-9   Deitchman
2087-8; author reply 2088-9   Gerr
2087-8; author reply 2088-9                 Letter
2087; author reply 2088-9     Mackinnon
2087; author reply 2088-9     Novak
2087; author reply 2088-9                   Letter
2087; author reply 2088-9     Daniell
2087; author reply 2088-9                   Comment
2085-6; author reply 2086-7   Nicholson
2085-6; author reply 2086-7                 Comment
2085-6; author reply 2086-7                 Letter
2085; author reply 2086-7     Lieberman
2085; author reply 2086-7     Cohen
2085; author reply 2086-7     Frigoletto
2085; author reply 2086-7     Lang
2085; author reply 2086-7                   Comment
2085; author reply 2086-7                   Letter
2084-5; author reply 2086-7   Herschel
2084-5; author reply 2086-7   Mittendorf
2084-5; author reply 2086-7                 Comment
2084-5; author reply 2086-7                 Letter
2083-4                        van Leeuwen
2083-4                                      Comment
2083-4                                      Letter
2083; author reply 2084       Henley
2083; author reply 2084                     Comment
2083; author reply 2084                     Letter
2080-2                                      Journal Article
2076-7                        Jefferson
2076-7                                      News
2075-6                        Phillips
2075-6                                      News
2073-4                        Phillips
2073-4                                      News
2070-2                        Winston
2070-2                        Durbin
2070-2                                      Journal Article
2070-2                                      Research Support, Non-U.S. Gov't
2160                                        Journal Article
2247-8                        Cohen
2247-8                                      Comment
2247-8                                      Editorial
2245-7                        Smith
2245-7                        Howland
2245-7                 Comment
2245-7                 Editorial
2245-7                 Research Support, Non-U.S. Gov't
2245-7                 Research Support, U.S. Gov't, P.H.S.
2245-7
2243-4    Franks
2243-4    Steinberg
2243-4                 Comment
2243-4                 Editorial
2239-42   Rosenberg
2239-42   Anderson
2239-42                Journal Article
2231-8
2231-8    Choudhry
2231-8    Etchells
2231-8                 Journal Article
2231-8                 Research Support, Non-U.S. Gov't
2225-30
2225-30   Brugnara
2225-30   Zurakowski
2225-30   DiCanzio
2225-30   Boyd
2225-30   Platt
2225-30                Journal Article
2217-24
2217-24   Mak
2217-24   Zielenski
2217-24   Tsui
2217-24   Durie
2217-24   Zini
2217-24   Martin
2217-24   Longley
2217-24   Jarvi
2217-24                Journal Article
2217-24                Research Support, Non-U.S. Gov't
2217-24                Research Support, U.S. Gov't, P.H.S.
2211-6
2211-6    Green
2211-6    Scott
2211-6    McDonald
2211-6    Woodworth
2211-6    Sheffield
2211-6    Smith
2211-6                 Journal Article
2211-6                 Research Support, U.S. Gov't, P.H.S.
2203-10
2203-10   Wahr
2203-10                   Parks
2203-10                   Boisvert
2203-10                   Comunale
2203-10                   Fabian
2203-10                   Ramsay
2203-10                   Mangano
2203-10                                Journal Article
2203-10                                Multicenter Study
2203-10                                Research Support, Non-U.S. Gov't
2198-202
2198-202                  Cummings
2198-202                  Quan
2198-202                               Journal Article
2198-202                               Research Support, U.S. Gov't, P.H.S.
2189-97
2189-97                   Cummings
2189-97                   Eckert
2189-97                   Krueger
2189-97                   Grady
2189-97                   Powles
2189-97                   Cauley
2189-97                   Norton
2189-97                   Nickelsen
2189-97                   Bjarnason
2189-97                   Morrow
2189-97                   Lippman
2189-97                   Black
2189-97                   Glusman
2189-97                   Costa
2189-97                   Jordan
2189-97                                Clinical Trial
2189-97                                Journal Article
2189-97                                Multicenter Study
2189-97                                Randomized Controlled Trial
2189-97                                Research Support, Non-U.S. Gov't
2186-7                    Harris
2186-7                    Garzozi
2186-7                    Chung
2186-7                                 Comment
2186-7                                 Letter
2185-6                    Potterat
2185-6                    Brody
2185-6                                 Comment
2185-6                                 Letter
2185; author reply 2186   Rind
2185; author reply 2186   Bauserman
2185; author reply 2186   Tromovitch
2185; author reply 2186                      Comment
2185; author reply 2186                      Letter
2184-5                        Wecht
2184-5                                       Comment
2184-5                                       Letter
2183-4; author reply 2184-5   Machin
2183-4; author reply 2184-5                  Comment
2183-4; author reply 2184-5                  Letter
2183; author reply 2184-5     Saqi
2183; author reply 2184-5     Hoda
2183; author reply 2184-5                    Comment
2183; author reply 2184-5                    Letter
2183; author reply 2184-5     Gistrak
2183; author reply 2184-5     Bewtra
2182-3; author reply 2184-5   Sangani
2182-3; author reply 2184-5   Kalyanaraman
2182-3; author reply 2184-5   Bhargava
2182-3; author reply 2184-5   Dwek
2182-3; author reply 2184-5                  Comment
2182-3; author reply 2184-5                  Letter
2182; author reply 2184-5     Goldhahn
2182; author reply 2184-5                    Comment
2182; author reply 2184-5                    Letter
2181-2; author reply 2184-5   Atkins
2181-2; author reply 2184-5                  Comment
2181-2; author reply 2184-5                  Letter
2181; author reply 2184-5     Madigan
2181; author reply 2184-5                    Comment
2181; author reply 2184-5                    Letter
2181; author reply 2184-5     Lynn
2181; author reply 2184-5     Cobbs
2181; author reply 2184-5     Orenstein
2180                                         Journal Article
2178-80                                      Journal Article
2177-8                                       Journal Article
2176                          DeParle
2176                                         Journal Article
2174                          Marwick
2174                                         News
2173-4                        Marwick
2173-4                                       News
2172                          Mitka
2172                                         News
2171-2                        Mitka
2171-2                                       News
2168                          Wong
2168                                         Journal Article
2260                        Journal Article
2169-70   Wainberg
2169-70                     Journal Article
2169-70                     Research Support, Non-U.S. Gov't
2344-6    Davies
2344-6    Rennie
2344-6                      Editorial
2344-6                      Research Support, Non-U.S. Gov't
2342-3    Knochel
2342-3                      Editorial
2340-2    Matte
2340-2                      Comment
2340-2                      Editorial
2330-9
2330-9    Tan
2330-9    Williams
2330-9    Khan
2330-9    Champion
2330-9    Nielsen
2330-9                      Journal Article
2329      Delbanco
2329      Hartman
2329                        Comment
2329                        Journal Article
2321-8    Guyatt
2321-8                      Case Reports
2321-8                      Clinical Conference
2321-8                      Journal Article
2321-8                      Research Support, Non-U.S. Gov't
2316-20
2316-20   Weber
2316-20   Chin
2316-20   Rodriguez-Bigas
2316-20   Keitz
2316-20   Gilligan
2316-20   O'Malley
2316-20   Urf
2316-20   Diba
2316-20   Pazik
2316-20   Petrelli
2316-20                     Journal Article
2316-20                     Research Support, Non-U.S. Gov't
2316-20                     Research Support, U.S. Gov't, P.H.S.
2305-15
2305-15   Shapiro
2305-15   Morton
2305-15   McCaffrey
2305-15    Senterfitt
2305-15    Fleishman
2305-15    Perlman
2305-15    Athey
2305-15    Keesey
2305-15    Goldman
2305-15    Berry
2305-15    Bozzette
2305-15                 Journal Article
2305-15                 Research Support, Non-U.S. Gov't
2305-15                 Research Support, U.S. Gov't, P.H.S.
2299-304
2299-304   Ayus
2299-304   Arieff
2299-304                Clinical Trial
2299-304                Comparative Study
2299-304                Journal Article
2299-304                Multicenter Study
2299-304                Research Support, U.S. Gov't, P.H.S.
2294-8
2294-8     Moss
2294-8     Lanphear
2294-8     Auinger
2294-8                  Journal Article
2294-8                  Research Support, U.S. Gov't, P.H.S.
2289-93
2289-93    Simon
2289-93    Hudes
2289-93                 Journal Article
2289-93                 Research Support, Non-U.S. Gov't
2289-93                 Research Support, U.S. Gov't, P.H.S.
2287-8     Koepp
2287-8     Miles
2287-8                  Comment
2287-8                  Letter
2287-8                  Research Support, Non-U.S. Gov't
2286-7     Wellbery
2286-7                  Letter
2285-6     Schifrin
2285-6                  Letter
2284-5     Seidell
2284-5     Bouchard
2284-5                  Comment
2284-5                  Letter
2283-4     Li
2283-4     Tosiello
2283-4                  Comment
2283-4                       Letter
2283      Appleton
2283                         Comment
2283                         Letter
2282-3    Levi
2282-3                       Comment
2282-3                       Letter
2279-80                      Journal Article
2278-9                       Journal Article
2275-6    Mitka
2275-6                       News
2274-5    Gunby
2274-5                       News
2273-4    Stephenson
2273-4                       News
2271-3    Friedrich
2271-3                       Historical Article
2271-3                       News
2268-70   Glaser
2268-70   Rabin
2268-70   Chesney
2268-70   Cohen
2268-70   Natelson
2268-70                      Journal Article
2268-70                      Research Support, U.S. Gov't, P.H.S.
2268-70
2406                         Journal Article
79-80     Wormser
79-80     Aguero-Rosenfeld
79-80     Nadelman
79-80                        Comment
79-80                        Editorial
77-8      Hudson
77-8                         Comment
77-8                         Editorial
75-7      Patriarca
75-7                         Comment
75-7                         Editorial
67-74     Randolph
67-74     Haynes
67-74     Wyatt
67-74     Cook
67-74     Guyatt
67-74                        Journal Article
62-6
62-6      Brown
62-6      Hansen
62-6    Langone
62-6                 Journal Article
54-61
54-61   Ranieri
54-61   Suter
54-61   Tortorella
54-61   De Tullio
54-61   Dayer
54-61   Brienza
54-61   Bruno
54-61   Slutsky
54-61                Clinical Trial
54-61                Journal Article
54-61                Multicenter Study
54-61                Randomized Controlled Trial
54-61                Research Support, Non-U.S. Gov't
47-53
47-53   Salmon
47-53   Haber
47-53   Gangarosa
47-53   Phillips
47-53   Smith
47-53   Chen
47-53                Journal Article
47-53                Research Support, U.S. Gov't, P.H.S.
40-6
40-6    Haan
40-6    Shemanski
40-6    Jagust
40-6    Manolio
40-6    Kuller
40-6                 Journal Article
36-9
36-9    Katzman
36-9    Dagher
36-9    Patronas
36-9                 Journal Article
31-5
31-5    Monto
31-5    Robinson
31-5    Herlocher
31-5    Hinson
31-5    Elliott
31-5    Crisp
31-5                 Clinical Trial
31-5                 Journal Article
31-5                 Multicenter Study
31-5                                     Randomized Controlled Trial
31-5                                     Research Support, Non-U.S. Gov't
28-9                      Melchart
28-9                      Linde
28-9                      Weidenhammer
28-9                      Hager
28-9                      Shaw
28-9                      Bauer
28-9                                     Letter
27-8                      Walter
27-8                      Berendes
27-8                      Claviez
27-8                      Suttorp
27-8                                     Case Reports
27-8                                     Letter
27-8                                     Research Support, Non-U.S. Gov't
25                        Floren
25                                       Comment
25                                       Letter
25; author reply 26-7     Stanley
25; author reply 26-7                    Comment
25; author reply 26-7                    Letter
24-5; author reply 26-7   Cronbach
24-5; author reply 26-7                  Comment
24-5; author reply 26-7                  Letter
24; author reply 26-7     Lauster
24; author reply 26-7     Spear
24; author reply 26-7                    Comment
24; author reply 26-7                    Letter
24; author reply 27       Richmond
24; author reply 27                      Letter
23-4; author reply 26-7   Hodgson
23-4; author reply 26-7                  Comment
23-4; author reply 26-7                  Letter
23; author reply 26-7     Benshoof
23; author reply 26-7                    Comment
23; author reply 26-7                    Letter
21-2                                     Case Reports
21-2                                     Journal Article
20-1                                     Journal Article
19                        Nightingale
19                                       Journal Article
17-8                      Bosch
17-8                                     News
15-7                      Marwick
15-7                      Mitka
15-7                                     News
15       Lamberg
15                   News
13-4     Lamberg
13-4                 News
9-10     Lurie
9-10                 Journal Article
102                  Journal Article
189-94   Blendon
189-94   Benson
189-94   Brodie
189-94   Altman
189-94   James
189-94   Hugick
189-94               Journal Article
186-7    Franzblau
186-7    Werner
186-7                Comment
186-7                Editorial
184-5    Graboys
184-5                Comment
184-5                Editorial
184-5                Research Support, Non-U.S. Gov't
182-4    Poland
182-4    Couch
182-4                Comment
182-4                Editorial
175-81
175-81   Attia
175-81   Hatala
175-81   Cook
175-81   Wong
175-81               Journal Article
175-81               Meta-Analysis
171-4
171-4    Pantilat
171-4    Alpers
171-4    Wachter
171-4                Journal Article
171-4                Research Support, Non-U.S. Gov't
171-4                Research Support, U.S. Gov't, P.H.S.
164-70
164-70   Roush
164-70   Birkhead
164-70   Koo
164-70   Cobb
164-70   Fleming
164-70               Journal Article
159-63
159-63   Himmelstein
159-63   Woolhandler
159-63   Hellander
159-63   Wolfe
159-63                 Comparative Study
159-63                 Journal Article
153-8
153-8    Atroshi
153-8    Gummesson
153-8    Johnsson
153-8    Ornstein
153-8    Ranstam
153-8    Rosén
153-8                  Journal Article
153-8                  Research Support, Non-U.S. Gov't
145-52
145-52   Rosanio
145-52   Tocchi
145-52   Cutler
145-52   Uretsky
145-52   Stouffer
145-52   deFilippi
145-52   MacInerney
145-52   Runge
145-52   Aaron
145-52   Otero
145-52   Garg
145-52                 Journal Article
145-52                 Research Support, Non-U.S. Gov't
137-44
137-44   Nichol
137-44   Mendelman
137-44   Mallon
137-44   Jackson
137-44   Gorse
137-44   Belshe
137-44   Glezen
137-44   Wittes
137-44                 Clinical Trial
137-44                 Journal Article
137-44                 Multicenter Study
137-44                 Randomized Controlled Trial
137-44                 Research Support, Non-U.S. Gov't
137-44                 Research Support, U.S. Gov't, P.H.S.
135-6    Hemenway
135-6                  Comment
135-6                                  Letter
135                       Good
135                                    Comment
135                                    Letter
134-5                     Colman
134-5                     Stadel
134-5                                  Comment
134-5                                  Letter
133; author reply 134     Margolis
133; author reply 134                  Comment
133; author reply 134                  Letter
133; author reply 134     Schiebel
133; author reply 134     Ebbert
132-3                     Suchman
132-3                                  Comment
132-3                                  Letter
132; author reply 132-3   Hall
132; author reply 132-3                Comment
132; author reply 132-3                Letter
131-2                     Lear
131-2                                  Comment
131-2                                  Letter
130; author reply 131-2   Miller
130; author reply 131-2                Comment
130; author reply 131-2                Letter
130; author reply 131-2   Herbert
125-6                                  Case Reports
125-6                                  Journal Article
124-5                                  Journal Article
120-2                     Marwick
120-2                                  News
119-20                    Swan
119-20                                 News
119                       Stephenson
119                                    News
117-8                     Stephenson
117-8                                  News
113-5                     Rochon
113-5                     Gurwitz
113-5                                  Journal Article
111-2                     Herman
111-2                                  Journal Article
206                                    Journal Article
226                                    News
224                       Lamberg
224                                    News
281-2                     O'Leary
281-2                  Comment
281-2                  Editorial
279-80   Criqui
279-80   Golomb
279-80                 Comment
279-80                 Editorial
271-8    Young
271-8                  Case Reports
271-8                  Clinical Conference
271-8                  Journal Article
271-8                  Review
267-70
267-70   Leape
267-70   Cullen
267-70   Clapp
267-70   Burdick
267-70   Demonaco
267-70   Erickson
267-70   Bates
267-70                 Clinical Trial
267-70                 Journal Article
267-70                 Randomized Controlled Trial
267-70                 Research Support, Non-U.S. Gov't
261-6
261-6    Grumbach
261-6    Selby
261-6    Damberg
261-6    Bindman
261-6    Quesenberry
261-6    Truman
261-6    Uratsu
261-6                  Journal Article
261-6                  Research Support, U.S. Gov't, P.H.S.
254-60
254-60   Moroney
254-60   Tang
254-60   Berglund
254-60   Small
254-60   Merchant
254-60   Bell
254-60   Stern
254-60   Mayeux
254-60                 Journal Article
254-60                 Research Support, Non-U.S. Gov't
254-60                 Research Support, U.S. Gov't, P.H.S.
247-53
247-53   Syngal
247-53                      Fox
247-53                      Li
247-53                      Dovidio
247-53                      Eng
247-53                      Kolodner
247-53                      Garber
247-53                                     Journal Article
247-53                                     Research Support, Non-U.S. Gov't
239-46
239-46                      Valmadrid
239-46                      Klein
239-46                      Moss
239-46                      Cruickshanks
239-46                                     Journal Article
239-46                                     Research Support, Non-U.S. Gov't
239-46                                     Research Support, U.S. Gov't, P.H.S.
237                         Sovarino
237                                        Comment
237                                        Letter
236-7                       Krieger
236-7                       Nyberg
236-7                       Nickel
236-7                                      Letter
235-6                       Blanco
235-6                       Olfson
235-6                       Blanco-Jerez
235-6                                      Comment
235-6                                      Letter
234; author reply 235       Firenzuoli
234; author reply 235       Gori
234; author reply 235                      Letter
234; author reply 235       Schaller
234; author reply 235                      Comment
233-4; author reply 235     Badmaev
233-4; author reply 235     Majeed
233-4; author reply 235     Conte
233-4; author reply 235                    Comment
233-4; author reply 235                    Letter
232-3                       Marcus
232-3                                      Comment
232-3                                      Letter
232; author reply 232-3     Kaufman
232; author reply 232-3     Delaney
232; author reply 232-3                    Comment
232; author reply 232-3                    Letter
231-2; author reply 232-3   Felder
231-2; author reply 232-3                  Comment
231-2; author reply 232-3                 Letter
231                         Klovning
231                         Norheim
231                                       Comment
231                                       Letter
230                                       Journal Article
228-30                                    Journal Article
227-8                                     Case Reports
227-8                                     Journal Article
224-5                       Mitka
224-5                                     News
222-3                       Lamberg
222-3                                     News
221-2                       Friedrich
221-2                                     News
216                         Linebarger
216                                       Journal Article
298                                       Journal Article
219                         Poulin
219                         Sékaly
219                                       Journal Article
219                                       Research Support, Non-U.S. Gov't
317                                       Journal Article
381-2                       Brennan
381-2                                     Comment
381-2                                     Editorial
379-80                      Mascola
379-80                                    Comment
379-80                                    Editorial
378                         Parker
378                         Hartman
378                                       Comment
378                                       Journal Article
371-8                       Spiegel
371-8                                     Case Reports
371-8                                     Clinical Conference
371-8                                     Journal Article
371-8                                     Research Support, Non-U.S. Gov't
363-70
363-70                                    Guideline
363-70                                    Journal Article
363-70                                    Practice Guideline
363-70                                    Research Support, Non-U.S. Gov't
356-62
356-62                      Mills
356-62                      DerSimonian
356-62                      Raymond
356-62   Morrow
356-62   Roberts
356-62   Clemens
356-62   Hauth
356-62   Catalano
356-62   Sibai
356-62   Curet
356-62   Levine
356-62                Journal Article
356-62                Multicenter Study
356-62                Research Support, U.S. Gov't, P.H.S.
349-55
349-55   Baldwin
349-55   Hart
349-55   Oshel
349-55   Fordyce
349-55   Cohen
349-55   Rosenblatt
349-55                Journal Article
349-55                Research Support, U.S. Gov't, Non-P.H.S.
349-55                Research Support, U.S. Gov't, P.H.S.
341-8
341-8    Berger
341-8    Schulman
341-8    Gersh
341-8    Pirzada
341-8    Breall
341-8    Johnson
341-8    Every
341-8                 Comparative Study
341-8                 Journal Article
341-8                 Research Support, Non-U.S. Gov't
341-8                 Research Support, U.S. Gov't, P.H.S.
331-40
331-40   Corey
331-40   Langenberg
331-40   Ashley
331-40   Sekulovich
331-40   Izu
331-40   Douglas
331-40   Handsfield
331-40   Warren
331-40   Marr
331-40   Tyring
331-40   DiCarlo
331-40   Adimora
331-40   Leone
331-40                      Dekker
331-40                      Burke
331-40                      Leong
331-40                      Straus
331-40                                       Clinical Trial
331-40                                       Journal Article
331-40                                       Multicenter Study
331-40                                       Randomized Controlled Trial
331-40                                       Research Support, Non-U.S. Gov't
331-40                                       Research Support, U.S. Gov't, P.H.S.
329                         Jackson
329                         AuBuchon
329                         Birkmeyer
329                                          Comment
329                                          Letter
328-9                       Miller
328-9                       Ashford
328-9                                        Comment
328-9                                        Letter
327-8; author reply 328-9   Hunt
327-8; author reply 328-9   Richardson
327-8; author reply 328-9                    Comment
327-8; author reply 328-9                    Letter
327; author reply 328-9     Haley
327; author reply 328-9                      Comment
327; author reply 328-9                      Letter
326-7                       Du
326-7                                        Comment
326-7                                        Letter
325-6                       Daniels
325-6                       Zaman
325-6                                        Comment
325-6                                        Letter
324-5                       Cummings
324-5                       Black
324-5                       Barrett-Connor
324-5                       Scott
324-5                       Wallace
324-5                                        Comment
324-5                                        Letter
323-4                       Baldessarini
323-4                       Viguera
323-4                                        Comment
323-4                                        Letter
321-2                                        Journal Article
319-21                                       Historical Article
319-21                                       Journal Article
318-9                     Journal Article
315-6    Marwick
315-6                     News
314-5    Marwick
314-5                     News
313-4    Stephenson
313-4                     News
310-2    Ballard
310-2                     Journal Article
307      Rosner
307                       Journal Article
402                       Journal Article
414-8                     Directory
485-90
485-90   Frank
485-90   Bauer
485-90   Arican
485-90   Fincanci
485-90   Iacopino
485-90                    Journal Article
485-90                    Research Support, Non-U.S. Gov't
481-3    Cole
481-3    Flanagin
481-3                     Editorial
479-81   Iacopino
479-81   Waldman
479-81                    Comment
479-81                    Editorial
475-8    Wintemute
475-8                     Journal Article
468-74
468-74   Rodriguez
468-74   Bauer
468-74   McLoughlin
468-74   Grumbach
468-74                    Journal Article
468-74                    Research Support, Non-U.S. Gov't
463-7
463-7    Herman-Giddens
463-7    Brown
463-7    Verbiest
463-7    Carlson
463-7    Hooten
463-7    Howell
463-7    Butts
463-7                     Journal Article
463-7                     Research Support, U.S. Gov't, Non-P.H.S.
463-7                   Research Support, U.S. Gov't, P.H.S.
455-62
455-62   Neugebauer
455-62   Hoek
455-62   Susser
455-62                  Journal Article
455-62                  Research Support, Non-U.S. Gov't
447-54
447-54   Cook
447-54   Lawrence
447-54   Ludwig
447-54   Miller
447-54                  Journal Article
447-54                  Research Support, Non-U.S. Gov't
440-6
440-6    Brener
440-6    Simon
440-6    Krug
440-6    Lowry
440-6                   Journal Article
433-9
433-9    Mollica
433-9    McInnes
433-9    Sarajlić
433-9    Lavelle
433-9    Massagli
433-9                   Journal Article
433-9                   Research Support, Non-U.S. Gov't
433-9                   Research Support, U.S. Gov't, Non-P.H.S.
433-9                   Research Support, U.S. Gov't, P.H.S.
431      Obernosterer
431      Schippinger
431      Lipp
431      Wirnsberger
431      Roller
431      Pilger
431                     Letter
430-1    Thorburn
430-1                   Letter
429-30   Hayes
429-30   LeBrun
429-30   Christoffel
429-30                  Letter
428-9    VanRooyen
428-9    Grabowski
428-9    Eliades
428-9    Stress
428-9                       Juric
428-9                                        Letter
428                         Pelletier
428                         Quinlan
428                         Sacks
428                         Van Gilder
428                         Gilchrist
428                         Ahluwalia
428                                          Letter
427                         Doege
427                                          Letter
426-7                       Wood
426-7                                        Comment
426-7                                        Letter
425-6; author reply 426-7   Blackman
425-6; author reply 426-7                    Comment
425-6; author reply 426-7                    Letter
425; author reply 426-7     Fotis
425; author reply 426-7                      Comment
425; author reply 426-7                      Letter
424                         Satcher
424                                          Congresses
422-3                       Friedrich
422-3                                        News
420-1                       Friedrich
420-1                                        News
419-20                      Mitka
419-20                                       News
413                         Mitka
413                                          News
410                         Kamau
410                                          Journal Article
500                                          Journal Article
583-9
583-9                       Cooper-Patrick
583-9                       Gallo
583-9                       Gonzales
583-9                       Vu
583-9                       Powe
583-9                       Nelson
583-9                       Ford
583-9                                        Journal Article
583-9                                        Research Support, Non-U.S. Gov't
583-9                                        Research Support, U.S. Gov't, P.H.S.
579-81                      Kumar
579-81                      Short
579-81                      Parrillo
579-81                Comment
579-81                Editorial
577-9    Mofenson
577-9                 Comment
577-9                 Editorial
572-6    Udey
572-6    Stanley
572-6                 Case Reports
572-6                 Clinical Conference
572-6                 Journal Article
569-71
569-71   Deppisch
569-71   Centeno
569-71   Gemmel
569-71   Torres
569-71                Biography
569-71                Historical Article
569-71                Journal Article
561-8
561-8    Mira
561-8    Cariou
561-8    Grall
561-8    Delclaux
561-8    Losser
561-8    Heshmati
561-8    Cheval
561-8    Monchi
561-8    Teboul
561-8    Riché
561-8    Leleu
561-8    Arbibe
561-8    Mignon
561-8    Delpech
561-8    Dhainaut
561-8                 Journal Article
561-8                 Multicenter Study
561-8                 Research Support, Non-U.S. Gov't
554-60
554-60   Veenstra
554-60   Saint
554-60   Sullivan
554-60                Journal Article
554-60                Research Support, Non-U.S. Gov't
554-60                Research Support, U.S. Gov't, P.H.S.
547-53
547-53   Davis
547-53   Rubanowice
547-53   Shinefield
547-53   Lewis
547-53   Gu
547-53   Black
547-53   DeStefano
547-53   Gargiullo
547-53   Mullooly
547-53   Thompson
547-53   Chen
547-53                Journal Article
547-53                Research Support, U.S. Gov't, P.H.S.
539-46
539-46   Staessen
539-46   Thijs
539-46   Fagard
539-46   O'Brien
539-46   Clement
539-46   de Leeuw
539-46   Mancia
539-46   Nachev
539-46   Palatini
539-46   Parati
539-46   Tuomilehto
539-46   Webster
539-46                Clinical Trial
539-46                Comparative Study
539-46                Journal Article
539-46                Randomized Controlled Trial
539-46                Research Support, Non-U.S. Gov't
531-8
531-8    Lindegren
531-8    Byers
531-8    Thomas
531-8    Davis
531-8    Caldwell
531-8    Rogers
531-8    Gwinn
531-8    Ward
531-8    Fleming
531-8                 Journal Article
529      McNutt
529      Hafner
529      Xue
529                   Comment
529                   Letter
527-9    Zuccotti
527-9    Agostoni
527-9                       D'Auria
527-9                       Torcoletti
527-9                       Riva
527-9                                    Comment
527-9                                    Letter
527                         Estrada
527                         Barnes
527                         Collins
527                         Byrd
527                                      Comment
527                                      Letter
526-7                       Roter
526-7                       Rudd
526-7                       Koch-Weser
526-7                                    Comment
526-7                                    Letter
525-6; author reply 526-7   Kellerman
525-6; author reply 526-7   Weiss
525-6; author reply 526-7                Comment
525-6; author reply 526-7                Letter
524; author reply 525       Szekacs
524; author reply 525       Vajo
524; author reply 525       Szepezdi
524; author reply 525                    Comment
524; author reply 525                    Letter
524; author reply 525       Simonovska
523-4; author reply 525     Fisher
523-4; author reply 525                  Comment
523-4; author reply 525                  Letter
523; author reply 525       Messerli
523; author reply 525       Nunez
523; author reply 525       Garavaglia
523; author reply 525       Schmieder
523; author reply 525       Ventura
523; author reply 525                    Comment
523; author reply 525                    Letter
523; author reply 525                    Research Support, Non-U.S. Gov't
522                                      Directory
522                                      Journal Article
520-1                                    Journal Article
517-8                       Mitka
517-8                                    News
516-7                       Marwick
516-7                                    News
515                         Stephenson
515                                      News
513-4                       Cole
513-4                  News
511-2    Koff
511-2                  Journal Article
511-2                  Research Support, Non-U.S. Gov't
606                    Journal Article
625      Stephenson
625                    Journal Article
691-4    Brand
691-4    Kliger
691-4                  Journal Article
689-90   Yager
689-90                 Comment
689-90                 Editorial
687-9    McClung
687-9                  Comment
687-9                  Editorial
687-9                  Research Support, Non-U.S. Gov't
677-86
677-86   Dye
677-86   Scheele
677-86   Dolin
677-86   Pathania
677-86   Raviglione
677-86                 Journal Article
671-6    Krasner
671-6                  Case Reports
671-6                  Clinical Conference
671-6                  Journal Article
664-70
664-70   DerSimonian
664-70   Levine
664-70                 Journal Article
664-70                 Review
657-63
657-63   Birketvedt
657-63   Florholmen
657-63   Sundsfjord
657-63   Osterud
657-63   Dinges
657-63   Bilker
657-63   Stunkard
657-63                 Journal Article
657-63                 Research Support, Non-U.S. Gov't
651-6
651-6    Druss
651-6    Rosenheck
651-6                  Journal Article
651-6                    Research Support, U.S. Gov't, P.H.S.
646-50
646-50   Jacobson
646-50   Thomas
646-50   Morton
646-50   Offutt
646-50   Shevlin
646-50   Ray
646-50                   Clinical Trial
646-50                   Journal Article
646-50                   Randomized Controlled Trial
646-50                   Research Support, Non-U.S. Gov't
646-50                   Research Support, U.S. Gov't, P.H.S.
637-45
637-45   Ettinger
637-45   Black
637-45   Mitlak
637-45   Knickerbocker
637-45   Nickelsen
637-45   Genant
637-45   Christiansen
637-45   Delmas
637-45   Zanchetta
637-45   Stakkestad
637-45   Glüer
637-45   Krueger
637-45   Cohen
637-45   Eckert
637-45   Ensrud
637-45   Avioli
637-45   Lips
637-45   Cummings
637-45                   Clinical Trial
637-45                   Journal Article
637-45                   Multicenter Study
637-45                   Randomized Controlled Trial
637-45                   Research Support, Non-U.S. Gov't
634-5    Allen
634-5    Olkin
634-5                    Letter
633-4    Chi-Lum
633-4    Durkin
633-4                    Letter
633-4                    Research Support, Non-U.S. Gov't
632-3    Ludwig
632-3    Tölg
632-3    Richardt
632-3                     Katus
632-3                     Diedrich
632-3                                     Case Reports
632-3                                     Letter
631                       Chattopadhyay
631                                       Letter
630-1; author reply 631   Kessel
630-1; author reply 631                   Letter
630                       Rosenstein
630                                       Letter
630                       Propp
630                                       Comment
629                       Bell
629                       Urbach
629                                       Comment
629                                       Letter
627-8                                     Journal Article
626-7                                     Case Reports
626-7                                     Journal Article
622-3                     Mitka
622-3                                     News
621-2                     Friedrich
621-2                                     News
619-21                    Lamberg
619-21                                    News
615-6                     Fahnestock
615-6                                     Journal Article
704                                       Journal Article
790-5                     Temple
790-5                                     Journal Article
786-90                    Psaty
786-90                    Weiss
786-90                    Furberg
786-90                    Koepsell
786-90                    Siscovick
786-90                    Rosendaal
786-90                    Smith
786-90                    Heckbert
786-90                    Kaplan
786-90                    Lin
786-90                    Fleming
786-90                    Wagner
786-90                                    Journal Article
786-90                                    Research Support, Non-U.S. Gov't
786-90                                    Research Support, U.S. Gov't, P.H.S.
786-90
783-4                     Rennie
783-4                       Editorial
781-3    Fowler
781-3    Bertolli
781-3    Nieburg
781-3                       Comment
781-3                       Editorial
779-80   Edwards
779-80   Elwyn
779-80                      Comment
779-80                      Editorial
771-8    Bucher
771-8    Guyatt
771-8    Cook
771-8    Holbrook
771-8    McAlister
771-8                       Journal Article
770      Hartman
770      Daley
770                         Comment
770                         Journal Article
763-70   Williams
763-70                      Case Reports
763-70                      Clinical Conference
763-70                      Journal Article
763-70                      Research Support, Non-U.S. Gov't
763-70                      Research Support, U.S. Gov't, P.H.S.
763-70
755-62
755-62   North
755-62   Nixon
755-62   Shariat
755-62   Mallonee
755-62   McMillen
755-62   Spitznagel
755-62   Smith
755-62                      Journal Article
755-62                      Research Support, U.S. Gov't, P.H.S.
750-4
750-4    Clarke
750-4    Cox
750-4    Gonder-Frederick
750-4    Kovatchev
750-4                       Journal Article
750-4                       Research Support, U.S. Gov't, P.H.S.
744-9
744-9    Miotti
744-9    Taha
744-9                       Kumwenda
744-9                       Broadhead
744-9                       Mtimavalye
744-9                       Van der Hoeven
744-9                       Chiphangwi
744-9                       Liomba
744-9                       Biggar
744-9                                        Journal Article
744-9                                        Research Support, U.S. Gov't, P.H.S.
737-43
737-43                      Man-Son-Hing
737-43                      Laupacis
737-43                      O'Connor
737-43                      Biggs
737-43                      Drake
737-43                      Yetisir
737-43                      Hart
737-43                                       Clinical Trial
737-43                                       Journal Article
737-43                                       Multicenter Study
737-43                                       Randomized Controlled Trial
737-43                                       Research Support, Non-U.S. Gov't
737-43                                       Research Support, U.S. Gov't, P.H.S.
735                         Gahlinger
735                                          Letter
734                         Valdez
734                         Purvis
734                         Lederman
734                         Fillingame
734                         Zimmerman
734                                          Letter
733                         Kunii
733                         Shibuya
733                                          Letter
732-3                       Desbiens
732-3                       Schmitt
732-3                       Panda
732-3                                        Comment
732-3                                        Letter
732; author reply 732-3     Tokuda
732; author reply 732-3     Kato
732; author reply 732-3                      Comment
732; author reply 732-3                      Letter
731-2; author reply 732-3   Colwell
731-2; author reply 732-3                    Comment
731-2; author reply 732-3                    Letter
730-1                       Neill
730-1                                   Comment
730-1                                   Letter
729-30                  Gurwitz
729-30                                  Comment
729-30                                  Letter
729; author reply 730   Roemer
729; author reply 730                   Comment
729; author reply 730                   Letter
726-8                                   Journal Article
724-6                                   Journal Article
722                     Marwick
722                                     News
719-20                  Voelker
719-20                                  News
716-7                   Greengold
716-7                                   Journal Article
806                                     Journal Article
893-906                                 Journal Article
892                                     Directory
883-91                                  Directory
881-2                   Ludmerer
881-2                                   Comment
881-2                                   Editorial
881-2                                   Research Support, Non-U.S. Gov't
875-80
875-80                  Loudon
875-80                  Anderson
875-80                  Gill
875-80                  Greenfield
875-80                                  Journal Article
875-80                                  Research Support, Non-U.S. Gov't
875-80                                  Review
867-74
867-74                  Davis
867-74                  O'Brien
867-74                  Freemantle
867-74                  Wolf
867-74                  Mazmanian
867-74                  Taylor-Vaisey
867-74                                  Journal Article
867-74                                  Meta-Analysis
867-74                                  Research Support, Non-U.S. Gov't
867-74                                  Research Support, U.S. Gov't, P.H.S.
861-6
861-6                   Issenberg
861-6                   McGaghie
861-6                   Hart
861-6    Mayer
861-6    Felner
861-6    Petrusa
861-6    Waugh
861-6    Brown
861-6    Safford
861-6    Gessner
861-6    Gordon
861-6    Ewy
861-6                Journal Article
861-6                Research Support, Non-U.S. Gov't
855-60
855-60   Miller
855-60   Dunn
855-60   Richter
855-60               Journal Article
847-54
847-54   Krakower
847-54   Williams
847-54   Jones
847-54               Journal Article
840-6
840-6    Barzansky
840-6    Jonas
840-6    Etzel
840-6                Journal Article
833-9
833-9    Epstein
833-9                Journal Article
833-9                Research Support, Non-U.S. Gov't
830-2
830-2    Swick
830-2    Szenas
830-2    Danoff
830-2    Whitcomb
830-2                Journal Article
825-9
825-9    Ferry
825-9    Grissino
825-9    Runfola
825-9                Journal Article
825-9                Research Support, Non-U.S. Gov't
822      Furmanski
822                  Comment
822                  Historical Article
822                  Letter
820-1    Reirden
820-1                 Journal Article
819      Breen
819                   Journal Article
818      Lin
818                   Editorial
914                   Journal Article
1010                  Journal Article
989-91   Kelly
989-91                Comment
989-91                Editorial
987-9    Gates
987-9                 Comment
987-9                 Editorial
984-6    Pellegrino
984-6    Relman
984-6                 Journal Article
974-83
974-83                Consensus Development Conference
974-83                Consensus Development Conference, NIH
974-83                Journal Article
974-83                Review
971-3
971-3    Matser
971-3    Kessels
971-3    Lezak
971-3    Jordan
971-3    Troost
971-3                 Journal Article
964-70
964-70   Collins
964-70   Grindel
964-70   Lovell
964-70   Dede
964-70   Moser
964-70   Phalin
964-70   Nogle
964-70   Wasik
964-70   Cordry
964-70   Daugherty
964-70   Sears
964-70   Nicolette
964-70   Indelicato
964-70   McKeag
964-70                Journal Article
964-70                Research Support, Non-U.S. Gov't
958-63
958-63   Powell
958-63   Barber-Foss
958-63                 Journal Article
958-63                 Research Support, Non-U.S. Gov't
954-7
954-7    Thurman
954-7    Guerrero
954-7                  Journal Article
945-53
945-53   Paradise
945-53   Bluestone
945-53   Colborn
945-53   Bernard
945-53   Smith
945-53   Rockette
945-53   Kurs-Lasky
945-53                 Clinical Trial
945-53                 Comparative Study
945-53                 Journal Article
945-53                 Randomized Controlled Trial
945-53                 Research Support, U.S. Gov't, P.H.S.
943      Cheng
943                    Comment
943                    Letter
942-3    Lang
942-3    McCord
942-3                  Comment
942-3                  Letter
941-2    Kaplan
941-2                  Comment
941-2                  Letter
941-2    Hyman
941-2    Berkman
940-1    Karlawish
940-1    Casarett
940-1                  Comment
940-1                  Letter
939-41   Garg
939-41   Khaishgi
939-41   Dandona
939-41                 Comment
939-41                 Letter
939      Wolicki
939                    Comment
939                    Letter
938-9    Volpintesta
938-9                  Comment
938-9                  Letter
938; author reply 939   Foucar
938; author reply 939                Comment
938; author reply 939                Letter
937-8                   Weed
937-8                                Comment
937-8                                Letter
935-6                                Journal Article
934-5                                Journal Article
932                     Henney
932                                  Journal Article
929-31                  Phillips
929-31                               News
927-8                   Stephenson
927-8                                News
925-6                   Press
925-6                   Lawler
925-6                   Smith
925-6                                Journal Article
923-4                   Loxterkamp
923-4                                Journal Article
1087-91
1087-91                 Floyd
1087-91                 Reid
1087-91                 Wilkinson
1087-91                 Gilks
1087-91                              Journal Article
1087-91                              Research Support, Non-U.S. Gov't
1083-5                  Berlin
1083-5                  Rennie
1083-5                               Comment
1083-5                               Editorial
1076-82
1076-82                 Harlan
1076-82                 Kirk
1076-82                              Journal Article
1076-82                              Research Support, U.S. Gov't, Non-P.H.S.
1076-82                              Review
1073-5
1073-5                  Liu
1073-5                  Ajani
1073-5                  Chae
1073-5                  Hennekens
1073-5                  Buring
1073-5                  Manson
1073-5                               Clinical Trial
1073-5                               Journal Article
1073-5                               Randomized Controlled Trial
1073-5                     Research Support, U.S. Gov't, P.H.S.
1067-72
1067-72   Bailey
1067-72   Van Brunt
1067-72   Mirvis
1067-72   McDaniel
1067-72   Spears
1067-72   Chang
1067-72   Schaberg
1067-72                    Journal Article
1061-6
1061-6    Lijmer
1061-6    Mol
1061-6    Heisterkamp
1061-6    Bonsel
1061-6    Prins
1061-6    van der Meulen
1061-6    Bossuyt
1061-6                     Journal Article
1054-60
1054-60   Jüni
1054-60   Witschi
1054-60   Bloch
1054-60   Egger
1054-60                    Journal Article
1047-53
1047-53   Kwok
1047-53   Miller
1047-53   Christian
1047-53   Hodge
1047-53   Gibbons
1047-53                    Journal Article
1041-6
1041-6    Garcia Peña
1041-6    Mandl
1041-6    Kraus
1041-6    Fischer
1041-6    Fleisher
1041-6    Lund
1041-6    Taylor
1041-6                     Clinical Trial
1041-6                     Journal Article
1038-9    L'Hériteau
1038-9    Lucet
1038-9    Scanvic
1038-9    Bouvet
1038-9                     Case Reports
1038-9                                          Letter
1037-8                        Dennis
1037-8                                          Letter
1037-8                                          Research Support, Non-U.S. Gov't
1037                          Olds
1037                                            Letter
1036-7                        Wong
1036-7                                          Comment
1036-7                                          Letter
1035-6; author reply 1036-7   Kaptchuk
1035-6; author reply 1036-7                     Comment
1035-6; author reply 1036-7                     Letter
1035; author reply 1036-7     Lu
1035; author reply 1036-7                       Comment
1035; author reply 1036-7                       Letter
1034-5                        Ahmadi
1034-5                                          Comment
1034-5                                          Letter
1033-4                        Asplin
1033-4                        Yealy
1033-4                        White
1033-4                                          Comment
1033-4                                          Letter
1033                          Arrieta
1033                          Infante-Rivard
1033                                            Comment
1033                                            Letter
1029-32                                         Historical Article
1029-32                                         Journal Article
1025-6                        Bosch
1025-6                                          News
1023-5                        Friedrich
1023-5                                          News
1019-20                       Asta
1019-20                                         Journal Article
1102                                            Journal Article
1021-2                        Finkel
1021-2                                          Journal Article
1112                          Reiling
1112                                            Historical Article
1112                                            Journal Article
1184-90
1184-90                       Schneider
1184-90                       Riehl
1184-90                       Courte-Wienecke
1184-90                       Eddy
1184-90                       Sennett
1184-90                Journal Article
1184-90                Research Support, Non-U.S. Gov't
1181-2    McDonald
1181-2                 Comment
1181-2                 Editorial
1179-81   Sage
1179-81                Comment
1179-81                Editorial
1177-9    Pomerantz
1177-9                 Comment
1177-9                 Editorial
1176      Delbanco
1176      Hartman
1176                   Case Reports
1176                   Comment
1176                   Journal Article
1169-75   Grimes
1169-75                Case Reports
1169-75                Clinical Conference
1169-75                Journal Article
1169-75                Research Support, Non-U.S. Gov't
1163-8
1163-8    Kalb
1163-8                 Journal Article
1157-62
1157-62   Fischer
1157-62   Stewart
1157-62   Bloch
1157-62   Lorig
1157-62   Laurent
1157-62   Holman
1157-62                Comparative Study
1157-62                Journal Article
1157-62                Research Support, U.S. Gov't, P.H.S.
1150-6
1150-6    Kotagal
1150-6    Atherton
1150-6    Eshett
1150-6    Schoettker
1150-6    Perlstein
1150-6                 Journal Article
1150-6                 Research Support, Non-U.S. Gov't
1142-9
1142-9    Little
1142-9    Daar
1142-9    D'Aquila
1142-9    Keiser
1142-9                      Connick
1142-9                      Whitcomb
1142-9                      Hellmann
1142-9                      Petropoulos
1142-9                      Sutton
1142-9                      Pitt
1142-9                      Rosenberg
1142-9                      Koup
1142-9                      Walker
1142-9                      Richman
1142-9                                    Journal Article
1142-9                                    Research Support, Non-U.S. Gov't
1142-9                                    Research Support, U.S. Gov't, Non-P.H.S.
1142-9                                    Research Support, U.S. Gov't, P.H.S.
1135-41
1135-41                     Boden
1135-41                     Hurley
1135-41                     Zhang
1135-41                     Cao
1135-41                     Guo
1135-41                     Jones
1135-41                     Tsay
1135-41                     Ip
1135-41                     Farthing
1135-41                     Limoli
1135-41                     Parkin
1135-41                     Markowitz
1135-41                                   Journal Article
1135-41                                   Research Support, U.S. Gov't, P.H.S.
1134                        Rhame
1134                                      Letter
1133-4                      Harrell
1133-4                      Kline
1133-4                                    Letter
1132-3                      Cooper
1132-3                      Holle
1132-3                      Lopez
1132-3                                    Letter
1132                        Poothullil
1132                                      Comment
1132                                      Letter
1131; author reply 1131-2   Scott
1131; author reply 1131-2                 Comment
1131; author reply 1131-2                 Letter
1131; author reply 1131-2   Wendel
1130; author reply 1130-1   Lesser
1130; author reply 1130-1                 Comment
1130; author reply 1130-1                 Letter
1130; author reply 1130-1   Finucane
1129                        Edes
1129                                      Comment
1129                                      Letter
1128                        Portnoi
1128                                      Comment
1128                                      Letter
1125-6                                    Journal Article
1123-5                                    Case Reports
1123-5                                    Journal Article
1122-3                                    Journal Article
1119-20                     Fitzpatrick
1119-20                                   News
1118-9                      Phillips
1118-9                                    News
1117-8                      Phillips
1117-8                                    News
1113-5                      Liebelt
1113-5                      DeAngelis
1113-5                                    Journal Article
1112                        Pisetsky
1112                                      Journal Article
1200                                      Journal Article
1290, 1292                  Brogan
1290, 1292                  Frank
1290, 1292                  Elon
1290, 1292                  Sivanesan
1290, 1292                  O'Hanlan
1290, 1292                                Journal Article
1291-2                      Remafedi
1291-2                                    Journal Article
1291-2                                    Research Support, U.S. Gov't, P.H.S.
1291-2
1289, 1292                  O'Hanlan
1289, 1292                                Journal Article
1287-8                      Schneider
1287-8                      Levin
1287-8                                    Journal Article
1286                        Yom
1286                                      JOURNAL ARTICLE
1284                        Cole
1284                                      Comment
1284                                      Editorial
1281-3                      Mayer
1281-3                      Cates
1281-3                                    Journal Article
1270-80
1270-80   Barton
1270-80   Harris
1270-80   Fletcher
1270-80                Case Reports
1270-80                Journal Article
1270-80                Meta-Analysis
1270-80                Research Support, Non-U.S. Gov't
1264-9
1264-9    Wisner
1264-9    Gelenberg
1264-9    Leonard
1264-9    Zarin
1264-9    Frank
1264-9                 Journal Article
1264-9                 Research Support, U.S. Gov't, P.H.S.
1264-9                 Review
1258-63
1258-63   Robinson
1258-63                Journal Article
1258-63                Research Support, Non-U.S. Gov't
1254-7
1254-7    Sheehan
1254-7    Sheahan
1254-7    O'Donoghue
1254-7    MacSweeney
1254-7    Conroy
1254-7    Fitzgerald
1254-7    Murray
1254-7                 Journal Article
1254-7                 Research Support, Non-U.S. Gov't
1247-53
1247-53   Yang
1247-53   Fan
1247-53   Tan
1247-53   Qi
1247-53   Zhang
1247-53   Samet
1247-53   Taylor
1247-53   Becker
1247-53   Xu
1247-53                Journal Article
1247-53                Research Support, Non-U.S. Gov't
1240-6
1240-6    Hayden
1240-6    Treanor
1240-6    Fritz
1240-6                        Lobo
1240-6                        Betts
1240-6                        Miller
1240-6                        Kinnersley
1240-6                        Mills
1240-6                        Ward
1240-6                        Straus
1240-6                                     Clinical Trial
1240-6                                     Journal Article
1240-6                                     Randomized Controlled Trial
1240-6                                     Research Support, Non-U.S. Gov't
1240-6                                     Research Support, U.S. Gov't, P.H.S.
1233-9
1233-9                        Joshipura
1233-9                        Ascherio
1233-9                        Manson
1233-9                        Stampfer
1233-9                        Rimm
1233-9                        Speizer
1233-9                        Hennekens
1233-9                        Spiegelman
1233-9                        Willett
1233-9                                     Journal Article
1233-9                                     Research Support, Non-U.S. Gov't
1233-9                                     Research Support, U.S. Gov't, P.H.S.
1229                          Cohen
1229                                       Comment
1229                                       Letter
1229                                       Research Support, Non-U.S. Gov't
1228; discusson 1228-9        Drachtman
1228; discusson 1228-9                     Letter
1228; author reply 1228-9     Kosseim
1228; author reply 1228-9                  Comment
1228; author reply 1228-9                  Letter
1227; author reply 1227-8     Rosner
1227; author reply 1227-8     Kark
1227; author reply 1227-8     Packer
1227; author reply 1227-8     Bennett
1227; author reply 1227-8     Berger
1227; author reply 1227-8                  Comment
1227; author reply 1227-8                  Letter
1226-7; author reply 1227-8   Alper
1226-7; author reply 1227-8                Comment
1226-7; author reply 1227-8                Letter
1225-6                        Kopans
1225-6                                     Comment
1225-6                                     Letter
1224-5                      Sgarbossa
1224-5                      Pinski
1224-5                      Wagner
1224-5                                   Comment
1224-5                                   Letter
1223-4; author reply 1224   Wittkowski
1223-4; author reply 1224   Shiff
1223-4; author reply 1224   Hirsch
1223-4; author reply 1224                Comment
1223-4; author reply 1224                Letter
1223; author reply 1224     Newmark
1223; author reply 1224                  Comment
1223; author reply 1224                  Letter
1222                                     Journal Article
1222                                     JOURNAL ARTICLE
1220-2                                   Journal Article
1219-20                                  Journal Article
1218                        Henney
1218                                     Journal Article
1217                        Marwick
1217                                     News
1216-7                      Mitka
1216-7                                   Congresses
1216-7                                   News
1215                        Friedrich
1215                                     News
1213-4                      Friedrich
1213-4                                   News
1211-2                      Cole
1211-2                                   Directory
1209-10                     Chandra
1209-10                                  Journal Article
1304                                     Journal Article
1380-1                      McCann
1380-1                                   Comment
1380-1                                   Editorial
1378-80                     Gradishar
1378-80                                  Comment
1378-80                                  Editorial
1371-7                      McAlister
1371-7                      Laupacis
1371-7                      Wells
1371-7                      Sackett
1371-7                                   Journal Article
1371-7                                   Research Support, Non-U.S. Gov't
1365-70
1365-70                     Finucane
1365-70   Christmas
1365-70   Travis
1365-70                Journal Article
1365-70                Review
1359-64
1359-64   Dietz
1359-64   Spitz
1359-64   Anda
1359-64   Williamson
1359-64   McMahon
1359-64   Santelli
1359-64   Nordenberg
1359-64   Felitti
1359-64   Kendrick
1359-64                Journal Article
1359-64                Research Support, Non-U.S. Gov't
1359-64                Research Support, U.S. Gov't, P.H.S.
1353-8
1353-8    Serdula
1353-8    Mokdad
1353-8    Williamson
1353-8    Galuska
1353-8    Mendlein
1353-8    Heath
1353-8                 Journal Article
1344-52
1344-52   Harris
1344-52   Watts
1344-52   Genant
1344-52   McKeever
1344-52   Hangartner
1344-52   Keller
1344-52   Chesnut
1344-52   Brown
1344-52   Eriksen
1344-52   Hoseyni
1344-52   Axelrod
1344-52   Miller
1344-52                Clinical Trial
1344-52                Journal Article
1344-52                Multicenter Study
1344-52                Randomized Controlled Trial
1344-52                Research Support, Non-U.S. Gov't
1335-43
1335-43   Rowlings
1335-43   Williams
1335-43   Antman
1335-43   Fields
1335-43   Fay
1335-43   Reed
1335-43   Pelz
1335-43   Klein
1335-43   Sobocinski
1335-43   Kennedy
1335-43   Freytes
1335-43   McCarthy
1335-43   Herzig
1335-43   Stadtmauer
1335-43   Lazarus
1335-43   Pecora
1335-43   Bitran
1335-43   Wolff
1335-43   Gale
1335-43   Armitage
1335-43   Vaughan
1335-43   Spitzer
1335-43   Horowitz
1335-43                Journal Article
1335-43                Multicenter Study
1335-43                Research Support, Non-U.S. Gov't
1335-43                Research Support, U.S. Gov't, Non-P.H.S.
1335-43                Research Support, U.S. Gov't, P.H.S.
1334      Mitty
1334      McKenzie
1334      Stenzel
1334      Flanigan
1334      Carpenter
1334                   Comment
1334                   Letter
1334                   Research Support, Non-U.S. Gov't
1333-4    Cox
1333-4    Breazna
1333-4    Davidson
1333-4    Myers
1333-4    Clarkson
1333-4                 Comment
1333-4                 Letter
1332-3    Lederberg
1332-3                 Letter
1332      Rosenberg
1332      Slivka
1332                   Letter
1331-2    Halevy
1331-2    Brody
1331-2                                       Comment
1331-2                                       Letter
1330-1                       Sokas
1330-1                                       Comment
1330-1                                       Letter
1330; author reply 1331      Porter
1330; author reply 1331                      Comment
1330; author reply 1331                      Letter
1329; author reply 1329-30   Ernst
1329; author reply 1329-30                   Comment
1329; author reply 1329-30                   Letter
1329; author reply 1329-30   Wong
1328; author reply 1328-9    Simon
1328; author reply 1328-9                    Comment
1328; author reply 1328-9                    Letter
1328; author reply 1328-9    Parker
1328; author reply 1328-9    Swerdlow
1328; author reply 1328-9    Parks
1328; author reply 1328-9    Davis
1328; author reply 1328-9    Trimmer
1328; author reply 1328-9    Bennett
1328; author reply 1328-9    Wooten
1326                                         Case Reports
1326                                         Journal Article
1324-6                                       Journal Article
1323-4                                       Journal Article
1320-1                       Marwick
1320-1                                       News
1318-9                       Marwick
1318-9                                       News
1317-8                       Stephenson
1317-8                                       News
1314-6                       Leshner
1314-6                                       Journal Article
1314-6                                       Review
1396                                         Journal Article
1477-83
1477-83                      Levinson
1477-83                      Gorawara-Bhat
1477-83                      Dueck
1477-83                      Egener
1477-83                      Kao
1477-83                      Kerr
1477-83                      Lo
1477-83                      Perry
1477-83                      Pollitz
1477-83                      Reifsteck
1477-83   Stein
1477-83   Santa
1477-83   Kemp-White
1477-83                Journal Article
1477-83                Research Support, Non-U.S. Gov't
1474-5    Krimsky
1474-5                 Comment
1474-5                 Editorial
1472-4    Higginson
1472-4                 Comment
1472-4                 Editorial
1466-71
1466-71   Hodge
1466-71   Gostin
1466-71   Jacobson
1466-71                Journal Article
1466-71                Research Support, Non-U.S. Gov't
1458-65
1458-65   Cabana
1458-65   Rand
1458-65   Powe
1458-65   Wu
1458-65   Wilson
1458-65   Abboud
1458-65   Rubin
1458-65                Journal Article
1458-65                Research Support, Non-U.S. Gov't
1458-65                Review
1453-7
1453-7    Friedberg
1453-7    Saffran
1453-7    Stinson
1453-7    Nelson
1453-7    Bennett
1453-7                 Journal Article
1453-7                 Research Support, Non-U.S. Gov't
1447-52
1447-52   Bellomo
1447-52   Narducci
1447-52   Rondoni
1447-52   Pastorelli
1447-52   Stangoni
1447-52   Angeli
1447-52   Verdecchia
1447-52                Clinical Trial
1447-52                Controlled Clinical Trial
1447-52                Journal Article
1440-6
1440-6                      Shay
1440-6                      Holman
1440-6                      Newman
1440-6                      Liu
1440-6                      Stout
1440-6                      Anderson
1440-6                                     Journal Article
1433-9
1433-9                      Hu
1433-9                      Sigal
1433-9                      Rich-Edwards
1433-9                      Colditz
1433-9                      Solomon
1433-9                      Willett
1433-9                      Speizer
1433-9                      Manson
1433-9                                     Comparative Study
1433-9                                     Journal Article
1433-9                                     Research Support, Non-U.S. Gov't
1433-9                                     Research Support, U.S. Gov't, P.H.S.
1427-32
1427-32                     Yawn
1427-32                     Hodge
1427-32                     Kurland
1427-32                     Shaughnessy
1427-32                     Ilstrup
1427-32                     Jacobsen
1427-32                                    Journal Article
1427-32                                    Research Support, Non-U.S. Gov't
1427-32                                    Research Support, U.S. Gov't, P.H.S.
1424-5                      Roubenoff
1424-5                      Lennon
1424-5                      Mason
1424-5                      Rosenberg
1424-5                      Saltzman
1424-5                                     Comment
1424-5                                     Letter
1424; author reply 1425     Weyandt
1424; author reply 1425     Karzai
1424; author reply 1425                    Comment
1424; author reply 1425                    Letter
1423-4; author reply 1425   Khaodhiar
1423-4; author reply 1425   Bistrian
1423-4; author reply 1425                  Comment
1423-4; author reply 1425                  Letter
1422-3                      Oudiz
1422-3                                  Comment
1422-3                                  Letter
1421-2                    Plunkett
1421-2                                  Comment
1421-2                                  Letter
1421; author reply 1422   Becker
1421; author reply 1422   Gupta
1421; author reply 1422                 Comment
1421; author reply 1422                 Letter
1421; author reply 1422   Lavin
1419-20                   Sedlacek
1419-20                                 Comment
1419-20                                 Letter
1419; author reply 1420   Leidy
1419; author reply 1420   Brown
1419; author reply 1420   Luce
1419; author reply 1420   Sheets
1419; author reply 1420                 Comment
1419; author reply 1420                 Letter
1417-8                                  Journal Article
1416-7                                  Journal Article
1414                      Fitzpatrick
1414                                    News
1411-4                    Goldsmith
1411-4                                  News
1410-1                    Marwick
1410-1                                  News
1409-10                   Mitka
1409-10                                 News
1492                                    Journal Article
1405-7                    Steiner
1405-7                                  Journal Article
1508-9                    Friedrich
1508-9                                  News
1583-8
1583-8                    Wee
1583-8                    McCarthy
1583-8                    Davis
1583-8                    Phillips
1583-8                                  Journal Article
1583-8                                  Research Support, Non-U.S. Gov't
1583-8                                  Research Support, U.S. Gov't, P.H.S.
1581-2                    Fontanarosa
1581-2                                  Comment
1581-2                                  Editorial
1579-81                   Koplan
1579-81                   Dietz
1579-81                  Editorial
1576-8
1576-8    Galuska
1576-8    Will
1576-8    Serdula
1576-8    Ford
1576-8                   Journal Article
1568-75
1568-75   Heymsfield
1568-75   Greenberg
1568-75   Fujioka
1568-75   Dixon
1568-75   Kushner
1568-75   Hunt
1568-75   Lubina
1568-75   Patane
1568-75   Self
1568-75   McCamish
1568-75                  Clinical Trial
1568-75                  Journal Article
1568-75                  Multicenter Study
1568-75                  Randomized Controlled Trial
1568-75                  Research Support, Non-U.S. Gov't
1568-75                  Research Support, U.S. Gov't, P.H.S.
1561-7
1561-7    Robinson
1561-7                   Clinical Trial
1561-7                   Journal Article
1561-7                   Randomized Controlled Trial
1561-7                   Research Support, Non-U.S. Gov't
1561-7                   Research Support, U.S. Gov't, P.H.S.
1554-60
1554-60   Jakicic
1554-60   Winters
1554-60   Lang
1554-60   Wing
1554-60                  Clinical Trial
1554-60                  Journal Article
1554-60                  Randomized Controlled Trial
1554-60                  Research Support, U.S. Gov't, P.H.S.
1547-53
1547-53   Wei
1547-53   Kampert
1547-53   Barlow
1547-53   Nichaman
1547-53   Gibbons
1547-53   Paffenbarger
1547-53   Blair
1547-53                Journal Article
1547-53                Research Support, Non-U.S. Gov't
1547-53                Research Support, U.S. Gov't, P.H.S.
1539-46
1539-46   Ludwig
1539-46   Pereira
1539-46   Kroenke
1539-46   Hilner
1539-46   Van Horn
1539-46   Slattery
1539-46   Jacobs
1539-46                Journal Article
1539-46                Multicenter Study
1539-46                Research Support, Non-U.S. Gov't
1539-46                Research Support, U.S. Gov't, P.H.S.
1530-8
1530-8    Allison
1530-8    Fontaine
1530-8    Manson
1530-8    Stevens
1530-8    VanItallie
1530-8                 Journal Article
1530-8                 Research Support, U.S. Gov't, P.H.S.
1523-9
1523-9    Must
1523-9    Spadano
1523-9    Coakley
1523-9    Field
1523-9    Colditz
1523-9    Dietz
1523-9                 Journal Article
1523-9                 Research Support, Non-U.S. Gov't
1519-22
1519-22   Mokdad
1519-22   Serdula
1519-22   Dietz
1519-22   Bowman
1519-22   Marks
1519-22   Koplan
1519-22                Journal Article
1517-8    Fujioka
1517-8    Patane
1517-8    Lubina
1517-8    Lau
1517-8                 Letter
1517-8                 Research Support, Non-U.S. Gov't
1516-7                        Smith
1516-7                        Ebrahim
1516-7                                       Comment
1516-7                                       Letter
1515-6; author reply 1516-7   Winett
1515-6; author reply 1516-7   Carpinelli
1515-6; author reply 1516-7                  Comment
1515-6; author reply 1516-7                  Letter
1515; author reply 1516-7     Williams
1515; author reply 1516-7                    Comment
1515; author reply 1516-7                    Letter
1513-4                                       Journal Article
1512-3                                       Journal Article
1509-10                       Marwick
1509-10                                      News
1507-8                        Stephenson
1507-8                                       News
1504-6                        Yanovski
1504-6                                       Journal Article
1596                                         Journal Article
1615                                         Journal Article
1678-9                        Webster
1678-9                                       Journal Article
1676-7, 1679                  Rifkin
1676-7, 1679                                 Journal Article
1675                          Ubel
1675                                         Journal Article
1675                                         Research Support, Non-U.S. Gov't
1675                                         Research Support, U.S. Gov't, Non-P.H.S.
1674                          Kinghorn
1674                                         Editorial
1670-2                        Finucane
1670-2                                       Comment
1670-2                                       Editorial
1668-9                        D'Aquila
1668-9                        Walker
1668-9                                       Comment
1668-9                                       Editorial
1668-9                                       Research Support, Non-U.S. Gov't
1665-8                        Ginzberg
1665-8                                       Historical Article
1665-8                                       Journal Article
1659-64
1659-64                       Cortez-Pinto
1659-64                       Chatham
1659-64                       Chacko
1659-64                       Arnold
1659-64   Rashid
1659-64   Diehl
1659-64                    Journal Article
1659-64                    Research Support, Non-U.S. Gov't
1652-8
1652-8    Anda
1652-8    Croft
1652-8    Felitti
1652-8    Nordenberg
1652-8    Giles
1652-8    Williamson
1652-8    Giovino
1652-8                     Journal Article
1652-8                     Research Support, Non-U.S. Gov't
1652-8                     Research Support, U.S. Gov't, P.H.S.
1646-51
1646-51   Ananth
1646-51   Berkowitz
1646-51   Savitz
1646-51   Lapinski
1646-51                    Journal Article
1646-51                    Research Support, Non-U.S. Gov't
1638-45
1638-45   Fox
1638-45   Landrum-McNiff
1638-45   Zhong
1638-45   Dawson
1638-45   Wu
1638-45   Lynn
1638-45                    Journal Article
1638-45                    Multicenter Study
1638-45                    Research Support, Non-U.S. Gov't
1633-7
1633-7    Whitcup
1633-7    Fortin
1633-7    Lindblad
1633-7    Griffiths
1633-7    Metcalf
1633-7    Robinson
1633-7    Manischewitz
1633-7    Baird
1633-7    Perry
1633-7    Kidd
1633-7    Vrabec
1633-7    Davey
1633-7    Falloon
1633-7    Walker
1633-7                        Kovacs
1633-7                        Lane
1633-7                        Nussenblatt
1633-7                        Smith
1633-7                        Masur
1633-7                        Polis
1633-7                                      Clinical Trial
1633-7                                      Journal Article
1633-7                                      Research Support, U.S. Gov't, P.H.S.
1627-32
1627-32                       Dornadula
1627-32                       Zhang
1627-32                       VanUitert
1627-32                       Stern
1627-32                       Livornese
1627-32                       Ingerman
1627-32                       Witek
1627-32                       Kedanis
1627-32                       Natkin
1627-32                       DeSimone
1627-32                       Pomerantz
1627-32                                     Journal Article
1627-32                                     Research Support, U.S. Gov't, P.H.S.
1625                          Pentz
1625                          Young
1625                          Amos
1625                          Hess
1625                          Wei
1625                          Anderlik
1625                                        Letter
1624-5                        Nalin
1624-5                                      Comment
1624-5                                      Letter
1623-4                        Bangsberg
1623-4                        Goldschmidt
1623-4                                      Comment
1623-4                                      Letter
1622; author reply 1622-3     Kymes
1622; author reply 1622-3     Shaw
1622; author reply 1622-3     Fletcher
1622; author reply 1622-3                   Comment
1622; author reply 1622-3                   Letter
1621-2; author reply 1622-3   O'Keefe
1621-2; author reply 1622-3   Bateman
1621-2; author reply 1622-3   Gibbons
1621-2; author reply 1622-3                 Comment
1621-2; author reply 1622-3                 Letter
1621; author reply 1622-3      Dickinson
1621; author reply 1622-3      Dworkin
1621; author reply 1622-3                    Comment
1621; author reply 1622-3                    Letter
1619-20; author reply 1620-1   Larkin
1619-20; author reply 1620-1   Marco
1619-20; author reply 1620-1   Fields
1619-20; author reply 1620-1                 Comment
1619-20; author reply 1620-1                 Letter
1619; author reply 1620-1      Yarmolinsky
1619; author reply 1620-1                    Comment
1619; author reply 1620-1                    Letter
1619; author reply 1620-1      Volpintesta
1619; author reply 1620-1      Pollner
1619; author reply 1620-1      Wooten
1617-8                                       Journal Article
1615-7                                       Journal Article
1614-5                                       Journal Article
1613                           Henney
1613                                         Journal Article
1611-2                         Friedrich
1611-2                                       News
1610-1                         Voelker
1610-1                                       News
1609-10                        Mitka
1609-10                                      News
1605-6                         Rayson
1605-6                                       Journal Article
1692                                         Journal Article
1769-75
1769-75                        Landon
1769-75                        Epstein
1769-75                                      Journal Article
1769-75                                      Research Support, Non-U.S. Gov't
1766-8                         Rennie
1766-8                                       Comment
1766-8                                       Editorial
1763-6                         Halsey
1763-6                                       Comment
1763-6                                       Editorial
1763-6                                       Research Support, Non-U.S. Gov't
1763-6                                       Research Support, U.S. Gov't, P.H.S.
1760-3                         Smith
1760-3                         Rosenbaum
1760-3                                       Journal Article
1752-9
1752-9                         Johansen
1752-9                    Gotzsche
1752-9                                     Journal Article
1752-9                                     Research Support, Non-U.S. Gov't
1745-51
1745-51                   Chaix
1745-51                   Durand-Zaleski
1745-51                   Alberti
1745-51                   Brun-Buisson
1745-51                                    Journal Article
1745-51                                    Research Support, Non-U.S. Gov't
1737-44
1737-44                   Spitzer
1737-44                   Kroenke
1737-44                   Williams
1737-44                                    Journal Article
1737-44                                    Research Support, Non-U.S. Gov't
1731-6
1731-6                    Giri
1731-6                    Thompson
1731-6                    Kiernan
1731-6                    Clive
1731-6                    Fram
1731-6                    Mitchel
1731-6                    Hirst
1731-6                    McKay
1731-6                    Waters
1731-6                                     Comparative Study
1731-6                                     Journal Article
1731-6                                     Research Support, Non-U.S. Gov't
1731-6                                     Research Support, U.S. Gov't, P.H.S.
1725-30
1725-30                   Lauderdale
1725-30                   Oram
1725-30                   Goldstein
1725-30                   Daum
1725-30                                    Journal Article
1725-30                                    Research Support, Non-U.S. Gov't
1723                      Kleerekoper
1723                                       Comment
1723                                       Letter
1722-3                    Thompson
1722-3                                     Comment
1722-3                                     Letter
1722; author reply 1723   Imperato
1722; author reply 1723                    Comment
1722; author reply 1723                    Letter
1722; author reply 1723   Gerace
1721                          Weber
1721                                        Comment
1721                                        Letter
1720-1                        Matz
1720-1                                      Comment
1720-1                                      Letter
1719-20                       Rubinstein
1719-20                                     Letter
1717-8; author reply 1718-9   McCullough
1717-8; author reply 1718-9   Marks
1717-8; author reply 1718-9                 Comment
1717-8; author reply 1718-9                 Letter
1717; author reply 1718-9     Bennett
1717; author reply 1718-9     Davidson
1717; author reply 1718-9     Green
1717; author reply 1718-9     Weinberg
1717; author reply 1718-9     Feldman
1717; author reply 1718-9                   Comment
1717; author reply 1718-9                   Letter
1715-6                                      Journal Article
1714                                        Journal Article
1711-2                        Voelker
1711-2                                      News
1710-1                        Jefferson
1710-1                                      News
1707-9                        Gunby
1707-9                                      News
1701-3                        Antman
1701-3                        Heitjan
1701-3                        Hortobagyi
1701-3                                      Journal Article
1790                                        Journal Article
1875                          Mark
1875                          Glass
1875                                        Editorial
1873-4                        Simpson
1873-4                                      Comment
1873-4                                      Editorial
1869-72                       Perry
1869-72                       Thamer
1869-72                                     Journal Article
1865-9                        Eisenberg
1865-9                                      Journal Article
1857-64
1857-64                       Sloan
1857-64                       Koenigsberg
1857-64                       Gens
1857-64   Cipolle
1857-64   Runge
1857-64   Mallory
1857-64   Rodman
1857-64                Clinical Trial
1857-64                Journal Article
1857-64                Multicenter Study
1857-64                Randomized Controlled Trial
1857-64                Research Support, Non-U.S. Gov't
1851-6
1851-6    Friedman
1851-6    Elstein
1851-6    Wolf
1851-6    Murphy
1851-6    Franz
1851-6    Heckerling
1851-6    Fine
1851-6    Miller
1851-6    Abraham
1851-6                 Clinical Trial
1851-6                 Journal Article
1851-6                 Multicenter Study
1851-6                 Randomized Controlled Trial
1851-6                 Research Support, U.S. Gov't, P.H.S.
1845-50
1845-50   Effler
1845-50   Ching-Lee
1845-50   Bogard
1845-50   Ieong
1845-50   Nekomoto
1845-50   Jernigan
1845-50                Comparative Study
1845-50                Journal Article
1845-50                Research Support, U.S. Gov't, P.H.S.
1839-44
1839-44   Tamada
1839-44   Garg
1839-44   Jovanovic
1839-44   Pitzer
1839-44   Fermi
1839-44   Potts
1839-44                Comparative Study
1839-44                Journal Article
1839-44                Multicenter Study
1839-44                Research Support, Non-U.S. Gov't
1832-8
1832-8    Schieve
1832-8    Peterson
1832-8    Meikle
1832-8    Jeng
1832-8    Danel
1832-8    Burnett
1832-8    Wilcox
1832-8                       Journal Article
1832-8                       Research Support, Non-U.S. Gov't
1832-8                       Research Support, U.S. Gov't, P.H.S.
1826-31
1826-31   Sutton
1826-31   Adzick
1826-31   Bilaniuk
1826-31   Johnson
1826-31   Crombleholme
1826-31   Flake
1826-31                      Journal Article
1819-25
1819-25   Bruner
1819-25   Tulipan
1819-25   Paschall
1819-25   Boehm
1819-25   Walsh
1819-25   Silva
1819-25   Hernanz-Schulman
1819-25   Lowe
1819-25   Reed
1819-25                      Journal Article
1819-25                      Research Support, Non-U.S. Gov't
1817      Peloso
1817      Baillie
1817                         Case Reports
1817                         Letter
1816      Koller
1816      Summer
1816      Moser
1816                         Letter
1814-6    Dreyer
1814-6    Loughlin
1814-6    Rothman
1814-6                       Letter
1814-6                       Research Support, Non-U.S. Gov't
1814      Temianka
1814                         Comment
1814                         Letter
1813-4    Lipshultz
1813-4    Adamson
1813-4                                   Letter
1813                        Portnoi
1813                                     Comment
1813                                     Letter
1812; author reply 1813     Peterson
1812; author reply 1813                  Comment
1812; author reply 1813                  Letter
1811; author reply 1811-2   Gandhi
1811; author reply 1811-2   Tosiello
1811; author reply 1811-2                Comment
1811; author reply 1811-2                Letter
1811; author reply 1811-2   Plaut
1807-10                                  Historical Article
1807-10                                  Journal Article
1806-7                                   Journal Article
1804                        Marwick
1804                                     News
1803                        Mitka
1803                                     News
1801-2                      Stephenson
1801-2                                   News
1799                        Horowitz
1799                                     Journal Article
1888                                     Journal Article
1965                        Winker
1965                        Flanagin
1965                                     Editorial
1965                                     Journal Article
1967-72
1967-72                     Martin
1967-72                     Kilgallen
1967-72                     Tsui
1967-72                     Maitra
1967-72                     Singh
1967-72                     Kupper
1967-72                                  Journal Article
1967-72                                  Research Support, U.S. Gov't, Non-P.H.S.
1963-5                      Ellis
1963-5                                   Comment
1963-5                                   Editorial
1961-3                      Peterson
1961-3                      Cryer
1961-3                                   Comment
1961-3                                   Editorial
1961-3                                   Research Support, Non-U.S. Gov't
1960                        Parker
1960                        Hartman
1960                   Comment
1960                   Journal Article
1953-60   Garber
1953-60                Case Reports
1953-60                Clinical Conference
1953-60                Journal Article
1953-60                Research Support, Non-U.S. Gov't
1947-52
1947-52   Woodward
1947-52                Historical Article
1947-52                Journal Article
1942-6
1942-6    Schutzer
1942-6    Coyle
1942-6    Reid
1942-6    Holland
1942-6                 Journal Article
1942-6                 Research Support, Non-U.S. Gov't
1942-6                 Research Support, U.S. Gov't, P.H.S.
1934-41
1934-41   Rhodes
1934-41   Kjerulff
1934-41   Langenberg
1934-41   Guzinski
1934-41                Journal Article
1934-41                Research Support, U.S. Gov't, P.H.S.
1929-33
1929-33   Langman
1929-33   Jensen
1929-33   Watson
1929-33   Harper
1929-33   Zhao
1929-33   Quan
1929-33   Bolognese
1929-33   Simon
1929-33                Comparative Study
1929-33                Journal Article
1929-33                Meta-Analysis
1929-33                Research Support, Non-U.S. Gov't
1921-8
1921-8    Simon
1921-8    Weaver
1921-8    Graham
1921-8    Kivitz
1921-8    Lipsky
1921-8    Hubbard
1921-8    Isakson
1921-8                        Verburg
1921-8                        Yu
1921-8                        Zhao
1921-8                        Geis
1921-8                                     Clinical Trial
1921-8                                     Journal Article
1921-8                                     Multicenter Study
1921-8                                     Randomized Controlled Trial
1921-8                                     Research Support, Non-U.S. Gov't
1919                          Gershon
1919                          Chang
1919                          Purvis
1919                          Salive
1919                                       Case Reports
1919                                       Letter
1918-9                        Lief
1918-9                                     Comment
1918-9                                     Letter
1918-9                        Berkowitz
1917-8; author reply 1918-9   Bogart
1917-8; author reply 1918-9   Pinkerton
1917-8; author reply 1918-9   Cecil
1917-8; author reply 1918-9   Myaskovsky
1917-8; author reply 1918-9   Wagstaff
1917-8; author reply 1918-9   Abramson
1917-8; author reply 1918-9                Comment
1917-8; author reply 1918-9                Letter
1917-8; author reply 1918-9                Research Support, U.S. Gov't, P.H.S.
1917-8; author reply 1918-9
1917; author reply 1918-9     Trotter
1917; author reply 1918-9                  Comment
1917; author reply 1918-9                  Letter
1917; author reply 1918-9     Turner
1916-7; author reply 1918-9   Burland
1916-7; author reply 1918-9                Comment
1916-7; author reply 1918-9                Letter
1914-5; author reply 1915-6   Ringel
1914-5; author reply 1915-6   Bradley
1914-5; author reply 1915-6   Spencer
1914-5; author reply 1915-6                Comment
1914-5; author reply 1915-6                Letter
1914; author reply 1915-6     Rockey
1914; author reply 1915-6                  Comment
1914; author reply 1915-6                  Letter
1913-4; author reply 1915-6   Genel
1913-4; author reply 1915-6   Jonas
1913-4; author reply 1915-6   Tuckson
1913-4; author reply 1915-6   Korn
1913-4; author reply 1915-6   Meyer
1913-4; author reply 1915-6   Moskowitz
1913-4; author reply 1915-6   Thompson
1913-4; author reply 1915-6                Comment
1913-4; author reply 1915-6                Letter
1913; author reply 1915-6     Lee
1913; author reply 1915-6                  Comment
1913; author reply 1915-6                  Letter
1909-12                                    Historical Article
1909-12                                    Journal Article
1906-7                        Lurie
1906-7                                     News
1905                          Stephenson
1905                                       News
1903-5                        Friedrich
1903-5                                     News
1899-901                      Kumana
1899-901                      Cheung
1899-901                      Lauder
1899-901                                   Journal Article
1897-8                        Frey
1897-8                                     Journal Article
1982                                       Journal Article
2080-1
2080-1                        Mangus
2080-1                        Dipiero
2080-1                        Hawkins
2080-1                                     Journal Article
2079                          Francis
2079                                       Journal Article
2078                          Sloan
2078                          Taylor
2078                                       Journal Article
2077                          Callahan
2077                                       Journal Article
2076                          Weiss
2076                                       Editorial
2071-3                        Shor
2071-3                        Phillips
2071-3                                     Journal Article
2071-3                                     Review
2068-70                       Lenfant
2068-70                                    Comment
2068-70                                    Editorial
2058-67
2058-67                       Anand
2058-67   Yusuf
2058-67               Journal Article
2058-67               Meta-Analysis
2058-67               Research Support, Non-U.S. Gov't
2051-7
2051-7    Ansell
2051-7    Watson
2051-7    Fogelman
2051-7                Journal Article
2051-7                Research Support, U.S. Gov't, P.H.S.
2051-7                Review
2043-50
2043-50   Steinberg
2043-50   Gotto
2043-50               Historical Article
2043-50               Journal Article
2035-42
2035-42   Malek
2035-42   Alper
2035-42   Izumo
2035-42               Journal Article
2035-42               Research Support, Non-U.S. Gov't
2035-42               Research Support, U.S. Gov't, P.H.S.
2027-34
2027-34   He
2027-34   Ogden
2027-34   Vupputuri
2027-34   Bazzano
2027-34   Loria
2027-34   Whelton
2027-34               Journal Article
2027-34               Research Support, Non-U.S. Gov't
2027-34               Research Support, U.S. Gov't, Non-P.H.S.
2027-34               Research Support, U.S. Gov't, P.H.S.
2019-26
2019-26   Clark
2019-26   Wissman
2019-26   Albers
2019-26   Jhamandas
2019-26   Madden
2019-26   Hamilton
2019-26               Clinical Trial
2019-26               Clinical Trial, Phase III
2019-26               Journal Article
2019-26               Multicenter Study
2019-26               Randomized Controlled Trial
2019-26               Research Support, Non-U.S. Gov't
2012-8
2012-8                           Stamler
2012-8                           Neaton
2012-8                           Wentworth
2012-8                           Daviglus
2012-8                           Garside
2012-8                           Dyer
2012-8                           Liu
2012-8                           Greenland
2012-8                                          Journal Article
2012-8                                          Research Support, Non-U.S. Gov't
2012-8                                          Research Support, U.S. Gov't, P.H.S.
2003-11
2003-11                          Furlan
2003-11                          Higashida
2003-11                          Wechsler
2003-11                          Gent
2003-11                          Rowley
2003-11                          Kase
2003-11                          Pessin
2003-11                          Ahuja
2003-11                          Callahan
2003-11                          Clark
2003-11                          Silver
2003-11                          Rivera
2003-11                                         Clinical Trial
2003-11                                         Journal Article
2003-11                                         Multicenter Study
2003-11                                         Randomized Controlled Trial
2003-11                                         Research Support, Non-U.S. Gov't
2001                             Hassaballa
2001                                            Comment
2001                                            Letter
2000-1                           Schattner
2000-1                                          Comment
2000-1                                          Letter
1999-2000; author reply 2000-1   Chaturvedi
1999-2000; author reply 2000-1                  Comment
1999-2000; author reply 2000-1                  Letter
1998-9                           Hammerschlag
1998-9                                          Comment
1998-9                                          Letter
1998; author reply 1999          Hahn
1998; author reply 1999                         Comment
1998; author reply 1999                         Letter
1997-8; author reply 1999        Golub
1997-8; author reply 1999        Greenwald
1997-8; author reply 1999   Thompson
1997-8; author reply 1999                 Comment
1997-8; author reply 1999                 Letter
1997-8; author reply 1999                 Research Support, Non-U.S. Gov't
1997; author reply 1999     Glenn
1997; author reply 1999                   Comment
1997; author reply 1999                   Letter
1997; author reply 1999     Haider
1997; author reply 1999     Luna
1997; author reply 1999     Patel
1997; author reply 1999     Gaziano
1996                        Satcher
1996                                      Journal Article
1995                        Henney
1995                                      Journal Article
1994                        Stephenson
1994                                      News
1992-4                      Voelker
1992-4                                    News
1991-2                      Mitka
1991-2                                    News
2092                                      Journal Article
2173-7
2173-7                      Goto
2173-7                      Reich
2173-7                      Aitken
2173-7                                    Journal Article
2173-7                                    Research Support, Non-U.S. Gov't
2169-71                     Danesh
2169-71                                   Comment
2169-71                                   Editorial
2169-71                                   Research Support, Non-U.S. Gov't
2167-9                      Ehrlich
2167-9                      Post
2167-9                                    Comment
2167-9                                    Editorial
2164-6
2164-6                      Horne
2164-6                      Chang
2164-6                                    Case Reports
2164-6                                    Clinical Conference
2164-6                                    Journal Article
2156-63
2156-63                     Kerlikowske
2156-63                     Salzmann
2156-63                     Phillips
2156-63                     Cauley
2156-63   Cummings
2156-63                 Journal Article
2156-63                 Research Support, U.S. Gov't, P.H.S.
2149-55
2149-55   Jee
2149-55   Suh
2149-55   Kim
2149-55   Appel
2149-55                 Journal Article
2149-55                 Research Support, Non-U.S. Gov't
2143-8
2143-8    Crabtree
2143-8    Pelletier
2143-8    Gleason
2143-8    Pruett
2143-8    Sawyer
2143-8                  Journal Article
2136-42
2136-42   Fine
2136-42   Colditz
2136-42   Coakley
2136-42   Moseley
2136-42   Manson
2136-42   Willett
2136-42   Kawachi
2136-42                 Journal Article
2136-42                 Research Support, U.S. Gov't, P.H.S.
2131-5
2131-5    Visser
2131-5    Bouter
2131-5    McQuillan
2131-5    Wener
2131-5    Harris
2131-5                  Journal Article
2125-30
2125-30   Casselbrant
2125-30   Mandel
2125-30   Fall
2125-30   Rockette
2125-30   Kurs-Lasky
2125-30   Bluestone
2125-30   Ferrell
2125-30                 Journal Article
2125-30                 Research Support, U.S. Gov't, P.H.S.
2125-30                 Twin Study
2123-4    Fung
2123-4                  Comment
2123-4                                         Letter
2122; author reply 2122-3     Newman
2122; author reply 2122-3                      Comment
2122; author reply 2122-3                      Letter
2122; author reply 2122-3     Levinson
2121-2; author reply 2122-3   Grabowski
2121-2; author reply 2122-3   Creson
2121-2; author reply 2122-3   Rhoades
2121-2; author reply 2122-3   Schmitz
2121-2; author reply 2122-3                    Comment
2121-2; author reply 2122-3                    Letter
2120-1                        La Vecchia
2120-1                        Negri
2120-1                        Levi
2120-1                                         Comment
2120-1                                         Letter
2120-1                                         Research Support, Non-U.S. Gov't
2119-20; author reply 2121    Katner
2119-20; author reply 2121    Baynham
2119-20; author reply 2121                     Comment
2119-20; author reply 2121                     Letter
2118-9                        Ordman
2118-9                                         Comment
2118-9                                         Letter
2118; author reply 2119       Johnston
2118; author reply 2119                        Comment
2118; author reply 2119                        Letter
2115-6                                         Journal Article
2114-5                                         Journal Article
2114                                           Journal Article
2113-4                                         Journal Article
2112-3                                         Journal Article
2108-10                       Marwick
2108-10                                        News
2107-8                        Lurie
2107-8                                         News
2104-6                        Friedlander
2104-6                        Pittman
2104-6                        Parker
2104-6                                         Journal Article
2101                          Lynn
2101                                           Journal Article
2186                                           Journal Article
2260-2                        Blaser
2260-2                                         Comment
2260-2                                         Editorial
2259-60                       Kiecolt-Glaser
2259-60   Glaser
2259-60                 Comment
2259-60                 Editorial
2259-60                 Research Support, U.S. Gov't, P.H.S.
2259-60
2252-8
2252-8    Golden
2252-8                  Biography
2252-8                  Historical Article
2252-8                  Journal Article
2252-8                  Portraits
2246-51
2246-51   Kuntz
2246-51   Tsevat
2246-51   Weinstein
2246-51   Goldman
2246-51                 Journal Article
2246-51                 Research Support, U.S. Gov't, P.H.S.
2240-5
2240-5    Parsonnet
2240-5    Shmuely
2240-5    Haggerty
2240-5                  Journal Article
2240-5                  Research Support, U.S. Gov't, P.H.S.
2235-9
2235-9    Pronk
2235-9    Goodman
2235-9    O'Connor
2235-9    Martinson
2235-9                  Journal Article
2235-9                  Research Support, Non-U.S. Gov't
2227-34
2227-34   Ford
2227-34   Bearman
2227-34   Moody
2227-34                 Journal Article
2227-34                 Research Support, U.S. Gov't, P.H.S.
2220-6
2220-6    Ledergerber
2220-6    Egger
2220-6    Erard
2220-6    Weber
2220-6    Hirschel
2220-6    Furrer
2220-6    Battegay
2220-6    Vernazza
2220-6    Bernasconi
2220-6    Opravil
2220-6    Kaufmann
2220-6    Sudre
2220-6    Francioli
2220-6    Telenti
2220-6                Journal Article
2220-6                Research Support, Non-U.S. Gov't
2215-9
2215-9    Schulz
2215-9    Beach
2215-9                Journal Article
2215-9                Research Support, Non-U.S. Gov't
2215-9                Research Support, U.S. Gov't, P.H.S.
2212-3    Chadi
2212-3                Comment
2212-3                Letter
2212      Shlim
2212                  JOURNAL ARTICLE
2211      Cavanagh
2211      Hogan
2211                  Comment
2211                  Letter
2210-1    O'Brien
2210-1                Comment
2210-1                Letter
2209-10   Petticrew
2209-10   Hunter
2209-10               Comment
2209-10               Letter
2208-9    Bartus
2208-9    Emerich
2208-9                Comment
2208-9                Letter
2207-8    Moulding
2207-8                Comment
2207-8                Letter
2204-6                Case Reports
2204-6                Journal Article
2202-4                Biography
2202-4                Historical Article
2202-4                Journal Article
2200      Friedrich
2200                  News
2199      Marwick
2199                  News
2198-9    Friedrich
2198-9                News
2197-8    Stephenson
2197-8                 News
2195-6    Koenig
2195-6                 Journal Article
2272                   Journal Article
2358-65
2358-65   Woolf
2358-65                Journal Article
2356-7    Barry
2356-7                 Comment
2356-7                 Editorial
2355-6    Mellors
2355-6                 Comment
2355-6                 Editorial
2355-6                 Research Support, Non-U.S. Gov't
2354      Parker
2354      Hartman
2354                   Comment
2354                   Journal Article
2347-54   Adamson
2347-54                Case Reports
2347-54                Clinical Conference
2347-54                Journal Article
2347-54                Research Support, Non-U.S. Gov't
2340-6
2340-6    LaRosa
2340-6    He
2340-6    Vupputuri
2340-6                 Journal Article
2340-6                 Meta-Analysis
2333-9
2333-9    Goodlin
2333-9    Zhong
2333-9    Lynn
2333-9    Teno
2333-9    Fago
2333-9    Desbiens
2333-9    Connors
2333-9    Wenger
2333-9    Phillips
2333-9                 Journal Article
2333-9                 Research Support, Non-U.S. Gov't
2328-32
2328-32   Benson
2328-32   Mohtadi
2328-32   Rose
2328-32   Meeuwisse
2328-32                 Comparative Study
2328-32                 Journal Article
2328-32                 Research Support, Non-U.S. Gov't
2321-7
2321-7    Bifani
2321-7    Mathema
2321-7    Liu
2321-7    Moghazeh
2321-7    Shopsin
2321-7    Tempalski
2321-7    Driscol
2321-7    Frothingham
2321-7    Musser
2321-7    Alcabes
2321-7    Kreiswirth
2321-7                  Journal Article
2321-7                  Research Support, U.S. Gov't, Non-P.H.S.
2321-7                  Research Support, U.S. Gov't, P.H.S.
2313-20
2313-20   Braddock
2313-20   Edwards
2313-20   Hasenberg
2313-20   Laidley
2313-20   Levinson
2313-20                 Journal Article
2313-20                 Research Support, Non-U.S. Gov't
2313-20                 Research Support, U.S. Gov't, P.H.S.
2305-12
2305-12   Kahn
2305-12   Lagakos
2305-12   Wulfsohn
2305-12   Cherng
2305-12   Miller
2305-12   Cherrington
2305-12   Hardy
2305-12   Beall
2305-12   Cooper
2305-12   Murphy
2305-12   Basgoz
2305-12   Ng
2305-12   Deeks
2305-12   Winslow
2305-12   Toole
2305-12   Coakley
2305-12                 Clinical Trial
2305-12                 Journal Article
2305-12                 Multicenter Study
2305-12                                 Randomized Controlled Trial
2305-12                                 Research Support, Non-U.S. Gov't
2302-3                    Maron
2302-3                    McKenna
2302-3                    Elliott
2302-3                    Spirito
2302-3                    Frenneaux
2302-3                    Keren
2302-3                    Cecchi
2302-3                    Borggrefe
2302-3                    Williams
2302-3                                  Comment
2302-3                                  Letter
2301-2                    Wilkinson
2301-2                                  Comment
2301-2                                  Letter
2299-301                  Nissenblatt
2299-301                  Karp
2299-301                                Case Reports
2299-301                                Letter
2298-9                    Sterns
2298-9                                  Comment
2298-9                                  Letter
2298; author reply 2299   Smith
2298; author reply 2299                 Comment
2298; author reply 2299                 Letter
2297-8                    Lurie
2297-8                    Sasich
2297-8                                  Comment
2297-8                                  Letter
2295-6                                  Journal Article
2293-4                                  Case Reports
2293-4                                  Journal Article
2287-90                   Goldsmith
2287-90                                 News
2283-5                    Collins
2283-5                    Lovell
2283-5                    Mckeag
2283-5                                  Journal Article
2422                                    Journal Article

				
DOCUMENT INFO
Categories:
Tags:
Stats:
views:25
posted:8/1/2012
language:English
pages:402